TTDTargetID	Target_Name	Indication	ICD9	ICD10
TTDS00001	Muscarinic acetylcholine receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00001	Muscarinic acetylcholine receptor	Glaucoma	365	H40-H42
TTDS00001	Muscarinic acetylcholine receptor	Histamine induced bronchospasm	728.85	R25.2
TTDS00001	Muscarinic acetylcholine receptor	Motion sickness	994.6	T75.3
TTDS00001	Muscarinic acetylcholine receptor	Obstructive airway disease	.	.
TTDS00001	Muscarinic acetylcholine receptor	Organophosphate poisoning	989.3	T60.0
TTDS00001	Muscarinic acetylcholine receptor	Schizophrenia	295, 710.0	F20, M32
TTDS00001	Muscarinic acetylcholine receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDS00001	Muscarinic acetylcholine receptor	Xerostomia	527.7	K11.7, R68.2
TTDC00001	RNA-dependent RNA polymerase	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDC00001	RNA-dependent RNA polymerase	Influenza A virus infections	487, 488	J10, J11
TTDC00001	RNA-dependent RNA polymerase	Severe acute respiratory syndrome	.	.
TTDC00002	Hemagglutinin	Influenza A virus infections	487, 488	J10, J11
TTDS00002	Muscarinic acetylcholine receptor M1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00002	Muscarinic acetylcholine receptor M1	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDS00002	Muscarinic acetylcholine receptor M1	Histamine induced bronchospasm	728.85	R25.2
TTDS00002	Muscarinic acetylcholine receptor M1	Schizophrenia	295, 710.0	F20, M32
TTDR00003	K(ATP) channels	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00003	Muscarinic acetylcholine receptor M2	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00003	Muscarinic acetylcholine receptor M2	Analgesics	338	R52
TTDS00003	Muscarinic acetylcholine receptor M2	Autoimmune cardiomyopathy	.	.
TTDS00003	Muscarinic acetylcholine receptor M2	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00003	Muscarinic acetylcholine receptor M2	Cold air-induced bronchoconstriction	493	J45
TTDS00003	Muscarinic acetylcholine receptor M2	Hypothermia	991.6	T68
TTDS00003	Muscarinic acetylcholine receptor M2	Neurogenic bladder	188	C67
TTDS00003	Muscarinic acetylcholine receptor M2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00003	Muscarinic acetylcholine receptor M2	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00004	Muscarinic acetylcholine receptor M3	Airway hyperreactivity	.	.
TTDS00004	Muscarinic acetylcholine receptor M3	Urge incontinence	787.6, 788.3	N39.3-N39.4, R15, R32
TTDR00004	Prokaryotic primase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00005	Kallikrein	Clotting disorders	286	D65-D69
TTDS00005	Muscarinic acetylcholine receptor M4	Analgesics	338	R52
TTDS00005	Muscarinic acetylcholine receptor M4	Manic disorder	.	.
TTDS00005	Muscarinic acetylcholine receptor M4	Neurologic and psychiatric diseases	.	.
TTDS00005	Muscarinic acetylcholine receptor M4	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00005	Muscarinic acetylcholine receptor M4	Parkinson's disease	332	F02.3, G20
TTDC00005	Serine/threonine-protein kinase Chk1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00006	Aurora kinase A	Colorectal cancer	153, 154	C18-C21
TTDC00006	Aurora kinase A	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDC00006	Aurora kinase A	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00006	Follicle stimulating hormone	Psychosis	290-299	F20-F29
TTDR00006	Follicle stimulating hormone	Respiratory diseases	.	.
TTDR00006	Follicle stimulating hormone	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDS00006	Muscarinic acetylcholine receptor M5	Opioid dependence	304	F11.2
TTDS00006	Muscarinic acetylcholine receptor M5	Schizophrenia	295, 710.0	F20, M32
TTDR00007	Multidrug resistance protein 1	Cancer	140-229	C00-C96
TTDC00007	Toll-like receptor 3	HPV-related diseases	.	.
TTDC00007	Toll-like receptor 3	HPV-related high-grade anal intraepithelial neoplasia	154	C21
TTDC00007	Toll-like receptor 3	Human papillomavirus infections	078.1079.4	B97.7
TTDS00007	Vascular endothelial growth factor receptor 1	Angiogenesis	.	.
TTDS00007	Vascular endothelial growth factor receptor 1	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00008	Glucose-6-phosphate dehydrogenase	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDS00008	Vascular endothelial growth factor receptor 2	Angiogenesis	.	.
TTDS00008	Vascular endothelial growth factor receptor 2	Cancer	140-229	C00-C96
TTDC00009	5-hydroxy-tryptamine 3B receptor	Diarrhea	787.91	A09, K59.1
TTDC00009	5-hydroxy-tryptamine 3B receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDR00010	Diamine oxidase	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDS00010	Dopamine receptor	Hypotension	458, 796.3	I95
TTDS00010	Dopamine receptor	Nausea and vomiting	787, 787.0	R11
TTDS00010	Dopamine receptor	Neuroleptic malignant syndrome	.	.
TTDS00010	Dopamine receptor	Neurotensin-like immunoreactivity	.	.
TTDS00010	Dopamine receptor	Schizophrenia	295, 710.0	F20, M32
TTDC00010	Serine/threonine-protein kinase Chk2	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00011	Dopamine D1 receptor	Parkinson's disease	332	F02.3, G20
TTDR00011	FMLP receptor	Gastric ulcer	531	K25
TTDS00012	D(2) dopamine receptor	Anxiety disorders	300	F40-F42
TTDS00012	D(2) dopamine receptor	Attention deficit hyperactivity disorder	314.00, 314.01	F90
TTDS00012	D(2) dopamine receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00012	D(2) dopamine receptor	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDS00012	D(2) dopamine receptor	Delusional disorder	297.1	F22.0
TTDS00012	D(2) dopamine receptor	Depression	311	F32
TTDS00012	D(2) dopamine receptor	Disabling peak-dose dyskinesias	333.8	G24.9
TTDS00012	D(2) dopamine receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDS00012	D(2) dopamine receptor	Gastric emptying disorders	.	.
TTDS00012	D(2) dopamine receptor	Gilles de la tourette's disorder	.	.
TTDS00012	D(2) dopamine receptor	Nausea and vomiting	787, 787.0	R11
TTDS00012	D(2) dopamine receptor	Neuroleptic malignant syndrome	.	.
TTDS00012	D(2) dopamine receptor	Neurological diseases	320-359	G00-G99
TTDS00012	D(2) dopamine receptor	Parkinson's disease	332	F02.3, G20
TTDS00012	D(2) dopamine receptor	Psychiatric illness	.	.
TTDS00012	D(2) dopamine receptor	Respiratory diseases	.	.
TTDS00012	D(2) dopamine receptor	Schizophrenia	295, 710.0	F20, M32
TTDS00012	D(2) dopamine receptor	Vomiting	787	R11
TTDC00012	Fibronectin	Kidney cancer	140-229	C00-C96
TTDC00012	Fibronectin	Melanoma	172.9	C43
TTDR00012	Interleukin 3 receptor	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDR00013	1,3-beta-D-glucan-UDP glucosyltransferase	Fungal diseases	110-118	B35-B49
TTDS00013	D(3) dopamine receptor	Drug dependence	303-305	F10-F19
TTDS00013	D(3) dopamine receptor	Neurological diseases	320-359	G00-G99
TTDS00013	D(3) dopamine receptor	Psychiatric illness	.	.
TTDS00013	D(3) dopamine receptor	Respiratory diseases	.	.
TTDS00013	D(3) dopamine receptor	Schizophrenia	295, 710.0	F20, M32
TTDC00013	Plasma kallikrein	Hereditary angioedema	277.6	D84.1
TTDR00014	Carnitine O-acetyltransferase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00014	Glucosylceramidase	Metabolic disease	270-279	E70-E89
TTDS00015	D(1B) dopamine receptor	Respiratory diseases	.	.
TTDR00015	Prolyl endopeptidase	Dementia	290-294, 331.0	F01-F07, G30
TTDR00015	Prolyl endopeptidase	Neurological diseases	320-359	G00-G99
TTDC00015	Protein kinase C gamma type	Cancer	140-229	C00-C96
TTDC00015	Protein kinase C gamma type	Myeloid leukemia	208.9	C91-C95
TTDC00016	Alpha-galactosidase A	Fabry disease	272.7	E75.2
TTDS00016	Dopamine reuptake	Depression	311	F32
TTDS00016	Dopamine reuptake	Obesity	278	E66
TTDC00017	Calcitonin gene-related peptide 1	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
TTDS00017	Sodium-dependent dopamine transporter	Parkinson's disease	332	F02.3, G20
TTDR00018	3-beta-hydroxysterol delta-24-reductase	Hypercholesterolaemia	.	E78.0
TTDS00018	Gamma-aminobutyric acid receptor	Anxiety disorders	300	F40-F42
TTDS00018	Gamma-aminobutyric acid receptor	Helminth infection	001-139	A00-B99
TTDS00018	Gamma-aminobutyric acid receptor	Huntington's disease	294.1, 333.4	F02.2, G10
TTDS00018	Gamma-aminobutyric acid receptor	Hypertonia and apnoeic episodes	.	.
TTDS00018	Gamma-aminobutyric acid receptor	Mood affective disorders	.	.
TTDS00018	Gamma-aminobutyric acid receptor	Parkinson's disease	332	F02.3, G20
TTDC00018	Heat shock protein HSP 90	Breast cancer	174, 175, 217	C50, D24
TTDC00018	Heat shock protein HSP 90	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDC00018	Heat shock protein HSP 90	Gastrointestinal stromal tumors	150-159	C15-C26
TTDC00018	Heat shock protein HSP 90	HER2-positive metastatic breast cancer	174, 175	C50
TTDC00018	Heat shock protein HSP 90	Hematologic malignancies	200-209	C81-C96
TTDC00018	Heat shock protein HSP 90	Melanoma	172.9	C43
TTDC00018	Heat shock protein HSP 90	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00018	Heat shock protein HSP 90	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00018	Heat shock protein HSP 90	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00018	Heat shock protein HSP 90	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00018	Heat shock protein HSP 90	Refractory hematological malignancies	140-239, 200-209	C00-C96, C81-C96
TTDC00018	Heat shock protein HSP 90	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00019	Alcohol dehydrogenase 2	Amoebiasis	6	A06
TTDR00019	Alcohol dehydrogenase 2	Giardiasis infections	001-139, 007.1	A00-B99, A07.1
TTDC00019	Cathepsin G	Alpha 1 antitrypsin deficiency	273.4	E88.0
TTDC00019	Cathepsin G	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDC00019	Cathepsin G	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00019	Gamma-aminobutyric acid A receptor	Alcoholism	303	F10.2
TTDS00019	Gamma-aminobutyric acid A receptor	Anxiety disorders	300	F40-F42
TTDS00019	Gamma-aminobutyric acid A receptor	Disorders of initiating and maintaining sleep	710	M32
TTDS00019	Gamma-aminobutyric acid A receptor	Dyskinesia	333.8	G24.9
TTDS00019	Gamma-aminobutyric acid A receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDS00019	Gamma-aminobutyric acid A receptor	Hyperkinetic extrapyramidal movement disorders	333.9, 781.0	F44.4, F98.4, G25.8-G25.9, R25
TTDS00019	Gamma-aminobutyric acid A receptor	Neurological diseases	320-359	G00-G99
TTDS00019	Gamma-aminobutyric acid A receptor	Primary headache disorders	339, 784.0	G43-G44, R51
TTDC00020	Integrin alpha-5	Macular degeneration	362.5	H35.3
TTDR00020	Multidrug resistance-associated protein 2	Cancer	140-229	C00-C96
TTDR00021	Glycerol-3-phosphate oxidase	Trypanosomiasis	086.5-086	B56-B57
TTDR00022	3-Deoxy-D-manno-octulosonate 8-phosphate synthase 	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00022	Gamma-aminobutyric acid B receptor	Analgesics	338	R52
TTDS00022	Gamma-aminobutyric acid B receptor	Anxiety disorders	300	F40-F42
TTDS00022	Gamma-aminobutyric acid B receptor	Asthma	493	J45
TTDS00022	Gamma-aminobutyric acid B receptor	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDS00022	Gamma-aminobutyric acid B receptor	Convulsions	780.3	R56.0
TTDS00022	Gamma-aminobutyric acid B receptor	Depression	311	F32
TTDS00022	Gamma-aminobutyric acid B receptor	Dyskinesia	333.8	G24.9
TTDS00022	Gamma-aminobutyric acid B receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDS00022	Gamma-aminobutyric acid B receptor	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
TTDS00022	Gamma-aminobutyric acid B receptor	Hyperkinetic extrapyramidal movement disorders	333.9, 781.0	F44.4, F98.4, G25.8-G25.9, R25
TTDS00022	Gamma-aminobutyric acid B receptor	Meige's disease	.	.
TTDS00022	Gamma-aminobutyric acid B receptor	Neurological diseases	320-359	G00-G99
TTDS00022	Gamma-aminobutyric acid B receptor	Nociceptive disorders	.	.
TTDS00022	Gamma-aminobutyric acid B receptor	Parkinson's disease	332	F02.3, G20
TTDS00022	Gamma-aminobutyric acid B receptor	Psychiatric illness	.	.
TTDC00022	mRNA of Myb proto-oncogene protein	Cancer	140-229	C00-C96
TTDC00022	mRNA of Myb proto-oncogene protein	Myeloid leukemia	208.9	C91-C95
TTDR00023	DTDP-4-dehydrorhamnose 3,5-epimerase rmlC	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00023	Gamma-aminobutyric acid uptake	Convulsions	780.3	R56.0
TTDS00023	Gamma-aminobutyric acid uptake	Epilepsy	290-319, 345	F01-F99, G40
TTDC00023	Lysosomal alpha-glucosidase	Cardiovascular disorders	390-459	I00-I99
TTDC00023	Lysosomal alpha-glucosidase	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDC00023	Lysosomal alpha-glucosidase	Type 2 diabetes	250.00, 250.02	E11
TTDS00024	4-aminobutyrate aminotransferase, mitochondrial	Convulsions	780.3	R56.0
TTDS00024	4-aminobutyrate aminotransferase, mitochondrial	Epilepsy	290-319, 345	F01-F99, G40
TTDS00024	4-aminobutyrate aminotransferase, mitochondrial	Huntington's disease	294.1, 333.4	F02.2, G10
TTDS00024	4-aminobutyrate aminotransferase, mitochondrial	Tardive dyskinesia	333.85	G24.0
TTDC00024	Basic fibroblast growth factor receptor 1	Peripheral vascular disease	443.9	I73.9
TTDC00024	Basic fibroblast growth factor receptor 1	Severe coronary heart disease	414	I25.1
TTDC00024	Basic fibroblast growth factor receptor 1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00024	Basic fibroblast growth factor receptor 1	Ulcers	556	K51
TTDR00024	Probable naphthoate synthase menB	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00025	Cdc2-related kinase 3	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDC00025	Phospholipase A2, membrane associated	Atherosclerosis	414.0, 440	I70
TTDC00025	Phospholipase A2, membrane associated	Coronary artery disease	410-414, 429.2	I20-I25
TTDS00026	Alpha adrenergic receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00026	Alpha adrenergic receptor	Hypertonicity of bladder	188	C67
TTDC00026	Interleukin-2 receptor subunit beta	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDC00026	Interleukin-2 receptor subunit beta	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00026	Interleukin-2 receptor subunit beta	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00026	Ribonucleoside-diphosphate reductase small chain	Parasitic diseases	.	.
TTDS00027	Alpha-1 adrenergic receptor	Benign prostatic hyperplasia	600	N40
TTDS00027	Alpha-1 adrenergic receptor	Chronic cardiac failure	428	I50
TTDS00027	Alpha-1 adrenergic receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDS00027	Alpha-1 adrenergic receptor	Gastrointestinal disturbances	.	.
TTDS00027	Alpha-1 adrenergic receptor	Hyperlipidemia	272.0-272.4	E78
TTDS00027	Alpha-1 adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00027	Alpha-1 adrenergic receptor	Lower urinary tract symptoms associated with benign prostatic hyperplasia	600	N40
TTDS00027	Alpha-1 adrenergic receptor	Nasal congestion	478.19	J34.89
TTDS00027	Alpha-1 adrenergic receptor	Orthostatic hypotension	458	I95.1
TTDS00027	Alpha-1 adrenergic receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00027	Alpha-1 adrenergic receptor	Shy-Drager syndrome	.	.
TTDC00027	Histidine decarboxylase	Skin infections	680-709	L00-L99
TTDR00027	Possible RNA methyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00028	Cell division control protein 28	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00028	Tissue kallikrein	Alpha 1 antitrypsin deficiency	273.4	E88.0
TTDC00028	Tissue kallikrein	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDC00028	Tissue kallikrein	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00029	Alpha-1B adrenergic receptor	Shy-Drager syndrome	.	.
TTDC00029	Atrial natriuretic peptide receptor B	Crohn's disease	555	K50
TTDC00029	Atrial natriuretic peptide receptor B	Heart disease	390-429	I00-I52
TTDC00029	Atrial natriuretic peptide receptor B	Inflammatory bowel disease	555, 556	K50, K51
TTDC00029	Atrial natriuretic peptide receptor B	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00029	Atrial natriuretic peptide receptor B	Ulcerative colitis	556	K51
TTDR00029	Matrilysin	Cancer	140-229	C00-C96
TTDR00029	Matrilysin	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00030	Alpha-1D adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00030	Glycosyltransferase MurG	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00030	P-glycoprotein	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDS00031	Alpha-2 adrenergic receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00031	Alpha-2 adrenergic receptor	Analgesics	338	R52
TTDS00031	Alpha-2 adrenergic receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00031	Alpha-2 adrenergic receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDS00031	Alpha-2 adrenergic receptor	Gastrointestinal disturbances	.	.
TTDS00031	Alpha-2 adrenergic receptor	Heart failure	410, 428	I21, I22, I50
TTDS00031	Alpha-2 adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00031	Alpha-2 adrenergic receptor	Ischemic heart disease	410-414	I20-I25
TTDS00031	Alpha-2 adrenergic receptor	Mechanical allodynia associated with neuropathic pain of spinal origin	204.0, 338, 356.0, 356.8,780	C91.0, G64, G90.0, R52, G89
TTDS00031	Alpha-2 adrenergic receptor	Nasal congestion	478.19	J34.89
TTDS00031	Alpha-2 adrenergic receptor	Open-angle glaucoma	365	H40-H42
TTDS00031	Alpha-2 adrenergic receptor	Peri-operative ischemia	459.89	I99.8
TTDS00031	Alpha-2 adrenergic receptor	Prefrontal cognitive deficits	.	.
TTDS00031	Alpha-2 adrenergic receptor	Spasticity associated with cerebral or spinal damage	.	.
TTDS00031	Alpha-2 adrenergic receptor	Systemic sclerosis	710.1	M34
TTDS00031	Alpha-2 adrenergic receptor	Tachycardia	427, 785.0	I47-I49, R00.0
TTDS00031	Alpha-2 adrenergic receptor	Vasospastic attacks associated with idiopathic raynaud's disease	443	I73.0
TTDC00031	Integrin beta-7	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00031	Synthesis of leukotrienes	Coronary heart disease	414	I25.1
TTDS00032	Alpha-2A adrenergic receptor	Heart failure	410, 428	I21, I22, I50
TTDS00032	Alpha-2A adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00032	Alpha-2A adrenergic receptor	Ischemic heart disease	410-414	I20-I25
TTDR00032	Ciliary neurotrophic factor	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDC00032	Tyrosine-protein phosphatase non-receptor type 6	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00033	Aldo-keto reductase family 1 member C3	Cancer	140-229	C00-C96
TTDR00033	Aldo-keto reductase family 1 member C3	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDC00033	Interleukin-12	Autoimmune diseases	279	D84.9, M35.9
TTDC00033	Interleukin-12	Crohn's disease	555	K50
TTDC00033	Interleukin-12	Guillain-Barre syndrome	.	.
TTDC00033	Interleukin-12	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00033	Interleukin-12	Lupus erythematosus	695, 710.0	L51-L54, M32
TTDC00033	Interleukin-12	Psoriasis; Psoriatic disorders	696	L40
TTDC00033	Interleukin-12	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00034	Prostaglandin E2 receptor, EP3 subtype	Asthma	493	J45
TTDC00034	Somatostatin receptor type 4	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00035	Beta adrenergic receptor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00035	Beta adrenergic receptor	Obesity	278	E66
TTDS00035	Beta adrenergic receptor	Schizophrenia	295, 710.0	F20, M32
TTDR00035	Sodium/hydrogen exchanger 3	Renal inflammation	.	.
TTDS00036	Beta-1 adrenergic receptor	Anxiety disorders	300	F40-F42
TTDS00036	Beta-1 adrenergic receptor	Asthma	493	J45
TTDS00036	Beta-1 adrenergic receptor	Cardiac arrhythmias	427	I47-I49
TTDS00036	Beta-1 adrenergic receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00036	Beta-1 adrenergic receptor	Coronary heart disease	414	I25.1
TTDS00036	Beta-1 adrenergic receptor	Dilated cardiomyopathy	359.4-359.9, 425.4, 728-728	G71-G72, I42.0, M60-M63
TTDS00036	Beta-1 adrenergic receptor	Glaucoma	365	H40-H42
TTDS00036	Beta-1 adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00036	Ras-related protein Rab-9A	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDS00037	Beta-2 adrenergic receptor	Anxiety disorders	300	F40-F42
TTDS00037	Beta-2 adrenergic receptor	Asthma	493	J45
TTDS00037	Beta-2 adrenergic receptor	Cardiac arrhythmias	427	I47-I49
TTDS00037	Beta-2 adrenergic receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00037	Beta-2 adrenergic receptor	Depression	311	F32
TTDS00037	Beta-2 adrenergic receptor	Glaucoma	365	H40-H42
TTDS00037	Beta-2 adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00037	Beta-2 adrenergic receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00037	Beta-2 adrenergic receptor	Multiple sclerosis	340	G35
TTDS00037	Beta-2 adrenergic receptor	Obstructive airway disease	.	.
TTDS00037	Beta-2 adrenergic receptor	Respiratory distress syndrome	518.5, 518.82	J80
TTDS00037	Beta-2 adrenergic receptor	Skeletal muscle wasting	.	.
TTDS00037	Beta-2 adrenergic receptor	Skeletal muscle weakness	728.87	M62.8
TTDC00037	Prostaglandin E2 receptor EP3 subtype	Peripheral vascular disease	443.9	I73.9
TTDR00037	Scytalone dehydratase	Fungal diseases	110-118	B35-B49
TTDR00038	Manganese ABC transporter substrate-binding lipoprotein	Pneumococcal disease	.	.
TTDS00038	Noradrenergic re-uptake	Depression	311	F32
TTDS00038	Noradrenergic re-uptake	Obesity	278	E66
TTDS00038	Noradrenergic re-uptake	Post-anaesthetic shivering	.	.
TTDS00038	Noradrenergic re-uptake	St John's Wort	.	.
TTDC00038	Voltage-dependent anion-selective channel protein 2	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00039	Cyclooxygenase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00039	Cyclooxygenase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00039	Glycine receptor	Tobacco dependence	305.1	F17
TTDR00039	Sensor-like histidine kinase senX3	Tuberculosis	010-018	A15-A19
TTDR00040	Forkhead box protein O1A	Cancer	140-229	C00-C96
TTDC00040	Neuropeptide Y receptor type 2	Obesity	278	E66
TTDS00040	Prostaglandin G/H synthase 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00040	Prostaglandin G/H synthase 1	Chronic inflammatory diseases	.	.
TTDC00041	Parathyroid hormone receptor	Menopause	627.2	N95.0
TTDC00041	Parathyroid hormone receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00041	Parathyroid hormone receptor	Psoriasis; Psoriatic disorders	696	L40
TTDS00041	Prostaglandin G/H synthase 2	Abdominal aortic aneurysm	442	I72
TTDS00041	Prostaglandin G/H synthase 2	Adenomatous polyposis	153, 154	C18-C21
TTDS00041	Prostaglandin G/H synthase 2	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00041	Prostaglandin G/H synthase 2	Analgesics	338	R52
TTDS00041	Prostaglandin G/H synthase 2	Arthritis	710-719	M00-M25
TTDS00041	Prostaglandin G/H synthase 2	Bladder cancer	140-229, 188	C00-C96, C67
TTDS00041	Prostaglandin G/H synthase 2	Breast cancer	174, 175, 217	C50, D24
TTDS00041	Prostaglandin G/H synthase 2	Cancer	140-229	C00-C96
TTDS00041	Prostaglandin G/H synthase 2	Carcinoma in situ	230-234	D00-D09
TTDS00041	Prostaglandin G/H synthase 2	Carpal tunnel syndrome	354	G56.0
TTDS00041	Prostaglandin G/H synthase 2	Colorectal cancer	153, 154	C18-C21
TTDS00041	Prostaglandin G/H synthase 2	Dysmenorrhea	625.3	N94.4-N94.6
TTDS00041	Prostaglandin G/H synthase 2	Endometriosis	617	N80
TTDS00041	Prostaglandin G/H synthase 2	Genitourinary tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00041	Prostaglandin G/H synthase 2	Gestational hypertension	401	I10, I11, I12, I13, I15
TTDS00041	Prostaglandin G/H synthase 2	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00041	Prostaglandin G/H synthase 2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00041	Prostaglandin G/H synthase 2	Lung cancer	162	C33-C34
TTDS00041	Prostaglandin G/H synthase 2	Malignant mesothelioma	163	C45
TTDS00041	Prostaglandin G/H synthase 2	Meningioma	225.2	C70, D32
TTDS00041	Prostaglandin G/H synthase 2	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDS00041	Prostaglandin G/H synthase 2	Oropharyngeal squamous cell carcinoma	199	C44
TTDS00041	Prostaglandin G/H synthase 2	Osteoarthritis	715	M15-M19, M47
TTDS00041	Prostaglandin G/H synthase 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00041	Prostaglandin G/H synthase 2	Pathological angiogenesis	.	.
TTDS00041	Prostaglandin G/H synthase 2	Peutz-Jeghers syndrome	.	.
TTDS00041	Prostaglandin G/H synthase 2	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00041	Prostaglandin G/H synthase 2	Pyresis	.	.
TTDS00041	Prostaglandin G/H synthase 2	Renal cell carcinoma	189	C64
TTDS00041	Prostaglandin G/H synthase 2	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00041	Prostaglandin G/H synthase 2	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00041	Prostaglandin G/H synthase 2	Vascular lesion regression	.	.
TTDR00041	S-adenosyl-L-methionine-C-24-delta-sterol-methyltransferase	Pneumocystis infections	001-139	A00-B99
TTDR00042	Beta-hydroxyacyl-acp dehydratase	Malaria	84	B50-B54
TTDC00042	Matrix metalloproteinase-14	Brain cancer	191, 225.0	C71, D33
TTDC00042	Matrix metalloproteinase-14	Hormone-refractory prostate cancer	140-229, 185, 203.0	C00-C96, C61, C90.0
TTDC00042	Matrix metalloproteinase-14	Kaposi's sarcoma	176	C46
TTDC00042	Matrix metalloproteinase-14	Lung cancer	162	C33-C34
TTDC00042	Matrix metalloproteinase-14	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00042	Matrix metalloproteinase-14	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00042	Matrix metalloproteinase-14	Osteoarthritis	715	M15-M19, M47
TTDC00042	Matrix metalloproteinase-14	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00042	Matrix metalloproteinase-14	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00043	Class 1 lysyl-tRNA synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00043	Gastrin/cholecystokinin type B receptor	Acid-related diseases	531-534	K25-K27
TTDS00043	Gastrin/cholecystokinin type B receptor	Anxiety disorders	300	F40-F42
TTDS00043	Gastrin/cholecystokinin type B receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00043	Gastrin/cholecystokinin type B receptor	Gastrin sensitive tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00043	Gastrin/cholecystokinin type B receptor	Gastrointestinal adenocarcinomas	140-199	C00-C75, C7A, C7B
TTDS00043	Gastrin/cholecystokinin type B receptor	Gastrointestinal motility disorders	.	.
TTDS00043	Gastrin/cholecystokinin type B receptor	Malignant gliomas	191	C71
TTDS00043	Gastrin/cholecystokinin type B receptor	Medullary thyroid carcinoma	193	C73
TTDS00043	Gastrin/cholecystokinin type B receptor	Neuroendocrine tumors	140-199, 209, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00043	Gastrin/cholecystokinin type B receptor	Small cell lung cancer	162.9	C34.90
TTDS00043	Gastrin/cholecystokinin type B receptor	Stromal ovarian tumors	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDC00043	Neuropeptide Y receptor type 4	Obesity	278	E66
TTDC00043	Neuropeptide Y receptor type 4	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
TTDR00044	GDP-mannose pyrophosphorylase	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDC00044	MAP kinase p38	Acute pain; Chronic pain	338,780	R52, G89
TTDC00044	MAP kinase p38	Analgesics	338	R52
TTDC00044	MAP kinase p38	Cancer	140-229	C00-C96
TTDC00044	MAP kinase p38	Cardiovascular disorders	390-459	I00-I99
TTDC00044	MAP kinase p38	Coronary artery disease	410-414, 429.2	I20-I25
TTDC00044	MAP kinase p38	Inflammatory bowel disease	555, 556	K50, K51
TTDC00044	MAP kinase p38	Inflammatory disorders	.	.
TTDC00044	MAP kinase p38	Neurological diseases	320-359	G00-G99
TTDC00044	MAP kinase p38	Oral facial pain	338,780	R52, G89
TTDC00044	MAP kinase p38	Psoriasis; Psoriatic disorders	696	L40
TTDC00044	MAP kinase p38	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00044	Potassium-transporting ATPase alpha chain 1	Acid-related diseases	531-534	K25-K27
TTDS00044	Potassium-transporting ATPase alpha chain 1	Gastric acid hypersecretion	.	.
TTDS00044	Potassium-transporting ATPase alpha chain 1	Gastric ulcer	531	K25
TTDS00044	Potassium-transporting ATPase alpha chain 1	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
TTDC00045	Ephrin type-B receptor 4	Lung cancer	162	C33-C34
TTDC00045	Ephrin type-B receptor 4	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00045	Interleukin-1 receptor-associated kinase-4	Autoimmune diseases	279	D84.9, M35.9
TTDR00045	Interleukin-1 receptor-associated kinase-4	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00045	Interleukin-1 receptor-associated kinase-4	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDS00045	Sodium/potassium-transporting ATPase alpha-1 chain	Atrial fibrillation; Atrial flutter	427.31, 487, 488	I48, J10, J11
TTDS00045	Sodium/potassium-transporting ATPase alpha-1 chain	Heart failure	410, 428	I21, I22, I50
TTDC00046	Nuclear factor NF-kappa-B	Cancer	140-229	C00-C96
TTDC00046	Nuclear factor NF-kappa-B	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDC00046	Nuclear factor NF-kappa-B	Kidney cancer	140-229	C00-C96
TTDC00046	Nuclear factor NF-kappa-B	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDC00046	Nuclear factor NF-kappa-B	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00046	Nuclear factor NF-kappa-B	Pediatric disease	.	.
TTDC00046	Nuclear factor NF-kappa-B	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00046	Nuclear factor NF-kappa-B	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00046	RING-box protein 2	Cancer	140-229	C00-C96
TTDR00046	RING-box protein 2	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00046	Sodium/potassium-transporting ATPase	Chronic renal failure	585.9585.1-585.5403	N18
TTDS00046	Sodium/potassium-transporting ATPase	Peptic ulcer	531-534	K25-K27
TTDR00047	Papain-like cysteine protease	Arthritis	710-719	M00-M25
TTDR00047	Papain-like cysteine protease	Cancer	140-229	C00-C96
TTDR00047	Papain-like cysteine protease	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR00047	Papain-like cysteine protease	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00048	Induced myeloid leukemia cell differentiation protein Mcl-1	Lymphoid leukemia	208.9	C91-C95
TTDC00048	Induced myeloid leukemia cell differentiation protein Mcl-1	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00048	Induced myeloid leukemia cell differentiation protein Mcl-1	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00048	Voltage-dependent T-type calcium channel alpha-1I subunit	Analgesics	338	R52
TTDR00048	Voltage-dependent T-type calcium channel alpha-1I subunit	Epilepsy	290-319, 345	F01-F99, G40
TTDR00048	Voltage-dependent T-type calcium channel alpha-1I subunit	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00049	5-HT-moduline	Mood affective disorders	.	.
TTDC00049	Transient receptor potential cation channel subfamily V member 1	Acute migraine	346	G43
TTDC00049	Transient receptor potential cation channel subfamily V member 1	Acute pain; Chronic pain	338,780	R52, G89
TTDC00049	Transient receptor potential cation channel subfamily V member 1	Analgesics	338	R52
TTDC00049	Transient receptor potential cation channel subfamily V member 1	Chronic pathological pain	338,780	R52, G89
TTDC00049	Transient receptor potential cation channel subfamily V member 1	Osteoarthritis pain	338, 715,780	M15-M19, M47, R52, G89
TTDC00049	Transient receptor potential cation channel subfamily V member 1	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDR00050	ATP-independent DNA topoisomerase II	Trypanosomiasis	086.5-086	B56-B57
TTDC00050	Glucose-dependent insulinotropic receptor	Type 2 diabetes	250.00, 250.02	E11
TTDR00051	CGMP-dependent protein kinase	Intestinal parasites infections	001-139	A00-B99
TTDC00051	Gamma-secretase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00052	Growth arrest and DNA-damage-inducible protein GADD45	Cancer	140-229	C00-C96
TTDC00052	NAD-dependent deacetylase sirtuin-1	Neurological diseases	320-359	G00-G99
TTDC00052	NAD-dependent deacetylase sirtuin-1	Type 2 diabetes	250.00, 250.02	E11
TTDS00053	Aldehyde dehydrogenase	Chronic alcoholism	303	F10.2
TTDC00053	Carboxypeptidase B2	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR00054	HIV-1 peptidase	Human immunodeficiency virus infection	279.3	D84.9
TTDC00054	Hypoxia-inducible factor-prolyl hydroxylase	Anemia	280-285	D50-D64
TTDC00054	Hypoxia-inducible factor-prolyl hydroxylase	Kidney disease	580-589	N00-N29
TTDS00054	Succinate semialdehyde dehydrogenase, mitochondrial	Riboflavin deficiency	.	.
TTDS00055	3-beta-hydroxysteroid dehydrogenase	Autoimmune polyendocrinopathies	.	.
TTDS00055	3-beta-hydroxysteroid dehydrogenase	Female infertility; Hyperprolactinemia	606, 628	N46, N97.0
TTDS00055	3-beta-hydroxysteroid dehydrogenase	Premature ovarian failure	256.31	E28.3
TTDS00055	3-beta-hydroxysteroid dehydrogenase	Primary aldosteronism	.	.
TTDS00055	3-beta-hydroxysteroid dehydrogenase	Tumors (androgen sensitive)	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00055	HIV-1 Tat protein-TAR RNA	Human immunodeficiency virus infection	279.3	D84.9
TTDC00055	Telomerase protein component 1	Lymphoid leukemia	208.9	C91-C95
TTDC00055	Telomerase protein component 1	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00055	Telomerase protein component 1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00056	Pre-mRNA splicing factor PRP8	Fungal diseases	110-118	B35-B49
TTDC00056	Toll-like receptor 8	Genital warts	78.11	A63.0
TTDC00056	Toll-like receptor 8	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDS00056	Xanthine dehydrogenase/oxidase	Gout	274.00274.1274.8274.9	M10
TTDR00057	Melanocortin receptor	Obesity	278	E66
TTDC00057	Sphingomyelin phosphodiesterase 4	Depression	311	F32
TTDS00058	Glutamate dehydrogenase	Malaria	84	B50-B54
TTDR00058	P16 gene	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00058	Sphingosine kinase 2	Late-stage ovarian cancer	140-229, 183, 188	C00-C96, C56, C67
TTDC00058	Sphingosine kinase 2	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Arthritis	710-719	M00-M25
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Autoimmune diseases	279	D84.9, M35.9
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Cancer	140-229	C00-C96
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Fungal diseases	110-118	B35-B49
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Hepatocellular carcinoma	155	C22.0
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Immunosuppression	.	.
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Malaria	84	B50-B54
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Parasitic diseases	.	.
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Pneumocystis infections	001-139	A00-B99
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Proliferative diseases	.	.
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00059	Dihydroorotate dehydrogenase, mitochondrial	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00059	P2X receptor (bacterial)	Schistosomiasis	120	B65
TTDC00059	Serine/threonine-protein kinase 13	Myeloid leukemia	208.9	C91-C95
TTDC00059	Serine/threonine-protein kinase 13	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00060	Alcohol dehydrogenase	Methanol poisoning	.	.
TTDC00060	Heparanase	Hepatocellular cancer following curative resection	155	C22.0
TTDC00060	Heparanase	Lung cancer	162	C33-C34
TTDC00060	Heparanase	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00060	Protease resistant isoform	Prion diseases	.	.
TTDR00061	Rnase P protein	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00061	Voltage-dependent anion-selective channel protein 3	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00062	5-lipoxygenase activating protein	Arthritis	710-719	M00-M25
TTDC00062	5-lipoxygenase activating protein	Asthma	493	J45
TTDC00062	5-lipoxygenase activating protein	Cardiovascular disorders	390-459	I00-I99
TTDC00062	5-lipoxygenase activating protein	Coronary artery disease; Heart attack	410, 410-414, 429.2	I20-I25, I21-I22
TTDC00062	5-lipoxygenase activating protein	Inflammatory disorders	.	.
TTDC00062	5-lipoxygenase activating protein	Psoriasis	696	L40
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Cancer	140-229	C00-C96
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Immunosuppression	.	.
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Infections	001-139	A00-B99
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Influenza A virus infections	487, 488	J10, J11
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Leukemia	208.9	C91-C95
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Lung cancer	162	C33-C34
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Malaria	84	B50-B54
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Microbial infections	001-139	A00-B99
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Parasitic diseases	.	.
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Severe acute respiratory syndrome	.	.
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Trichomoniasis	131	A59
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Tritrichomonial infections	001-139	A00-B99
TTDS00062	Inosine-5'-monophosphate dehydrogenase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00062	Voltage-gated calcium channel	Epilepsy	290-319, 345	F01-F99, G40
TTDS00063	Inosine-5'-monophosphate dehydrogenase 2	Leukemia	208.9	C91-C95
TTDC00063	Nitric-oxide synthase, brain	Helminth infection	001-139	A00-B99
TTDC00063	Nitric-oxide synthase, brain	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
TTDC00063	Nitric-oxide synthase, brain	Schizophrenia	295, 710.0	F20, M32
TTDR00063	Wld(S) protein	Axon death in CNS; PNS disease	.	.
TTDR00063	Wld(S) protein	Neurological diseases	320-359	G00-G99
TTDC00064	Centromeric protein E	Cancer	140-229	C00-C96
TTDC00064	Centromeric protein E	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00064	HCMV DNA polymerase	Cytomegalovirus retinitis	78.5	B25.8, H30.9
TTDR00064	HCMV DNA polymerase	GCV-resistant HCMV	.	.
TTDS00064	Lipase	Acne vulgaris	706.1	L70.0
TTDS00064	Lipase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00064	Lipase	Dermatitis	692.9	L20-L30
TTDS00064	Lipase	Hyperlipidemia	272.0-272.4	E78
TTDS00064	Lipase	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00064	Lipase	Obesity	278	E66
TTDS00064	Lipase	Skin rash	.	.
TTDR00065	Aspartyl protease (Candida albicans secreted)	Fungal diseases	110-118	B35-B49
TTDC00065	Farnesyltransferase	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDC00065	Farnesyltransferase	Amebiasis	6	A06
TTDC00065	Farnesyltransferase	Bladder cancer	140-229, 188	C00-C96, C67
TTDC00065	Farnesyltransferase	Breast cancer	174, 175, 217	C50, D24
TTDC00065	Farnesyltransferase	Cancer	140-229	C00-C96
TTDC00065	Farnesyltransferase	Colorectal cancer	153, 154	C18-C21
TTDC00065	Farnesyltransferase	Malaria	84	B50-B54
TTDC00065	Farnesyltransferase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00065	Farnesyltransferase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00065	Farnesyltransferase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00065	Phospholipase A2	Arthritis	710-719	M00-M25
TTDS00065	Phospholipase A2	Eicosanoid-mediated disorders	.	.
TTDS00065	Phospholipase A2	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00066	DnaB-like helicase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00066	Lipoprotein lipase	Dyslipidemia	272	E78
TTDC00066	Protein kinase C, epsilon type	Anxiety disorders	300	F40-F42
TTDC00066	Protein kinase C, epsilon type	Astroglial brain tumors	140-199, 191, 210-229, 225.0	C00-C75, C71, C7A, C7B, D10-D36, D33, D3A
TTDC00066	Protein kinase C, epsilon type	Immune disease	.	.
TTDC00066	Protein kinase C, epsilon type	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00066	Protein kinase C, epsilon type	Ischemic reperfusion injury	.	.
TTDC00066	Protein kinase C, epsilon type	Myocardial hypertrophy	.	.
TTDC00067	Cathepsin S	Autoimmune diseases	279	D84.9, M35.9
TTDC00067	Cathepsin S	Psoriasis; Psoriatic disorders	696	L40
TTDR00067	Ribosomal ATPase RbbA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00067	Ribosomal ATPase RbbA	Fungal diseases	110-118	B35-B49
TTDC00068	Cathepsin K	Bone Metastases	198.5	C79.51
TTDC00068	Cathepsin K	Cancer	140-229	C00-C96
TTDC00068	Cathepsin K	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00068	Cathepsin K	Postmenopausal women with osteoporosis	733	M80-M81
TTDC00068	Cathepsin K	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00068	Corticosteroid-binding globulin	Cortisol driven obesity	278	E66
TTDR00068	DNA helicase/primase complex associated protein	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDC00069	Peroxisome proliferator activated receptor delta	Atherosclerosis	414.0, 440	I70
TTDC00069	Peroxisome proliferator activated receptor delta	Hyperlipidemia	272.0-272.4	E78
TTDC00069	Peroxisome proliferator activated receptor delta	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00069	Peroxisome proliferator activated receptor delta	Metabolic disease	270-279	E70-E89
TTDC00069	Peroxisome proliferator activated receptor delta	Metabolic syndrome X	277.7	E88.81
TTDC00069	Peroxisome proliferator activated receptor delta	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00069	Peroxisome proliferator activated receptor delta	Obesity	278	E66
TTDC00069	Peroxisome proliferator activated receptor delta	Skin diseases	.	.
TTDR00069	Stromelysin	Connective tissue disorders	727	M65-M67
TTDR00069	Stromelysin	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00069	Stromelysin	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00070	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDC00070	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Metabolic disease	270-279	E70-E89
TTDC00070	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Neurodegenerative diseases	330-337	G30-G32
TTDC00070	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00070	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Obesity	278	E66
TTDC00070	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Type 2 diabetes	250.00, 250.02	E11
TTDR00070	Cysteine protease	Chagas' disease	86	B57
TTDR00071	Potassium voltage-gated channel subfamily B member 1	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00071	Proteinase activated receptor 1	Acute coronary syndromes	411.1	I20.0
TTDC00071	Proteinase activated receptor 1	Analgesics	338	R52
TTDC00071	Proteinase activated receptor 1	Cardiovascular disorders	390-459	I00-I99
TTDC00071	Proteinase activated receptor 1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00071	Proteinase activated receptor 1	Ischemic stroke	434.91	I61-I63
TTDC00071	Proteinase activated receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00071	Proteinase activated receptor 1	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00072	Melanocortin-4 receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDC00072	Melanocortin-4 receptor	Female sexual dysfunction	302.7	F52, R37
TTDC00072	Melanocortin-4 receptor	Obesity	278	E66
TTDR00072	Metalloproteinase-4	Arthritis	710-719	M00-M25
TTDR00072	Metalloproteinase-4	Cancer	140-229	C00-C96
TTDS00072	Retinoic acid receptor	Acne vulgaris	706.1	L70.0
TTDS00072	Retinoic acid receptor	Immune disease	.	.
TTDS00072	Retinoic acid receptor	Psoriasis	696	L40
TTDS00072	Retinoic acid receptor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00072	Retinoic acid receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDC00073	Corticotropin releasing factor receptor 1	Anxiety disorders	300	F40-F42
TTDC00073	Corticotropin releasing factor receptor 1	Depression	311	F32
TTDC00073	Corticotropin releasing factor receptor 1	Innate anxiety	300	F40-F42
TTDC00073	Corticotropin releasing factor receptor 1	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDC00073	Corticotropin releasing factor receptor 1	Obesity	278	E66
TTDC00073	Corticotropin releasing factor receptor 1	Stress-related disorders	296	F30-F39
TTDS00073	Retinoic acid receptor alpha	Acute promyelocytic leukemia	205	C92.4
TTDR00073	Vascular endothelial growth factor receptor	Cancer	140-229	C00-C96
TTDR00073	Vascular endothelial growth factor receptor	Leukemia	208.9	C91-C95
TTDR00073	Vascular endothelial growth factor receptor	Retinopathy	362.0-362.2	H35-H35.2
TTDR00074	Choline transporter	Malaria	84	B50-B54
TTDC00074	Corticotropin releasing factor receptor 2	Angiogenesis	.	.
TTDC00074	Corticotropin releasing factor receptor 2	Congestive heart failure	428, 428.0	I50
TTDC00074	Corticotropin releasing factor receptor 2	Eating disorders	307.5	F50
TTDC00074	Corticotropin releasing factor receptor 2	Obesity	278	E66
TTDC00074	Corticotropin releasing factor receptor 2	Stress-related disorders	296	F30-F39
TTDR00075	Apicoplast ribosome	Malaria	84	B50-B54
TTDS00075	Retinoic acid receptor gamma	Acne vulgaris	706.1	L70.0
TTDS00075	Retinoic acid receptor gamma	Emphysema	492	J43
TTDS00075	Retinoic acid receptor gamma	Photoaging	.	.
TTDS00075	Retinoic acid receptor gamma	Psoriasis	696	L40
TTDC00075	Thioredoxin	Cancer	140-229	C00-C96
TTDC00075	Thioredoxin	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDC00075	Thioredoxin	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00076	92 kDa type IV collagenase	Advanced lung cancer	140-229, 162	C00-C96, C33-C34
TTDC00076	92 kDa type IV collagenase	Atherosclerosis	414.0, 440	I70
TTDC00076	92 kDa type IV collagenase	Brain cancer	191, 225.0	C71, D33
TTDC00076	92 kDa type IV collagenase	Guillain-Barre syndrome	.	.
TTDC00076	92 kDa type IV collagenase	Hormone-refractory prostate cancer	140-229, 185, 203.0	C00-C96, C61, C90.0
TTDC00076	92 kDa type IV collagenase	Kaposi's sarcoma	176	C46
TTDC00076	92 kDa type IV collagenase	Lung cancer	162	C33-C34
TTDC00076	92 kDa type IV collagenase	Multiple sclerosis	340	G35
TTDC00076	92 kDa type IV collagenase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00076	92 kDa type IV collagenase	Osteoarthritis	715	M15-M19, M47
TTDC00076	92 kDa type IV collagenase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00076	92 kDa type IV collagenase	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00076	92 kDa type IV collagenase	Renal cell carcinoma	189	C64
TTDC00076	92 kDa type IV collagenase	Restenosis	.	I51.89
TTDC00076	92 kDa type IV collagenase	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00076	DNA gyrase	Malaria	84	B50-B54
TTDS00076	Growth hormone receptor	Acromegaly; Pituitary gigantism	253	E22.0, E34.4
TTDR00077	Cytochrome c oxidoreductase	Malaria	84	B50-B54
TTDS00077	Glycoprotein IIb/IIIa receptor	Acute coronary syndromes	411.1	I20.0
TTDS00077	Glycoprotein IIb/IIIa receptor	Atherothrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00077	Glycoprotein IIb/IIIa receptor	Cancer	140-229	C00-C96
TTDS00077	Glycoprotein IIb/IIIa receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00077	Glycoprotein IIb/IIIa receptor	Ischemic complications of nonurgent coronary stent implantation	.	.
TTDS00077	Glycoprotein IIb/IIIa receptor	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDS00077	Glycoprotein IIb/IIIa receptor	Platelet aggregation	.	.
TTDS00077	Glycoprotein IIb/IIIa receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00078	Aldehyde oxidase	Acute leukaemia	208.9	C91-C95
TTDS00078	Aldehyde oxidase	Psychiatric illness	.	.
TTDC00078	Coagulation factor IX	Blood; Blood forming organ disorders	280-289	D50-D89
TTDC00078	Coagulation factor IX	Cardiac surgery	.	.
TTDC00078	Coagulation factor IX	Coronary artery disease	410-414, 429.2	I20-I25
TTDC00078	Coagulation factor IX	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDC00078	Coagulation factor IX	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00078	Coagulation factor IX	Venous thromboembolism	453	I80-I82
TTDS00079	DNA topoisomerase I	Brain tumors	191, 225.0	C71, D33
TTDS00079	DNA topoisomerase I	Breast cancer	174, 175, 217	C50, D24
TTDS00079	DNA topoisomerase I	Cancer	140-229	C00-C96
TTDS00079	DNA topoisomerase I	Colorectal cancer	153, 154	C18-C21
TTDS00079	DNA topoisomerase I	Esophageal squamous cell cancer	140-229	C00-C96
TTDS00079	DNA topoisomerase I	Fungal diseases	110-118	B35-B49
TTDS00079	DNA topoisomerase I	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDS00079	DNA topoisomerase I	Lung cancer	162	C33-C34
TTDS00079	DNA topoisomerase I	Lymphoblast tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00079	DNA topoisomerase I	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00079	Histamine H3 receptor	Acid-related diseases	531-534	K25-K27
TTDC00079	Histamine H3 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDC00079	Histamine H3 receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00079	Histamine H3 receptor	Attention-deficit hyperactivity disorder	314	F90
TTDC00079	Histamine H3 receptor	Central nervous system diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
TTDC00079	Histamine H3 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00079	Histamine H3 receptor	Schizophrenia	295, 710.0	F20, M32
TTDR00079	New permeability pathways	Malaria	84	B50-B54
TTDS00080	DNA topoisomerase II	Acute promyelocytic leukemia	205	C92.4
TTDS00080	DNA topoisomerase II	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00080	DNA topoisomerase II	Cancer	140-229	C00-C96
TTDS00080	DNA topoisomerase II	Fungal diseases	110-118	B35-B49
TTDS00080	DNA topoisomerase II	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDS00080	DNA topoisomerase II	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDS00080	DNA topoisomerase II	Malaria	84	B50-B54
TTDS00080	DNA topoisomerase II	Trichomoniasis	131	A59
TTDC00080	Interleukin-6	Cachexia	799.4	R64
TTDC00080	Interleukin-6	Glioblastoma multiforme	191	C71
TTDC00080	Interleukin-6	Hyperinflammatory provoked organ injury	.	.
TTDC00080	Interleukin-6	Inflammatory disorders	.	.
TTDC00080	Interleukin-6	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00080	Interleukin-6	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00080	Interleukin-6	Systemic-onset juvenile idiopathic arthritis	710-719	M00-M25
TTDC00081	Interleukin-4 receptor alpha chain	Asthma	493	J45
TTDC00081	Interleukin-4 receptor alpha chain	Brain cancer	191, 225.0	C71, D33
TTDC00081	Interleukin-4 receptor alpha chain	Cancer	140-229	C00-C96
TTDC00081	Interleukin-4 receptor alpha chain	Gastric carcinoma	151	C16
TTDC00081	Interleukin-4 receptor alpha chain	Kidney cancer	140-229	C00-C96
TTDC00081	Interleukin-4 receptor alpha chain	Lung cancer	162	C33-C34
TTDR00081	P2Y purinoceptor 1	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDC00082	Cholecystokinin type A receptor	Acid-related diseases	531-534	K25-K27
TTDC00082	Cholecystokinin type A receptor	Alcoholism	303	F10.2
TTDC00082	Cholecystokinin type A receptor	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
TTDC00082	Cholecystokinin type A receptor	Gastrointestinal diseases	.	.
TTDC00082	Cholecystokinin type A receptor	Gastrointestinal motility disorders	.	.
TTDC00082	Cholecystokinin type A receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDC00082	Cholecystokinin type A receptor	Obesity	278	E66
TTDC00082	Cholecystokinin type A receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00082	Mitochondrial brown fat uncoupling protein 1	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00082	Mitochondrial brown fat uncoupling protein 1	Obesity	278	E66
TTDR00083	Mitochondrial uncoupling protein 2	Obesity	278	E66
TTDS00083	Topoisomerase IV	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00084	Mitochondrial uncoupling protein 3	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00084	Mitochondrial uncoupling protein 3	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00084	Mitochondrial uncoupling protein 3	Obesity	278	E66
TTDS00084	Topoisomerase IV subunit A	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00084	Topoisomerase IV subunit A	Urinary tract infections	599	N39.0
TTDC00084	Tyrosine-protein kinase JAK3	Acute graft-versus-host disease	279.5	T86.0
TTDC00084	Tyrosine-protein kinase JAK3	Chronic graft-versus-host disease	279.5	T86.0
TTDC00084	Tyrosine-protein kinase JAK3	Immunosuppression	.	.
TTDC00084	Tyrosine-protein kinase JAK3	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00085	Complement C1s component	Hereditary angioedema	277.6	D84.1
TTDC00085	Complement C1s component	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00085	Dual specificity protein phosphatase 1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00085	Dual specificity protein phosphatase 1	Parkinson's disease	332	F02.3, G20
TTDS00085	Histamine receptor	Schizophrenia	295, 710.0	F20, M32
TTDS00086	Histamine H1 receptor	Acute lymphoblastic leukaemia	208.9	C91-C95
TTDS00086	Histamine H1 receptor	Allergic diseases	995.3	T78.4
TTDS00086	Histamine H1 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDS00086	Histamine H1 receptor	Anxiety disorders	300	F40-F42
TTDS00086	Histamine H1 receptor	Chronic rhinitis	472.0, 477	J00, J30, J31.0
TTDS00086	Histamine H1 receptor	Chronic urticaria	708	L50
TTDS00086	Histamine H1 receptor	Epidermal hyperplasia	.	.
TTDS00086	Histamine H1 receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDS00086	Histamine H1 receptor	Hypotension	458, 796.3	I95
TTDS00086	Histamine H1 receptor	Intimal hyperplasia	.	.
TTDS00086	Histamine H1 receptor	Ischemia	459.89	I99.8
TTDS00086	Histamine H1 receptor	Motion sickness	994.6	T75.3
TTDS00086	Histamine H1 receptor	Nausea and vomiting	787, 787.0	R11
TTDS00086	Histamine H1 receptor	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
TTDS00086	Histamine H1 receptor	Systemic arterial vasodilation	.	.
TTDR00086	Interleukin-4	Allergic diseases	995.3	T78.4
TTDR00086	Interleukin-4	Asthma	493	J45
TTDR00086	Interleukin-4	Ocular allergy	360-379	H00-H59
TTDR00086	Interleukin-4	Parasitic infections of the eye	001-139	A00-B99
TTDR00086	Interleukin-4	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00086	Interleukin-4	Type I hypersensitivity	995.3	T78.4
TTDC00086	Thromboxane-A synthase	Asthma	493	J45
TTDC00086	Thromboxane-A synthase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00086	Thromboxane-A synthase	Cerebral circulatory disorders	.	.
TTDC00086	Thromboxane-A synthase	Inflammatory bowel disease	555, 556	K50, K51
TTDC00086	Thromboxane-A synthase	Ischemic heart disease	410-414	I20-I25
TTDC00086	Thromboxane-A synthase	Peripheral vascular disease	443.9	I73.9
TTDC00086	Thromboxane-A synthase	Thromboembolic disorder	437.6, 453, 671.5, 671.9	I80-I82
TTDC00087	High affinity interleukin-8 receptor B	Acute respiratory distress syndrome	518.5, 518.82	J80
TTDC00087	High affinity interleukin-8 receptor B	Asthma	493	J45
TTDC00087	High affinity interleukin-8 receptor B	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDC00087	High affinity interleukin-8 receptor B	Colorectal cancer	153, 154	C18-C21
TTDC00087	High affinity interleukin-8 receptor B	Lung injury	.	S00-T98
TTDS00087	Histamine H2 receptor	Epidermal hyperplasia	.	.
TTDS00087	Histamine H2 receptor	Lasting tachycardia	427, 785.0	I47-I49, R00.0
TTDS00087	Histamine H2 receptor	Peptic ulcer	531-534	K25-K27
TTDS00087	Histamine H2 receptor	Systemic arterial vasodilation	.	.
TTDS00087	Histamine H2 receptor	Zollinger-Ellison syndrome	251.5	E16.4
TTDC00088	Cell division protein kinase 2	Acute lymphoblastic leukaemia	208.9	C91-C95
TTDC00088	Cell division protein kinase 2	Advanced solid tumor	140-199	C00-C75, C7A, C7B
TTDC00088	Cell division protein kinase 2	B-cell malignancies	202.8	C85.1
TTDC00088	Cell division protein kinase 2	Cancer	140-229	C00-C96
TTDC00088	Cell division protein kinase 2	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00088	Cell division protein kinase 2	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDC00088	Cell division protein kinase 2	Hepatocellular carcinoma	155	C22.0
TTDC00088	Cell division protein kinase 2	Nasopharyngeal cancer	140-229	C00-C96
TTDC00088	Cell division protein kinase 2	Non-Hodgkin's Lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00088	Cell division protein kinase 2	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00088	Cell division protein kinase 2	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00088	Cell division protein kinase 2	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00088	Interleukin-5	Allergic inflammation	995.3	T78.4
TTDR00088	Interleukin-5	Asthma	493	J45
TTDR00088	Interleukin-5	Asthmatic bronchial mucosal inflammation	.	.
TTDR00089	D-amino acid aminotransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00089	D-amino acid aminotransferase	Vitamin B6 deficiency	266.1	E53.1
TTDS00089	Histamine N-methyltransferase	Malaria	84	B50-B54
TTDC00089	Neuropeptide Y receptor type 5	Epilepsy	290-319, 345	F01-F99, G40
TTDC00089	Neuropeptide Y receptor type 5	Obesity	278	E66
TTDC00089	Neuropeptide Y receptor type 5	Opioid dependence	304	F11.2
TTDC00089	Neuropeptide Y receptor type 5	Temporal lobe epilepsy	345	G40
TTDS00090	FL cytokine receptor	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDS00090	FL cytokine receptor	Autoimmune diseases	279	D84.9, M35.9
TTDS00090	FL cytokine receptor	MLL-rearranged acute lymphoblastic leukemias	204.0, 208.9	C91-C95, C91.0
TTDC00090	Substance-K receptor	Acute pain; Chronic pain	338,780	R52, G89
TTDC00090	Substance-K receptor	Analgesics	338	R52
TTDC00090	Substance-K receptor	Anxiety disorders	300	F40-F42
TTDC00090	Substance-K receptor	Asthma	493	J45
TTDC00090	Substance-K receptor	Depression	311	F32
TTDC00090	Substance-K receptor	Generalized anxiety disorders	300	F40-F42
TTDC00090	Substance-K receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDR00090	mRNA of intercellular adhesion molecule 1	Crohn's disease	555	K50
TTDS00091	Myeloid cell surface antigen CD33	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDC00091	Purine nucleoside phosphorylase	B-cell acute lymphoblastic leukemia	204.0, 208.9	C91-C95, C91.0
TTDC00091	Purine nucleoside phosphorylase	Cutaneous T-cell lymphoma	202.1, 202.2, 202.8, 208.9	C81-C96, C84.0, C84.1, C91-C95
TTDC00091	Purine nucleoside phosphorylase	Malaria	84	B50-B54
TTDC00091	Purine nucleoside phosphorylase	Moderate-to-severe plaque psoriasis	696	L40
TTDC00091	Purine nucleoside phosphorylase	Psoriasis	696	L40
TTDC00091	Purine nucleoside phosphorylase	Refractory cutaneous T-cell lymphoma	202.1, 202.2, 202.8	C81-C96, C84.0, C84.1
TTDC00091	Purine nucleoside phosphorylase	Schistosomiasis	120	B65
TTDC00091	Purine nucleoside phosphorylase	T-cell proliferation	.	.
TTDC00091	Purine nucleoside phosphorylase	Trypanosomatid infections	001-139	A00-B99
TTDC00091	Purine nucleoside phosphorylase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00092	Adenosine deaminase	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDS00092	Adenosine deaminase	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDS00092	Adenosine deaminase	Chronic myeloid leukemia	205.1	C92.1
TTDS00092	Adenosine deaminase	Hairy-cell leukemia	208.9	C91-C95
TTDS00092	Adenosine deaminase	Non-Hodgkin's Lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDS00092	Adenosine deaminase	Peripheral and cutaneous T-cell lymphomas	202.1, 202.2, 202.8	C81-C96, C84.0, C84.1
TTDC00092	Beta-secretase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00092	mRNA of the major immediate-early region protein	Cytomegalovirus retinitis	78.5	B25.8, H30.9
TTDC00093	Calcitonin gene-related peptide type 1 receptor	Cluster headaches	339.00, 339.01, 339.02	G44.0
TTDC00093	Calcitonin gene-related peptide type 1 receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDC00093	Calcitonin gene-related peptide type 1 receptor	Migraine	346	G43
TTDC00093	Calcitonin gene-related peptide type 1 receptor	Opioid dependence	304	F11.2
TTDS00093	Dipeptidyl peptidase IV	Autoimmune diseases	279	D84.9, M35.9
TTDS00093	Dipeptidyl peptidase IV	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00093	Dipeptidyl peptidase IV	Malignancies	140-239	C00-C96
TTDS00093	Dipeptidyl peptidase IV	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00093	Dipeptidyl peptidase IV	Obesity	278	E66
TTDR00093	Penicillin binding protein 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00094	Cell division protein kinase 7	B-cell malignancies	202.8	C85.1
TTDC00094	Cell division protein kinase 7	Cancer	140-229	C00-C96
TTDC00094	Cell division protein kinase 7	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00094	Transketolase	Thiamine deficiency	.	E51
TTDC00095	Cell division protein kinase 9	Cancer	140-229	C00-C96
TTDC00095	Cell division protein kinase 9	Heart disease	390-429	I00-I52
TTDC00095	Cell division protein kinase 9	Leukemia	208.9	C91-C95
TTDC00095	Cell division protein kinase 9	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDC00095	Cell division protein kinase 9	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00095	Cell division protein kinase 9	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00095	Histone deacetylase 1	Cancer	140-229	C00-C96
TTDS00095	Histone deacetylase 1	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
TTDS00095	Histone deacetylase 1	Proliferative diseases	.	.
TTDR00096	Agouti-related protein	Anorexia nervosa	307.1	F50.0-F50.1
TTDR00096	Agouti-related protein	Obesity	278	E66
TTDR00096	Agouti-related protein	Obesity-associated disorders	.	.
TTDS00096	CAMPATH-1 antigen	Acute promyelocytic leukemia	205	C92.4
TTDC00096	Interferon gamma	Multiple sclerosis	340	G35
TTDC00096	Interferon gamma	Psoriasis; Psoriatic disorders	696	L40
TTDS00097	5-hydroxytryptamine receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00097	5-hydroxytryptamine receptor	Chronic thromboembolic pulmonary hypertension	401, 416.0	I10, I11, I12, I13, I15, I27.0, I27.2
TTDS00097	5-hydroxytryptamine receptor	Cushing's disease	255	E24.0
TTDS00097	5-hydroxytryptamine receptor	Diarrhea	787.91	A09, K59.1
TTDS00097	5-hydroxytryptamine receptor	Drug-induced malabsorption	.	.
TTDS00097	5-hydroxytryptamine receptor	Gastrointestinal motility disorders	.	.
TTDC00097	Nitric-oxide synthase, endothelial	Angina	413	I20
TTDC00097	Nitric-oxide synthase, endothelial	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00097	Nitric-oxide synthase, endothelial	Colon cancer	153, 154	C18-C21
TTDC00097	Nitric-oxide synthase, endothelial	Coronary artery disease	410-414, 429.2	I20-I25
TTDC00097	Nitric-oxide synthase, endothelial	Helminth infection	001-139	A00-B99
TTDC00097	Nitric-oxide synthase, endothelial	Hypertension, Angina	401, 413	I10, I11, I12, I13, I15, I20
TTDC00097	Nitric-oxide synthase, endothelial	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00097	Nitric-oxide synthase, endothelial	Schizophrenia	295, 710.0	F20, M32
TTDC00097	Nitric-oxide synthase, endothelial	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDS00098	5-hydroxytryptamine 1A receptor	Anxiety disorders	300	F40-F42
TTDS00098	5-hydroxytryptamine 1A receptor	Brain ischemia	435, 437	G45.9, I67.8
TTDS00098	5-hydroxytryptamine 1A receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00098	5-hydroxytryptamine 1A receptor	Depression	311	F32
TTDS00098	5-hydroxytryptamine 1A receptor	Detrusor hyperreflexia	596.51	N32.81
TTDS00098	5-hydroxytryptamine 1A receptor	Mood affective disorders	.	.
TTDS00098	5-hydroxytryptamine 1A receptor	Skeletal muscle associated spasticity	.	.
TTDS00098	5-hydroxytryptamine 1A receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDC00098	E-selectin	Asthma	493	J45
TTDC00098	E-selectin	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDC00098	E-selectin	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDC00098	E-selectin	Inflammatory skin disorder	.	.
TTDC00098	E-selectin	Ischemic stroke	434.91	I61-I63
TTDC00098	E-selectin	Psoriasis; Psoriatic disorders	696	L40
TTDR00098	Monoamine uptake	Depression	311	F32
TTDR00098	Monoamine uptake	Mood affective disorders	.	.
TTDS00099	5-hydroxytryptamine 1B receptor	Anxiety disorders	300	F40-F42
TTDS00099	5-hydroxytryptamine 1B receptor	Migraine	346	G43
TTDS00099	5-hydroxytryptamine 1B receptor	Obsessive-compulsive disorder	300.3	F42
TTDS00099	5-hydroxytryptamine 1B receptor	Pulmonary hypertension	416	I27.0, I27.2
TTDC00099	Glycogen phosphorylase, muscle form	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00099	Glycogen phosphorylase, muscle form	Type 2 diabetes	250.00, 250.02	E11
TTDR00099	Proto-oncogene protein c-fos	Breast cancer	174, 175, 217	C50, D24
TTDR00099	Proto-oncogene protein c-fos	Neurological symptom	.	.
TTDS00100	5-hydroxytryptamine 1D receptor	Migraine	346	G43
TTDS00100	5-hydroxytryptamine 1D receptor	Obsessive-compulsive disorder	300.3	F42
TTDS00100	5-hydroxytryptamine 1D receptor	Vascular headache	339, 784.0	G43-G44, R51
TTDS00100	5-hydroxytryptamine 1D receptor	Vomiting	787	R11
TTDC00100	Metabotropic glutamate receptor 5	Analgesics	338	R52
TTDC00100	Metabotropic glutamate receptor 5	Anxiety disorders	300	F40-F42
TTDC00100	Metabotropic glutamate receptor 5	Convulsions	780.3	R56.0
TTDC00100	Metabotropic glutamate receptor 5	Depression	311	F32
TTDC00100	Metabotropic glutamate receptor 5	Drug dependence	303-305	F10-F19
TTDC00100	Metabotropic glutamate receptor 5	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
TTDC00100	Metabotropic glutamate receptor 5	Inflammatory pain	338,780	R52, G89
TTDC00100	Metabotropic glutamate receptor 5	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
TTDC00100	Metabotropic glutamate receptor 5	Neuronal injury	.	.
TTDC00100	Metabotropic glutamate receptor 5	Parkinson's disease	332	F02.3, G20
TTDC00101	Hypoxia-inducible factor 1 alpha	Cancer	140-229	C00-C96
TTDC00101	Hypoxia-inducible factor 1 alpha	Chronic lung diseases	490-496, 770.7	J40-J44, J45, J47, P27.1
TTDC00101	Hypoxia-inducible factor 1 alpha	Heart disease	390-429	I00-I52
TTDC00101	Hypoxia-inducible factor 1 alpha	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDC00101	Hypoxia-inducible factor 1 alpha	Renal cancer	140-229, 189	C00-C96, C64
TTDC00101	Hypoxia-inducible factor 1 alpha	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00101	Hypoxia-inducible factor 1 alpha	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDC00101	Hypoxia-inducible factor 1 alpha	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00101	Orotate phosphoribosyltransferase	Bladder cancer	140-229, 188	C00-C96, C67
TTDR00101	Orotate phosphoribosyltransferase	Malaria	84	B50-B54
TTDS00102	5-hydroxytryptamine 2 receptor	Acute respiratory distress syndrome	518.5, 518.82	J80
TTDS00102	5-hydroxytryptamine 2 receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00102	5-hydroxytryptamine 2 receptor	Detrusor hyperreflexia	596.51	N32.81
TTDS00102	5-hydroxytryptamine 2 receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00102	5-hydroxytryptamine 2 receptor	Skeletal muscle associated spasticity	.	.
TTDS00102	5-hydroxytryptamine 2 receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDC00102	Mitogen-activated protein kinase 8	Cancer	140-229	C00-C96
TTDC00102	Mitogen-activated protein kinase 8	Crohn's disease	555	K50
TTDC00102	Mitogen-activated protein kinase 8	Hearing loss	389	H90-H91
TTDC00102	Mitogen-activated protein kinase 8	Inflammatory disorders	.	.
TTDC00102	Mitogen-activated protein kinase 8	Insulin resistance	.	E00-E90
TTDC00102	Mitogen-activated protein kinase 8	Obesity	278	E66
TTDS00103	5-hydroxytryptamine 2A receptor	Acute ureteric colic	788	N23
TTDS00103	5-hydroxytryptamine 2A receptor	Anxiety disorders	300	F40-F42
TTDS00103	5-hydroxytryptamine 2A receptor	Arterial embolism; Thrombosis	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
TTDS00103	5-hydroxytryptamine 2A receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00103	5-hydroxytryptamine 2A receptor	Depression	311	F32
TTDS00103	5-hydroxytryptamine 2A receptor	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDS00103	5-hydroxytryptamine 2A receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDS00103	5-hydroxytryptamine 2A receptor	Essential hypertension	401	I10, I11, I12, I13, I15
TTDS00103	5-hydroxytryptamine 2A receptor	Migraine	346	G43
TTDS00103	5-hydroxytryptamine 2A receptor	Schizophrenia	295, 710.0	F20, M32
TTDC00103	Macrophage migration inhibitory factor	Cancer	140-229	C00-C96
TTDC00103	Macrophage migration inhibitory factor	Glomerulonephritis	580-582	N00, N01, N03, N18
TTDC00103	Macrophage migration inhibitory factor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00103	Macrophage migration inhibitory factor	Inflammatory lung disease	.	.
TTDC00103	Macrophage migration inhibitory factor	Inflammatory neurological disease	.	.
TTDC00103	Macrophage migration inhibitory factor	Inflammatory response in alcoholic liver disease	570-574	K70-K77
TTDC00103	Macrophage migration inhibitory factor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00103	Macrophage migration inhibitory factor	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDC00103	Macrophage migration inhibitory factor	Septic shock	785.52	A41.9
TTDC00103	Macrophage migration inhibitory factor	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDC00103	Macrophage migration inhibitory factor	Ulcerative colitis	556	K51
TTDR00103	Nonstructural protein NS3	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDR00103	Nonstructural protein NS3	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDS00104	5-hydroxytryptamine 2B receptor	Anxiety disorders	300	F40-F42
TTDS00104	5-hydroxytryptamine 2B receptor	Migraine	346	G43
TTDS00104	5-hydroxytryptamine 2B receptor	P-chloroamphetamine-induced hyperglycemia	790.29	R73.9
TTDC00104	72 kDa type IV collagenase	Brain cancer	191, 225.0	C71, D33
TTDC00104	72 kDa type IV collagenase	Breast cancer	174, 175, 217	C50, D24
TTDC00104	72 kDa type IV collagenase	Cancer	140-229	C00-C96
TTDC00104	72 kDa type IV collagenase	Hepatocellular carcinoma	155	C22.0
TTDC00104	72 kDa type IV collagenase	Hormone-refractory prostate cancer	140-229, 185, 203.0	C00-C96, C61, C90.0
TTDC00104	72 kDa type IV collagenase	Kaposi's sarcoma	176	C46
TTDC00104	72 kDa type IV collagenase	Lung cancer	162	C33-C34
TTDC00104	72 kDa type IV collagenase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00104	72 kDa type IV collagenase	Osteoarthritis	715	M15-M19, M47
TTDC00104	72 kDa type IV collagenase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00104	72 kDa type IV collagenase	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00104	72 kDa type IV collagenase	Renal cell carcinoma	189	C64
TTDC00104	72 kDa type IV collagenase	Smooth muscle hyperplasia	.	.
TTDR00104	Cystathionine beta-lyase	Vitamin B6 deficiency	266.1	E53.1
TTDS00105	5-hydroxytryptamine 2C receptor	Acute ureteric colic	788	N23
TTDS00105	5-hydroxytryptamine 2C receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00105	5-hydroxytryptamine 2C receptor	Motor disorder	.	.
TTDS00105	5-hydroxytryptamine 2C receptor	Schizophrenia	295, 710.0	F20, M32
TTDR00105	Peroxisome proliferator activated receptor	Bladder cancer	140-229, 188	C00-C96, C67
TTDR00105	Peroxisome proliferator activated receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00105	Peroxisome proliferator activated receptor	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDR00105	Peroxisome proliferator activated receptor	Glomerulosclerosis	.	.
TTDR00105	Peroxisome proliferator activated receptor	Kidney tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00105	Peroxisome proliferator activated receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00105	Stromelysin-1	Brain cancer	191, 225.0	C71, D33
TTDC00105	Stromelysin-1	Cancer	140-229	C00-C96
TTDC00105	Stromelysin-1	Lung cancer	162	C33-C34
TTDC00105	Stromelysin-1	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00105	Stromelysin-1	Osteoarthritis	715	M15-M19, M47
TTDC00105	Stromelysin-1	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00105	Stromelysin-1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00105	Stromelysin-1	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00106	5-hydroxytryptamine 3 receptor	Alcohol dependence	303	F10.2
TTDS00106	5-hydroxytryptamine 3 receptor	Alcoholism	303	F10.2
TTDS00106	5-hydroxytryptamine 3 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDS00106	5-hydroxytryptamine 3 receptor	Nausea and vomiting	787, 787.0	R11
TTDS00106	5-hydroxytryptamine 3 receptor	Pruritus	698	L29
TTDC00106	Farnesyl-diphosphate farnesyltransferase	Hypercholesterolemia	272	E78.0
TTDC00106	Farnesyl-diphosphate farnesyltransferase	Hyperlipidemia	272.0-272.4	E78
TTDC00106	Farnesyl-diphosphate farnesyltransferase	Hypocholesterolemia	.	.
TTDR00106	Plasmepsin 2	Human immunodeficiency virus infection	279.3	D84.9
TTDR00106	Plasmepsin 2	Malaria	84	B50-B54
TTDR00106	Plasmepsin 2	Parasitic diseases	.	.
TTDS00107	5-hydroxytryptamine 4 receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00107	5-hydroxytryptamine 4 receptor	Cardiac arrhythmias	427	I47-I49
TTDS00107	5-hydroxytryptamine 4 receptor	Dementia	290-294, 331.0	F01-F07, G30
TTDS00107	5-hydroxytryptamine 4 receptor	Diarrhoea-predominant irritable bowel syndrome	564.1	K58
TTDS00107	5-hydroxytryptamine 4 receptor	Drug dependence	303-305	F10-F19
TTDS00107	5-hydroxytryptamine 4 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDS00107	5-hydroxytryptamine 4 receptor	Psychiatric illness	.	.
TTDR00107	Plasmepsin 1	Malaria	84	B50-B54
TTDC00107	Toll-like receptor 9	Autoimmune diseases	279	D84.9, M35.9
TTDC00107	Toll-like receptor 9	Colorectal cancer	153, 154	C18-C21
TTDC00107	Toll-like receptor 9	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00107	Toll-like receptor 9	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDR00108	Pleiotrophin	Breast cancer	174, 175, 217	C50, D24
TTDR00108	Pleiotrophin	Cancer	140-229	C00-C96
TTDC00108	Von Willebrand factor	Cardiovascular disorders	390-459	I00-I99
TTDC00108	Von Willebrand factor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR00109	Proteinase activated receptor 2	Coronary atherosclerotic lesions	414.0, 440	I70
TTDR00109	Proteinase activated receptor 2	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00109	Proteinase activated receptor 2	Inflammatory skin disorder	.	.
TTDR00109	Proteinase activated receptor 2	Neurogenic inflammation	.	.
TTDR00109	Proteinase activated receptor 2	Pruritus	698	L29
TTDR00109	Proteinase activated receptor 2	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00109	Proteinase activated receptor 2	Tissue injury	.	.
TTDS00109	Vasopressin V1a receptor	Congestive heart failure	428, 428.0	I50
TTDS00109	Vasopressin V1a receptor	Dysmenorrhea	625.3	N94.4-N94.6
TTDS00109	Vasopressin V1a receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00109	Vasopressin V1a receptor	Raynaud's syndrome	443	I73.0
TTDS00109	Vasopressin V1a receptor	Renal diseases	580-599	N00-N39
TTDS00109	Vasopressin V1a receptor	Vasoconstriction	.	.
TTDS00109	Vasopressin V1a receptor	Water-retaining diseases	.	.
TTDC00110	Hepatocyte growth factor receptor	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDC00110	Hepatocyte growth factor receptor	Hepatocellular carcinoma	155	C22.0
TTDC00110	Hepatocyte growth factor receptor	Lung cancer	162	C33-C34
TTDC00110	Hepatocyte growth factor receptor	Metastatic prostate cancer	140-229, 185, 208.9	C00-C96, C61, C91-C95
TTDC00110	Hepatocyte growth factor receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00110	Hepatocyte growth factor receptor	Renal cell carcinoma	189	C64
TTDC00110	Hepatocyte growth factor receptor	Small cell lung cancer	162.9	C34.90
TTDC00110	Hepatocyte growth factor receptor	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00110	Proteinase activated receptor 3	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00111	B2 bradykinin receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00111	B2 bradykinin receptor	Analgesics	338	R52
TTDC00111	B2 bradykinin receptor	Arthritis	710-719	M00-M25
TTDC00111	B2 bradykinin receptor	Asthma	493	J45
TTDC00111	B2 bradykinin receptor	Brain cancer	191, 225.0	C71, D33
TTDC00111	B2 bradykinin receptor	Cardiac hypertrophy	429.3	I51.7
TTDC00111	B2 bradykinin receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00111	B2 bradykinin receptor	Cerebral edema	348.5	G93.6
TTDC00111	B2 bradykinin receptor	Chronic rhinitis	472.0, 477	J00, J30, J31.0
TTDC00111	B2 bradykinin receptor	Colitis	556.9	K50-K52
TTDC00111	B2 bradykinin receptor	Diabetic disorders	250	E08-E13
TTDC00111	B2 bradykinin receptor	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDC00111	B2 bradykinin receptor	Hepatorenal syndrome	.	K76.7
TTDC00111	B2 bradykinin receptor	Hereditary angioedema	277.6	D84.1
TTDC00111	B2 bradykinin receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDC00111	B2 bradykinin receptor	Liver disease	570-574	K70-K77
TTDC00111	B2 bradykinin receptor	Lung cancer	162	C33-C34
TTDC00111	B2 bradykinin receptor	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00111	B2 bradykinin receptor	Pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDC00111	B2 bradykinin receptor	Pediatric disease	.	.
TTDC00111	B2 bradykinin receptor	Restenosis	.	I51.89
TTDC00111	B2 bradykinin receptor	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDC00111	B2 bradykinin receptor	Tissue injury	.	.
TTDC00111	B2 bradykinin receptor	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDC00111	B2 bradykinin receptor	Visceral pain	338,780	R52, G89
TTDR00111	Proteinase activated receptor 4	Brain inflammation	.	.
TTDR00111	Proteinase activated receptor 4	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00111	Vasopressin V2 receptor	Cerebral edema	348.5	G93.6
TTDS00111	Vasopressin V2 receptor	Congestive heart failure	428, 428.0	I50
TTDS00111	Vasopressin V2 receptor	Diabetes insipidus	253.5, 588.1	E23.2, N25.1
TTDS00111	Vasopressin V2 receptor	Glaucoma	365	H40-H42
TTDS00111	Vasopressin V2 receptor	Hydronephrosis	591	N13.0-N13.3
TTDS00111	Vasopressin V2 receptor	Hyponatremia	276.1, 428	E87.1, I50
TTDS00111	Vasopressin V2 receptor	Liver cirrhosis	.	K70.3,K71.7,K74
TTDS00111	Vasopressin V2 receptor	Nephrogenic diabetes insipidus	250, 253.5, 588.1	E08-E13, E23.2, N25.1
TTDS00111	Vasopressin V2 receptor	Ocular hypertension	365.04	H40.0
TTDS00111	Vasopressin V2 receptor	Renal colic pain	788	N23
TTDS00111	Vasopressin V2 receptor	Renal diseases	580-599	N00-N39
TTDS00111	Vasopressin V2 receptor	Syndrome of inappropriate secretion of antidiuretic hormone	.	.
TTDS00111	Vasopressin V2 receptor	Von Willebrand's disease	286.4	D68.0
TTDS00111	Vasopressin V2 receptor	Water-retaining diseases	.	.
TTDS00112	Arachidonate 5-lipoxygenase	Adult respiratory distress syndrome	518.5, 518.82	J80
TTDS00112	Arachidonate 5-lipoxygenase	Allergic diseases	995.3	T78.4
TTDS00112	Arachidonate 5-lipoxygenase	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDS00112	Arachidonate 5-lipoxygenase	Antigen-induced decrease in coronary flow and cardiac anaphylaxis	995	T78.2
TTDS00112	Arachidonate 5-lipoxygenase	Asthma	493	J45
TTDS00112	Arachidonate 5-lipoxygenase	Bronchiolar carcinoma	162	C34
TTDS00112	Arachidonate 5-lipoxygenase	Cerebral vasospasm	443.9	I73.9
TTDS00112	Arachidonate 5-lipoxygenase	Cervical cancer	140-229, 180	C00-C96, C53
TTDS00112	Arachidonate 5-lipoxygenase	Chronic myeloid leukemia	205.1	C92.1
TTDS00112	Arachidonate 5-lipoxygenase	Dermatological disorders	.	.
TTDS00112	Arachidonate 5-lipoxygenase	Gastrointestinal cancers	150-159	C15-C26
TTDS00112	Arachidonate 5-lipoxygenase	Glomerulonephritis	580-582	N00, N01, N03, N18
TTDS00112	Arachidonate 5-lipoxygenase	Inflammatory bowel disease	555, 556	K50, K51
TTDS00112	Arachidonate 5-lipoxygenase	Inflammatory lung disease	.	.
TTDS00112	Arachidonate 5-lipoxygenase	Magnesium deficiency dermatitis	692.9	L20-L30
TTDS00112	Arachidonate 5-lipoxygenase	Nephrosis	.	.
TTDS00112	Arachidonate 5-lipoxygenase	Osteoarthritis	715	M15-M19, M47
TTDS00112	Arachidonate 5-lipoxygenase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00112	Arachidonate 5-lipoxygenase	Polyarthritis	.	.
TTDS00112	Arachidonate 5-lipoxygenase	Prion diseases	.	.
TTDS00112	Arachidonate 5-lipoxygenase	Psoriasis	696	L40
TTDS00112	Arachidonate 5-lipoxygenase	Pulmonary fibrosis	515, 516.3	J84.1
TTDS00112	Arachidonate 5-lipoxygenase	Sjogren-Larsson syndrome	757.1	Q87.1
TTDS00112	Arachidonate 5-lipoxygenase	Ulcerative colitis	556	K51
TTDS00112	Arachidonate 5-lipoxygenase	Urological cancers	140-229	C00-C96
TTDS00112	Arachidonate 5-lipoxygenase	Vasospasm	.	.
TTDC00112	Somatostatin receptor type 1	Cushing's disease	255	E24.0
TTDC00112	Somatostatin receptor type 1	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
TTDC00112	Somatostatin receptor type 1	Refractory renal cell carcinoma	189	C64
TTDR00113	Adenylosuccinate synthetase	Malaria	84	B50-B54
TTDS00113	P2Y purinoceptor 12	Aggregation and activation of platelets	.	.
TTDS00113	P2Y purinoceptor 12	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00113	P2Y purinoceptor 12	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDC00113	STAT-1 transcription factor	Inflammatory disorders	.	.
TTDC00113	STAT-1 transcription factor	Ischemic injury	.	.
TTDC00113	STAT-1 transcription factor	Myocardial ischemia; Reperfusion injury	459.89	I99.8
TTDC00113	STAT-1 transcription factor	Skin infections	680-709	L00-L99
TTDC00114	Receptor protein-tyrosine kinase erbB-4	Dermatologic complications	.	.
TTDC00114	Receptor protein-tyrosine kinase erbB-4	Ependymoma	191, 225	C71, D33
TTDC00114	Receptor protein-tyrosine kinase erbB-4	Metastatic Stage IV breast cancer	140-229, 174, 175	C00-C96, C50
TTDR00114	Vasoactive intestinal polypeptide receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00115	Aldose reductase	Analgesics	338	R52
TTDS00115	Aldose reductase	Diabetic complications	250	E08-E13
TTDS00115	Aldose reductase	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDS00115	Aldose reductase	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDS00115	Aldose reductase	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDS00115	Aldose reductase	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00115	GTP cyclohydrolase I	Lesch-nyhan syndrome	.	E79.1
TTDR00115	GTP cyclohydrolase I	Malaria	84	B50-B54
TTDR00115	GTP cyclohydrolase I	Parkinson's disease	332	F02.3, G20
TTDR00116	M-phase inducer phosphatase 2	Cancer	140-229	C00-C96
TTDC00116	Platelet-activating factor acetylhydrolase	Atherosclerosis	414.0, 440	I70
TTDC00116	Platelet-activating factor acetylhydrolase	Cardiovascular disorders	390-459	I00-I99
TTDC00116	Platelet-activating factor acetylhydrolase	Coronary atherosclerosis	414.0, 440	I70
TTDS00116	Solute carrier family 12 member 1	Congestive heart failure	428, 428.0	I50
TTDS00116	Solute carrier family 12 member 1	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDC00117	Nigral tachykinin NK(3) receptor	Arterial hypertension	401	I10, I11, I12, I13, I15
TTDC00117	Nigral tachykinin NK(3) receptor	Depression	311	F32
TTDC00117	Nigral tachykinin NK(3) receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDC00117	Nigral tachykinin NK(3) receptor	Parkinson's disease	332	F02.3, G20
TTDC00117	Nigral tachykinin NK(3) receptor	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
TTDS00117	Solute carrier family 12 member 3	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDS00117	Solute carrier family 12 member 3	Renal failure	584, 585	N17, N18, N19
TTDR00118	Bombesin receptor subtype-3	Cancer	140-229	C00-C96
TTDR00118	Bombesin receptor subtype-3	Obesity	278	E66
TTDC00118	Cellular tumor antigen p53	Bladder cancer	140-229, 188	C00-C96, C67
TTDC00118	Cellular tumor antigen p53	Cancer	140-229	C00-C96
TTDC00118	Cellular tumor antigen p53	Hepatocellular carcinoma	155	C22.0
TTDC00118	Cellular tumor antigen p53	Kidney cancer	140-229	C00-C96
TTDC00118	Cellular tumor antigen p53	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00118	Synaptic vesicle amine transporter	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00118	Synaptic vesicle amine transporter	Neurodegenerative diseases	330-337	G30-G32
TTDR00119	Orexin	Obesity	278	E66
TTDC00119	Transcription factor AP-1	Allergic airway inflammation	460-519, 995.3	J00-J99, T78.4
TTDC00119	Transcription factor AP-1	Breast cancer	174, 175, 217	C50, D24
TTDC00119	Transcription factor AP-1	Cancer	140-229	C00-C96
TTDC00119	Transcription factor AP-1	Melanoma	172.9	C43
TTDC00119	Transcription factor AP-1	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00119	Transcription factor AP-1	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDR00120	Dopamine D2-like receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR00120	Dopamine D2-like receptor	Parkinson's disease	332	F02.3, G20
TTDS00120	Glutamate-gated chloride channel	Helminth infection	001-139	A00-B99
TTDC00120	Protein-glutamine gamma-glutamyltransferase	Burns; Burn infections	001-139	A00-B99
TTDC00120	Protein-glutamine gamma-glutamyltransferase	Coeliac disease	579	K90.0
TTDC00120	Protein-glutamine gamma-glutamyltransferase	Fibrosis	709.2	L90.5
TTDC00120	Protein-glutamine gamma-glutamyltransferase	Neurodegenerative diseases	330-337	G30-G32
TTDC00120	Protein-glutamine gamma-glutamyltransferase	Renal fibrosis	709.2	L90.5
TTDC00120	Protein-glutamine gamma-glutamyltransferase	Scar tissue	.	L00-L99
TTDC00121	C-X-C chemokine receptor type 4	Breast cancer	174, 175, 217	C50, D24
TTDC00121	C-X-C chemokine receptor type 4	HIV infection	001-139, 042	A00-B99, B20
TTDC00121	C-X-C chemokine receptor type 4	Human immunodeficiency virus infection	279.3	D84.9
TTDC00121	C-X-C chemokine receptor type 4	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00121	C-X-C chemokine receptor type 4	Metastatic prostate cancer	140-229, 185, 208.9	C00-C96, C61, C91-C95
TTDC00121	C-X-C chemokine receptor type 4	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00121	C-X-C chemokine receptor type 4	Non-Hodgkin's Lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00121	C-X-C chemokine receptor type 4	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00121	Glutamate receptor AMPA subtype	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDC00122	C-C chemokine receptor type 2	Inflammatory demyelination	.	.
TTDC00122	C-C chemokine receptor type 2	Multiple sclerosis	340	G35
TTDC00122	C-C chemokine receptor type 2	Obese insulin-resistant	250	E11
TTDC00122	C-C chemokine receptor type 2	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00122	Cyclophilin	Cancer	140-229	C00-C96
TTDS00122	Glutamate receptor, ionotropic kainate 1	Analgesics	338	R52
TTDS00122	Glutamate receptor, ionotropic kainate 1	Epilepsy	290-319, 345	F01-F99, G40
TTDS00122	Glutamate receptor, ionotropic kainate 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00123	Glutamate [NMDA] receptor subunit epsilon 1	Analgesics	338	R52
TTDS00123	Glutamate [NMDA] receptor subunit epsilon 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00123	Microsomal triglyceride transfer protein, large subunit	Atherosclerosis	414.0, 440	I70
TTDC00123	Microsomal triglyceride transfer protein, large subunit	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00123	Microsomal triglyceride transfer protein, large subunit	Hyperlipidemia	272.0-272.4	E78
TTDR00123	mRNA of Protein kinase C, alpha type	Cancer	140-229	C00-C96
TTDC00124	Cholesteryl ester transfer protein	Atherosclerosis	414.0, 440	I70
TTDC00124	Cholesteryl ester transfer protein	Coronary atherosclerosis	414.0, 440	I70
TTDC00124	Cholesteryl ester transfer protein	Hypercholesterolemia	272	E78.0
TTDC00124	Cholesteryl ester transfer protein	Hyperlipidemia	272.0-272.4	E78
TTDC00124	Cholesteryl ester transfer protein	Peripheral vascular disease	443.9	I73.9
TTDR00124	mRNA of bcl2	Cancer	140-229	C00-C96
TTDC00125	C-X-C chemokine receptor type 3	Autoimmune diseases	279	D84.9, M35.9
TTDC00125	C-X-C chemokine receptor type 3	Focal stroke	434.91	I61-I63
TTDC00125	C-X-C chemokine receptor type 3	Inflammatory disorders	.	.
TTDC00125	C-X-C chemokine receptor type 3	Insulin-dependent diabetes mellitus	250	E08-E13
TTDC00125	C-X-C chemokine receptor type 3	Multiple sclerosis	340	G35
TTDC00125	C-X-C chemokine receptor type 3	Psoriasis; Psoriatic disorders	696	L40
TTDS00125	Opioid receptor	Alcoholism	303	F10.2
TTDS00125	Opioid receptor	Analgesics	338	R52
TTDS00125	Opioid receptor	Drug dependence	303-305	F10-F19
TTDS00125	Opioid receptor	Eating disorders	307.5	F50
TTDS00125	Opioid receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDS00125	Opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00126	Metabotropic glutamate receptor 3	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00126	Metabotropic glutamate receptor 3	Analgesics	338	R52
TTDC00126	Metabotropic glutamate receptor 3	Epilepsy	290-319, 345	F01-F99, G40
TTDC00126	Metabotropic glutamate receptor 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00126	Metabotropic glutamate receptor 3	Psychosis	290-299	F20-F29
TTDC00126	Metabotropic glutamate receptor 3	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
TTDC00126	Metabotropic glutamate receptor 3	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDS00126	Mu-type opioid receptor	Analgesics	338	R52
TTDS00126	Mu-type opioid receptor	Cough	786.2	R05
TTDS00126	Mu-type opioid receptor	Diarrhea	787.91	A09, K59.1
TTDS00126	Mu-type opioid receptor	Dyspnea	786.09	R06.0
TTDS00126	Mu-type opioid receptor	Opioid-induced bowel dysfunction	.	.
TTDS00126	Mu-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00127	Growth hormone secretagogue receptor type 1	Anorexia	307.1	F50.0-F50.1
TTDC00127	Growth hormone secretagogue receptor type 1	Cachexia	799.4	R64
TTDC00127	Growth hormone secretagogue receptor type 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00127	Growth hormone secretagogue receptor type 1	Gastrointestinal diseases	.	.
TTDC00127	Growth hormone secretagogue receptor type 1	Gastroparesis	536.3	K31.8
TTDC00127	Growth hormone secretagogue receptor type 1	Ileus	537.2, 560.1, 560.31, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, P76.1
TTDC00127	Growth hormone secretagogue receptor type 1	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00127	Kappa-type opioid receptor	Alcohol dependence	303	F10.2
TTDS00127	Kappa-type opioid receptor	Analgesics	338	R52
TTDS00127	Kappa-type opioid receptor	Behcet's disease	136.1	M35.2
TTDS00127	Kappa-type opioid receptor	Diarrhea	787.91	A09, K59.1
TTDS00127	Kappa-type opioid receptor	Dyspnea	786.09	R06.0
TTDS00127	Kappa-type opioid receptor	Focal ischemia	459.89	I99.8
TTDS00127	Kappa-type opioid receptor	Immune disease	.	.
TTDS00127	Kappa-type opioid receptor	Neurodegenerative diseases	330-337	G30-G32
TTDS00127	Kappa-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00128	Delta-type opioid receptor	Analgesics	338	R52
TTDS00128	Delta-type opioid receptor	Cough	786.2	R05
TTDS00128	Delta-type opioid receptor	Dyspnea	786.09	R06.0
TTDS00128	Delta-type opioid receptor	Ischemia	459.89	I99.8
TTDS00128	Delta-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00128	Delta-type opioid receptor	Parkinson's disease	332	F02.3, G20
TTDC00128	Potassium voltage-gated channel subfamily KQT member 3	Analgesics	338	R52
TTDC00128	Potassium voltage-gated channel subfamily KQT member 3	Epilepsy	290-319, 345	F01-F99, G40
TTDC00128	Potassium voltage-gated channel subfamily KQT member 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00128	mRNA of protein kinase C	Cancer	140-229	C00-C96
TTDC00129	Leukotriene B4 receptor 1	Adverse effects in chemotherapy	.	.
TTDC00129	Leukotriene B4 receptor 1	Asthma	493	J45
TTDC00129	Leukotriene B4 receptor 1	Cancer	140-229	C00-C96
TTDC00129	Leukotriene B4 receptor 1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDC00129	Leukotriene B4 receptor 1	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDC00129	Leukotriene B4 receptor 1	Immunological disorders	.	.
TTDC00129	Leukotriene B4 receptor 1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00129	Leukotriene B4 receptor 1	Renal cell carcinoma	189	C64
TTDC00129	Leukotriene B4 receptor 1	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00129	Sigma(1)-type opioid receptor	Neuropsychiatric disorders	.	.
TTDR00129	mRNA of Raf	Lung cancer	162	C33-C34
TTDC00130	Leukotriene A-4 hydrolase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00130	Leukotriene A-4 hydrolase	Myeloid leukemia	208.9	C91-C95
TTDC00130	Leukotriene A-4 hydrolase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00130	Leukotriene A-4 hydrolase	Oesophageal cancer	140-229	C00-C96
TTDC00130	Leukotriene A-4 hydrolase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00130	Tryptase	Allergic airway inflammation	460-519, 995.3	J00-J99, T78.4
TTDS00130	Tryptase	Asthma	493	J45
TTDS00130	Tryptase	Coagulative disorders	286	D65-D69
TTDS00130	Tryptase	Conjunctivitis	372	H10
TTDS00130	Tryptase	Mast cell-mediated diseases	.	.
TTDS00130	Tryptase	Rhinitis	472.0, 477	J00, J30, J31.0
TTDC00131	Fibroblast growth factor receptor 3	Achondroplasia	756.4	Q77.4
TTDC00131	Fibroblast growth factor receptor 3	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00131	Fibroblast growth factor receptor 3	Osteopenic disorders	.	.
TTDC00131	Fibroblast growth factor receptor 3	Skeletal disorders	.	.
TTDC00131	Fibroblast growth factor receptor 3	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00131	Fibroblast growth factor receptor 3	T myeloma	203	C90.0
TTDR00131	Melanin-concentrating hormone receptor	Obesity	278	E66
TTDS00131	Tumor necrosis factor	Asthma	493	J45
TTDS00131	Tumor necrosis factor	Behcet's disease	136.1	M35.2
TTDS00131	Tumor necrosis factor	Chronic inflammatory diseases	.	.
TTDS00131	Tumor necrosis factor	Congestive heart failure	428, 428.0	I50
TTDS00131	Tumor necrosis factor	Crohn's disease	555	K50
TTDS00131	Tumor necrosis factor	Heart failure	410, 428	I21, I22, I50
TTDS00131	Tumor necrosis factor	Hyperimmunoglobulinemia D	.	.
TTDS00131	Tumor necrosis factor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00131	Tumor necrosis factor	Periodic fever syndrome	780.6	R50
TTDS00131	Tumor necrosis factor	Rheumatic diseases	.	.
TTDS00131	Tumor necrosis factor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00131	Tumor necrosis factor	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00132	Immunoglobulin E	Allergic diseases	995.3	T78.4
TTDS00132	Immunoglobulin E	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDS00132	Immunoglobulin E	Asthma	493	J45
TTDR00133	L-lactate dehydrogenase	Malaria	84	B50-B54
TTDR00133	L-lactate dehydrogenase	Toxoplasmic encephalitis	323	A83-A86, B94.1, G05
TTDS00133	Lyso-PAF: acetyl-CoA acetyltransferase 	Allergic diseases	995.3	T78.4
TTDS00133	Lyso-PAF: acetyl-CoA acetyltransferase 	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00133	Melanin-concentrating hormone receptor 1	Obesity	278	E66
TTDC00133	Melanin-concentrating hormone receptor 1	Social anxiety disorder	300	F40-F42
TTDC00133	Melanin-concentrating hormone receptor 1	Vitiligo	709.01	L80
TTDC00134	Heme oxygenase 1	Atherosclerosis	414.0, 440	I70
TTDC00134	Heme oxygenase 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00134	Heme oxygenase 1	Cerebral vasospasm	443.9	I73.9
TTDC00134	Heme oxygenase 1	Chronic myeloid leukemia	205.1	C92.1
TTDC00134	Heme oxygenase 1	Crohn's disease	555	K50
TTDC00134	Heme oxygenase 1	Ischemic injury of the liver	.	.
TTDC00134	Heme oxygenase 1	Kaposi's sarcoma	176	C46
TTDC00134	Heme oxygenase 1	Neonatal hyperbilirubinemia; Jaundice	773, 774, 782.4	P58, P59, R17
TTDC00134	Heme oxygenase 1	Oxidative tissue injuries	.	.
TTDC00134	Heme oxygenase 1	Ulcerative colitis	556	K51
TTDC00134	Heme oxygenase 1	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00134	Insulin-degrading Enzyme	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00134	P185HER-2	Breast cancer	174, 175, 217	C50, D24
TTDR00134	P185HER-2	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00135	B-lymphocyte antigen CD19	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00135	B-lymphocyte antigen CD19	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDR00135	Endothelin-converting enzyme 1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00135	Endothelin-converting enzyme 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00135	NMDA receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00135	NMDA receptor	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDS00135	NMDA receptor	Analgesics	338	R52
TTDS00135	NMDA receptor	Chronic pain	338.2,780	R52.1-R52.2, G89
TTDS00135	NMDA receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDS00135	NMDA receptor	Parkinson's disease	332	F02.3, G20
TTDS00135	NMDA receptor	Psychosis	290-299	F20-F29
TTDS00135	NMDA receptor	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR00136	Endothelin-converting enzyme 2	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00136	Glycogen synthase kinase-3	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00136	Glycogen synthase kinase-3	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDS00136	Glycogen synthase kinase-3	Cancer	140-229	C00-C96
TTDS00136	Glycogen synthase kinase-3	Chronic inflammatory diseases	.	.
TTDS00136	Glycogen synthase kinase-3	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00136	Glycogen synthase kinase-3	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00136	Glycogen synthase kinase-3	Traumatic head injury	800-879	S00.0S09
TTDC00136	Interleukin-7 receptor alpha chain	Acquired immune deficiency syndrome (AIDS)	001-139, 042	A00-B99, B20
TTDC00136	Interleukin-7 receptor alpha chain	Cancer	140-229	C00-C96
TTDC00136	Interleukin-7 receptor alpha chain	Immunodeficiency	279.3	D84.9
TTDC00136	Interleukin-7 receptor alpha chain	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00137	Neural-cadherin	Breast cancer	174, 175, 217	C50, D24
TTDC00137	Neural-cadherin	Cancer	140-229	C00-C96
TTDC00137	Neural-cadherin	Melanoma	172.9	C43
TTDC00137	Neural-cadherin	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00137	Neural-cadherin	Restenosis	.	I51.89
TTDC00137	Neural-cadherin	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00137	Neural-cadherin	Vascular bypass graft failure	.	.
TTDR00137	Threonine deaminase	Vitamin B6 deficiency	266.1	E53.1
TTDS00138	Interleukin 1 receptor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00138	Interleukin-10	Group B streptococcus arthritis	710-719	M00-M25
TTDR00138	Interleukin-10	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00138	Interleukin-10	Lupus erythematosus	695, 710.0	L51-L54, M32
TTDR00138	Interleukin-10	Osteoarthritis	715	M15-M19, M47
TTDR00138	Interleukin-10	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDC00138	NRH dehydrogenase [quinone] 2	Cancer	140-229	C00-C96
TTDC00138	NRH dehydrogenase [quinone] 2	Malaria	84	B50-B54
TTDC00138	NRH dehydrogenase [quinone] 2	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00139	Interleukin-2 receptor	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDS00139	Interleukin-2 receptor	Neoplastic diseases	.	.
TTDC00139	Serine/threonine protein kinase 12	Cancer	140-229	C00-C96
TTDC00139	Serine/threonine protein kinase 12	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00139	Serine/threonine protein kinase 12	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00140	Acetylcholinesterase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00140	Acetylcholinesterase	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDS00140	Acetylcholinesterase	Hypoxic-ischemic encephalopathy	.	.
TTDS00140	Acetylcholinesterase	Motor neurone disease	335.2	G12.2
TTDS00140	Acetylcholinesterase	Parkinson's disease	332	F02.3, G20
TTDC00140	PI3K gamma	Angioedema	277.6, 995.1	D84.1, T78.3
TTDC00140	PI3K gamma	Cancer	140-229	C00-C96
TTDC00140	PI3K gamma	Heart failure	410, 428	I21, I22, I50
TTDC00140	PI3K gamma	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00140	PI3K gamma	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00141	Glucokinase	Diabetes mellitus	250, 278	E08-E13
TTDR00141	Interleukin-2	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00141	Neuronal acetylcholine receptor protein, alpha-4 chain	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00141	Neuronal acetylcholine receptor protein, alpha-4 chain	Analgesics	338	R52
TTDS00141	Neuronal acetylcholine receptor protein, alpha-4 chain	Drug dependence	303-305	F10-F19
TTDS00141	Neuronal acetylcholine receptor protein, alpha-4 chain	Frontal lobe epilepsy	345	G40
TTDS00141	Neuronal acetylcholine receptor protein, alpha-4 chain	Neurodegenerative diseases	330-337	G30-G32
TTDS00141	Neuronal acetylcholine receptor protein, alpha-4 chain	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00142	DNA topoisomerase	Cancer	140-229	C00-C96
TTDC00142	mRNA of Clusterin	Advanced lung cancer	140-229, 162	C00-C96, C33-C34
TTDC00142	mRNA of Clusterin	Breast cancer	174, 175, 217	C50, D24
TTDC00142	mRNA of Clusterin	Lung cancer	162	C33-C34
TTDC00142	mRNA of Clusterin	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00143	Cholinesterase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00143	Cholinesterase	Schizophrenia	295, 710.0	F20, M32
TTDC00143	Kinesin-like protein KIF11	Cancer	140-229	C00-C96
TTDC00143	Kinesin-like protein KIF11	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDC00143	Kinesin-like protein KIF11	Lung cancer	162	C33-C34
TTDC00143	Kinesin-like protein KIF11	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00143	Kinesin-like protein KIF11	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00143	Kinesin-like protein KIF11	Pediatric disease	.	.
TTDC00143	Kinesin-like protein KIF11	Renal cell carcinoma	189	C64
TTDC00143	Kinesin-like protein KIF11	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00144	Erythropoietin Receptor	Anemia	280-285	D50-D64
TTDC00144	Neurotensin receptor type 1	Acute pain; Chronic pain	338,780	R52, G89
TTDC00144	Neurotensin receptor type 1	Analgesics	338	R52
TTDC00144	Neurotensin receptor type 1	Colorectal cancer	153, 154	C18-C21
TTDC00144	Neurotensin receptor type 1	Depression	311	F32
TTDC00144	Neurotensin receptor type 1	Lung cancer	162	C33-C34
TTDC00144	Neurotensin receptor type 1	NTR-positive tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00144	Neurotensin receptor type 1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00144	Neurotensin receptor type 1	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00144	Neurotensin receptor type 1	Psychosis	290-299	F20-F29
TTDC00144	Neurotensin receptor type 1	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
TTDS00145	Calcium-activated potassium channel	Acute graft-versus-host disease	279.5	T86.0
TTDS00145	Calcium-activated potassium channel	Anemia	280-285	D50-D64
TTDS00145	Calcium-activated potassium channel	Autoimmune diseases	279	D84.9, M35.9
TTDS00145	Calcium-activated potassium channel	Chronic graft-versus-host disease	279.5	T86.0
TTDS00145	Calcium-activated potassium channel	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDS00145	Calcium-activated potassium channel	Diarrhea	787.91	A09, K59.1
TTDS00145	Calcium-activated potassium channel	Sickle cell anemia	280-285	D50-D64
TTDR00145	Prostaglandin E receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDC00145	Ribosomal protein S6 kinase	Cancer	140-229	C00-C96
TTDC00145	Ribosomal protein S6 kinase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00146	Mitogen-activated protein kinase kinase kinase 4	Breast cancer	174, 175, 217	C50, D24
TTDR00146	Mitogen-activated protein kinase kinase kinase 4	Melanoma	172.9	C43
TTDR00146	Mitogen-activated protein kinase kinase kinase 4	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00146	Mitogen-activated protein kinase kinase kinase 4	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00146	Mitogen-activated protein kinase kinase kinase 4	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00147	Dual specificity mitogen-activated protein kinase kinase 7	Cancer	140-229	C00-C96
TTDR00147	Dual specificity mitogen-activated protein kinase kinase 7	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00147	Dual specificity mitogen-activated protein kinase kinase 7	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00147	Interstitial collagenase	Cancer	140-229	C00-C96
TTDC00147	Interstitial collagenase	Chondrosarcoma	170.9	C41.9
TTDC00147	Interstitial collagenase	Emphysema	492	J43
TTDC00147	Interstitial collagenase	Hormone-refractory prostate cancer	140-229, 185, 203.0	C00-C96, C61, C90.0
TTDC00147	Interstitial collagenase	Kaposi's sarcoma	176	C46
TTDC00147	Interstitial collagenase	Lung cancer	162	C33-C34
TTDC00147	Interstitial collagenase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00147	Interstitial collagenase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00147	Interstitial collagenase	Osteoarthritis	715	M15-M19, M47
TTDC00147	Interstitial collagenase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00147	Potassium voltage-gated channel subfamily H member 2	Cardiac arrhythmias	427	I47-I49
TTDR00148	Dual specificity mitogen-activated protein kinase kinase 1	Breast cancer	174, 175, 217	C50, D24
TTDR00148	Dual specificity mitogen-activated protein kinase kinase 1	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00148	Integrin beta-1	Asthma	493	J45
TTDC00148	Integrin beta-1	Macular degeneration	362.5	H35.3
TTDC00148	Integrin beta-1	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00148	Integrin beta-1	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00148	Potassium voltage-gated channel subfamily KQT member 1	Cardiac arrhythmias	427	I47-I49
TTDR00149	Dual specificity mitogen-activated protein kinase kinase 5	Breast cancer	174, 175, 217	C50, D24
TTDS00149	Potassium voltage-gated channel subfamily KQT member 4	Convulsions	780.3	R56.0
TTDC00149	Steryl-sulfatase	Androgen-dependent diseases	.	.
TTDC00149	Steryl-sulfatase	Breast cancer	174, 175, 217	C50, D24
TTDC00149	Steryl-sulfatase	Estrogen disorders	.	.
TTDC00149	Steryl-sulfatase	Hormone-sensitive breast cancer	140-229, 174, 175	C00-C96, C50
TTDC00149	Steryl-sulfatase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00150	ATP-sensitive K+ channel	Hypertonicity of bladder	188	C67
TTDS00150	ATP-sensitive K+ channel	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00150	Collagenase 3	Brain cancer	191, 225.0	C71, D33
TTDC00150	Collagenase 3	Hormone-refractory prostate cancer	140-229, 185, 203.0	C00-C96, C61, C90.0
TTDC00150	Collagenase 3	Kaposi's sarcoma	176	C46
TTDC00150	Collagenase 3	Lung cancer	162	C33-C34
TTDC00150	Collagenase 3	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00150	Collagenase 3	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00150	Collagenase 3	Osteoarthritis	715	M15-M19, M47
TTDC00150	Collagenase 3	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00150	Collagenase 3	Squamous cell carcinoma	199	C44
TTDR00150	Mitogen-activated protein kinase kinase	Breast cancer	174, 175, 217	C50, D24
TTDR00150	Mitogen-activated protein kinase kinase	Lung cancer	162	C33-C34
TTDC00151	Prostaglandin E2 receptor, EP4 subtype	Dry eye	370.33	H16.229
TTDC00151	Prostaglandin E2 receptor, EP4 subtype	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00151	Prostaglandin E2 receptor, EP4 subtype	Renal failure	584, 585	N17, N18, N19
TTDC00151	Prostaglandin E2 receptor, EP4 subtype	Ulcerative colitis	556	K51
TTDC00152	Fructose-1,6-bisphosphatase	Type 2 diabetes	250.00, 250.02	E11
TTDR00152	G2/mitotic-specific cyclin B1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00153	Na-K-2Cl cotransporter	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDC00153	Orexin receptor type 1	Gastrointestinal motility disorders	.	.
TTDC00153	Orexin receptor type 1	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDC00153	Orexin receptor type 1	Insulin disorders	.	.
TTDC00153	Orexin receptor type 1	Nausea and vomiting	787, 787.0	R11
TTDC00153	Orexin receptor type 1	Nutritional disorders	260-269	E40-E64
TTDC00153	Orexin receptor type 1	Sleep disorders	307.4, 327, 780.5	F51, G47
TTDC00153	Orexin receptor type 1	Sleeping sickness	.	.
TTDR00154	Lactase-phlorizin hydrolase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00155	5-hydroxytryptamine 1 receptor	Migraine	346	G43
TTDC00155	Motilin receptor	Eating disorders	307.5	F50
TTDC00155	Motilin receptor	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
TTDC00155	Motilin receptor	Gastrointestinal diseases	.	.
TTDC00155	Motilin receptor	Gastrointestinal reflux disorders	530	K21
TTDC00155	Motilin receptor	Gastroparesis	536.3	K31.8
TTDC00155	Motilin receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDC00155	Motilin receptor	Obesity	278	E66
TTDS00155	Sodium channel	Analgesics	338	R52
TTDS00155	Sodium channel	Cardiac dysrhythmias	427	I47-I49
TTDS00155	Sodium channel	Epilepsy	290-319, 345	F01-F99, G40
TTDS00155	Sodium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00156	Tyrosine-protein kinase SYK	Allergic reaction	995.3	T78.4
TTDC00156	Tyrosine-protein kinase SYK	Asthma	493	J45
TTDC00156	Tyrosine-protein kinase SYK	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00156	Tyrosine-protein kinase SYK	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00156	Tyrosine-protein kinase SYK	Obstructive airway disease	.	.
TTDC00156	Tyrosine-protein kinase SYK	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00156	Tyrosine-protein kinase SYK	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
TTDS00156	Voltage-gated sodium channel	Analgesics	338	R52
TTDS00156	Voltage-gated sodium channel	Epilepsy	290-319, 345	F01-F99, G40
TTDS00156	Voltage-gated sodium channel	Injury to spine and spinal cord	.	.
TTDS00156	Voltage-gated sodium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00157	5-hydroxytryptamine 7 receptor	Migraine	346	G43
TTDR00157	5-hydroxytryptamine 7 receptor	Neuropsychiatric disorders	.	.
TTDC00157	Macrophage metalloelastase	Atherosclerosis	414.0, 440	I70
TTDC00157	Macrophage metalloelastase	Crohn's disease	555	K50
TTDC00157	Macrophage metalloelastase	Emphysema	492	J43
TTDC00157	Macrophage metalloelastase	Gastro-intestinal ulcers	531	K25
TTDC00157	Macrophage metalloelastase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDC00157	Macrophage metalloelastase	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00157	Macrophage metalloelastase	Renal cell carcinoma	189	C64
TTDC00157	Macrophage metalloelastase	Ulcerative colitis	556	K51
TTDS00157	Voltage-gated sodium channel subunit alpha Nav1.8	Analgesics	338	R52
TTDS00157	Voltage-gated sodium channel subunit alpha Nav1.8	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00157	Voltage-gated sodium channel subunit alpha Nav1.8	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDS00157	Voltage-gated sodium channel subunit alpha Nav1.8	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00158	Alanine racemase, biosynthetic	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00158	Alanine racemase, biosynthetic	Tuberculosis	010-018	A15-A19
TTDR00158	Alanine racemase, biosynthetic	Vitamin B6 deficiency	266.1	E53.1
TTDS00158	Amiloride-sensitive sodium channel alpha-subunit	Analgesics	338	R52
TTDS00158	Amiloride-sensitive sodium channel alpha-subunit	Convulsions	780.3	R56.0
TTDS00158	Amiloride-sensitive sodium channel alpha-subunit	Depression	311	F32
TTDS00158	Amiloride-sensitive sodium channel alpha-subunit	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00158	Amiloride-sensitive sodium channel alpha-subunit	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDC00158	Sodium/glucose cotransporter 2	Atherosclerosis	414.0, 440	I70
TTDC00158	Sodium/glucose cotransporter 2	Hyperglycemia	790.29	R73.9
TTDC00158	Sodium/glucose cotransporter 2	Hyperinsulinemia	.	E16.1
TTDC00158	Sodium/glucose cotransporter 2	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00158	Sodium/glucose cotransporter 2	Obesity	278	E66
TTDC00158	Sodium/glucose cotransporter 2	Type 2 diabetes	250.00, 250.02	E11
TTDC00159	Histone deacetylase 4	Acne vulgaris	706.1	L70.0
TTDC00159	Histone deacetylase 4	Basal cell carcinoma	140-199, 173, 210-229	C00-C75, C44, C7A, C7B, D10-D36, D3A
TTDC00159	Histone deacetylase 4	Bladder cancer	140-229, 188	C00-C96, C67
TTDC00159	Histone deacetylase 4	Colorectal cancer	153, 154	C18-C21
TTDC00159	Histone deacetylase 4	Cutaneous T-cell lymphoma	202.1, 202.2, 202.8, 208.9	C81-C96, C84.0, C84.1, C91-C95
TTDC00159	Histone deacetylase 4	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
TTDC00159	Histone deacetylase 4	Liver cancers	155.2	C22.9
TTDC00159	Histone deacetylase 4	Lymphoid leukemia	208.9	C91-C95
TTDC00159	Histone deacetylase 4	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDC00159	Histone deacetylase 4	Melanoma; Prostate cancer	140-229, 172, 185	C00-C96, C43, C61
TTDC00159	Histone deacetylase 4	Mesothelioma	163	C45
TTDC00159	Histone deacetylase 4	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00159	Histone deacetylase 4	Myelodisplastic syndrome	238.7	D46
TTDC00159	Histone deacetylase 4	Myeloid leukemia	208.9	C91-C95
TTDC00159	Histone deacetylase 4	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00159	Histone deacetylase 4	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00159	Histone deacetylase 4	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00159	Histone deacetylase 4	Renal cell carcinoma	189	C64
TTDC00159	Histone deacetylase 4	Sarcoma	202.8	C81-C96
TTDC00159	Histone deacetylase 4	Skin cancer	172, 173	C43-C44
TTDC00159	Histone deacetylase 4	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00159	Isoleucyl-tRNA synthetase, cytoplasmic (human)	Autoimmune diseases	279	D84.9, M35.9
TTDC00160	Serine/threonine-protein kinase PLK1	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDC00160	Serine/threonine-protein kinase PLK1	Advanced solid tumor	140-199	C00-C75, C7A, C7B
TTDC00160	Serine/threonine-protein kinase PLK1	Cancer	140-229	C00-C96
TTDC00160	Serine/threonine-protein kinase PLK1	Metastatic hormone refractory Prostate cancer	185	C61
TTDC00160	Serine/threonine-protein kinase PLK1	Non-Hodgkin's Lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00160	Serine/threonine-protein kinase PLK1	Non-small cell lung cancer 	162	C33-C34
TTDC00160	Serine/threonine-protein kinase PLK1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00160	Serine/threonine-protein kinase PLK1	Pancreatic cancer; Prostate cancer	140-229, 157, 185	C00-C96, C25, C61
TTDS00160	Voltage-dependent L-type calcium channel	Analgesics	338	R52
TTDS00160	Voltage-dependent L-type calcium channel	Angina pectoris	413	I20
TTDS00160	Voltage-dependent L-type calcium channel	Bronchoconstriction	493	J45
TTDS00160	Voltage-dependent L-type calcium channel	Cardiac dysrhythmias	427	I47-I49
TTDS00160	Voltage-dependent L-type calcium channel	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00160	Voltage-dependent L-type calcium channel	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00160	Voltage-dependent L-type calcium channel	Iron-overload cardiomyopathy	.	.
TTDS00160	Voltage-dependent L-type calcium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00160	Voltage-dependent L-type calcium channel	Psychiatric illness	.	.
TTDC00161	Angiopoietin 1 receptor	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00161	Platelet activating factor	Acute pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDR00161	Platelet activating factor	Allergic diseases	995.3	T78.4
TTDR00161	Platelet activating factor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDR00161	Platelet activating factor	Asthma	493	J45
TTDR00161	Platelet activating factor	Cerebral edema	348.5	G93.6
TTDR00161	Platelet activating factor	Cerebral ischemia	459.89	I99.8
TTDR00161	Platelet activating factor	Gut barrier dysfunction	.	.
TTDR00161	Platelet activating factor	Hepatic warm ischemic injury	.	.
TTDR00161	Platelet activating factor	Hypotension	458, 796.3	I95
TTDR00161	Platelet activating factor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00161	Platelet activating factor	Ischemia reperfusion injuries	459.89	I99.8
TTDR00161	Platelet activating factor	Male infertility asthenospermia	606, 628	N46, N97.0
TTDR00161	Platelet activating factor	Mild pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDR00161	Platelet activating factor	Myocardial ischemia; Reperfusion injury	459.89	I99.8
TTDR00161	Platelet activating factor	Necrotizing enterocolitis	.	.
TTDR00161	Platelet activating factor	Ocular inflammation	.	H00-H59
TTDR00161	Platelet activating factor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00161	Platelet activating factor	Septic shock	785.52	A41.9
TTDR00161	Platelet activating factor	Shock hemorrhagic	.	.
TTDR00161	Platelet activating factor	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Analgesics	338	R52
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Angina pectoris	413	I20
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Cardiac dysrhythmias	427	I47-I49
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Epilepsy	290-319, 345	F01-F99, G40
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Heart failure	410, 428	I21, I22, I50
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Hypoinsulinemia	.	.
TTDS00161	Voltage-dependent T-type calcium channel alpha-1G subunit	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDC00162	Glycogen synthase kinase-3 beta	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00162	Glycogen synthase kinase-3 beta	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDC00162	Glycogen synthase kinase-3 beta	Brain injury	.	S09.90
TTDC00162	Glycogen synthase kinase-3 beta	Immunodeficiency	279.3	D84.9
TTDC00162	Glycogen synthase kinase-3 beta	Ischemia	459.89	I99.8
TTDC00162	Glycogen synthase kinase-3 beta	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00163	Calcium channel	Analgesics	338	R52
TTDS00163	Calcium channel	Cerebral ischemia	459.89	I99.8
TTDS00163	Calcium channel	Epilepsy	290-319, 345	F01-F99, G40
TTDS00163	Calcium channel	Head injury	800-879	S00.0S09
TTDS00163	Calcium channel	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00163	Calcium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00163	Calcium channel	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00163	Calcium channel	Unstable angina	411.1	I20.0
TTDC00163	Protein kinase C, beta type	B-lineage malignancies	140-239	C00-C96
TTDC00163	Protein kinase C, beta type	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDC00163	Protein kinase C, beta type	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDC00163	Protein kinase C, beta type	Macular edema	362.01, 362.53	H35.8
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Cancer	140-229	C00-C96
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Heart failure	410, 428	I21, I22, I50
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Immunodeficiency	279.3	D84.9
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Proliferative diseases	.	.
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Psoriasis	696	L40
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Restenosis	.	I51.89
TTDC00164	Dual specificity mitogen-activated protein kinase kinase	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00164	Extracellular calcium-sensing receptor	Hyperparathyroidism	252.02, 588.81	E21.1
TTDR00164	Neuronal acetylcholine receptor protein, beta-4 chain	Specific cognitive deficits associated with aging and neurological diseases	.	.
TTDC00165	Cell division protein kinase 4	Cancer	140-229	C00-C96
TTDC00165	Cell division protein kinase 4	Insulin-dependent diabetes mellitus	250	E08-E13
TTDC00165	Cell division protein kinase 4	Squamous cell carcinoma	199	C44
TTDR00165	D-alanine--D-alanine ligase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00165	Ryanodine receptor 1	Malignant hyperthermia	995.86	T88.3
TTDC00166	Cell division control protein 2 homolog	Cancer	140-229	C00-C96
TTDC00166	Cell division control protein 2 homolog	Malaria	84	B50-B54
TTDR00166	Glutamate-1-semialdehyde aminomutase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00166	Glutamate-1-semialdehyde aminomutase	Vitamin B6 deficiency	266.1	E53.1
TTDS00167	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00167	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR00167	Dihydroorotase	Malaria	84	B50-B54
TTDC00168	Antiapoptotic protein BCL-XL	Anaplastic large cell lymphomas	202.8	C81-C96
TTDC00168	Antiapoptotic protein BCL-XL	Colorectal cancer	153, 154	C18-C21
TTDC00168	Antiapoptotic protein BCL-XL	Mesothelioma	163	C45
TTDR00168	Cannabinoid receptor	Atherosclerosis	414.0, 440	I70
TTDR00168	Cannabinoid receptor	Essential hypertension	401	I10, I11, I12, I13, I15
TTDR00168	Cannabinoid receptor	Heart failure	410, 428	I21, I22, I50
TTDR00168	Cannabinoid receptor	Pulmonary hypertension	416	I27.0, I27.2
TTDR00168	Cannabinoid receptor	Subarachnoid hemorrhage	430, 852.0, 852.1	I60, P10.3, S06.6
TTDS00168	Prostaglandin E2 receptor, EP2 subtype	Cerebral oxidative damage	.	.
TTDC00169	Cell division protein kinase 6	Cancer	140-229	C00-C96
TTDR00169	Heat shock protein 70	Arthritis	710-719	M00-M25
TTDR00169	Heat shock protein 70	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00169	Heat shock protein 70	Polyglutamine diseases	.	.
TTDS00169	Prostaglandin F2-alpha receptor	Bone disorders	710-739	M00-M99
TTDS00169	Prostaglandin F2-alpha receptor	Dysmenorrhea	625.3	N94.4-N94.6
TTDS00169	Prostaglandin F2-alpha receptor	Glaucoma	365	H40-H42
TTDS00169	Prostaglandin F2-alpha receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00169	Prostaglandin F2-alpha receptor	Ocular hypertension	365.04	H40.0
TTDC00170	Phosphodiesterase isozyme 4; PDE4	Asthma	493	J45
TTDC00170	Phosphodiesterase isozyme 4; PDE4	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDC00170	Phosphodiesterase isozyme 4; PDE4	Osteosarcoma	170	C40-C41
TTDS00170	Prostacyclin receptor	Analgesics	338	R52
TTDS00170	Prostacyclin receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00170	Prostacyclin receptor	Inflammatory pain	338,780	R52, G89
TTDR00170	Putative tryptase delta	Asthma	493	J45
TTDR00171	CAD protein	Cancer	140-229	C00-C96
TTDS00171	Fibroblast growth factor receptor 2	Angiogenesis	.	.
TTDC00171	Guanylyl cyclase C	Colorectal cancer	153, 154	C18-C21
TTDR00172	Cholinephosphate cytidylyltransferase	Cancer	140-229	C00-C96
TTDR00172	Cholinephosphate cytidylyltransferase	Malaria	84	B50-B54
TTDS00172	Serotonin re-uptake	Anxiety disorders	300	F40-F42
TTDS00172	Serotonin re-uptake	Depression	311	F32
TTDS00172	Serotonin re-uptake	Dysphoria	.	.
TTDS00172	Serotonin re-uptake	Obesity	278	E66
TTDS00172	Serotonin re-uptake	Psychiatric illness	.	.
TTDS00172	Serotonin re-uptake	Social phobias	300.23	F40.1
TTDR00173	Adenylate cyclase, type II	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR00173	Adenylate cyclase, type II	Heart failure	410, 428	I21, I22, I50
TTDR00173	Adenylate cyclase, type II	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00174	Neuraminidase	Influenza virus infection	487, 488	J10, J11
TTDR00174	Potassium channel	Cerebral vasospasm	443.9	I73.9
TTDR00174	Potassium channel	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00175	Influenza A virus M2 protein	Influenza A virus infections	487, 488	J10, J11
TTDR00175	Integrin beta-3	Platelet adhesion	.	.
TTDC00176	Placenta growth factor	Angiogenesis	.	.
TTDC00176	Placenta growth factor	Cancer	140-229	C00-C96
TTDC00176	Placenta growth factor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00176	Placenta growth factor	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00176	Placenta growth factor	Myocardial ischemia	410, 459.89	I21, I22, I99.8
TTDR00176	Vasopressin V1 receptor	Syndrome of inappropriate secretion of antidiuretic hormone	.	.
TTDS00177	Fatty-acid amide hydrolase	Analgesics	338	R52
TTDS00177	Fatty-acid amide hydrolase	Anesthetic	338	R52
TTDS00177	Fatty-acid amide hydrolase	Anxiety disorders	300	F40-F42
TTDS00177	Fatty-acid amide hydrolase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00177	Fatty-acid amide hydrolase	Sedation	338	R52
TTDR00177	Immunoglobulin A	Arthritis	710-719	M00-M25
TTDC00177	Interleukin-13	Airway hyperreactivity in asthma	493	J45
TTDC00177	Interleukin-13	Allergy	995.3	T78.4
TTDC00177	Interleukin-13	Asthma	493	J45
TTDC00177	Interleukin-13	Atopic disease	691.8	L20
TTDC00177	Interleukin-13	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00177	Interleukin-13	Ocular allergy	360-379	H00-H59
TTDC00177	Interleukin-13	Parasitic infections of the eye	001-139	A00-B99
TTDC00177	Interleukin-13	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00178	DNA gyrase A subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00178	DNA gyrase A subunit	Urinary tract infections	599	N39.0
TTDC00178	Protein kinase C, theta type	Immune disease	.	.
TTDC00178	Protein kinase C, theta type	T cell leukemias	208.9	C91-C95
TTDC00179	P2Y purinoceptor 2	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDC00179	P2Y purinoceptor 2	Dry eye	370.33	H16.229
TTDC00179	P2Y purinoceptor 2	Glaucoma	365	H40-H42
TTDC00179	P2Y purinoceptor 2	Oesophageal cancer	140-229	C00-C96
TTDS00179	Prolyl 4-hydroxylase alpha subunit	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00179	Prolyl 4-hydroxylase alpha subunit	Vitamin C deficiency	267	E54
TTDR00179	V beta 3 T-cell receptor	Arthritis	710-719	M00-M25
TTDR00179	V beta 3 T-cell receptor	Autoimmune diseases	279	D84.9, M35.9
TTDC00180	Amyloid beta A4 protein	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00180	Amyloid beta A4 protein	Dementia	290-294, 331.0	F01-F07, G30
TTDC00180	Amyloid beta A4 protein	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00180	Transforming growth factor receptor b	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDR00180	Transforming growth factor receptor b	Liver cancers	155.2	C22.9
TTDS00181	Angiotensin-converting enzyme	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00181	Angiotensin-converting enzyme	Heart failure	410, 428	I21, I22, I50
TTDS00181	Angiotensin-converting enzyme	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00181	Angiotensin-converting enzyme	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00181	Protein kinase C	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDC00181	Protein kinase C	Cancer	140-229	C00-C96
TTDC00181	Protein kinase C	Proteinuria-induced tubular injury	.	.
TTDC00181	Protein kinase C	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDR00181	Transforming growth factor alpha	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00182	D-alanyl-D-alanine carboxypeptidase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00182	Protein kinase C, alpha type	Leukemia	208.9	C91-C95
TTDC00182	Protein kinase C, alpha type	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00182	T-cell receptor beta chain V region CTL-L17	Arthritis	710-719	M00-M25
TTDR00182	T-cell receptor beta chain V region CTL-L17	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00183	Cysteinyl leukotriene receptor 1	Asthma	493	J45
TTDR00183	Gamma-aminobutyric acid gated chloride channel	Convulsions	780.3	R56.0
TTDR00183	Gamma-aminobutyric acid gated chloride channel	Dermacentor variabilis infection	001-139	A00-B99
TTDC00183	Neuropilin-1	Cancer	140-229	C00-C96
TTDC00184	Beta-3 adrenergic receptor	Cardiac arrhythmias	427	I47-I49
TTDC00184	Beta-3 adrenergic receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDC00184	Beta-3 adrenergic receptor	Gain weight in morbid obesity	278	E66
TTDC00184	Beta-3 adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDC00184	Beta-3 adrenergic receptor	Hypertonicity of bladder	188	C67
TTDC00184	Beta-3 adrenergic receptor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00184	Beta-3 adrenergic receptor	Obesity	278	E66
TTDC00184	Beta-3 adrenergic receptor	Overactive bladder disorder	188, 596.51	C67, N32.81
TTDR00184	Galanin receptor type 1	Convulsions	780.3	R56.0
TTDR00184	Galanin receptor type 1	Obesity	278	E66
TTDC00185	5-hydroxytryptamine 6 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDC00185	5-hydroxytryptamine 6 receptor	Nausea and vomiting	787, 787.0	R11
TTDC00185	5-hydroxytryptamine 6 receptor	Pruritus in chronic liver disease	570-574, 698	K70-K77, L29
TTDC00185	5-hydroxytryptamine 6 receptor	Schizophrenia	295, 710.0	F20, M32
TTDS00185	Adenosine receptor	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00185	N-myc proto-oncogene protein	Cancer	140-229	C00-C96
TTDS00186	Adenosine A1 receptor	Analgesics	338	R52
TTDS00186	Adenosine A1 receptor	Asthma	493	J45
TTDS00186	Adenosine A1 receptor	Cardiac arrhythmias	427	I47-I49
TTDS00186	Adenosine A1 receptor	Chronic ileitis	555-558	K50-K52
TTDS00186	Adenosine A1 receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00186	Adenosine A1 receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDS00186	Adenosine A1 receptor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00186	Adenosine A1 receptor	Obesity-related insulin resistance	.	.
TTDS00186	Adenosine A1 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00186	Adenosine A1 receptor	Renal failure	584, 585	N17, N18, N19
TTDC00186	Interleukin-9	Asthma	493	J45
TTDR00186	Soluble guanylate cyclase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00186	Soluble guanylate cyclase	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR00186	Soluble guanylate cyclase	Heart failure	410, 428	I21, I22, I50
TTDR00186	Soluble guanylate cyclase	Unstable angina	411.1	I20.0
TTDR00186	Soluble guanylate cyclase	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00187	Adenosine A2a receptor	Analgesics	338	R52
TTDS00187	Adenosine A2a receptor	Brain injury	.	S09.90
TTDS00187	Adenosine A2a receptor	Depression	311	F32
TTDS00187	Adenosine A2a receptor	Dyskinesia	333.8	G24.9
TTDS00187	Adenosine A2a receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00187	Adenosine A2a receptor	Ischemia reperfusion injuries	459.89	I99.8
TTDS00187	Adenosine A2a receptor	Neurodegenerative diseases	330-337	G30-G32
TTDS00187	Adenosine A2a receptor	Neuropsychiatric disorders	.	.
TTDS00187	Adenosine A2a receptor	Oxygen-induced retinopathy	362.0-362.2	H35-H35.2
TTDS00187	Adenosine A2a receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00187	Adenosine A2a receptor	Parkinson's disease	332	F02.3, G20
TTDS00187	Adenosine A2a receptor	Renal diseases	580-599	N00-N39
TTDC00187	Tyrosine-protein kinase JAK2	Hodgkin's disease	201	C81
TTDC00187	Tyrosine-protein kinase JAK2	Leukemia	208.9	C91-C95
TTDC00187	Tyrosine-protein kinase JAK2	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00188	Adenosine A2b receptor	Asthma	493	J45
TTDR00188	HIV-2 reverse transcriptase	Human immunodeficiency virus infection	279.3	D84.9
TTDR00188	HIV-2 reverse transcriptase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDC00188	Tumor necrosis factor receptor superfamily member 5	Cancer	140-229	C00-C96
TTDC00188	Tumor necrosis factor receptor superfamily member 5	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00188	Tumor necrosis factor receptor superfamily member 5	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDS00189	Adenosine A3 receptor	Cancer	140-229	C00-C96
TTDS00189	Adenosine A3 receptor	Chronic ileitis	555-558	K50-K52
TTDS00189	Adenosine A3 receptor	Depression	311	F32
TTDS00189	Adenosine A3 receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDS00189	Adenosine A3 receptor	Myocardial ischemia; Reperfusion injury	459.89	I99.8
TTDC00189	Tumor necrosis factor receptor superfamily member 16	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00189	Tumor necrosis factor receptor superfamily member 16	Analgesics	338	R52
TTDC00189	Tumor necrosis factor receptor superfamily member 16	Cancer	140-229	C00-C96
TTDC00189	Tumor necrosis factor receptor superfamily member 16	Neurodegenerative diseases	330-337	G30-G32
TTDC00189	Tumor necrosis factor receptor superfamily member 16	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDC00189	Tumor necrosis factor receptor superfamily member 16	Traumatic neuroma formation	.	.
TTDC00190	High affinity interleukin-8 receptor A	Acute respiratory distress syndrome	518.5, 518.82	J80
TTDC00190	High affinity interleukin-8 receptor A	Asthma	493	J45
TTDC00190	High affinity interleukin-8 receptor A	Human cytomegalovirus infections	001-139, 078.5	A00-B99, B25
TTDC00190	High affinity interleukin-8 receptor A	Lung injury	.	S00-T98
TTDR00190	Tumor necrosis factor receptor	Crohn's disease	555	K50
TTDR00190	Tumor necrosis factor receptor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00191	Poly [ADP-ribose] polymerase-1	Asthma	493	J45
TTDS00191	Poly [ADP-ribose] polymerase-1	Cancer	140-229	C00-C96
TTDS00191	Poly [ADP-ribose] polymerase-1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00191	Poly [ADP-ribose] polymerase-1	Diabetic cardiovascular dysfunction	250	E08-E13
TTDS00191	Poly [ADP-ribose] polymerase-1	Diabetic endothelial dysfunction	250	E08-E13
TTDS00191	Poly [ADP-ribose] polymerase-1	Multiple sclerosis	340	G35
TTDS00191	Poly [ADP-ribose] polymerase-1	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDS00191	Poly [ADP-ribose] polymerase-1	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00192	Glutathione S-transferase	Asthma	493	J45
TTDS00192	Glutathione S-transferase	Cancer	140-229	C00-C96
TTDS00192	Glutathione S-transferase	Helminth infection	001-139	A00-B99
TTDS00192	Glutathione S-transferase	Malaria	84	B50-B54
TTDS00192	Glutathione S-transferase	Multiple sclerosis	340	G35
TTDS00192	Glutathione S-transferase	Neurodegenerative diseases	330-337	G30-G32
TTDS00192	Glutathione S-transferase	Schistosomiasis	120	B65
TTDS00192	Glutathione S-transferase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00192	Tumor necrosis factor receptor superfamily member 8	Cancer	140-229	C00-C96
TTDR00192	Tumor necrosis factor receptor superfamily member 8	Hodgkin's disease	201	C81
TTDC00192	mRNA of Intercellular adhesion molecule-1	Asthma	493	J45
TTDC00192	mRNA of Intercellular adhesion molecule-1	Autoimmune diseases	279	D84.9, M35.9
TTDC00192	mRNA of Intercellular adhesion molecule-1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00192	mRNA of Intercellular adhesion molecule-1	Multiple sclerosis	340	G35
TTDC00193	Neuropeptide Y receptor type 1	Analgesics	338	R52
TTDC00193	Neuropeptide Y receptor type 1	Anxiety disorders	300	F40-F42
TTDC00193	Neuropeptide Y receptor type 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00193	Neuropeptide Y receptor type 1	Convulsions	780.3	R56.0
TTDC00193	Neuropeptide Y receptor type 1	Drug dependence	303-305	F10-F19
TTDC00193	Neuropeptide Y receptor type 1	Metabolic disease	270-279	E70-E89
TTDC00193	Neuropeptide Y receptor type 1	Obesity	278	E66
TTDC00193	Neuropeptide Y receptor type 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00193	Neuropeptide Y receptor type 1	Rhinitis	472.0, 477	J00, J30, J31.0
TTDR00193	Tumor necrosis factor receptor superfamily member 11B	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00194	Hepatocyte growth factor	Renal fibrosis	709.2	L90.5
TTDR00194	Phosphotransketolase	Thiamine deficiency	.	E51
TTDS00194	Substance-P receptor	Analgesics	338	R52
TTDS00194	Substance-P receptor	Asthma	493	J45
TTDS00194	Substance-P receptor	Mood affective disorders	.	.
TTDS00194	Substance-P receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDS00194	Substance-P receptor	Visceral pain	338,780	R52, G89
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Atherosclerosis	414.0, 440	I70
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Cervical cancer	140-229, 180	C00-C96, C53
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Coronary heart disease	414	I25.1
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Dyslipidemia	272	E78
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Head and neck squamous cell carcinomas	199	C44
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Hypercholesterolemia	272	E78.0
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
TTDS00195	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDR00195	Nicotinic acetylcholine receptor alpha2 / alpha3	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00195	Nicotinic acetylcholine receptor alpha2 / alpha3	Analgesics	338	R52
TTDR00195	Nicotinic acetylcholine receptor alpha2 / alpha3	Drug dependence	303-305	F10-F19
TTDR00195	Nicotinic acetylcholine receptor alpha2 / alpha3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00195	Telomerase reverse transcriptase	Barrett's esophageal adenocarcinoma	140-199, 150	C00-C75, C15, C7A, C7B
TTDC00195	Telomerase reverse transcriptase	Cancer	140-229	C00-C96
TTDC00195	Telomerase reverse transcriptase	Malaria	84	B50-B54
TTDC00195	Telomerase reverse transcriptase	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDS00196	Aldosterone receptor	Atherosclerosis	414.0, 440	I70
TTDS00196	Aldosterone receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00196	Aldosterone receptor	Heart failure	410, 428	I21, I22, I50
TTDS00196	Aldosterone receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDC00196	Tumor necrosis factor ligand superfamily member 13B	Autoimmune diseases	279	D84.9, M35.9
TTDC00196	Tumor necrosis factor ligand superfamily member 13B	Rheumatic diseases	.	.
TTDC00196	Tumor necrosis factor ligand superfamily member 13B	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDR00197	Chymase	Asthma	493	J45
TTDR00197	Chymase	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDR00197	Chymase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00197	Chymase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00197	Chymase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDC00197	P-selectin	Inflammatory skin disorder	.	.
TTDC00197	P-selectin	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR00198	C-ets-1 protein	Cancer	140-229	C00-C96
TTDS00198	Endothelin-1 receptor	Atopic asthma	493	J45
TTDS00198	Endothelin-1 receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00198	Endothelin-1 receptor	Chronic renal failure	585.9585.1-585.5403	N18
TTDS00198	Endothelin-1 receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00198	Endothelin-1 receptor	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00198	HCV polymerase	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00199	Endothelin B receptor	Atopic asthma	493	J45
TTDS00199	Endothelin B receptor	Glial proliferation	.	.
TTDS00199	Endothelin B receptor	Melanoma	172.9	C43
TTDS00199	Endothelin B receptor	Neuronal injury	.	.
TTDC00199	Myeloperoxidase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00199	Myeloperoxidase	Atherosclerosis	414.0, 440	I70
TTDC00199	Myeloperoxidase	Lung cancer	162	C33-C34
TTDC00199	Myeloperoxidase	Multiple sclerosis	340	G35
TTDR00199	Voltage-dependent P/Q-type calcium channel alpha-1A subunit	Analgesics	338	R52
TTDR00199	Voltage-dependent P/Q-type calcium channel alpha-1A subunit	Cerebral ischemia	459.89	I99.8
TTDR00199	Voltage-dependent P/Q-type calcium channel alpha-1A subunit	Migraine	346	G43
TTDR00199	Voltage-dependent P/Q-type calcium channel alpha-1A subunit	Neurogenic inflammation	.	.
TTDR00199	Voltage-dependent P/Q-type calcium channel alpha-1A subunit	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Asthma	493	J45
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Hepatic ischemia-reperfusion injury	459.89	I99.8
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Malignant tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Peripheral arterial disease	443.9	I73.9
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00200	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00200	NAD(P)H dehydrogenase [quinone] 1	Cancer	140-229	C00-C96
TTDC00200	NAD(P)H dehydrogenase [quinone] 1	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR00200	Voltage-dependent R-type calcium channel alpha-1E subunit	Analgesics	338	R52
TTDR00200	Voltage-dependent R-type calcium channel alpha-1E subunit	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00201	CAMP-phosphodiesterase	Atopic disease	691.8	L20
TTDR00201	Gamma-aminobutyric acid transporter 4	Convulsions	780.3	R56.0
TTDC00201	Mitogen-activated protein kinase 14	Adult respiratory distress syndrome	518.5, 518.82	J80
TTDC00201	Mitogen-activated protein kinase 14	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00201	Mitogen-activated protein kinase 14	Crescentic glomerulonephritis	580-582	N00, N01, N03, N18
TTDC00201	Mitogen-activated protein kinase 14	Crohn's disease	555	K50
TTDC00201	Mitogen-activated protein kinase 14	Cytokine-mediated diseases	.	.
TTDC00201	Mitogen-activated protein kinase 14	Endotoxemia	.	.
TTDC00201	Mitogen-activated protein kinase 14	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00201	Mitogen-activated protein kinase 14	Insulin resistance	.	E00-E90
TTDC00201	Mitogen-activated protein kinase 14	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDC00201	Mitogen-activated protein kinase 14	Psoriasis	696	L40
TTDC00201	Mitogen-activated protein kinase 14	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00201	Mitogen-activated protein kinase 14	Skin diseases	.	.
TTDC00201	Mitogen-activated protein kinase 14	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR00202	M-phase inducer phosphatase 1	Breast cancer	174, 175, 217	C50, D24
TTDR00202	M-phase inducer phosphatase 1	Cancer	140-229	C00-C96
TTDC00202	Rho-associated protein kinase 1	Asthma	493	J45
TTDC00202	Rho-associated protein kinase 1	Atherosclerotic cardiovascular disease	390-459	I00-I99
TTDC00202	Rho-associated protein kinase 1	Cardiac allograft vasculopathy	996.8	T86
TTDC00202	Rho-associated protein kinase 1	Glaucoma	365	H40-H42
TTDC00202	Rho-associated protein kinase 1	Hepatic fibrosis	709.2	L90.5
TTDC00202	Rho-associated protein kinase 1	Hypertensive vascular disease	325, 430-459	G45-G46, I60-I95
TTDC00202	Rho-associated protein kinase 1	Intimal hyperplasia	.	.
TTDC00202	Rho-associated protein kinase 1	Liver fibrogenesis	.	.
TTDC00202	Rho-associated protein kinase 1	Primary pulmonary hypertension	401, 416.0	I10, I11, I12, I13, I15, I27.0, I27.2
TTDC00202	Rho-associated protein kinase 1	Pulmonary hypertension	416	I27.0, I27.2
TTDC00202	Rho-associated protein kinase 1	Restenosis	.	I51.89
TTDC00202	Rho-associated protein kinase 1	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00202	Rho-associated protein kinase 1	Ventricular hypertrophy	.	.
TTDS00202	Thrombin	Coagulative disorders	286	D65-D69
TTDS00202	Thrombin	Coronary atherosclerosis	414.0, 440	I70
TTDS00202	Thrombin	Gliomas	191	C71
TTDS00202	Thrombin	Heparin-induced thrombocytopenia type II	287.3, 287.4, 287.5	D69.6, P61.0
TTDS00202	Thrombin	Multiple organ failure	.	.
TTDS00202	Thrombin	Thromboembolic disorder	437.6, 453, 671.5, 671.9	I80-I82
TTDS00202	Thrombin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00202	Thrombin	Thrombotic disease	.	.
TTDS00203	Coagulation factor Xa	Atrial fibrillation; Atrial flutter	427.31, 487, 488	I48, J10, J11
TTDS00203	Coagulation factor Xa	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00203	Coagulation factor Xa	Coagulative disorders	286	D65-D69
TTDS00203	Coagulation factor Xa	Thromboembolic disorder	437.6, 453, 671.5, 671.9	I80-I82
TTDS00203	Coagulation factor Xa	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
TTDS00203	Coagulation factor Xa	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00203	Coagulation factor Xa	Thrombotic disease	.	.
TTDC00203	Transforming growth factor-beta	Brain tumors	191, 225.0	C71, D33
TTDC00203	Transforming growth factor-beta	Breast cancer	174, 175, 217	C50, D24
TTDC00203	Transforming growth factor-beta	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDC00203	Transforming growth factor-beta	Malignant gliomas	191	C71
TTDC00203	Transforming growth factor-beta	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00203	Transforming growth factor-beta	Renal fibrosis	709.2	L90.5
TTDS00204	Coagulation Factor Va	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDR00204	Tar rRNA	Human immunodeficiency virus infection	279.3	D84.9
TTDC00204	Vasoactive intestinal polypeptide receptor 1	Autoimmune diseases	279	D84.9, M35.9
TTDC00204	Vasoactive intestinal polypeptide receptor 1	Human immunodeficiency virus infection	279.3	D84.9
TTDS00205	Coagulation Factor VIIIa	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDC00205	Glucagon-like peptide 1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00205	Glucagon-like peptide 1	Obesity	278	E66
TTDR00205	Interleukin-8	Angiogenesis	.	.
TTDR00205	Interleukin-8	Arthritis	710-719	M00-M25
TTDR00205	Interleukin-8	Human cytomegalovirus infections	001-139, 078.5	A00-B99, B25
TTDR00205	Interleukin-8	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00205	Interleukin-8	Mechanical nociceptor hypersensitivity	995.3	T78.4
TTDR00205	Interleukin-8	Meningitis	320-322	G00-G03
TTDS00206	Mineralocorticoid receptor	Autoimmune; Sudden sensorineural hearing loss	389	H90-H91
TTDS00206	Mineralocorticoid receptor	Brain injury	.	S09.90
TTDC00206	Ubiquitin-protein ligase E3 Mdm2	Breast cancer	174, 175, 217	C50, D24
TTDC00206	Ubiquitin-protein ligase E3 Mdm2	Cancer	140-229	C00-C96
TTDC00206	Ubiquitin-protein ligase E3 Mdm2	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDC00206	Ubiquitin-protein ligase E3 Mdm2	Osteosarcoma	170	C40-C41
TTDC00206	Ubiquitin-protein ligase E3 Mdm2	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00207	C-C chemokine receptor type 3	Allergic diseases	995.3	T78.4
TTDR00207	Neuronal kinesin heavy chain	Neurological symptom	.	.
TTDS00208	Dihydrofolate reductase	Autoimmune diseases	279	D84.9, M35.9
TTDS00208	Dihydrofolate reductase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00208	Dihydrofolate reductase	Cancer	140-229	C00-C96
TTDS00208	Dihydrofolate reductase	Chagas' disease	86	B57
TTDS00208	Dihydrofolate reductase	Fungal diseases	110-118	B35-B49
TTDS00208	Dihydrofolate reductase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00208	Dihydrofolate reductase	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDS00208	Dihydrofolate reductase	Leprosy	.	.
TTDS00208	Dihydrofolate reductase	Malaria	84	B50-B54
TTDS00208	Dihydrofolate reductase	Microbial infections	001-139	A00-B99
TTDS00208	Dihydrofolate reductase	P. carinii pneumonia	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
TTDS00208	Dihydrofolate reductase	Parasitic diseases	.	.
TTDS00208	Dihydrofolate reductase	Toxoplasma infections	001-139	A00-B99
TTDS00208	Dihydrofolate reductase	Trypanosomatid infections	001-139	A00-B99
TTDS00208	Dihydrofolate reductase	Tuberculosis	010-018	A15-A19
TTDR00208	M-phase inducer phosphatase 3	Cancer	140-229	C00-C96
TTDC00208	T-cell-specific surface glycoprotein CD28	Lung mucosal allergic inflammation	204.0, 995.3	C91.0, T78.4
TTDS00209	AMP-activated protein kinase	Autoimmune inflammation	.	.
TTDS00209	AMP-activated protein kinase	Ischemia reperfusion injuries	459.89	I99.8
TTDS00209	AMP-activated protein kinase	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00209	AMP-activated protein kinase	Obesity	278	E66
TTDR00209	Carbonic anhydrase IV	Glaucoma	365	H40-H42
TTDR00209	Carbonic anhydrase IV	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00209	Carbonic anhydrase IV	Renal failure	584, 585	N17, N18, N19
TTDR00209	Carbonic anhydrase IV	Salivary glands cancer	140-229	C00-C96
TTDC00209	Toll-like receptor 4	LPS-induced left ventricular dysfunction	428	I50
TTDC00210	Angiopoietin-2	Breast cancer	174, 175, 217	C50, D24
TTDR00210	Carbonic anhydrase VI	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00210	Carbonic anhydrase VI	Salivary glands cancer	140-229	C00-C96
TTDS00210	Penicillin binding protein	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00211	Carbonic anhydrase IX	Bladder cancer	140-229, 188	C00-C96, C67
TTDR00211	Carbonic anhydrase IX	Head and neck squamous cell carcinomas	199	C44
TTDR00211	Carbonic anhydrase IX	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00211	Carbonic anhydrase IX	Renal cell carcinoma	189	C64
TTDC00211	HIV integrase	Human immunodeficiency virus infection	279.3	D84.9
TTDS00211	Penicillin binding protein 2	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00212	Carbonic anhydrase XII	Colorectal cancer	153, 154	C18-C21
TTDR00212	Carbonic anhydrase XII	Gastrointestinal cancers	150-159	C15-C26
TTDR00212	Carbonic anhydrase XII	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00212	Carbonic anhydrase XII	Renal failure	584, 585	N17, N18, N19
TTDC00212	Cyclin-dependent kinase	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00212	Penicillin binding protein 3	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00213	Carbonic anhydrase XIV	Renal failure	584, 585	N17, N18, N19
TTDC00213	Connective tissue growth factor	Atherosclerosis	414.0, 440	I70
TTDC00213	Connective tissue growth factor	Fibrotic disease	709.2	L90.5
TTDC00213	Connective tissue growth factor	Fibrotic renal disease	.	.
TTDC00213	Connective tissue growth factor	Lung fibrosis	709.2	L90.5
TTDC00213	Connective tissue growth factor	Rhabdomyosarcoma	171	C49
TTDC00213	Connective tissue growth factor	Scleroderma	701.0710.1	L94.0-L94.1, M34
TTDC00213	Connective tissue growth factor	Tubulointerstitial fibrosis	709.2	L90.5
TTDS00213	DNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00213	DNA	Cancer	140-229	C00-C96
TTDS00213	DNA	Human immunodeficiency virus infection	279.3	D84.9
TTDS00213	DNA	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00214	Interleukin-17	Allograft rejection	996.8	T86
TTDC00214	Interleukin-17	Neutrophilic airway inflammation	460-519	J00-J99
TTDC00214	Interleukin-17	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00214	Sodium/potassium-transporting ATPase alpha-2 chain	Atrial fibrillation; Atrial flutter	427.31, 487, 488	I48, J10, J11
TTDR00214	Sodium/potassium-transporting ATPase alpha-2 chain	Heart failure	410, 428	I21, I22, I50
TTDC00215	C-C chemokine receptor type 1	Autoimmune diseases	279	D84.9, M35.9
TTDC00215	C-C chemokine receptor type 1	Chronic inflammatory diseases	.	.
TTDC00215	C-C chemokine receptor type 1	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDC00215	C-C chemokine receptor type 1	Renal fibrosis	709.2	L90.5
TTDS00216	16S rRNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00216	16S rRNA	Malaria	84	B50-B54
TTDC00216	mRNA of C-reactive protein	Atherosclerosis	414.0, 440	I70
TTDC00216	mRNA of C-reactive protein	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00217	23S rRNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00217	23S rRNA	Malaria	84	B50-B54
TTDC00217	Interleukin-5 receptor	Eosinophilia associated with chronic allergic disease	204.0, 995.3	C91.0, T78.4
TTDR00217	mRNA of VLA-4	Allergy	995.3	T78.4
TTDR00217	mRNA of VLA-4	Multiple sclerosis	340	G35
TTDR00218	O-acetylserine sulfhydrylase	Vitamin B6 deficiency	266.1	E53.1
TTDC00218	P2X purinoceptor 7	Analgesics	338	R52
TTDC00218	P2X purinoceptor 7	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00218	P2X purinoceptor 7	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00219	30S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Chagas' disease	86	B57
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Giardiasis infections	001-139, 007.1	A00-B99, A07.1
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Malaria	84	B50-B54
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Parasitic diseases	.	.
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Schistosomiasis	120	B65
TTDR00219	Hypoxanthine-guanine phosphoribosyltransferase	Sleeping sickness	.	.
TTDC00219	Tumor necrosis factor receptor superfamily member 4	Autoimmune diseases	279	D84.9, M35.9
TTDS00220	50S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00220	Metabotropic glutamate receptor 1	Analgesics	338	R52
TTDC00220	Metabotropic glutamate receptor 1	Convulsions	780.3	R56.0
TTDC00220	Metabotropic glutamate receptor 1	Neuronal injury	.	.
TTDC00220	Metabotropic glutamate receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00220	Vasopeptidase	Heart failure	410, 428	I21, I22, I50
TTDR00220	Vasopeptidase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00221	70S prokaryotic ribosome	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00221	Interleukin-18	Autoimmune diseases	279	D84.9, M35.9
TTDC00221	Interleukin-18	Group B streptococci induced septic arthritis	710-719	M00-M25
TTDC00221	Interleukin-18	Group B streptococci infection	001-139	A00-B99
TTDC00221	Interleukin-18	Inflammatory arthritis	710-719	M00-M25
TTDC00221	Interleukin-18	Pancreatic necrosis	.	.
TTDR00221	Rhodopsin	Vitamin A deficiency	.	.
TTDR00222	Aspartate aminotransferase, cytoplasmic	Vitamin B6 deficiency	266.1	E53.1
TTDS00222	DNA-dependent RNA polymerase at the beta subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00222	Inhibitor of nuclear factor kappa-B kinase	Analgesics	338	R52
TTDC00222	Inhibitor of nuclear factor kappa-B kinase	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDC00222	Inhibitor of nuclear factor kappa-B kinase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00222	Inhibitor of nuclear factor kappa-B kinase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00222	Inhibitor of nuclear factor kappa-B kinase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00222	Inhibitor of nuclear factor kappa-B kinase	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00223	Isoleucyl-tRNA synthetase (bacterial)	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00223	Isoleucyl-tRNA synthetase (bacterial)	Microbial infections	001-139	A00-B99
TTDR00223	Omega-amino acid:pyruvate aminotransferase	Vitamin B6 deficiency	266.1	E53.1
TTDR00224	Proliferating cell nuclear antigen; Cyclin-A2	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00224	Tumor necrosis factor ligand superfamily member 11	Arthritis	710-719	M00-M25
TTDC00224	Tumor necrosis factor ligand superfamily member 11	Osteolytic metastatic cancer	140-229	C00-C96
TTDC00224	Tumor necrosis factor ligand superfamily member 11	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00224	Tumor necrosis factor ligand superfamily member 11	Periodontitis	523.5	K05.4
TTDS00225	DNA-dependent RNA polymerase	Tuberculosis	010-018	A15-A19
TTDR00225	Low-density lipoprotein receptor	Parkinson's disease	332	F02.3, G20
TTDC00225	Macrophage inflammatory protein-2-alpha	Influenza virus pneumonia	480-486, 487, 488, 770.0	J10, J11, J12, J13, J14, J15, J16, J17, J18, P23
TTDC00226	C-C chemokine receptor type 4	Asthma	493	J45
TTDS00226	Plastid RNA polymerase beta-subunit	Malaria	84	B50-B54
TTDR00226	Serine hydroxymethyltransferase, mitochondrial	Cancer	140-229	C00-C96
TTDR00226	Serine hydroxymethyltransferase, mitochondrial	Malaria	84	B50-B54
TTDS00227	RNA polymerase; bacterial RNA polymerase switch region	Cancer	140-229	C00-C96
TTDS00227	RNA polymerase; bacterial RNA polymerase switch region	Human cytomegalovirus infections	001-139, 078.5	A00-B99, B25
TTDS00227	RNA polymerase; bacterial RNA polymerase switch region	Malaria	84	B50-B54
TTDS00227	RNA polymerase; bacterial RNA polymerase switch region	Respiratory syncytial virus infections	001-139, 079.6	A00-B99, B97.4
TTDC00227	Sodium- and chloride-dependent glycine transporter 1	Disorders associated with NMDAR hypofunction	.	.
TTDS00228	Beta-lactamase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00228	DNA gyrase B subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00228	mRNA of Eukaryotic translation initiation factor 4E	Cancer	140-229	C00-C96
TTDR00229	Geranylgeranyltransferase I	Cancer	140-229	C00-C96
TTDR00229	Geranylgeranyltransferase I	Fungal diseases	110-118	B35-B49
TTDS00229	Peptidyl tranferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00230	Dehydropeptidase I	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00230	Elastase 1	Arthritis	710-719	M00-M25
TTDR00230	Elastase 1	Emphysema	492	J43
TTDC00230	Gastrin-releasing peptide receptor	Small cell lung cancer	162.9	C34.90
TTDC00231	G-protein coupled receptor 54	Human reproductive syndromes	.	.
TTDR00231	Orotidine 5'-monophosphate decarboxylase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDC00232	Cytochrome P450 26	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDC00232	Cytochrome P450 26	Eye diseases	.	.
TTDC00232	Cytochrome P450 26	Hyperproliferative disorders	.	.
TTDC00232	Cytochrome P450 26	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00232	Cytochrome P450 26	Neurodegenerative diseases	330-337	G30-G32
TTDC00232	Cytochrome P450 26	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00232	Cytochrome P450 26	Skin diseases	.	.
TTDR00232	Leukotriene C4 synthase	Asthma	493	J45
TTDC00233	Gamma secretase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00233	Tyrosine-protein kinase BTK	Acute lymphoblastic leukaemia	208.9	C91-C95
TTDR00233	Tyrosine-protein kinase BTK	B-cell immunodeficiency	279.3	D84.9
TTDS00233	UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00234	73-kDa molecular chaperone HSP73	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00234	Arachidonate 15-lipoxygenase	Atherosclerosis	414.0, 440	I70
TTDR00234	Arachidonate 15-lipoxygenase	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00234	Arachidonate 15-lipoxygenase	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDC00234	Interleukin-1 receptor, type II	Allergy	995.3	T78.4
TTDC00234	Interleukin-1 receptor, type II	Arthritis	710-719	M00-M25
TTDC00234	Interleukin-1 receptor, type II	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00234	Interleukin-1 receptor, type II	Inflammatory bowel disease	555, 556	K50, K51
TTDS00235	Enoyl-ACP reductase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00235	Enoyl-ACP reductase	Malaria	84	B50-B54
TTDS00236	1-deoxy-D-xylulose-5-phosphate reductoisomerase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00236	1-deoxy-D-xylulose-5-phosphate reductoisomerase	Malaria	84	B50-B54
TTDR00236	Rhinovirus coat protein; Genome polyprotein	Acute nasopharyngitis	462, 472.1	J02, J31.2
TTDC00236	mRNA of ApoB-100	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00237	Dihydropteroate synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00237	Dihydropteroate synthetase	Malaria	84	B50-B54
TTDR00237	PN3 Na+ channel	Analgesics	338	R52
TTDR00237	PN3 Na+ channel	Bladder pain	188, 338,780	C67, R52, G89
TTDC00237	Putative G-protein coupled receptor 44	Asthma	493	J45
TTDC00237	Putative G-protein coupled receptor 44	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDC00238	EGF-like domain-containing protein 7	Cancer	140-229	C00-C96
TTDR00238	Leptin receptor	Obesity	278	E66
TTDR00239	Arachidonate 12-lipoxygenase, 12S-type	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00239	Arachidonate 12-lipoxygenase, 12S-type	Melanoma	172.9	C43
TTDC00239	Neuronal acetylcholine receptor subunit alpha-9	Analgesics	338	R52
TTDC00239	Neuronal acetylcholine receptor subunit alpha-9	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDS00240	5-alpha reductase	Benign prostatic hyperplasia	600	N40
TTDS00240	5-alpha reductase	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00240	Angiogenin	Cancer	140-229	C00-C96
TTDC00240	Voltage-dependent calcium channel subunit alpha-2/delta-2	Analgesics	338	R52
TTDC00240	Voltage-dependent calcium channel subunit alpha-2/delta-2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00240	Voltage-dependent calcium channel subunit alpha-2/delta-2	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
TTDS00241	17 alpha-hydroxylase-C17, 20-lyase 	Benign prostatic hyperplasia	600	N40
TTDS00241	17 alpha-hydroxylase-C17, 20-lyase 	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00241	2-oxoglutarate decarboxylase	Thiamine deficiency	.	E51
TTDC00241	mRNA of HIF-1 responsive protein RTP801	Age-related macular degeneration	362.5	H35.3
TTDC00241	mRNA of HIF-1 responsive protein RTP801	Diabetic macular degeneration	362.01, 362.53	H35.8
TTDR00242	Cytochrome P450 1B1	Breast cancer	174, 175, 217	C50, D24
TTDR00242	Cytochrome P450 1B1	Colon adenocarcinoma	140-199	C00-C75, C7A, C7B
TTDR00242	Cytochrome P450 1B1	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00242	Estrogen receptor	Brain injury	.	S09.90
TTDS00242	Estrogen receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00242	Estrogen receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00242	Estrogen receptor	Coronary atherosclerosis	414.0, 440	I70
TTDS00242	Estrogen receptor	Endocrine independent cancer	140-229	C00-C96
TTDS00242	Estrogen receptor	Neurodegenerative diseases	330-337	G30-G32
TTDS00242	Estrogen receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDS00242	Estrogen receptor	Postmenopausal symptoms	627.2	N95.0
TTDC00242	Neuronal acetylcholine receptor subunit alpha-10	Analgesics	338	R52
TTDC00242	Neuronal acetylcholine receptor subunit alpha-10	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDR00243	Oncogenic GTP-binding protein	Cancer	140-229	C00-C96
TTDC00243	Solute carrier family 22 member 12	Gout	274.00274.1274.8274.9	M10
TTDC00244	Bcl-2-like protein 2	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDC00244	Bcl-2-like protein 2	Hematologic malignancies	200-209	C81-C96
TTDC00244	Bcl-2-like protein 2	Lymphoid malignancies	202	C81-C96
TTDC00244	Bcl-2-like protein 2	Small cell lung cancer	162.9	C34.90
TTDR00244	Integrin alpha V beta 3	Angiogenesis	.	.
TTDR00244	Integrin alpha V beta 3	Kaposi's sarcoma	176	C46
TTDR00244	Integrin alpha V beta 3	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00244	Integrin alpha V beta 3	Tumor angiogenesis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00244	Leutinizing-hormone-releasing hormone	Breast cancer	174, 175, 217	C50, D24
TTDC00245	NEDD8-activating enzyme E1 catalytic subunit	Advanced malignancies	140-229	C00-C96
TTDS00245	Progesterone receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00246	Ribonucleoside-diphosphate reductase	Breast cancer	174, 175, 217	C50, D24
TTDS00246	Ribonucleoside-diphosphate reductase	Cancer	140-229	C00-C96
TTDS00246	Ribonucleoside-diphosphate reductase	Herpes simplex virus infections	001-139, 054.0, 054.1, 054.2, 054.3, 771.2	A00-B99, A60, B00, G05.1, P35.2
TTDS00246	Ribonucleoside-diphosphate reductase	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDS00246	Ribonucleoside-diphosphate reductase	Human immunodeficiency virus infection	279.3	D84.9
TTDS00246	Ribonucleoside-diphosphate reductase	Malaria	84	B50-B54
TTDS00246	Ribonucleoside-diphosphate reductase	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00246	Ribonucleoside-diphosphate reductase	Retrovirus-induced immunodeficiency disease	279.3	D84.9
TTDS00246	Ribonucleoside-diphosphate reductase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00246	Synaptic vesicle glycoprotein 2A	Epilepsy	290-319, 345	F01-F99, G40
TTDR00247	5-methyltetrahydrofolate--homocysteine methyltransferase	Cancer	140-229	C00-C96
TTDR00247	5-methyltetrahydrofolate--homocysteine methyltransferase	Myeloneuropathy	.	.
TTDR00247	5-methyltetrahydrofolate--homocysteine methyltransferase	Vitamin B12 deficiency	266.2	E53.8
TTDC00247	Angiopoietin-1	Cancer	140-229	C00-C96
TTDS00247	Proto-oncogene tyrosine-protein kinase SRC	Breast cancer	174, 175, 217	C50, D24
TTDS00247	Proto-oncogene tyrosine-protein kinase SRC	Cancer	140-229	C00-C96
TTDS00247	Proto-oncogene tyrosine-protein kinase SRC	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDC00248	Mucosal addressin cell adhesion molecule 1	Inflammatory bowel disease	555, 556	K50, K51
TTDR00248	V beta 14 T-cell receptor	Arthritis	710-719	M00-M25
TTDR00249	Ornithine aminotransferase, mitochondrial	Hyperammonemia	270.6	E72.2
TTDC00249	Puromycin-sensitive aminopeptidase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00249	Receptor protein-tyrosine kinase erbB-2	Breast cancer	174, 175, 217	C50, D24
TTDS00249	Receptor protein-tyrosine kinase erbB-2	Cancer	140-229	C00-C96
TTDS00249	Receptor protein-tyrosine kinase erbB-2	Colon cancer	153, 154	C18-C21
TTDS00249	Receptor protein-tyrosine kinase erbB-2	Ependymoma	191, 225	C71, D33
TTDS00249	Receptor protein-tyrosine kinase erbB-2	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00250	Estrogen receptor beta	Breast cancer	174, 175, 217	C50, D24
TTDS00250	Estrogen receptor beta	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00250	Estrogen receptor beta	ER beta-positive prostate tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00250	Estrogen receptor beta	Neurodegenerative diseases	330-337	G30-G32
TTDS00250	Estrogen receptor beta	Vascular injury response	.	.
TTDC00250	Glutamate receptor 1	Schizophrenia	295, 710.0	F20, M32
TTDC00251	Interleukin-15	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00251	Thymidine phosphorylase	Angiogenesis	.	.
TTDR00251	Thymidine phosphorylase	Breast cancer	174, 175, 217	C50, D24
TTDR00251	Thymidine phosphorylase	Lung adenocarcinomas	140-199	C00-C75, C7A, C7B
TTDR00251	Thymidine phosphorylase	Renal cell carcinoma	189	C64
TTDS00251	Vitamin D receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00251	Vitamin D receptor	Colorectal cancer	153, 154	C18-C21
TTDS00251	Vitamin D receptor	Kaposi's sarcoma	176	C46
TTDS00251	Vitamin D receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00251	Vitamin D receptor	Vitamin D deficiency	268	E55
TTDS00252	Cytochrome P450 19	Breast cancer	174, 175, 217	C50, D24
TTDS00252	Cytochrome P450 19	Endometriosis	617	N80
TTDS00252	Cytochrome P450 19	Estrogen disorders	.	.
TTDS00252	Cytochrome P450 19	Male infertility	606	N46
TTDS00252	Cytochrome P450 19	McCune-albright syndrome	.	.
TTDS00252	Cytochrome P450 19	Neurodegenerative diseases	330-337	G30-G32
TTDS00252	Cytochrome P450 19	Peripheral precocious puberty	259.1	E22.8, E30.1
TTDR00252	Insulin-like growth factor II	Colorectal cancer	153, 154	C18-C21
TTDR00252	Insulin-like growth factor II	Medulloblastoma	191	C71
TTDR00252	Insulin-like growth factor II	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00252	Insulin-like growth factor II	Rhabdomyosarcoma	171	C49
TTDC00252	Pigment epithelium-derived factor	Exudative age-related macular degeneration	362.5	H35.3
TTDS00253	Gonadotropin-releasing hormone	Breast cancer	174, 175, 217	C50, D24
TTDS00253	Gonadotropin-releasing hormone	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00253	Ras proteins	Cancer	140-229	C00-C96
TTDC00253	Somatostatin receptor type 5	Cushing's disease	255	E24.0
TTDR00254	Aspartate carbamoyltransferase	Cancer	140-229	C00-C96
TTDR00254	Aspartate carbamoyltransferase	Colon cancer	153, 154	C18-C21
TTDR00254	Aspartate carbamoyltransferase	Intracerebral tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00254	Aspartate carbamoyltransferase	Lewis lung carcinoma	162	C33-C34
TTDR00254	Aspartate carbamoyltransferase	Neurological diseases	320-359	G00-G99
TTDR00254	Aspartate carbamoyltransferase	Proliferative diseases	.	.
TTDR00254	Aspartate carbamoyltransferase	Pseudomonas infection	041.7, 482.1	B96.5, J15.1, P23.5
TTDS00254	Lutropin-choriogonadotropic hormone receptor	Benign prostatic hyperplasia	600	N40
TTDS00254	Lutropin-choriogonadotropic hormone receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00254	Lutropin-choriogonadotropic hormone receptor	Endometriosis	617	N80
TTDS00254	Lutropin-choriogonadotropic hormone receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00254	Somatostatin receptor type 3	Cushing's disease	255	E24.0
TTDR00255	Inhibitor of nuclear factor kappa-B kinase alpha subunit	Asthma	493	J45
TTDS00255	Multidrug resistance protein	Acute leukaemia	208.9	C91-C95
TTDS00255	Multidrug resistance protein	Allograft rejection	996.8	T86
TTDS00255	Multidrug resistance protein	Autoimmune diseases	279	D84.9, M35.9
TTDS00255	Multidrug resistance protein	Cancer	140-229	C00-C96
TTDS00255	Multidrug resistance protein	Depression	311	F32
TTDC00255	Sodium-dependent serotonin transporter	Schizophrenia	295, 710.0	F20, M32
TTDS00256	Alkaline phosphatase, tissue-nonspecific	Cancer	140-229	C00-C96
TTDR00256	CGMP-dependent 3',5'-cyclic phosphodiesterase	Colorectal cancer	153, 154	C18-C21
TTDR00256	CGMP-dependent 3',5'-cyclic phosphodiesterase	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDC00256	Wee1-like protein kinase	Cancer	140-229	C00-C96
TTDR00257	Casein kinase II, alpha chain	Breast cancer	174, 175, 217	C50, D24
TTDR00257	Casein kinase II, alpha chain	Cancer	140-229	C00-C96
TTDC00257	Ciliary neurotrophic factor receptor alpha	Obesity	278	E66
TTDR00258	Carbamoyl-phosphate synthase II	Visceral leishmaniasis	085.0, 110-118	B35-B49, B55.0
TTDS00258	Parathyroid hormone/parathyroid hormone-related peptide receptor	Cancer-associated morbidity	140-229	C00-C96
TTDS00258	Parathyroid hormone/parathyroid hormone-related peptide receptor	Malignancy-associated hypercalcemia	275.42	E83.5
TTDC00258	Sphingosine 1-phosphate receptor 1	Autoimmune diseases	279	D84.9, M35.9
TTDC00259	Cytotoxic T-lymphocyte protein 4	Cell carcinoma	.	.
TTDC00259	Cytotoxic T-lymphocyte protein 4	Colorectal cancer	153, 154	C18-C21
TTDC00259	Cytotoxic T-lymphocyte protein 4	Gastrointestinal cancers	150-159	C15-C26
TTDC00259	Cytotoxic T-lymphocyte protein 4	Melanoma	172.9	C43
TTDR00260	Protein kinase A	Cancer	140-229	C00-C96
TTDR00260	Protein kinase A	Obesity	278	E66
TTDR00260	Protein kinase A	Parasitic diseases	.	.
TTDC00260	Sodium/glucose cotransporter 1	Diabetes	250	E08-E13
TTDR00261	Corticotropin-lipotropin	Obesity	278	E66
TTDS00261	Platelet-derived growth factor receptor	Cancer	140-229	C00-C96
TTDS00261	Platelet-derived growth factor receptor	Chronic myelomonocytic leukemia	208.9	C91-C95
TTDS00261	Platelet-derived growth factor receptor	Glioblastoma multiforme	191	C71
TTDR00262	Arginine vasopressin	Febrile convulsions	780.3	R56.0
TTDR00262	Arginine vasopressin	Heart failure	410, 428	I21, I22, I50
TTDR00262	Arginine vasopressin	Temporal lobe epilepsy	345	G40
TTDR00262	Arginine vasopressin	Vasodilatory shock	785.5	R57.9
TTDC00263	Macrophage colony-stimulating factor 1	Myelodisplastic syndrome	238.7	D46
TTDC00264	Beta-2-glycoprotein 1	Antiphospholipid syndrome	289.81	D68.8
TTDR00264	HIV envelope protein gp120	Human immunodeficiency virus infection	279.3	D84.9
TTDS00264	Oxytocin receptor	Cancer	140-229	C00-C96
TTDS00265	Serine/threonine-protein kinase mTOR	Cancer	140-229	C00-C96
TTDS00265	Serine/threonine-protein kinase mTOR	Immunosuppression	.	.
TTDR00265	Superoxide dismutase [Cu-Zn]	Cancer	140-229	C00-C96
TTDR00265	Superoxide dismutase [Cu-Zn]	Ischemic injury of the liver	.	.
TTDC00265	T-cell surface glycoprotein CD4	Rheumatoid arthritis	710-719, 714	M05-M06
TTDC00266	Tumor necrosis factor receptor superfamily member 10B	Colorectal cancer	153, 154	C18-C21
TTDR00267	Peptide deformylase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00267	Peptide deformylase	Malaria	84	B50-B54
TTDC00267	Tumor necrosis factor receptor superfamily member 10A	Cancer	140-229	C00-C96
TTDS00267	Type-1 angiotensin II receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00267	Type-1 angiotensin II receptor	Heart failure	410, 428	I21, I22, I50
TTDS00267	Type-1 angiotensin II receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00267	Type-1 angiotensin II receptor	Ischemic stroke	434.91	I61-I63
TTDS00267	Type-1 angiotensin II receptor	Parkinson's disease	332	F02.3, G20
TTDS00268	B-lymphocyte antigen CD20	B-cell lymphoma	202.8	C85.1
TTDS00268	B-lymphocyte antigen CD20	Cancer	140-229	C00-C96
TTDR00268	Hepatocyte nuclear factor 1-alpha	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDC00268	mRNA of TNF alpha	Inflammatory bowel disease	555, 556	K50, K51
TTDC00268	mRNA of TNF alpha	Psoriasis	696	L40
TTDC00268	mRNA of TNF alpha	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00269	Hepatocyte nuclear factor 4-alpha	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00269	Insulin-like growth factor I receptor	Cancer	140-229	C00-C96
TTDS00269	Insulin-like growth factor I receptor	Colorectal cancer	153, 154	C18-C21
TTDS00269	Insulin-like growth factor I receptor	Ewing's sarcoma	170	C41
TTDS00269	Insulin-like growth factor I receptor	Medulloblastoma	191	C71
TTDS00269	Insulin-like growth factor I receptor	Peripheral neuroectodermal tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00269	Insulin-like growth factor I receptor	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00269	mRNA of Heat shock 27 kDa protein	Colon adenocarcinoma	140-199	C00-C75, C7A, C7B
TTDC00270	HCV internal ribosome entry site (IRES)	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00270	Mast/stem cell growth factor receptor	Cancer	140-229	C00-C96
TTDS00270	Mast/stem cell growth factor receptor	Gastrointestinal stromal tumors	150-159	C15-C26
TTDS00270	Mast/stem cell growth factor receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00270	Mast/stem cell growth factor receptor	Malignant phyllodes tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00270	Mast/stem cell growth factor receptor	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00270	Mast/stem cell growth factor receptor	Phyllodes tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00270	Mast/stem cell growth factor receptor	Renal cell carcinoma	189	C64
TTDS00270	Mast/stem cell growth factor receptor	Small cell lung cancer	162.9	C34.90
TTDR00270	Steroid hormone receptor ERR1	Breast cancer	174, 175, 217	C50, D24
TTDR00270	Steroid hormone receptor ERR1	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00270	Steroid hormone receptor ERR1	Metabolic disease	270-279	E70-E89
TTDR00270	Steroid hormone receptor ERR1	Obesity	278	E66
TTDC00271	Myc proto-oncogene protein	Advanced melanoma	172	C43
TTDC00271	Myc proto-oncogene protein	Cancer	140-229	C00-C96
TTDC00271	Myc proto-oncogene protein	Hepatocellular carcinoma	155	C22.0
TTDC00271	Myc proto-oncogene protein	Restenosis	.	I51.89
TTDR00271	Orphan nuclear receptor DAX-1	Hypogonadotropic hypogonadism	257.2	E23.0, E28.3, E29.1
TTDR00271	Orphan nuclear receptor DAX-1	X-linked congenital adrenal hypoplasia	.	.
TTDS00271	Tubulin	Cancer	140-229	C00-C96
TTDS00271	Tubulin	Helminth infection	001-139	A00-B99
TTDS00271	Tubulin	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDS00271	Tubulin	Parasitic diseases	.	.
TTDS00272	Bile acid receptor	Cancer	140-229	C00-C96
TTDS00272	Bile acid receptor	Hypercholesterolemia	272	E78.0
TTDS00272	Bile acid receptor	Intrahepatic cholestasis	576.2	K83.1
TTDR00272	Thyroid hormone receptor	Nonthyroidal illness syndrome	.	.
TTDR00272	Thyroid hormone receptor	Thyrotoxicosis hyperthyroidism	242.9	E05
TTDC00272	Transforming growth factor beta 2	Cataract	366	H25-H26, H28, Q12.0
TTDR00273	3-phosphoinositide dependent protein kinase-1	Cancer	140-229	C00-C96
TTDR00273	3-phosphoinositide dependent protein kinase-1	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDC00273	Baculoviral IAP repeat-containing protein 5	Androgen-independent prostate cancer	140-229, 185	C00-C96, C61
TTDC00273	Baculoviral IAP repeat-containing protein 5	Astrocytic tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00273	Baculoviral IAP repeat-containing protein 5	B-cell lymphoma	202.8	C85.1
TTDC00273	Baculoviral IAP repeat-containing protein 5	Brain tumors	191, 225.0	C71, D33
TTDC00273	Baculoviral IAP repeat-containing protein 5	Cancer	140-229	C00-C96
TTDC00273	Baculoviral IAP repeat-containing protein 5	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDC00273	Baculoviral IAP repeat-containing protein 5	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00273	Baculoviral IAP repeat-containing protein 5	Lung cancer	162	C33-C34
TTDC00273	Baculoviral IAP repeat-containing protein 5	Melanoma	172.9	C43
TTDC00273	Baculoviral IAP repeat-containing protein 5	Mesothelioma	163	C45
TTDC00273	Baculoviral IAP repeat-containing protein 5	Non-Hodgkin's Lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDC00273	Baculoviral IAP repeat-containing protein 5	Prostate carcinoma	185	C61
TTDS00273	Gonadotropin-releasing hormone receptor	Cancer	140-229	C00-C96
TTDS00273	Gonadotropin-releasing hormone receptor	Hypogonadotropic hypogonadism	257.2	E23.0, E28.3, E29.1
TTDS00273	Gonadotropin-releasing hormone receptor	Reproductive disorder	600-629	N40-N99
TTDS00274	Heat shock protein 90	Cancer	140-229	C00-C96
TTDS00274	Heat shock protein 90	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00274	Heat shock protein 90	Ischemia	459.89	I99.8
TTDS00274	Heat shock protein 90	Malaria	84	B50-B54
TTDS00274	Heat shock protein 90	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00274	Liver carboxylesterase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00274	Liver carboxylesterase	Atherosclerosis	414.0, 440	I70
TTDR00274	Liver carboxylesterase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00274	Liver carboxylesterase	Cocaine overdose	304.2	F14.2
TTDR00274	Liver carboxylesterase	Hypercholesterolaemia	.	E78.0
TTDR00274	Liver carboxylesterase	Protection against chemical weapons like sarin, soman and VX gas	.	.
TTDC00274	mRNA of HIV Tar and Tat/Rev	AIDS	42	B20
TTDR00275	Acetyl-CoA carboxylase 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00275	Acetyl-CoA carboxylase 1	Malaria	84	B50-B54
TTDC00275	HCV genome conserved portion (unspecified)	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00275	Signal transducer and activator of transcription 3	Cancer	140-229	C00-C96
TTDS00275	Signal transducer and activator of transcription 3	Kidney disease induced by mesangial proliferation	580-589	N00-N29
TTDR00276	Integrin alpha-2	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00276	Thioredoxin reductase, cytoplasmic	Amebiasis	6	A06
TTDS00276	Thioredoxin reductase, cytoplasmic	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00276	Thioredoxin reductase, cytoplasmic	Cancer	140-229	C00-C96
TTDS00276	Thioredoxin reductase, cytoplasmic	Human immunodeficiency virus infection	279.3	D84.9
TTDS00276	Thioredoxin reductase, cytoplasmic	Leprosy	.	.
TTDS00276	Thioredoxin reductase, cytoplasmic	Malaria	84	B50-B54
TTDS00276	Thioredoxin reductase, cytoplasmic	Malignancies	140-239	C00-C96
TTDS00276	Thioredoxin reductase, cytoplasmic	Oxidative and free radical damage	.	.
TTDS00276	Thioredoxin reductase, cytoplasmic	Parasitic diseases	.	.
TTDS00276	Thioredoxin reductase, cytoplasmic	Pneumocystis infections	001-139	A00-B99
TTDS00276	Thioredoxin reductase, cytoplasmic	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00276	Thioredoxin reductase, cytoplasmic	Sjogren's syndrome	710.2	M35.0
TTDR00277	Alpha v beta 3 integrin receptor	Angiogenesis	.	.
TTDR00277	Alpha v beta 3 integrin receptor	Cancer	140-229	C00-C96
TTDR00277	Alpha v beta 3 integrin receptor	Kaposi's sarcoma	176	C46
TTDR00277	Alpha v beta 3 integrin receptor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00277	Alpha v beta 3 integrin receptor	Tumor angiogenesis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00277	mRNA of E1 region of human papillomavirus	Cancer	140-229	C00-C96
TTDS00278	Bile salt export pump	Cholestasis	576.2	K83.1
TTDS00278	Bile salt export pump	Intrahepatic cholestasis	576.2	K83.1
TTDR00278	P2X purinoceptor 3	Analgesics	338	R52
TTDR00278	P2X purinoceptor 3	Dysmotility	.	.
TTDR00278	P2X purinoceptor 3	Hypertonicity of bladder	188	C67
TTDR00278	P2X purinoceptor 3	Inflammatory bowel disease	555, 556	K50, K51
TTDR00278	P2X purinoceptor 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00278	mRNA of Inflammatory cytokines	Asthma	493	J45
TTDC00279	mRNA of respiratory syncytial virus nucleocapsid protein	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00280	Beta-adrenergic receptor kinase 1	Congestive heart failure	428, 428.0	I50
TTDR00280	Beta-adrenergic receptor kinase 1	Heart failure	410, 428	I21, I22, I50
TTDR00280	Beta-adrenergic receptor kinase 1	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00280	Beta-adrenergic receptor kinase 1	Ventricular dysfunction	.	.
TTDS00280	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDC00280	mRNA of Inhibitor of apoptosis protein	Hepatocellular carcinoma	155	C22.0
TTDC00280	mRNA of Inhibitor of apoptosis protein	Neoplasms	140-239	C00-D48
TTDC00280	mRNA of Inhibitor of apoptosis protein	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00281	CAP-dependent endonuclease	Influenza A virus infections	487, 488	J10, J11
TTDR00281	CAP-dependent endonuclease	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDC00281	MARK3	Leukemia	208.9	C91-C95
TTDC00281	MARK3	Renal cell carcinoma	189	C64
TTDS00282	Trypsin	Chronic tendon injury	.	.
TTDS00282	Trypsin	Hemorrhage	.	.
TTDS00282	Trypsin	Pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDC00282	mRNA of Integrin alpha V	Medulloblastoma	191	C71
TTDS00283	Glucocorticoid receptor	Cocaine dependence	304.2, 311	F14.2, F32
TTDS00283	Glucocorticoid receptor	Drug dependence	303-305	F10-F19
TTDS00283	Glucocorticoid receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDR00283	Monocyte differentiation antigen CD14	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDR00283	Monocyte differentiation antigen CD14	Systemic inflammatory response syndrome	995.9	R65.1
TTDC00283	mRNA of HIV-1 envelope protein	HIV infection	001-139, 042	A00-B99, B20
TTDR00284	Tumor necrosis factor ligand superfamily member 5	Arthritis	710-719	M00-M25
TTDR00284	Tumor necrosis factor ligand superfamily member 5	Atherosclerosis	414.0, 440	I70
TTDR00284	Tumor necrosis factor ligand superfamily member 5	Autoimmune diseases	279	D84.9, M35.9
TTDR00284	Tumor necrosis factor ligand superfamily member 5	Cancer	140-229	C00-C96
TTDR00284	Tumor necrosis factor ligand superfamily member 5	Lupus erythematosus	695, 710.0	L51-L54, M32
TTDR00284	Tumor necrosis factor ligand superfamily member 5	Lupus nephritis	583.81	M32.1, N08.5
TTDC00284	mRNA of HIV reverse transcriptase	HIV infection	001-139, 042	A00-B99, B20
TTDS00285	Alpha-1-antitrypsin	Conformational diseases	570-574	K70-K77
TTDR00285	Large subunit Cp complex Cdc68p	Fungal diseases	110-118	B35-B49
TTDC00285	mRNA of Survivin	Cancer	140-229	C00-C96
TTDS00286	Adrenocorticotropic hormone receptor	Cushing's syndrome	255	E24
TTDR00286	Calcitonin gene-related peptide type 2 receptor	Migraine	346	G43
TTDR00286	Calcitonin gene-related peptide type 2 receptor	Opioid dependence	304	F11.2
TTDC00286	mRNA of Glucagon receptor	Type 2 diabetes	250.00, 250.02	E11
TTDR00287	C-X-C chemokine receptor type 5	Human immunodeficiency virus infection	279.3	D84.9
TTDR00287	C-X-C chemokine receptor type 5	Inflammatory demyelination	.	.
TTDS00287	Chloride channel protein 2	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDC00287	mRNA of PKC-alpha	Cancer	140-229	C00-C96
TTDR00288	ATP-binding cassette, sub-family A, member 1	Atherosclerotic cardiovascular disease	390-459	I00-I99
TTDR00288	ATP-binding cassette, sub-family A, member 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00288	ATP-binding cassette, sub-family A, member 1	Hypercholesterolemia	272	E78.0
TTDR00288	ATP-binding cassette, sub-family A, member 1	Low high density lipoprotein syndromes	.	.
TTDS00288	Multidrug resistance-associated protein 1	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDS00288	Multidrug resistance-associated protein 1	Streptococcus pneumoniae infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
TTDC00288	mRNA of Vascular endothelial growth factor receptor	Choroid neovascularization; Age-related macular degeneration	362.5	H35.3
TTDS00289	Amine oxidase [flavin-containing] A	Depression	311	F32
TTDS00289	Amine oxidase [flavin-containing] A	Mood affective disorders	.	.
TTDS00289	Amine oxidase [flavin-containing] A	Social phobias	300.23	F40.1
TTDR00289	C-Jun N-terminal kinase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00289	C-Jun N-terminal kinase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00289	C-Jun N-terminal kinase	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00289	C-Jun N-terminal kinase	Skin diseases	.	.
TTDC00289	mRNA of Vascular endothelial growth factor A165 isoform	Exudative age-related macular degeneration	362.5	H35.3
TTDC00290	Vascular endothelial growth factor receptor 3	Angiogenesis	.	.
TTDR00291	Beta-ketoacyl-ACP synthase I	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00291	D(4) dopamine receptor	Parkinson's disease	332	F02.3, G20
TTDC00291	D(4) dopamine receptor	Psychiatric illness	.	.
TTDC00291	D(4) dopamine receptor	Respiratory diseases	.	.
TTDS00291	Maltase-glucoamylase, intestinal	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00292	3-oxoacyl-[acyl-carrier-protein] synthase II	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00292	3-oxoacyl-[acyl-carrier-protein] synthase II	Tuberculosis	010-018	A15-A19
TTDC00292	Alpha-1A adrenergic receptor	Benign prostatic hyperplasia	600	N40
TTDC00292	Alpha-1A adrenergic receptor	Hypertrophic vascular disease	325, 430-459	G45-G46, I60-I95
TTDS00292	Insulin receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDC00293	Alpha-2B adrenergic receptor	Heart failure	410, 428	I21, I22, I50
TTDC00293	Alpha-2B adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDC00293	Alpha-2B adrenergic receptor	Ischemic heart disease	410-414	I20-I25
TTDR00293	Gap junction alpha-1 protein	Heart disease	390-429	I00-I52
TTDS00293	Omega 1 Benzodiazepine receptor	Disorders of initiating and maintaining sleep	710	M32
TTDS00295	Fatty acid synthase	Endometrial carcinoma	182	C54.1
TTDS00295	Fatty acid synthase	Leukemia	208.9	C91-C95
TTDS00295	Fatty acid synthase	Malaria	84	B50-B54
TTDS00295	Fatty acid synthase	Mesothelioma	163	C45
TTDS00295	Fatty acid synthase	Metastatic osteosarcoma in the lung	170	C40-C41
TTDS00295	Fatty acid synthase	Obesity	278	E66
TTDS00295	Fatty acid synthase	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00295	Fatty acid synthase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00295	Triacylglycerol lipase, pancreatic	Obesity	278	E66
TTDS00296	CGMP-specific 3',5'-cyclic phosphodiesterase	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDS00296	CGMP-specific 3',5'-cyclic phosphodiesterase	Injury to spine and spinal cord	.	.
TTDS00296	CGMP-specific 3',5'-cyclic phosphodiesterase	Pulmonary hypertension	416	I27.0, I27.2
TTDS00296	CGMP-specific 3',5'-cyclic phosphodiesterase	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDR00296	Cell division protein kinase 5	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00296	Cell division protein kinase 5	Bladder cancer	140-229, 188	C00-C96, C67
TTDC00297	Histone deacetylase	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDC00297	Histone deacetylase	Cancer	140-229	C00-C96
TTDC00297	Histone deacetylase	Hematologic malignancies	200-209	C81-C96
TTDR00298	Cell division protein kinase 8	Cancer	140-229	C00-C96
TTDC00298	Vasopressin V1b receptor	Adrenocorticotrophic hormone-secreting tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00298	Vasopressin V1b receptor	Emotional diseases	312-314	F90-F98
TTDC00298	Vasopressin V1b receptor	Stress-related disorders	296	F30-F39
TTDS00299	1,3-Beta-Glucan synthase	Fungal diseases	110-118	B35-B49
TTDR00299	Cyclin-dependent protein kinase PfPK5	Malaria	84	B50-B54
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Alcohol dependence	303	F10.2
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Alcoholism	303	F10.2
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Analgesics	338	R52
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Chronic pain	338.2,780	R52.1-R52.2, G89
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Convulsions	780.3	R56.0
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Dementia	290-294, 331.0	F01-F07, G30
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Drug-induced dyskinesias	333.8	G24.9
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Parkinson's disease	332	F02.3, G20
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDC00299	Glutamate [NMDA] receptor subunit epsilon 2	Traumatic head injury	800-879	S00.0S09
TTDR00300	Cyclin-dependent protein kinase PfPK6	Malaria	84	B50-B54
TTDS00300	Human keratin	Fungal diseases	110-118	B35-B49
TTDC00300	Interleukin-1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00300	Interleukin-1	Chronic arthritis	710-719	M00-M25
TTDC00300	Interleukin-1	Chronic inflammatory diseases	.	.
TTDC00300	Interleukin-1	Head injury	800-879	S00.0S09
TTDC00300	Interleukin-1	Multiple sclerosis	340	G35
TTDC00300	Interleukin-1	Neurodegenerative diseases	330-337	G30-G32
TTDC00300	Interleukin-1	Parkinson's disease	332	F02.3, G20
TTDC00300	Interleukin-1	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR00301	Cyclin-dependent protein kinase Pfmrk	Malaria	84	B50-B54
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Analgesics	338	R52
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Drug dependence	303-305	F10-F19
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Frontal lobe epilepsy	345	G40
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Neurodegenerative diseases	330-337	G30-G32
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00301	Neuronal acetylcholine receptor protein, beta-2 chain	Parkinson's disease	332	F02.3, G20
TTDS00301	Thymidylate synthase	Breast cancer	174, 175, 217	C50, D24
TTDS00301	Thymidylate synthase	Colorectal cancer	153, 154	C18-C21
TTDS00301	Thymidylate synthase	Fungal diseases	110-118	B35-B49
TTDS00301	Thymidylate synthase	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDS00301	Thymidylate synthase	Hepatocellular carcinoma	155	C22.0
TTDS00301	Thymidylate synthase	Malaria	84	B50-B54
TTDS00301	Thymidylate synthase	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00301	Thymidylate synthase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00301	Thymidylate synthase	Proliferative diseases	.	.
TTDR00302	Cyclosporine receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00302	Squalene monooxygenase	Fungal diseases	110-118	B35-B49
TTDS00302	Squalene monooxygenase	Hypercholesterolemia	272	E78.0
TTDR00303	Enoyl-[acyl-carrier-protein] reductase [NADH] 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00303	Nicotinic acetylcholine receptor	Alcoholism	303	F10.2
TTDS00303	Nicotinic acetylcholine receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00303	Nicotinic acetylcholine receptor	Analgesics	338	R52
TTDS00303	Nicotinic acetylcholine receptor	Cancer	140-229	C00-C96
TTDS00303	Nicotinic acetylcholine receptor	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDS00303	Nicotinic acetylcholine receptor	Depression	311	F32
TTDS00303	Nicotinic acetylcholine receptor	Drug dependence	303-305	F10-F19
TTDS00303	Nicotinic acetylcholine receptor	Gilles de la tourette's disorder	.	.
TTDS00303	Nicotinic acetylcholine receptor	Helminth infection	001-139	A00-B99
TTDS00303	Nicotinic acetylcholine receptor	Mood affective disorders	.	.
TTDS00303	Nicotinic acetylcholine receptor	Neuropsychiatric disorders	.	.
TTDS00303	Nicotinic acetylcholine receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00303	Nicotinic acetylcholine receptor	Parkinson's disease	332	F02.3, G20
TTDC00303	Potassium voltage-gated channel subfamily A member 5	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00304	Carbonic anhydrase	Glaucoma	365	H40-H42
TTDS00304	Carbonic anhydrase	Ocular hypertension	365.04	H40.0
TTDR00304	Enoyl-[acyl-carrier-protein] reductase [NADH] 2	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00304	Sodium-dependent noradrenaline transporter	Depression	311	F32
TTDS00306	Carbonic anhydrase II	Glaucoma	365	H40-H42
TTDS00306	Carbonic anhydrase II	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00306	Carbonic anhydrase II	Renal failure	584, 585	N17, N18, N19
TTDR00306	FemA factor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00307	FK506-binding protein 1A	Autoimmune diseases	279	D84.9, M35.9
TTDR00307	FemB factor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00307	Fumarate reductase flavoprotein subunit	Helicobacter pylori infection	41.86	B96.81
TTDR00308	FemX factor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00308	Tubulin beta	Helminth infection	001-139	A00-B99
TTDC00308	mRNA of HIV-1 TAR	Human immunodeficiency virus infection	279.3	D84.9
TTDR00309	Fatty acid-binding protein, epidermal	Insulin resistance	.	E00-E90
TTDR00309	Fatty acid-binding protein, epidermal	Obesity	278	E66
TTDS00309	HBV polymerase	Hepatitis B infection	070.2, 070.3	B16, B18.0, B18.1
TTDS00310	DNA polymerase	Hepatitis B infection	070.2, 070.3	B16, B18.0, B18.1
TTDS00310	DNA polymerase	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDS00310	DNA polymerase	Parasitic diseases	.	.
TTDS00310	DNA polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00310	Immunoglobulin alpha Fc receptor	Cancer	140-229	C00-C96
TTDC00310	mRNA of RAF proto-oncogene serine/threonine-protein kinase	Cancer	140-229	C00-C96
TTDC00311	Alpha platelet-derived growth factor receptor	Hypereosinophilic syndrome	288.3	D72.1
TTDC00311	Alpha platelet-derived growth factor receptor	Lung cancer	162	C33-C34
TTDR00311	Fc gamma receptor I	Cancer	140-229	C00-C96
TTDR00311	Fc gamma receptor I	Invasive candidiasis	112	B37
TTDS00311	Toll-like receptor 7	Basal cell carcinoma	140-199, 173, 210-229	C00-C75, C44, C7A, C7B, D10-D36, D3A
TTDS00311	Toll-like receptor 7	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00311	Toll-like receptor 7	Skin cancer	172, 173	C43-C44
TTDS00312	DNA (cytosine-5)-methyltransferase	Hepatocellular carcinoma	155	C22.0
TTDS00312	DNA (cytosine-5)-methyltransferase	Leukemia	208.9	C91-C95
TTDS00312	DNA (cytosine-5)-methyltransferase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDC00312	Urokinase-type plasminogen activator	Cancer	140-229	C00-C96
TTDC00312	Urokinase-type plasminogen activator	Melanoma	172.9	C43
TTDC00313	Acetyl-CoA acetyltransferase, mitochondrial	Hypercholesterolemia	272	E78.0
TTDR00313	Heparin binding protein	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00313	Ornithine decarboxylase	African trypanosomiasis	86.5	B56
TTDS00313	Ornithine decarboxylase	Hereditary polyposis syndromes	.	.
TTDS00313	Ornithine decarboxylase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00313	Ornithine decarboxylase	Malaria	84	B50-B54
TTDS00313	Ornithine decarboxylase	Sleeping sickness	.	.
TTDS00314	4-hydroxyphenylpyruvate dioxygenase	Hereditary tyrosinemia type I	.	.
TTDS00314	4-hydroxyphenylpyruvate dioxygenase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDC00314	Cannabinoid receptor 2	Analgesics	338	R52
TTDC00314	Cannabinoid receptor 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00314	Fibroblast growth factor receptor	Angiogenesis	.	.
TTDR00314	Fibroblast growth factor receptor	Cancer	140-229	C00-C96
TTDS00315	DNA polymerase (HSV)	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDS00315	DNA polymerase (HSV)	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00315	Foot-and-mouth disease virus capsid protein VP1	Foot and mouth disease	.	.
TTDC00315	Phosphodiesterase	Silent brain infarction	.	.
TTDC00315	Phosphodiesterase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00316	DNA polymerase (HSV-2)	Human cytomegalovirus infections	001-139, 078.5	A00-B99, B25
TTDR00316	Foot-and-mouth disease virus capsid protein VP2	Foot and mouth disease	.	.
TTDC00316	Tyrosine-protein kinase	Chronic myeloid leukemia	205.1	C92.1
TTDR00317	Foot-and-mouth disease virus capsid protein VP3	Foot and mouth disease	.	.
TTDS00317	HIV-1 reverse transcriptase	Human immunodeficiency virus infection	279.3	D84.9
TTDC00317	Nicotinic acid receptor	Type IV and V hyperlipidemia	272.0-272.4	E78
TTDS00318	HIV reverse transcriptase	Human immunodeficiency virus infection	279.3	D84.9
TTDC00318	High affinity nerve growth factor receptor	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDC00318	High affinity nerve growth factor receptor	Analgesics	338	R52
TTDC00318	High affinity nerve growth factor receptor	Cancer	140-229	C00-C96
TTDC00318	High affinity nerve growth factor receptor	Neurodegenerative diseases	330-337	G30-G32
TTDC00318	High affinity nerve growth factor receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDC00318	High affinity nerve growth factor receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDC00318	High affinity nerve growth factor receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDC00319	Apoptosis regulator Bcl-2	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDC00319	Apoptosis regulator Bcl-2	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
TTDC00319	Apoptosis regulator Bcl-2	Waldenstrom's macroglobulinemia	273.3	C88.0
TTDR00319	Glycoprotein VI	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00319	HIV-1 protease	Human immunodeficiency virus infection	279.3	D84.9
TTDC00320	G protein-coupled receptor 110A niacin receptor	Dyslipidemia	272	E78
TTDR00320	Glutathione peroxidase	Oxidative and free radical damage	.	.
TTDR00320	Glutathione peroxidase	Selenium deficiency	269.3	E59
TTDS00320	HIV protease	Human immunodeficiency virus infection	279.3	D84.9
TTDC00321	HCV NS4B protein	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDR00321	Metabotropic glutamate receptor 2	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00321	Metabotropic glutamate receptor 2	Analgesics	338	R52
TTDR00321	Metabotropic glutamate receptor 2	Anxiety disorders	300	F40-F42
TTDR00321	Metabotropic glutamate receptor 2	Epilepsy	290-319, 345	F01-F99, G40
TTDR00321	Metabotropic glutamate receptor 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00321	Metabotropic glutamate receptor 2	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDR00322	Granulocyte-macrophage colony-stimulating factor	Experimental autoimmune encephalomyelitis	.	.
TTDR00322	Granulocyte-macrophage colony-stimulating factor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDC00322	HCV NS5A protein; NS5A protein	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00322	HIV-1 Tat protein	Human immunodeficiency virus infection	279.3	D84.9
TTDR00323	HCV helicase	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDC00323	M1 prime segment of membrane IgE	Asthma	493	J45
TTDS00323	Peptidyl-prolyl cis-trans isomerase A	Human immunodeficiency virus infection	279.3	D84.9
TTDC00324	MicroRNA miR-122	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00325	Transmembrane glycoprotein gp41	Human immunodeficiency virus infection	279.3	D84.9
TTDC00325	mRNA of copper zinc superoxide dismutase 1	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDS00326	C-C chemokine receptor type 5	Human immunodeficiency virus infection	279.3	D84.9
TTDC00326	Complement factor D	Geographic atrophy associated with age-related macular degeneration	362.5	H35.3
TTDR00326	Herpes simplex virus helicase-primase	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00327	Histidine kinase AlgR1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00327	Lymphotoxin alpha	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00328	Histidine kinase AlgR2	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00328	Niemann-Pick C1-like protein 1	Hypercholesterolemia	272	E78.0
TTDS00328	Niemann-Pick C1-like protein 1	Sitosterolemia	.	.
TTDC00328	mRNA of ApoC-III	Inflammation; High triglycerides; Atherosclerosis; Metabolic syndrome	277.7, 414.0, 440	E88.81, I70
TTDR00329	Histidine kinase KinA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDC00329	mRNA of transthyretin	Amyloidosis	277.3	E85
TTDR00330	HIV-1 gp160	Human immunodeficiency virus infection	279.3	D84.9
TTDC00330	mRNA of Factor XI	Clotting disorders	286	D65-D69
TTDC00331	Apolipoprotein B-100	High cholesterol	272	E78.0
TTDR00331	Holo-ACP synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00331	SUR1-type K(ATP) channel	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00332	Interferon alpha	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDR00332	Interferon alpha	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00332	Interferon alpha	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDS00332	SUR2-type K(ATP) channel	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00332	SUR2-type K(ATP) channel	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00332	SUR2-type K(ATP) channel	Unstable angina	411.1	I20.0
TTDC00332	mRNA of androgen receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00333	Insulin-like growth factor binding protein 1	Colorectal cancer	153, 154	C18-C21
TTDR00333	Insulin-like growth factor binding protein 1	Maturity-onset diabetes of the young	250	E08-E13
TTDC00333	Prolactin receptor	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
TTDS00334	Cannabinoid receptor 1	Analgesics	338	R52
TTDS00334	Cannabinoid receptor 1	Inflammatory bowel disease	555, 556	K50, K51
TTDS00334	Cannabinoid receptor 1	Migraine	346	G43
TTDS00334	Cannabinoid receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00334	Mitogen-activated protein kinase 9	Cancer	140-229	C00-C96
TTDR00334	Mitogen-activated protein kinase 9	Crohn's disease	555	K50
TTDR00334	Mitogen-activated protein kinase 9	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00334	Mitogen-activated protein kinase 9	Obesity	278	E66
TTDC00334	mRNA of VEGFR1	Exudative age-related macular degeneration	362.5	H35.3
TTDC00334	mRNA of VEGFR1	Neovascular age-related macular degeneration	362.5	H35.3
TTDR00335	Rhombotin-2	Cancer	140-229	C00-C96
TTDC00335	mRNA of connective tissue growth factor	Fibrosis	709.2	L90.5
TTDR00336	Phospholipid transfer protein	Coronary heart disease	414	I25.1
TTDR00336	Phospholipid transfer protein	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00336	Phospholipid transfer protein	Hyperlipidemia	272.0-272.4	E78
TTDR00336	Phospholipid transfer protein	Obesity	278	E66
TTDS00336	Serum albumin	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDC00336	mRNA of sodium-glucose transporter-2	Type 2 Diabetes	250.00, 250.02	E11
TTDC00337	CD70	Autoimmune disease	279.4	D84.9, M35.9
TTDC00337	CD70	Renal cell carcinoma; non-Hodgkin lymphoma	189, 200, 202, 202.8	C64, C81-C96, C82-C85
TTDR00337	Mitogen-activated protein kinase kinase kinase 2	Cancer	140-229	C00-C96
TTDS00337	Nitric oxide synthase, inducible	Ischemia reperfusion injuries	459.89	I99.8
TTDC00338	Activin receptor-like kinase-1	Advanced cancers; Age-related macular degeneration	140-229, 362.50	C00-C96, H35.3
TTDR00338	Matrix metalloproteinase	Atherosclerosis	414.0, 440	I70
TTDR00338	Matrix metalloproteinase	Leukemia	208.9	C91-C95
TTDR00338	Matrix metalloproteinase	Osteoarthritis	715	M15-M19, M47
TTDR00338	Matrix metalloproteinase	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00338	Peroxisome proliferator activated receptor gamma	Adrenocorticotrophic hormone-secreting pituitary tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00338	Peroxisome proliferator activated receptor gamma	Asthma	493	J45
TTDS00338	Peroxisome proliferator activated receptor gamma	Atherosclerosis	414.0, 440	I70
TTDS00338	Peroxisome proliferator activated receptor gamma	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDS00338	Peroxisome proliferator activated receptor gamma	Autoimmune diseases	279	D84.9, M35.9
TTDS00338	Peroxisome proliferator activated receptor gamma	Bladder cancer	140-229, 188	C00-C96, C67
TTDS00338	Peroxisome proliferator activated receptor gamma	Chronic inflammatory diseases	.	.
TTDS00338	Peroxisome proliferator activated receptor gamma	Crohn's disease	555	K50
TTDS00338	Peroxisome proliferator activated receptor gamma	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00338	Peroxisome proliferator activated receptor gamma	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00338	Peroxisome proliferator activated receptor gamma	Inflammatory bowel disease	555, 556	K50, K51
TTDS00338	Peroxisome proliferator activated receptor gamma	Insulin resistance	.	E00-E90
TTDS00338	Peroxisome proliferator activated receptor gamma	Ischemic heart disease	410-414	I20-I25
TTDS00338	Peroxisome proliferator activated receptor gamma	Multiple sclerosis	340	G35
TTDS00338	Peroxisome proliferator activated receptor gamma	Obesity	278	E66
TTDS00338	Peroxisome proliferator activated receptor gamma	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00338	Peroxisome proliferator activated receptor gamma	Psoriasis	696	L40
TTDS00338	Peroxisome proliferator activated receptor gamma	Renal cell carcinoma	189	C64
TTDS00338	Peroxisome proliferator activated receptor gamma	Testicular cancer	140-229	C00-C96
TTDS00338	Peroxisome proliferator activated receptor gamma	Thyroid follicular carcinoma	.	.
TTDS00338	Peroxisome proliferator activated receptor gamma	Ulcerative colitis	556	K51
TTDR00339	Mitogen-activated protein kinase kinase kinase 9	Cancer	140-229	C00-C96
TTDS00339	Vascular endothelial growth factor	Breast cancer	174, 175, 217	C50, D24
TTDS00339	Vascular endothelial growth factor	Cancer	140-229	C00-C96
TTDS00339	Vascular endothelial growth factor	Ischemic heart disease	410-414	I20-I25
TTDS00339	Vascular endothelial growth factor	Joint disorders	.	.
TTDS00339	Vascular endothelial growth factor	Proliferative retinopathy	362.0-362.2	H35-H35.2
TTDS00339	Vascular endothelial growth factor	Renal cell carcinoma	189	C64
TTDS00339	Vascular endothelial growth factor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00339	Vascular endothelial growth factor	Superficial bladder tumors	140-199, 188, 210-229	C00-C75, C67, C67.9, C7A, C7B, D10-D36, D3A
TTDC00339	mRNA of kinesin spindle protein	Liver cancers	155.2	C22.9
TTDC00340	Choline transporter-like protein 4	Pancreatic cancer; Prostate cancer	140-229, 157, 185	C00-C96, C25, C61
TTDR00340	Mitogen-activated protein kinase kinase kinase 10	Cancer	140-229	C00-C96
TTDS00340	Peroxisome proliferator activated receptor alpha	Hyperglycemia	790.29	R73.9
TTDS00340	Peroxisome proliferator activated receptor alpha	Hyperinsulinemia	.	E16.1
TTDS00340	Peroxisome proliferator activated receptor alpha	Insulin resistance	.	E00-E90
TTDS00340	Peroxisome proliferator activated receptor alpha	Lipid metabolic disorders	270-279	E70-E89
TTDS00340	Peroxisome proliferator activated receptor alpha	Obesity	278	E66
TTDS00341	Amine oxidase [flavin-containing] B	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDS00341	Amine oxidase [flavin-containing] B	Neurological diseases	320-359	G00-G99
TTDS00341	Amine oxidase [flavin-containing] B	Parkinson's disease	332	F02.3, G20
TTDR00341	Mitogen-activated protein kinase kinase kinase 11	Cancer	140-229	C00-C96
TTDR00341	Mitogen-activated protein kinase kinase kinase 11	Neurodegenerative diseases involving neuronal apoptosis	330-337	G30-G32
TTDC00341	Scavenger decapping enzyme DcpS	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
TTDC00342	Calcium-release activated calcium channel	Psoriasis	696	L40
TTDS00342	Delta-aminolevulinic acid dehydratase	Malaria	84	B50-B54
TTDR00342	mRNA of adenosine A1 receptor	Asthma	493	J45
TTDC00343	Nectin-4	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00343	mRNA of EGFR	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00344	mRNA of protein kinase A Rialpha subunit	Cancer	140-229	C00-C96
TTDC00345	mRNA of growth hormone receptor	Acromegaly	253	E22.0
TTDS00346	B-Raf proto-oncogene serine/threonine-protein kinase	Malignant melanoma	172, 208.9	C43, C91-C95
TTDS00346	B-Raf proto-oncogene serine/threonine-protein kinase	Melanoma	172.9	C43
TTDS00346	B-Raf proto-oncogene serine/threonine-protein kinase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00347	Fusion glycoprotein	Measles virus infections	001-139, 042-075, 055	A00-B99, A80-A99, B00-B34, B05
TTDR00347	Sodium/hydrogen exchanger 1	Heart failure	410, 428	I21, I22, I50
TTDR00347	Sodium/hydrogen exchanger 1	Myocardial ischemia; Reperfusion injury	459.89	I99.8
TTDR00348	Nicotinate-nucleotide adenylyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00348	Proto-oncogene tyrosine-protein kinase receptor ret	Medullary thyroid carcinoma	193	C73
TTDS00349	Nicotinic acetylcholine receptor alpha subunit	Muscle contraction	.	.
TTDR00349	Reticulon 4 receptor	Cancer	140-229	C00-C96
TTDR00349	Reticulon 4 receptor	Central nervous system injury	.	P11.9
TTDR00349	Reticulon 4 receptor	Neurodegenerative diseases	330-337	G30-G32
TTDI00350	AKT1 protein kinase	Cancer	140-229	C00-C96
TTDI00350	AKT1 protein kinase	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI00350	AKT1 protein kinase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI00350	AKT1 protein kinase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00350	Transient receptor potential channel 6, subfamily V	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00350	Transient receptor potential channel 6, subfamily V	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00351	Orphan nuclear receptor NR1I3	Neonatal jaundice	782.4	R17
TTDS00351	Orphan nuclear receptor NR1I3	Obesity	278	E66
TTDR00352	Mitogen-activated protein kinase 11	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00352	Mitogen-activated protein kinase 11	Psoriasis	696	L40
TTDR00352	Mitogen-activated protein kinase 11	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00353	P42/p44 mitogen-activated protein kinase	Neurodegenerative diseases	330-337	G30-G32
TTDR00353	P42/p44 mitogen-activated protein kinase	Proliferative diseases	.	.
TTDR00354	Pantothenate kinase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDS00354	Retinoid X receptor	Cancer	140-229	C00-C96
TTDS00354	Retinoid X receptor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00355	Epidermal growth factor receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00355	Epidermal growth factor receptor	Cancer	140-229	C00-C96
TTDS00355	Epidermal growth factor receptor	Colorectal cancer	153, 154	C18-C21
TTDS00355	Epidermal growth factor receptor	Glioblastoma multiforme	191	C71
TTDS00355	Epidermal growth factor receptor	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDS00355	Epidermal growth factor receptor	Head and neck tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00355	Epidermal growth factor receptor	Lymphangiomatosis	.	.
TTDS00355	Epidermal growth factor receptor	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDS00355	Epidermal growth factor receptor	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00355	Epidermal growth factor receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDS00355	Epidermal growth factor receptor	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00355	Epidermal growth factor receptor	Squamous cell carcinoma	199	C44
TTDS00355	Epidermal growth factor receptor	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00355	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00355	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	Cancer	140-229	C00-C96
TTDR00355	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	Hepatocellular carcinoma	155	C22.0
TTDR00356	Phosphoinositide 3 kinase	Autoimmune diseases	279	D84.9, M35.9
TTDR00356	Phosphoinositide 3 kinase	Cancer	140-229	C00-C96
TTDR00356	Phosphoinositide 3 kinase	Respiratory diseases	.	.
TTDS00357	Acetyl-CoA carboxylase 2	Obesity	278	E66
TTDR00357	Phosphoenolpyruvate transferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00358	Phospholipase D	Cardiopulmonary bypass-induced inflammation	.	.
TTDR00358	Phospholipase D	Colon cancer	153, 154	C18-C21
TTDR00358	Phospholipase D	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00359	Elongation factor 1-alpha 1	Malaria	84	B50-B54
TTDS00359	Fungal Cytochrome P450 51	Oropharyngeal candidiasis	112	B37
TTDR00360	5-enopyruvyl shikimate 3-phosphate synthase	Malaria	84	B50-B54
TTDS00360	Receptor-type protein-tyrosine phosphatase S	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDS00360	Receptor-type protein-tyrosine phosphatase S	Paget's disease	731	M88
TTDS00361	Aromatic-L-amino-acid decarboxylase	Parkinson's disease	332	F02.3, G20
TTDR00361	Beta-ketoacyl-ACP synthase III	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00361	Beta-ketoacyl-ACP synthase III	Malaria	84	B50-B54
TTDR00362	20S proteasome	Cancer	140-229	C00-C96
TTDS00362	Catechol-O-methyl-transferase	Parkinson's disease	332	F02.3, G20
TTDS00363	Calcineurin	Fungal diseases	110-118	B35-B49
TTDS00363	Calcineurin	Parkinson's disease	332	F02.3, G20
TTDS00363	Calcineurin	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDR00363	Serine/threonine protein phosphatase 2A, 56 kDa regulatory subunit, alpha isoform	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00364	Collagenase	Periodontal disease	.	K05
TTDR00365	Stress kinase p38	Skin diseases	.	.
TTDS00365	Tyrosine 3-monooxygenase	Pheochromocytoma	194.0, 227.0, 255.6	C74.1, D35.0
TTDR00366	Sulfur mustard-stimulated protease	Vesication	.	.
TTDS00367	Androgen receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00367	Androgen receptor	Spinal and bulbar muscular atrophy	728.2	M62.5
TTDS00368	T-cell surface antigen CD2	Psoriasis	696	L40
TTDR00369	Urokinase plasminogen activator surface receptor	Autoimmune diseases	279	D84.9, M35.9
TTDR00369	Urokinase plasminogen activator surface receptor	Breast cancer	174, 175, 217	C50, D24
TTDR00369	Urokinase plasminogen activator surface receptor	Cancer	140-229	C00-C96
TTDR00369	Urokinase plasminogen activator surface receptor	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDR00370	Vasopressin receptor	Congestive heart failure	428, 428.0	I50
TTDR00370	Vasopressin receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00370	Vasopressin receptor	Dysmenorrhea	625.3	N94.4-N94.6
TTDR00370	Vasopressin receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00370	Vasopressin receptor	Liver cirrhosis	.	K70.3,K71.7,K74
TTDR00370	Vasopressin receptor	Nephrotic syndrome	581.9	N04
TTDS00372	Farnesyl pyrophosphate synthetase	Cancer	140-229	C00-C96
TTDS00372	Farnesyl pyrophosphate synthetase	Chagas' disease	86	B57
TTDS00372	Farnesyl pyrophosphate synthetase	Hypercholesterolemia	272	E78.0
TTDS00372	Farnesyl pyrophosphate synthetase	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDS00372	Farnesyl pyrophosphate synthetase	Myeloma disease	203	C90.0
TTDS00372	Farnesyl pyrophosphate synthetase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDS00372	Farnesyl pyrophosphate synthetase	Skeletal disorders	.	.
TTDS00372	Farnesyl pyrophosphate synthetase	Toxoplasma infections	001-139	A00-B99
TTDS00372	Farnesyl pyrophosphate synthetase	Trypanosomatid infections	001-139	A00-B99
TTDR00372	Mitogen-activated protein kinase 1	Neurodegenerative diseases	330-337	G30-G32
TTDR00372	Mitogen-activated protein kinase 1	Proliferative diseases	.	.
TTDR00373	Mitogen-activated protein kinase 3	Neurodegenerative diseases	330-337	G30-G32
TTDR00373	Mitogen-activated protein kinase 3	Proliferative diseases	.	.
TTDR00373	Mitogen-activated protein kinase 3	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDS00373	Tyrosine oxidase	Skin diseases	.	.
TTDS00374	Benzodiazepine receptor	Anxiety disorders	300	F40-F42
TTDS00374	Benzodiazepine receptor	Disorders of initiating and maintaining sleep	710	M32
TTDS00374	Benzodiazepine receptor	Sleeping sickness	.	.
TTDR00374	Phospholipase D1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00375	Melanocortin-3 receptor	Chronic inflammatory diseases	.	.
TTDR00375	Melanocortin-3 receptor	Gouty arthritis	710-719	M00-M25
TTDR00375	Melanocortin-3 receptor	Obesity	278	E66
TTDS00377	Ceramide glucosyltransferase	Sphingolipid storage disorders	.	.
TTDR00377	Cholecystokinin	Acute pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDR00377	Cholecystokinin	Obesity	278	E66
TTDS00378	Heparin cofactor II	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR00378	mRNA of protein kinase A1	Cancer	140-229	C00-C96
TTDR00380	3-hydroxysteroid dehydrogenase	Primary aldosteronism	.	.
TTDS00380	Thyroid peroxidase	Thyrotoxicosis hyperthyroidism	242.9	E05
TTDR00381	Hydroxymethylglutaryl-CoA synthase, mitochondrial	Hypercholesterolemia	272	E78.0
TTDS00381	Thyroid hormone receptor alpha	Thyrotoxicosis hyperthyroidism	242.9	E05
TTDR00382	Low-density lipoprotein	Coronary heart disease	414	I25.1
TTDR00383	Low-density lipoprotein receptor-related protein	Glioblastoma multiforme	191	C71
TTDS00383	Probable arabinosyltransferase	Tuberculosis	010-018	A15-A19
TTDS00384	Enoyl-[acyl-carrier-protein] reductase [NADH]	Tuberculosis	010-018	A15-A19
TTDR00384	Scavenger receptor class B member 1	Atherosclerosis	414.0, 440	I70
TTDR00384	Scavenger receptor class B member 1	Atherosclerotic cardiovascular disease	390-459	I00-I99
TTDR00384	Scavenger receptor class B member 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00384	Scavenger receptor class B member 1	Hypercholesterolemia	272	E78.0
TTDR00384	Scavenger receptor class B member 1	Reproductive disorder	600-629	N40-N99
TTDR00385	Filamin A	Ischemic stroke	434.91	I61-I63
TTDR00386	Corticotropin-releasing factor binding protein	Excessive weight gain associated with obesity of multiple etiology	278	E66
TTDS00386	Fatty acid synthase subunit beta	Tuberculosis	010-018	A15-A19
TTDR00387	Corticoliberin	Childhood seizure disorders	345	G40
TTDR00387	Corticoliberin	Multiple sclerosis	340	G35
TTDR00387	Corticoliberin	West's syndrome	345.6	G40.4
TTDR00388	Nuclear receptor coactivator 4	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00389	Glycoprotein hormones alpha chain	ER alpha-positive prostate tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00389	Glycoprotein hormones alpha chain	Metastatic prostate cancer	140-229, 185, 208.9	C00-C96, C61, C91-C95
TTDS00389	Tubulin beta-2 chain	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00390	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Bronchial asthma	493	J45
TTDS00390	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Chronic myeloid leukemia	205.1	C92.1
TTDS00390	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Vascular diseases	325, 430-459	G45-G46, I60-I95
TTDR00390	Supervillin	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00391	Nuclear receptor binding SET domain containing protein 1	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00392	Plasminogen	Excessive postoperative bleeding	459	R58
TTDS00392	Plasminogen	Hemorrhage	.	.
TTDR00392	Prostate stem cell antigen	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00393	3-alpha-hydroxysteroid dehydrogenase	Androgen-dependent diseases	.	.
TTDR00393	3-alpha-hydroxysteroid dehydrogenase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00393	Melatonin receptor type 1A	Chronic Primary Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDS00393	Melatonin receptor type 1A	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDS00393	Melatonin receptor type 1A	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDR00394	High-affinity cationic amino acid transporter-1	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00394	Somatostatin receptor type 2	Cancer	140-229	C00-C96
TTDS00394	Somatostatin receptor type 2	Cushing's disease	255	E24.0
TTDS00394	Somatostatin receptor type 2	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
TTDR00395	Thrombomodulin	Radiation enteropathy	.	.
TTDR00395	Thrombomodulin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00395	Thromboxane A2 receptor	Platelet adhesion	.	.
TTDR00396	Tissue factor	Atherosclerosis	414.0, 440	I70
TTDR00396	Tissue factor	Coronary syndromes	411.1	I20.0
TTDR00396	Tissue factor	Disseminated intravascular coagulation	286.6	D65
TTDR00396	Tissue factor	Gliomas	191	C71
TTDR00396	Tissue factor	Over-expression of TF	.	.
TTDR00396	Tissue factor	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDR00396	Tissue factor	Thrombotic disease	.	.
TTDR00397	G1/S-specific cyclin D1	Breast cancer	174, 175, 217	C50, D24
TTDR00397	G1/S-specific cyclin D1	Cancer	140-229	C00-C96
TTDS00397	Pancreatic alpha-amylase	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
TTDS00397	Pancreatic alpha-amylase	Pancreatic disease	.	K85-K86
TTDS00398	Vitamin K epoxide reductase complex subunit 1	Thromboembolic disease	437.6, 453, 671.5, 671.9	I80-I82
TTDS00399	5-hydroxytryptamine receptor 3A	Chemotherapy-induced nausea; Vomiting	787, 787.0	R11
TTDS00399	5-hydroxytryptamine receptor 3A	Diarrhea	787.91	A09, K59.1
TTDS00399	5-hydroxytryptamine receptor 3A	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDS00399	5-hydroxytryptamine receptor 3A	Postoperative nausea and vomiting	787, 787.0	R11
TTDR00399	Trehalose-phosphatase	Fungal diseases	110-118	B35-B49
TTDR00400	Coagulation factor VIIa	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00400	Neuronal acetylcholine receptor subunit alpha-2	Anesthesia	338	R52
TTDS00400	Neuronal acetylcholine receptor subunit alpha-2	Postoperative residual curarisation	.	.
TTDS00401	Inosine-5'-monophosphate dehydrogenase 1	Inflammatory bowel disease	555, 556	K50, K51
TTDR00401	Macrophage mannose receptor	Leukemia	208.9	C91-C95
TTDR00402	Outer capsid glycoprotein VP7	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDS00402	Sodium channel protein type 5 subunit alpha	Analgesics	338	R52
TTDS00402	Sodium channel protein type 5 subunit alpha	Cardiac dysrhythmias	427	I47-I49
TTDS00402	Sodium channel protein type 5 subunit alpha	Epileptic seizures	345.9, 780.3	G40, P90, R56
TTDS00402	Sodium channel protein type 5 subunit alpha	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00402	Sodium channel protein type 5 subunit alpha	Refractory partial epilepsy	345	G40
TTDS00402	Sodium channel protein type 5 subunit alpha	Sustained ventricular tachycardia	427, 427.1, 785.0	I47-I49, I47.2, R00.0
TTDS00403	Gamma-aminobutyric acid receptor subunit alpha-1	Anxiety disorders	300	F40-F42
TTDS00403	Gamma-aminobutyric acid receptor subunit alpha-1	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDR00403	Serine proteinase alpha-thrombin	Haemostatic disorders	.	.
TTDR00404	Midkine	Cancer	140-229	C00-C96
TTDS00404	Sodium channel protein type 1 subunit alpha	Analgesics	338	R52
TTDS00404	Sodium channel protein type 1 subunit alpha	Local anesthesia	338	R52
TTDS00404	Sodium channel protein type 1 subunit alpha	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00404	Sodium channel protein type 1 subunit alpha	Seizures	345.9, 780.3	G40, P90, R56
TTDS00405	Adenine nucleotide translocator 1	Hypercalcemia of malignancy	275.42	E83.5
TTDS00405	Adenine nucleotide translocator 1	Osteolysis	.	.
TTDR00405	B1 bradykinin receptor	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDR00405	B1 bradykinin receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00405	B1 bradykinin receptor	Ischemic vascular disease	325, 430-459	G45-G46, I60-I95
TTDR00405	B1 bradykinin receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00406	Kininogen	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00406	Kininogen	Lung cancers with neuroendocrine features	140-229	C00-C96
TTDS00406	Proto-oncogene tyrosine-protein kinase Fyn	Philadelphia-positive leukemia	208.9	C91-C95
TTDR00407	Kinin B1 receptor	Analgesics	338	R52
TTDR00407	Kinin B1 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00407	Kinin B1 receptor	Inflammatory pain	338,780	R52, G89
TTDR00407	Kinin B1 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00407	Proto-oncogene tyrosine-protein kinase LCK	Philadelphia-positive leukemia	208.9	C91-C95
TTDR00408	Kinin B2 receptor	Analgesics	338	R52
TTDR00408	Kinin B2 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00408	Kinin B2 receptor	Salt-sensitive hypertension	401	I10, I11, I12, I13, I15
TTDS00408	Proto-oncogene tyrosine-protein kinase Yes	Philadelphia-positive leukemia	208.9	C91-C95
TTDS00409	Troponin C	Biventricular heart failure	428	I50
TTDS00409	Troponin C	Chronic heart failure	428	I50
TTDR00409	Vanilloid receptor	Analgesics	338	R52
TTDR00409	Vanilloid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00409	Vanilloid receptor	Skin inflammation	.	.
TTDS00410	Gamma-aminobutyric acid receptor subunit beta-2	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDR00411	Apolipoprotein E	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00411	Apolipoprotein E	Amyloidosis	277.3	E85
TTDR00411	Apolipoprotein E	Brain tumors	191, 225.0	C71, D33
TTDS00411	Macrophage colony-stimulating factor receptor	Bone marrow transplant	279.5, 996	D89.8, T86
TTDS00411	Macrophage colony-stimulating factor receptor	Febrile neutropenia	288	D70
TTDS00411	Macrophage colony-stimulating factor receptor	Non-myeloid cancer	140-199	C00-C75, C7A, C7B
TTDR00412	Endothelin-1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00412	Endothelin-1	Congestive heart failure	428, 428.0	I50
TTDS00412	Potassium voltage-gated channel subfamily D member 3	Analgesics	338	R52
TTDS00412	Potassium voltage-gated channel subfamily D member 3	Migraine	346	G43
TTDS00412	Potassium voltage-gated channel subfamily D member 3	Occlusive peripheral vascular disease	325, 430-459, 443.9	G45-G46, I60-I95, I73.9
TTDS00412	Potassium voltage-gated channel subfamily D member 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00412	Potassium voltage-gated channel subfamily D member 3	Vertigo of central and peripheral origin	438.85, 780.4	H81, R42
TTDR00413	Diphosphomevalonate decarboxylase	Hypercholesterolemia	272	E78.0
TTDS00413	Voltage-dependent T-type calcium channel subunit alpha-1H	Analgesics	338	R52
TTDS00413	Voltage-dependent T-type calcium channel subunit alpha-1H	Migraine	346	G43
TTDS00413	Voltage-dependent T-type calcium channel subunit alpha-1H	Occlusive peripheral vascular disease	325, 430-459, 443.9	G45-G46, I60-I95, I73.9
TTDS00413	Voltage-dependent T-type calcium channel subunit alpha-1H	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00413	Voltage-dependent T-type calcium channel subunit alpha-1H	Vertigo of central and peripheral origin	438.85, 780.4	H81, R42
TTDR00414	S-adenosylmethionine decarboxylase proenzyme	Cancer	140-229	C00-C96
TTDR00414	S-adenosylmethionine decarboxylase proenzyme	Parasitic diseases	.	.
TTDR00414	S-adenosylmethionine decarboxylase proenzyme	Proliferative diseases	.	.
TTDS00414	Voltage-dependent L-type calcium channel subunit alpha-1C	Heart disease	390-429	I00-I52
TTDS00414	Voltage-dependent L-type calcium channel subunit alpha-1C	Heart transplant	.	.
TTDR00415	Lactosylceramide alpha-2,3-sialyltransferase	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00415	Voltage-dependent calcium channel subunit alpha-2/delta-1	Analgesics	338	R52
TTDS00415	Voltage-dependent calcium channel subunit alpha-2/delta-1	Chronic stable angina	413	I20
TTDS00415	Voltage-dependent calcium channel subunit alpha-2/delta-1	Heart transplant	.	.
TTDS00415	Voltage-dependent calcium channel subunit alpha-2/delta-1	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00415	Voltage-dependent calcium channel subunit alpha-2/delta-1	Vasospastic angina	413	I20
TTDR00416	Endothelin converting enzyme	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00416	Endothelin converting enzyme	Coronary atherosclerosis	414.0, 440	I70
TTDR00416	Endothelin converting enzyme	Renal diseases	580-599	N00-N39
TTDR00416	Endothelin converting enzyme	Vein graft disease	.	.
TTDS00416	Sodium channel protein type 4 subunit alpha	Analgesics	338	R52
TTDS00416	Sodium channel protein type 4 subunit alpha	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00416	Sodium channel protein type 4 subunit alpha	Seizures in epilepsy	345, 345.9, 780.3	G40, G40, P90, R56
TTDS00416	Sodium channel protein type 4 subunit alpha	Seizures of lennox-gastaut syndrome	345.9, 780.3	G40, P90, R56
TTDR00417	Leucine-rich repeat-containing G protein-coupled receptor 5	Hepatocellular carcinoma	155	C22.0
TTDS00417	Peptidyl-prolyl cis-trans isomerase B	Heart disease	390-429	I00-I52
TTDS00418	Cytochrome P450 3A4	Hypothalamic-pituitary ACTH function	.	.
TTDR00418	Prolactin	Breast cancer	174, 175, 217	C50, D24
TTDR00419	CCAAT/enhancer binding protein beta	Kaposi's sarcoma	176	C46
TTDR00419	CCAAT/enhancer binding protein beta	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00419	CCAAT/enhancer binding protein beta	Obesity	278	E66
TTDS00419	Cytochrome P450 11A1, mitochondrial	Adrenocortical tumour	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00419	Cytochrome P450 11A1, mitochondrial	Cushing's syndrome	255	E24
TTDS00420	Cytochrome P450 11B1, mitochondrial	Adrenocortical tumour	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00420	Cytochrome P450 11B1, mitochondrial	Cushing's syndrome	255	E24
TTDR00420	Oxysterols receptor LXR-alpha	Atherosclerosis	414.0, 440	I70
TTDR00420	Oxysterols receptor LXR-alpha	Cancer	140-229	C00-C96
TTDR00421	Oxysterols receptor LXR-beta	Atherosclerosis	414.0, 440	I70
TTDR00421	Oxysterols receptor LXR-beta	Dyslipidemia	272	E78
TTDS00421	Ribonucleoside-diphosphate reductase subunit M2	Cancer	140-229	C00-C96
TTDR00422	Leukemia inhibitory factor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR00422	Leukemia inhibitory factor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00422	Melatonin receptor type 1B	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDS00423	3-beta-HSD	Cushing's syndrome	255	E24
TTDR00423	Eosinophil peroxidase	Allergen-triggered inflammatory tissue injury	.	.
TTDS00424	Guanylate cyclase soluble subunit beta-1	Heart failure	410, 428	I21, I22, I50
TTDR00426	Chemokine receptor	Sjogren's syndrome	710.2	M35.0
TTDS00426	Type I iodothyronine deiodinase	Massive metastatic follicular thyroid carcinoma	.	.
TTDR00427	Interferon regulatory factor 1	Ischemic stroke	434.91	I61-I63
TTDS00427	Vacuolar ATP synthase catalytic subunit A	Net blotch	.	.
TTDR00428	Class II cytokine receptor	Vascular injury	.	.
TTDS00428	Gamma-aminobutyric acid receptor subunit gamma-2	Brain injury	.	S09.90
TTDS00429	Gastric triacylglycerol lipase	Gastric disease	536, 750	K30-K31, Q40-Q41
TTDS00430	Equilibrative nucleoside transporter 1	Malaria	84	B50-B54
TTDR00430	Leukocyte surface antigen CD47	Acute and chronic graft-versus-host disease	279.5	T86.0
TTDR00430	Leukocyte surface antigen CD47	Allograft rejection	996.8	T86
TTDR00430	Leukocyte surface antigen CD47	Anergy	.	.
TTDR00430	Leukocyte surface antigen CD47	Autoimmune diseases	279	D84.9, M35.9
TTDR00430	Leukocyte surface antigen CD47	Inflammatory disease of mucosal surfaces	.	.
TTDS00431	ATP-sensitive inward rectifier potassium channel 10	Analgesics	338	R52
TTDS00431	ATP-sensitive inward rectifier potassium channel 10	Cardiac arrhythmias	427	I47-I49
TTDS00431	ATP-sensitive inward rectifier potassium channel 10	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00431	ATP-sensitive inward rectifier potassium channel 10	Sudden cardiac death	.	.
TTDS00431	ATP-sensitive inward rectifier potassium channel 10	Unstable angina	411.1	I20.0
TTDR00431	Monokine	Autoimmune inflammation	.	.
TTDR00431	Monokine	Cancer	140-229	C00-C96
TTDR00431	Monokine	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00432	Calmodulin	Atopic asthma	493	J45
TTDS00432	Calmodulin	Cancer	140-229	C00-C96
TTDR00432	Gastric inhibitory polypeptide	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00432	Gastric inhibitory polypeptide	Obesity	278	E66
TTDS00433	Carnitine O-palmitoyltransferase I	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00433	Carnitine O-palmitoyltransferase I	Obesity	278	E66
TTDR00433	Caspase-8	Neurodegenerative diseases	330-337	G30-G32
TTDS00434	Collagen	Dermal ulcers	707	L88, L89
TTDS00434	Collagen	Dupuytren's disease	728.6	M72.0
TTDS00434	Collagen	Skin burns	940-949	T20-T31
TTDS00434	Collagen	Vitamin C deficiency	267	E54
TTDR00434	Interleukin-1 beta convertase	Brain inflammation	.	.
TTDR00434	Interleukin-1 beta convertase	Cerebral ischemia	459.89	I99.8
TTDR00434	Interleukin-1 beta convertase	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDR00434	Interleukin-1 beta convertase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00435	Common lymphatic endothelial and vascular endothelial receptor-1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDS00435	Complement C5	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00436	Elongation factor G	Streptococcus pneumoniae infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
TTDR00436	Mitogen-activated protein kinase	Chronic myeloid leukemia	205.1	C92.1
TTDR00436	Mitogen-activated protein kinase	Reperfusion injury after brain ischemia	435, 437, 459.89	G45.9, I67.8, I99.8
TTDR00436	Mitogen-activated protein kinase	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDR00437	Cytokine	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00437	Cytokine	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDS00437	Ferrochelatase	Cancer	140-229	C00-C96
TTDS00437	Ferrochelatase	Photodynamic therapy	706.1	L70.0
TTDS00438	Follicle stimulating hormone receptor	Psychosis	290-299	F20-F29
TTDS00438	Follicle stimulating hormone receptor	Respiratory diseases	.	.
TTDS00438	Follicle stimulating hormone receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00438	Serum amyloid A-activating factor 1	Osteoarthritis	715	M15-M19, M47
TTDR00439	Endotoxin	Septic shock	785.52	A41.9
TTDS00439	Glucagon receptor	Hyperglycemia	790.29	R73.9
TTDS00439	Glucagon receptor	Insulin-dependent diabetes mellitus	250	E08-E13
TTDS00439	Glucagon receptor	Lipid metabolic disorders	270-279	E70-E89
TTDS00439	Glucagon receptor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00439	Glucagon receptor	Obesity	278	E66
TTDR00440	Apopain	Chronic experimental allergic encephalomyelitis	204.0, 995.3	C91.0, T78.4
TTDR00440	Apopain	Dysregulation of apoptosis	.	.
TTDR00440	Apopain	Multiple sclerosis	340	G35
TTDR00440	Apopain	Neurodegenerative diseases	330-337	G30-G32
TTDS00440	Glucagon-like peptide 1 receptor	Central nervous system diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
TTDS00440	Glucagon-like peptide 1 receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDS00440	Glucagon-like peptide 1 receptor	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDS00440	Glucagon-like peptide 1 receptor	Obesity	278	E66
TTDR00441	Apolipoprotein A-II	Amyloidosis	277.3	E85
TTDS00441	Glutamate carboxypeptidase II	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDS00441	Glutamate carboxypeptidase II	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00441	Glutamate carboxypeptidase II	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR00442	Glycosylphosphatidylinositol-anchored aspartyl protease	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00442	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Leukemia	208.9	C91-C95
TTDS00442	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00443	Cytosolic phospholipase A2	Atherosclerosis	414.0, 440	I70
TTDR00443	Cytosolic phospholipase A2	Cancer	140-229	C00-C96
TTDR00443	Cytosolic phospholipase A2	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00443	Cytosolic phospholipase A2	Lipid metabolic disorders	270-279	E70-E89
TTDR00443	Cytosolic phospholipase A2	Neurodegenerative diseases	330-337	G30-G32
TTDR00443	Cytosolic phospholipase A2	Obesity	278	E66
TTDS00443	Guanylate cyclase	Angina pectoris	413	I20
TTDS00443	Guanylate cyclase	Atherosclerosis	414.0, 440	I70
TTDS00443	Guanylate cyclase	Cardiac insufficiency	410	I21, I22
TTDS00443	Guanylate cyclase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00443	Guanylate cyclase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00443	Guanylate cyclase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDS00444	Lymphocyte function-associated antigen 1	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00444	Presenilin 1	Familial alzheimer's disease	331	G30
TTDS00445	Integrin alpha-4	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDS00445	Integrin alpha-4	Allergy	995.3	T78.4
TTDS00445	Integrin alpha-4	Asthma	493	J45
TTDS00445	Integrin alpha-4	Chronic experimental allergic encephalomyelitis	204.0, 995.3	C91.0, T78.4
TTDS00445	Integrin alpha-4	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDS00445	Integrin alpha-4	Eosinophil mediated disease	.	.
TTDS00445	Integrin alpha-4	Inflammatory bowel disease	555, 556	K50, K51
TTDS00445	Integrin alpha-4	Multiple sclerosis	340	G35
TTDS00445	Integrin alpha-4	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00445	Presenilin 2	Familial alzheimer's disease	331	G30
TTDS00446	Growth hormone-releasing hormone receptor	Chronic renal failure	585.9585.1-585.5403	N18
TTDS00446	Growth hormone-releasing hormone receptor	Growth hormone deficiencies; Abnormalities	.	.
TTDS00446	Growth hormone-releasing hormone receptor	Hormone deficiencies	.	.
TTDS00446	Growth hormone-releasing hormone receptor	Lipodystrophy	272.6	E88.1
TTDR00446	Serum amyloid P-component	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00446	Serum amyloid P-component	Amyloidosis	277.3	E85
TTDR00446	Serum amyloid P-component	Transmissible spongiform encephalopathies	.	.
TTDR00447	Cathepsin D	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00447	Cathepsin D	Breast cancer	174, 175, 217	C50, D24
TTDS00447	Interleukin-1 beta	Acne vulgaris	706.1	L70.0
TTDS00447	Interleukin-1 beta	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDS00447	Interleukin-1 beta	Chronic hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDS00447	Interleukin-1 beta	Pediatric disease	.	.
TTDS00447	Interleukin-1 beta	Psoriasis; Psoriatic disorders	696	L40
TTDS00448	Leukocyte elastase	Adult respiratory distress syndrome	518.5, 518.82	J80
TTDS00448	Leukocyte elastase	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDS00448	Leukocyte elastase	Asthma	493	J45
TTDS00448	Leukocyte elastase	Attenuated coronary flow reserve; Myocardial dysfunction	410	I21, I22
TTDS00448	Leukocyte elastase	Chronic bronchitis	491	J42
TTDS00448	Leukocyte elastase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDS00448	Leukocyte elastase	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDS00448	Leukocyte elastase	Emphysema	492	J43
TTDS00448	Leukocyte elastase	Mucociliary dysfunction	.	.
TTDS00448	Leukocyte elastase	Thrombin-induced pulmonary edema	782.3	R60.9
TTDR00448	Ribonuclease H	Human immunodeficiency virus infection	279.3	D84.9
TTDR00449	Insulin-like growth factor binding protein 3	Angiogenesis	.	.
TTDR00449	Insulin-like growth factor binding protein 3	Hepatocellular carcinoma	155	C22.0
TTDS00449	Neprilysin	Congestive heart failure	428, 428.0	I50
TTDS00449	Neprilysin	Early stage hormone sensitive prostate cancer	140-229, 185	C00-C96, C61
TTDS00449	Neprilysin	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00450	Mannose-6-phosphate isomerase	Fungal diseases	110-118	B35-B49
TTDR00450	Six-transmembrane epithelial antigen of the prostate 2	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00451	C-C motif chemokine 2	Acute coronary syndromes	411.1	I20.0
TTDR00451	C-C motif chemokine 2	Atherosclerosis	414.0, 440	I70
TTDR00451	C-C motif chemokine 2	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDR00451	C-C motif chemokine 2	Inflammatory diseases associated with hypoxia	799.02	R09.02
TTDR00451	C-C motif chemokine 2	Peyronie's disease	.	.
TTDR00451	C-C motif chemokine 2	Renal ischemia-reperfusion injury	459.89	I99.8
TTDR00451	C-C motif chemokine 2	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00451	Renin, renal	Cancer	140-229	C00-C96
TTDS00451	Renin, renal	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDS00452	Thyrotropin receptor	Graves' disease	.	E05.0
TTDR00452	Triggering receptor expressed on myeloid cells 1	Septic shock	785.52	A41.9
TTDS00453	T-lymphocyte activation antigen CD80	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00453	Vascular cell adhesion protein 1	Endotoxin-induced myocardial neutrophil accumulation; Contractile dysfunction	.	.
TTDS00454	Peripheral-type benzodiazepine receptor	Angina pectoris	413	I20
TTDS00454	Peripheral-type benzodiazepine receptor	Autoimmune diseases	279	D84.9, M35.9
TTDS00454	Peripheral-type benzodiazepine receptor	Brain tumors	191, 225.0	C71, D33
TTDS00454	Peripheral-type benzodiazepine receptor	Breast cancer	174, 175, 217	C50, D24
TTDS00454	Peripheral-type benzodiazepine receptor	Cancer	140-229	C00-C96
TTDS00454	Peripheral-type benzodiazepine receptor	Colorectal cancer	153, 154	C18-C21
TTDS00454	Peripheral-type benzodiazepine receptor	Dementia	290-294, 331.0	F01-F07, G30
TTDS00454	Peripheral-type benzodiazepine receptor	Melanoma	172.9	C43
TTDS00454	Peripheral-type benzodiazepine receptor	Myocardial ischemia	410, 459.89	I21, I22, I99.8
TTDS00454	Peripheral-type benzodiazepine receptor	Neurodegenerative diseases	330-337	G30-G32
TTDS00454	Peripheral-type benzodiazepine receptor	Neurological diseases	320-359	G00-G99
TTDS00454	Peripheral-type benzodiazepine receptor	Photodynamic tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00454	Peripheral-type benzodiazepine receptor	Porphyrin-derived photocytotoxicity	.	.
TTDS00454	Peripheral-type benzodiazepine receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00455	Caspase-11	Septic shock	785.52	A41.9
TTDS00455	Parasitic pyruvate:ferredoxin oxidoreductase	Diarrhea	787.91	A09, K59.1
TTDS00456	Peptidyl-transferase domain of the bacterial ribosome	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00456	Virion infectivity factor	Human immunodeficiency virus infection	279.3	D84.9
TTDR00457	Kallikrein 7	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00457	Peripheral carotid chemoreceptor	Respiratory stimulant	518.81	J96
TTDR00458	Oncostatin M	Liver injury	.	.
TTDR00458	Oncostatin M	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00458	TAG-72 antigen	Tumor imaging	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00459	Estramustine binding protein	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00459	mRNA of Telomerase reverse transcriptase	Cancer	140-229	C00-C96
TTDR00459	mRNA of Telomerase reverse transcriptase	Lung cancer	162	C33-C34
TTDR00459	mRNA of Telomerase reverse transcriptase	Prostate carcinoma	185	C61
TTDR00459	mRNA of Telomerase reverse transcriptase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00460	Food vacuoles	Malaria	84	B50-B54
TTDR00460	Oligophrenin 1	Colorectal cancer	153, 154	C18-C21
TTDS00461	26S proteasome	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDR00461	Neuropsin	Epilepsy	290-319, 345	F01-F99, G40
TTDR00461	Neuropsin	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDS00462	Bacterial outer membrane	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI00462	Nicotinic acid receptor 1	Arteriosclerosis	440	I70
TTDI00462	Nicotinic acid receptor 1	Atherosclerosis	414.0, 440	I70
TTDI00462	Nicotinic acid receptor 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI00462	Nicotinic acid receptor 1	Hyperlipidemia	272.0-272.4	E78
TTDI00462	Nicotinic acid receptor 1	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDR00462	Tumor necrosis factor ligand superfamily member 6	Hypoxia-induced EC injury	.	.
TTDS00463	Fungal outer membrane	Athlete's foot	110.4	B35.3
TTDS00463	Fungal outer membrane	Fungal infections	110-118	B35-B49
TTDS00464	Malignant cancer cells	Leukemia	208.9	C91-C95
TTDR00464	Paired box protein Pax-5	Transitional cell carcinoma	.	.
TTDR00465	Guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-7 subunit	Cancer	140-229	C00-C96
TTDS00465	Transient receptor potential cation channel subfamily A member 1	Analgesics	338	R52
TTDS00465	Transient receptor potential cation channel subfamily A member 1	Irritation	.	.
TTDS00465	Transient receptor potential cation channel subfamily A member 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00466	CAMP-specific 3',5'-cyclic phosphodiesterase 4B	Asthma	493	J45
TTDR00466	CAMP-specific 3',5'-cyclic phosphodiesterase 4B	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDS00466	Diglyceride acyltransferase	Lowering cholesterol	.	.
TTDS00467	Antithrombin-III	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR00468	Leptin	Epilepsy	290-319, 345	F01-F99, G40
TTDR00468	Leptin	Multiple sclerosis	340	G35
TTDR00469	Insulin receptor substrate-1	Insulin resistance	.	E00-E90
TTDR00469	Insulin receptor substrate-1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00469	NADH dehydrogenase	Parkinson's disease	332	F02.3, G20
TTDR00470	Proto-oncogene C-crk	Insulin resistance	.	E00-E90
TTDS00470	Vitamin K-dependent protein C	Varicose and spider veins of the leg	454-456, 671	I83, I85, I86
TTDR00471	Fetuin	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00471	Fetuin	Obesity	278	E66
TTDS00471	HLA class II histocompatibility antigen, DRB1-1	Relapsing-remitting multiple sclerosis	340	G35
TTDS00472	T-cell surface glycoprotein CD1a	Renal transplant rejection	279.5, 996	D89.8, T86
TTDR00473	Integrin alpha-V	Brain tumors	191, 225.0	C71, D33
TTDS00473	T-cell surface glycoprotein CD3 epsilon chain	Organ rejection	279.5, 996	D89.8, T86
TTDS00474	D-alanine-D-alanine ligase A	Tuberculosis	010-018	A15-A19
TTDR00474	Glucose-6-phosphatase	Hyperglycemia	790.29	R73.9
TTDR00475	Cyclin-dependent kinase inhibitor 1C	Beta-cell failure observed in diabetes	250	E08-E13
TTDS00475	Cytochrome P450 2D6	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDR00476	Fatty acid-binding protein, adipocyte	Atherosclerosis	414.0, 440	I70
TTDS00476	Indoleamine 2,3-dioxygenase	Depression	311	F32
TTDR00477	Ectonucleotide pyrophosphatase/phosphodiesterase 1	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00477	Ectonucleotide pyrophosphatase/phosphodiesterase 1	Disorders of bone mineralization	.	.
TTDS00477	Interferon-gamma receptor	Idiopathic pulmonary fibrosis	516.3	J84.1
TTDS00478	Atrial natriuretic peptide receptor A	Acutely decompensated congestive heart failure	428	I50
TTDR00478	Neurotrophin-3	Analgesics	338	R52
TTDR00478	Neurotrophin-3	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDR00478	Neurotrophin-3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00479	I1-imidazoline receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00479	I1-imidazoline receptor	Metabolic syndromes	.	.
TTDS00479	Urease	Urinary tract infections	599	N39.0
TTDS00480	B-cell receptor CD22	Lyme disease	88.81	A69.2
TTDR00480	T-box transcription factor TBX21	Autoimmune diseases	279	D84.9, M35.9
TTDR00480	T-box transcription factor TBX21	Chronic inflammatory diseases	.	.
TTDS00481	Mannose-6-phosphate receptor	Glycogen storage disease type II	271	E74.0
TTDS00481	Mannose-6-phosphate receptor	Mucopolysaccharidosis VI	277.5	E76.2
TTDR00481	Sigma receptor	Disorders resulting from noradrenergic imbalance in hippocampus	.	.
TTDR00482	IgG receptor FcRN large subunit P51	Autoimmune diseases	279	D84.9, M35.9
TTDS00482	Methylmalonyl-CoA mutase	B12 deficiency	266.2	E53.8
TTDR00483	L523S	Lung cancer	162	C33-C34
TTDS00483	Vesicle-associated membrane protein	Parkinson's disease	332	F02.3, G20
TTDS00484	High affinity immunoglobulin epsilon receptor	Risk of administering penicillin	.	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00484	Osteopontin	Metastatic hepatocellular carcinoma	155	C22.0
TTDR00484	Osteopontin	Multiple sclerosis	340	G35
TTDS00485	Calcitonin receptor	Post-menopausal osteoporosis	627.2, 733.0	M80-M81, N95.0
TTDR00485	Integrin-linked protein kinase 1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00485	Integrin-linked protein kinase 1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00486	Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase PTEN	Neurodegenerative diseases	330-337	G30-G32
TTDR00486	Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase PTEN	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00486	Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase PTEN	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00486	Vitamin K-dependent gamma-carboxylase	Anticoagulant	.	.
TTDS00486	Vitamin K-dependent gamma-carboxylase	Haemorrhagic conditions	.	.
TTDS00487	Carcinoembryonic antigen	Imaging colorectal tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00487	Plasminogen activator	Kawasaki disease related coronary artery lesions	446.1	M30.3
TTDR00488	Transcription factor GATA-4	Pulmonary hypertension	416	I27.0, I27.2
TTDS00489	Folate receptor	Dietary shortage	260-269	E40-E46
TTDS00489	Folate receptor	Folic acid deficiency	266.2	E53.8
TTDR00489	Nuclear receptor coactivator 3	Breast cancer	174, 175, 217	C50, D24
TTDR00490	Sodium/calcium exchanger	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00490	Sodium/calcium exchanger	Ventricular arrhythmias	427.1	I47.2
TTDS00490	T-lymphocyte activation antigen CD86	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00491	DNA replication licensing factor MCM6	Proliferative vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00491	Secretin receptor	Diagnosis of pancreatic exocrine dysfunction; Gastrinoma	157.4, 577.8	C25.4, K86.8
TTDR00492	DNA replication licensing factor MCM7	Proliferative vascular diseases	325, 430-459	G45-G46, I60-I95
TTDS00492	Interferon-alpha/beta receptor	AIDS-related kaposi's sarcoma	176	C46
TTDS00492	Interferon-alpha/beta receptor	Chronic hepatitis C	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDS00492	Interferon-alpha/beta receptor	Hairy-cell leukemia	208.9	C91-C95
TTDS00492	Interferon-alpha/beta receptor	Malignant melanoma	172, 208.9	C43, C91-C95
TTDS00492	Interferon-alpha/beta receptor	Multiple sclerosis	340	G35
TTDR00493	Suppressor of cytokine signaling 1	Enterovirus-induced cardiac injury	.	.
TTDS00494	Biliverdin reductase A	Primary biliary cirrhosis	571.6	K74.3
TTDR00494	Hexamethylene bisacetamide-inducible protein 1	Atherogenesis	440	I70
TTDR00494	Hexamethylene bisacetamide-inducible protein 1	Restenosis	.	I51.89
TTDS00495	Alpha-N-acetylglucosaminidase	Osteoarthritis	715	M15-M19, M47
TTDR00495	Calcium-dependent chloride channel-1	Asthma	493	J45
TTDR00495	Calcium-dependent chloride channel-1	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDR00495	Calcium-dependent chloride channel-1	Mucus overproduction in chronic pulmonary disorders	.	.
TTDR00496	4-aminopyridine sensitive K(+) channels	Neuronal damage after brain ischemia	435, 437, 459.89	G45.9, I67.8, I99.8
TTDS00496	Synaptosomal-associated protein 25	Blepharospasm	333.81	G24.5
TTDR00497	ETS-domain transcription factor ERF	Cancer	140-229	C00-C96
TTDS00497	Somatostatin	Disorders of cystine excretion	.	.
TTDS00498	Hemoglobin	Documented iron deficiency	280.9	E61.1
TTDS00498	Hemoglobin	Iron-deficiency anemia	280	D50
TTDR00498	Small inducible cytokine B10	Inflammatory bowel disease	555, 556	K50, K51
TTDS00499	Type IV phosphodiesterase	Asthma	493	J45
TTDR00499	Zinc finger protein A20	Chronic allograft rejection	996.8	T86
TTDS00500	Adenylate cyclase type 1	Dietary shortage	260-269	E40-E46
TTDR00500	Thymidine kinase	Bladder cancer	140-229, 188	C00-C96, C67
TTDR00500	Thymidine kinase	Cancer	140-229	C00-C96
TTDR00500	Thymidine kinase	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00500	Thymidine kinase	Renal cell carcinoma	189	C64
TTDR00500	Thymidine kinase	Trichomoniasis	131	A59
TTDR00500	Thymidine kinase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDS00501	Interleukin-11 receptor alpha chain	Chemotherapy-induced thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
TTDS00502	Inositol 1,4,5-trisphosphate receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00503	Prostate specific antigen	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00503	Voltage-gated sodium channel subunit alpha Nav1.7	Analgesics	338	R52
TTDS00503	Voltage-gated sodium channel subunit alpha Nav1.7	Chronic angina pectoris	413	I20
TTDS00503	Voltage-gated sodium channel subunit alpha Nav1.7	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00504	Organic anion transporter 1	Gout	274.00274.1274.8274.9	M10
TTDR00504	Osteonectin	Glioma cell proliferation	191	C71
TTDR00505	Calpain	Cerebral vasospasm	443.9	I73.9
TTDR00505	Calpain	Huntington's disease	294.1, 333.4	F02.2, G10
TTDR00505	Calpain	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00505	Calpain	Injury to spine and spinal cord	.	.
TTDR00505	Calpain	Malaria	84	B50-B54
TTDR00505	Calpain	Neurodegenerative diseases	330-337	G30-G32
TTDR00505	Calpain	Renal failure	584, 585	N17, N18, N19
TTDR00505	Calpain	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDS00505	Mannitol 2-dehydrogenase 	Renal failure	584, 585	N17, N18, N19
TTDS00506	Mannitol-1-phosphate 5-dehydrogenase	Renal failure	584, 585	N17, N18, N19
TTDR00506	Phosphatidylethanolamine N-methyltransferase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00506	Phosphatidylethanolamine N-methyltransferase	Hyperhomocysteinemia	.	.
TTDR00507	Cytochrome B-245 heavy chain	Angiogenesis	.	.
TTDR00507	Cytochrome B-245 heavy chain	Atherosclerosis	414.0, 440	I70
TTDR00507	Cytochrome B-245 heavy chain	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00507	Cytochrome B-245 heavy chain	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00507	Cytochrome B-245 heavy chain	Neutrophil-mediated liver injury	.	.
TTDS00507	Transient receptor potential cation channel subfamily M member 8	Analgesics	338	R52
TTDS00507	Transient receptor potential cation channel subfamily M member 8	Irritation	.	.
TTDS00507	Transient receptor potential cation channel subfamily M member 8	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00508	Lymphotoxin-beta	Infections	001-139	A00-B99
TTDR00508	Lymphotoxin-beta	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00509	Transforming protein p21	Colorectal cancer	153, 154	C18-C21
TTDS00510	Integral membrane protein LmrP	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00510	Serine protease hepsin	Prostate cancer	140-229, 185	C00-C96, C61
TTDS00511	Cycloinulo-oligosaccharide fructanotransferase	Measure kidney function	.	.
TTDR00511	Transforming growth factor beta 1	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00511	Transforming growth factor beta 1	Renal cell carcinoma	189	C64
TTDS00512	Gamma-hydroxybutyrate receptor	Alcoholism	303	F10.2
TTDS00512	Gamma-hydroxybutyrate receptor	Depression	311	F32
TTDS00512	Gamma-hydroxybutyrate receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDS00512	Gamma-hydroxybutyrate receptor	Narcolepsy	347	G47.4
TTDR00512	Protein-lysine 6-oxidase	Fibrotic renal disease	.	.
TTDR00512	Protein-lysine 6-oxidase	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00513	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00513	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	Myocardial hypertrophy	.	.
TTDS00513	Sodium-dependent vitamin C transporter 2	Primary biliary cirrhosis	571.6	K74.3
TTDS00514	Sodium channel protein type 10 subunit alpha	Analgesics	338	R52
TTDS00514	Sodium channel protein type 10 subunit alpha	Chronic angina pectoris	413	I20
TTDS00514	Sodium channel protein type 10 subunit alpha	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00515	Latent membrane protein 2A	Epstein-barr virus infections	001-139, 075	A00-B99, B27
TTDS00515	Low affinity immunoglobulin gamma Fc region receptor II-A	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDS00516	Acyl-CoA desaturase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00516	Acyl-CoA desaturase	Hyperlipidemia	272.0-272.4	E78
TTDS00516	Acyl-CoA desaturase	Tuberculosis	010-018	A15-A19
TTDR00516	Voltage-gated potassium channel	Cardiac dysrhythmias	427	I47-I49
TTDR00517	Cyclic-AMP-dependent transcription factor ATF-3	Doxorubicin-induced apoptosis	.	.
TTDS00517	Sarcoplasmic/endoplasmic reticulum calcium ATPase	Heart failure	410, 428	I21, I22, I50
TTDS00517	Sarcoplasmic/endoplasmic reticulum calcium ATPase	Malaria	84	B50-B54
TTDS00518	Fc gamma receptor III	Anaphylactic reaction	995.6	T78.0
TTDS00518	Fc gamma receptor III	Cancer	140-229	C00-C96
TTDS00518	Fc gamma receptor III	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00518	Fc gamma receptor III	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00518	High mobility group protein 1	Arthritis	710-719	M00-M25
TTDR00518	High mobility group protein 1	Endotoxin lethality	.	.
TTDR00518	High mobility group protein 1	Lethal systemic inflammatory diseases	.	.
TTDR00518	High mobility group protein 1	Synovitis and tenosynovitis	727	M65
TTDS00519	HIV-1 integrase	Human immunodeficiency virus infection	279.3	D84.9
TTDR00519	Interleukin-11	Senile osteoporosis	733	M80-M81
TTDS00520	Neuronal acetylcholine receptor protein, alpha-7 chain	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDS00520	Neuronal acetylcholine receptor protein, alpha-7 chain	Analgesics	338	R52
TTDS00520	Neuronal acetylcholine receptor protein, alpha-7 chain	Drug dependence	303-305	F10-F19
TTDS00520	Neuronal acetylcholine receptor protein, alpha-7 chain	Neuropsychiatric disorders	.	.
TTDS00520	Neuronal acetylcholine receptor protein, alpha-7 chain	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDS00520	Neuronal acetylcholine receptor protein, alpha-7 chain	Schizophrenia	295, 710.0	F20, M32
TTDR00521	Cell adhesion molecules	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDS00521	Interleukin-6 receptor	Rheumatoid arthritis	710-719, 714	M05-M06
TTDS00522	Noradrenaline uptake	Depression	311	F32
TTDR00524	Fractalkine	Acute allograft rejection	996.8	T86
TTDR00524	Fractalkine	Central nervous system diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
TTDS00524	Thrombopoietin Receptor	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
TTDR00525	CD44 antigen	Autoimmune diseases	279	D84.9, M35.9
TTDR00525	CD44 antigen	Insulin-dependent diabetes mellitus	250	E08-E13
TTDR00525	CD44 antigen	Systemic sclerosis	710.1	M34
TTDR00525	CD44 antigen	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDS00525	Type-2 angiotensin II receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00526	Cystathionine beta-synthase	Homocysteine-related vascular disease	325, 430-459	G45-G46, I60-I95
TTDR00526	Cystathionine beta-synthase	Homocystinuria	.	E88.9
TTDR00526	Cystathionine beta-synthase	Myeloma disease	203	C90.0
TTDS00526	mRNA of IE2 region of cytomegalovirus	CMV retinitis	78.5	B25.8, H30.9
TTDS00527	Adrenergic neuron	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00527	Caveolin-1	Androgen-independent prostate cancer	140-229, 185	C00-C96, C61
TTDR00527	Caveolin-1	Atherosclerosis	414.0, 440	I70
TTDR00527	Caveolin-1	Psoriasis	696	L40
TTDR00527	Caveolin-1	Vascular impairment associated with diabetes	250	E08-E13
TTDS00528	5-aminoimidazole-4-carboxamidoribonucleotide (AICAR) transformylase	Inflammatory bowel dieaseas; Rheumatoid arthritis	555, 556, 714	K50, K51, M05-M06
TTDR00529	Adenosine kinase	Analgesics	338	R52
TTDR00529	Adenosine kinase	Central and peripheral nervous system diseases	320-389	G00-G99
TTDR00529	Adenosine kinase	Epilepsy	290-319, 345	F01-F99, G40
TTDR00529	Adenosine kinase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00529	Adenosine kinase	Inflammatory bowel disease	555, 556	K50, K51
TTDR00529	Adenosine kinase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00529	Adenosine kinase	Toxoplasmosis	130	B58
TTDS00529	Voltage-dependent N-type calcium channel	Analgesics	338	R52
TTDS00529	Voltage-dependent N-type calcium channel	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDS00529	Voltage-dependent N-type calcium channel	Cerebral ischemia	459.89	I99.8
TTDS00529	Voltage-dependent N-type calcium channel	Malignant pain	338,780	R52, G89
TTDS00529	Voltage-dependent N-type calcium channel	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDR00530	Melanocyte stimulating hormone receptor	Melanoma	172.9	C43
TTDR00530	Melanocyte stimulating hormone receptor	Obesity	278	E66
TTDS00530	Pyruvate decarboxylase	Vitamin B1 deficiency	265.0, 265.1	E51
TTDS00531	Diacylglycerol O-acyltransferase 2	Dyslipidemia	272	E78
TTDS00531	Diacylglycerol O-acyltransferase 2	Lipid disorders; Cardiovascular disease	272, 390-459	E78, I00-I99
TTDR00531	Glutamyl aminopeptidase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00532	CAMP response element binding protein	Atherosclerotic cardiovascular disease	390-459	I00-I99
TTDR00532	CAMP response element binding protein	Depression	311	F32
TTDS00532	Corynebacterium diphtheriae CRM197 protein	Disease caused by streptococcus pneumoniae	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
TTDS00532	Corynebacterium diphtheriae CRM197 protein	Meningococcal disease caused by Neisseria meningitidis A, C, Y and W-135	.	.
TTDS00533	Carbamoyl-phosphate synthetase I	Acute hyperammonaemia	270.6	E72.2
TTDR00533	Intestinal GlcNAc-6-sulfotransferase	Cancer	140-229	C00-C96
TTDR00533	Intestinal GlcNAc-6-sulfotransferase	Chronic inflammatory diseases	.	.
TTDR00533	Intestinal GlcNAc-6-sulfotransferase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00533	Intestinal GlcNAc-6-sulfotransferase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00534	C-X-C chemokine receptor type 6	Human immunodeficiency virus infection	279.3	D84.9
TTDS00534	Interleukin-23	Crohn's disease; Inflammatory bowel disease	555, 556	K50, K51
TTDS00534	Interleukin-23	Moderate-to-severe plaque psoriasis	696	L40
TTDS00534	Interleukin-23	Psoriasis	696	L40
TTDR00535	Intrinsic factor-B12 receptor	Renal diseases	580-599	N00-N39
TTDR00536	Cyclophilin receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00537	Ectonucleoside triphosphate diphosphohydrolase 1	Platelet aggregation	.	.
TTDR00538	Epidermal growth factor receptor III	Brain tumors	191, 225.0	C71, D33
TTDR00539	Folylpolyglutamate synthase, mitochondrial	Cancer	140-229	C00-C96
TTDR00539	Folylpolyglutamate synthase, mitochondrial	Malaria	84	B50-B54
TTDR00540	FMLP-related receptor I	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00541	HCV nucleoside triphosphatase	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDR00542	Interleukin-13 receptor	Glioblastoma multiforme	191	C71
TTDR00542	Interleukin-13 receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00543	Solute carrier family 12 member	Hepatocellular carcinoma	155	C22.0
TTDR00543	Solute carrier family 12 member	Sickle cell anemia	280-285	D50-D64
TTDR00544	Potassium voltage-gated channel subfamily KQT member 2	Analgesics	338	R52
TTDR00544	Potassium voltage-gated channel subfamily KQT member 2	Epilepsy	290-319, 345	F01-F99, G40
TTDR00544	Potassium voltage-gated channel subfamily KQT member 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00545	Leukotriene B4 receptor 2	Immunological disorders	.	.
TTDR00545	Leukotriene B4 receptor 2	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00546	Low-density lipoprotein receptor-related protein 2	Renal diseases	580-599	N00-N39
TTDR00547	mRNA of 3-phosphoinositide-dependent kinase-1	Cancer	140-229	C00-C96
TTDR00548	mRNA of Htert	Cancer	140-229	C00-C96
TTDR00550	mRNA of Ki-ras	Colorectal cancer	153, 154	C18-C21
TTDR00551	mRNA of telomerase	Cancer	140-229	C00-C96
TTDR00552	mRNA of protein kinase A alpha subunit	Cancer	140-229	C00-C96
TTDR00553	Nerve growth factor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00553	Nerve growth factor	Analgesics	338	R52
TTDR00553	Nerve growth factor	Neurodegenerative diseases	330-337	G30-G32
TTDR00553	Nerve growth factor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00554	Orphan nuclear receptor NURR1	Parkinson's disease	332	F02.3, G20
TTDR00555	Acid phosphatase surE	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDR00556	Plasminogen activator inhibitor-1	Age-related macular degeneration	362.5	H35.3
TTDR00556	Plasminogen activator inhibitor-1	Asthma	493	J45
TTDR00556	Plasminogen activator inhibitor-1	Cancer	140-229	C00-C96
TTDR00556	Plasminogen activator inhibitor-1	Coagulative disorders	286	D65-D69
TTDR00556	Plasminogen activator inhibitor-1	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDR00556	Plasminogen activator inhibitor-1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00556	Plasminogen activator inhibitor-1	Renal fibrosis	709.2	L90.5
TTDR00556	Plasminogen activator inhibitor-1	Thrombotic disease	.	.
TTDR00557	Protein kinase C, zeta type	Cancer	140-229	C00-C96
TTDR00558	RNA endonuclease	Influenza virus infection	487, 488	J10, J11
TTDR00559	Sortase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00560	Trypsin-like serine protease	Asthma	493	J45
TTDR00560	Trypsin-like serine protease	Coagulative disorders	286	D65-D69
TTDR00561	UDP-glucuronosyltransferase	Autoimmune hepatitis	571.42	K75.4
TTDR00561	UDP-glucuronosyltransferase	Inflammatory liver diseases	570-574	K70-K77
TTDR00562	Urotensin II receptor	Congestive heart failure	428, 428.0	I50
TTDR00562	Urotensin II receptor	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDR00563	Vacuolar-type (H+)-ATPase	Cancer	140-229	C00-C96
TTDR00563	Vacuolar-type (H+)-ATPase	Lytic bone diseases	730-733	M80-M90
TTDR00563	Vacuolar-type (H+)-ATPase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR00563	Vacuolar-type (H+)-ATPase	Tumor invasion and metastasis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00564	5-hydroxytryptamine 1E receptor	Neurologic and psychiatric diseases	.	.
TTDR00565	5-hydroxytryptamine 5A receptor	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDR00565	5-hydroxytryptamine 5A receptor	Depression	311	F32
TTDR00565	5-hydroxytryptamine 5A receptor	Schizophrenia	295, 710.0	F20, M32
TTDR00566	CCK receptor	Acute pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDR00566	CCK receptor	Analgesics	338	R52
TTDR00566	CCK receptor	Biliary colic	574.2	K80.5
TTDR00566	CCK receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00567	Heparin-binding growth factor 2	Hepatic fibrosis	709.2	L90.5
TTDR00567	Heparin-binding growth factor 2	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00568	Phosphatidylinositol 3-kinase	Breast cancer	174, 175, 217	C50, D24
TTDR00568	Phosphatidylinositol 3-kinase	Tumor vascular endothelium	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00570	Ketol-acid reductoisomerase	Fungal diseases	110-118	B35-B49
TTDR00571	Dipeptidyl-peptidase I	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00571	Dipeptidyl-peptidase I	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDR00572	Gamma-glutamyl hydrolase	Cancer	140-229	C00-C96
TTDR00573	Endothelin	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00573	Endothelin	Heart failure	410, 428	I21, I22, I50
TTDR00574	Urotensin II	Cardiorenal disease	404	I13
TTDR00574	Urotensin II	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00575	Nucleolin	Cancer	140-229	C00-C96
TTDR00576	Epidermal growth factor receptor deltaEGFR	Breast cancer	174, 175, 217	C50, D24
TTDR00576	Epidermal growth factor receptor deltaEGFR	Glioblastoma multiforme	191	C71
TTDR00577	Vang-like protein 1	Hepatocellular carcinoma	155	C22.0
TTDR00578	14-3-3 proteins	Cancer	140-229	C00-C96
TTDR00579	EPAS-1/HIF-2alpha mRNA	Bladder cancer	140-229, 188	C00-C96, C67
TTDR00580	Lysophosphatidic acid receptor Edg-2	Multiple sclerosis	340	G35
TTDR00582	Endocytic receptor Endo180	Breast cancer	174, 175, 217	C50, D24
TTDR00583	Ghrelin	Anorexia nervosa	307.1	F50.0-F50.1
TTDR00583	Ghrelin	Cachexia	799.4	R64
TTDR00583	Ghrelin	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00583	Ghrelin	Obesity	278	E66
TTDR00584	Small inducible cytokine A22	Crescentic glomerulonephritis	580-582	N00, N01, N03, N18
TTDR00585	Trypanothione reductase	African trypanosomiasis	86.5	B56
TTDR00585	Trypanothione reductase	Chagas' disease	86	B57
TTDR00585	Trypanothione reductase	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDR00585	Trypanothione reductase	Parasitic diseases	.	.
TTDR00585	Trypanothione reductase	Sleeping sickness	.	.
TTDR00585	Trypanothione reductase	Trypanolytic infections	001-139	A00-B99
TTDR00585	Trypanothione reductase	Trypanosomatid infections	001-139	A00-B99
TTDR00586	Insulin-like growth factor binding protein 6	Cancer	140-229	C00-C96
TTDR00587	Estradiol 17 beta-dehydrogenase 1	Hormone-sensitive breast cancer	140-229, 174, 175	C00-C96, C50
TTDI00587	GTP cyclohydrolase-I	Parkinson's disease	332	F02.3, G20
TTDR00588	Tubulin associated unit Tau	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00589	Ganciclovir kinase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00590	Human cytomegalovirus protease	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00591	MTA/SAH nucleosidase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00592	Glycylpeptide N-tetradecanoyltransferase	Fungal diseases	110-118	B35-B49
TTDR00592	Glycylpeptide N-tetradecanoyltransferase	Human immunodeficiency virus infection	279.3	D84.9
TTDR00592	Glycylpeptide N-tetradecanoyltransferase	Kinetoplastida parasite infection	001-139	A00-B99
TTDR00592	Glycylpeptide N-tetradecanoyltransferase	Neoplastic diseases	.	.
TTDR00592	Glycylpeptide N-tetradecanoyltransferase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00593	Nuclear receptor ROR-alpha	Cholesterol-related diseases	.	.
TTDR00593	Nuclear receptor ROR-alpha	Chronic inflammatory diseases	.	.
TTDR00594	Immunogenic protein MPT63/MPB63	Tuberculosis	010-018	A15-A19
TTDR00595	Kgp protease	P. gingivalis infections	001-139	A00-B99
TTDR00596	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	Cancer	140-229	C00-C96
TTDR00596	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00596	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00597	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	African trypanosomiasis	86.5	B56
TTDR00598	Hexose transporter 1	Malaria	84	B50-B54
TTDR00599	Histidine-rich protein II	Malaria	84	B50-B54
TTDR00600	Delta-aminolevulinic acid synthetase	Malaria	84	B50-B54
TTDR00601	S-adenosyl-L-methionine:C-24 sterol methyl transferase	Pneumocystis infections	001-139	A00-B99
TTDR00602	Haemophilus influenzae NadR protein	Infections	001-139	A00-B99
TTDR00603	CAMP-specific 3',5'-cyclic phosphodiesterase 2C	Trypanolytic infections	001-139	A00-B99
TTDR00604	Cyclin-dependent kinase 4 inhibitor A	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI00605	Proliferating cell nuclear antigen	Retinal disorders	.	H30-H36
TTDI00605	Proliferating cell nuclear antigen	Submental fat removal	.	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00605	Protein HP59	Tumor angiogenesis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00606	Cysteine protease falcipain-2	Malaria	84	B50-B54
TTDR00607	Falcipain-3	Malaria	84	B50-B54
TTDR00608	Alpha-endosulfine	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00609	RNA triphosphatase	Fungal diseases	110-118	B35-B49
TTDR00609	RNA triphosphatase	Malaria	84	B50-B54
TTDR00610	Methionine gamma-lyase	Prokaryotic and eukaryotic anaerobic pathogens infections	001-139	A00-B99
TTDR00611	Leukocyte common antigen	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00612	Melanin-concentrating hormone receptor 2	Obesity	278	E66
TTDR00612	Melanin-concentrating hormone receptor 2	Social anxiety disorder	300	F40-F42
TTDR00613	Mycobacterium tuberculosis 30 kDa major secretory protein	Tuberculosis	010-018	A15-A19
TTDR00614	Elongation factor 3	Fungal diseases	110-118	B35-B49
TTDR00615	Glutamate--cysteine ligase regulatory subunit	Lung cancer	162	C33-C34
TTDR00615	Glutamate--cysteine ligase regulatory subunit	Malaria	84	B50-B54
TTDR00615	Glutamate--cysteine ligase regulatory subunit	Parasitic diseases	.	.
TTDR00615	Glutamate--cysteine ligase regulatory subunit	Trypanosomiasis	086.5-086	B56-B57
TTDR00617	Xanthine phosphoribosyltransferase	Parasitic diseases	.	.
TTDR00618	Hypoxanthine-guanine-xanthine phosphoribosyltransferase	Malaria	84	B50-B54
TTDR00618	Hypoxanthine-guanine-xanthine phosphoribosyltransferase	Parasitic diseases	.	.
TTDR00618	Hypoxanthine-guanine-xanthine phosphoribosyltransferase	Trichomoniasis	131	A59
TTDR00619	Isocitrate lyase	Tuberculosis	010-018	A15-A19
TTDR00620	Voltage-dependent L-type calcium channel alpha-1D subunit	Hepatitis virus infection	573.3	K75.9
TTDR00620	Voltage-dependent L-type calcium channel alpha-1D subunit	Sinoatrial node dysfunction	.	.
TTDR00621	Synapsin	Cyclosporine A-induced hypertension	401	I10, I11, I12, I13, I15
TTDR00622	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	Tuberculosis	010-018	A15-A19
TTDR00623	Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic	Chagas' disease	86	B57
TTDR00623	Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic	Parasitic diseases	.	.
TTDR00623	Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic	Sleeping sickness	.	.
TTDR00624	Methylated-DNA--protein-cysteine methyltransferase	Cancer	140-229	C00-C96
TTDR00625	Homoserine dehydrogenase	Fungal diseases	110-118	B35-B49
TTDR00626	Large neutral amino acids transporter small subunit 1	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00627	Cardiac phospholamban	Heart failure	410, 428	I21, I22, I50
TTDR00628	MNN9 protein	Fungal diseases	110-118	B35-B49
TTDR00629	CX3C chemokine receptor 1	Endothelium-related inflammatory diseases	.	.
TTDR00630	Prostaglandin E synthase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00630	Prostaglandin E synthase	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00631	Metal-transporter protein PsaA	Streptococcus pneumoniae infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
TTDR00632	Beta-ketoacyl-ACP synthase	Cancer	140-229	C00-C96
TTDR00632	Beta-ketoacyl-ACP synthase	Tuberculosis	010-018	A15-A19
TTDR00633	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	Tuberculosis	010-018	A15-A19
TTDR00634	Fatty acid-binding protein, liver	Schistosomiasis	120	B65
TTDR00635	Pyrophosphate-dependent phosphofructokinase	Parasitic diseases	.	.
TTDR00636	Laccase	Cryptococcosis	117.5	B45
TTDR00637	Triosephosphate isomerase (bacterial)	Malaria	84	B50-B54
TTDR00637	Triosephosphate isomerase (bacterial)	Trypanosomiasis	086.5-086	B56-B57
TTDR00638	DNA polymerase processivity factor	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00640	Fructose-bisphosphate aldolase	Malaria	84	B50-B54
TTDI00641	Protein phosphatase 2A	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI00641	Protein phosphatase 2A	Cancer	140-229	C00-C96
TTDI00641	Protein phosphatase 2A	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDR00641	SH2 containing inositol-5-phosphatase	Leukemia	208.9	C91-C95
TTDR00642	Endoglin	Cancer	140-229	C00-C96
TTDR00644	Suppressor of tumorigenicity 14	Breast cancer	174, 175, 217	C50, D24
TTDR00646	Beta 1, 2-Xylosyltransferase	Allergy	995.3	T78.4
TTDR00647	Phospholipase C gamma	Inflammatory bowel disease	555, 556	K50, K51
TTDR00647	Phospholipase C gamma	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00647	Phospholipase C gamma	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00648	CoA-independent transacylase	Proliferative diseases	.	.
TTDR00650	Alpha 4 beta 7 integrin receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDR00651	Integrin alpha-6	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00653	Monocarboxylate transporter 1	Neoplasms	140-239	C00-D48
TTDR00654	Protein phosphatase 1D	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
TTDR00655	Pyridoxal phosphate biosynthetic protein pdxJ	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00655	Pyridoxal phosphate biosynthetic protein pdxJ	Vitamin B6 deficiency	266.1	E53.1
TTDR00656	Myelin-oligodendrocyte glycoprotein	Multiple sclerosis	340	G35
TTDR00657	3-oxoacyl-[acyl-carrier protein] reductase	Malaria	84	B50-B54
TTDR00658	Actin	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00659	Bis(5'-adenosyl)-triphosphatase	Prostate carcinoma	185	C61
TTDR00660	Ly-6K antigen	Head and neck squamous cell carcinomas	199	C44
TTDR00661	Aconitate hydratase, mitochondrial	Acute cardiac allograft rejection	996.8	T86
TTDI00662	Connecting peptide (C-peptide)	Diabetic complication	.	E08-E13
TTDR00662	UDP-glucose 4-epimerase	Trypanolytic infections	001-139	A00-B99
TTDR00663	60 kDa heat shock protein, mitochondrial	Schizophrenia	295, 710.0	F20, M32
TTDR00665	520 kDa MYC-binding protein	Schizophrenia	295, 710.0	F20, M32
TTDR00666	Penicillin-binding protein 1B	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00667	Cyclin-dependent kinase inhibitor 1	Leukemia	208.9	C91-C95
TTDR00668	Pro-neuregulin-1	Breast cancer	174, 175, 217	C50, D24
TTDR00669	Focal adhesion kinase	Cancer	140-229	C00-C96
TTDR00669	Focal adhesion kinase	Gliomas	191	C71
TTDR00669	Focal adhesion kinase	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00669	Focal adhesion kinase	Pancreatic cancer 	157	C25
TTDR00670	Troponin I, cardiac muscle	Cardiac diseases	390-459	I00-I99
TTDR00673	Prostaglandin E2 receptor, EP1 subtype	Analgesics	338	R52
TTDR00673	Prostaglandin E2 receptor, EP1 subtype	Visceral pain	338,780	R52, G89
TTDR00674	Beta crystallin B1	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00675	Opioid-insensitive Ca2+ channel	Acute pain	338,780	R52, G89
TTDR00675	Opioid-insensitive Ca2+ channel	Analgesics	338	R52
TTDR00676	3-deoxy-manno-octulosonate cytidylyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00677	Interleukin-13 receptor alpha-2 chain	Localized cancer	140-229	C00-C96
TTDR00678	Glycoprotein coupled receptor	Cytomegalovirus-accelerated vascular disease	325, 430-459	G45-G46, I60-I95
TTDR00679	Alpha-fetoprotein	Hepatocellular carcinoma	155	C22.0
TTDR00680	2',3'-cyclic nucleotide 3'-phosphodiesterase	Multiple sclerosis	340	G35
TTDR00681	Carcinoembryonic antigen-related cell adhesion molecule 5	Colon cancer	153, 154	C18-C21
TTDR00681	Carcinoembryonic antigen-related cell adhesion molecule 5	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDR00681	Carcinoembryonic antigen-related cell adhesion molecule 5	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00682	Lactadherin	Breast cancer	174, 175, 217	C50, D24
TTDR00683	Tenascin	Meningioma	225.2	C70, D32
TTDR00684	Serum paraoxonase/arylesterase 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00685	Hepatocellular carcinoma-associated protein	Hepatocellular carcinoma	155	C22.0
TTDR00686	CAMP-dependent protein kinase A type I	HIV-induced T cell dysfunction	.	.
TTDR00686	CAMP-dependent protein kinase A type I	Immune disease	.	.
TTDR00687	Folate receptor beta	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDR00688	Wilms' tumor protein	Colon cancer	153, 154	C18-C21
TTDR00688	Wilms' tumor protein	Leukemia	208.9	C91-C95
TTDR00688	Wilms' tumor protein	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00689	Troponin T, cardiac muscle isoforms	Heart failure	410, 428	I21, I22, I50
TTDR00690	Dihydroneopterin aldolase	Microbial infections	001-139	A00-B99
TTDR00690	Dihydroneopterin aldolase	Parasitic diseases	.	.
TTDR00692	Bile-salt-activated lipase	Hypercholesterolemia	272	E78.0
TTDR00693	Annexin A10	Hepatocellular carcinoma	155	C22.0
TTDR00694	Tumor-associated carbohydrate antigen KH-1	Adenocarcinoma	140-199	C00-C75, C7A, C7B
TTDR00695	Rab geranylgeranyltransferase	Thrombocytosis	289.9	D75.8
TTDR00696	ADAMTS-4	Osteoarthritis	715	M15-M19, M47
TTDR00697	ADAMTS-5	Osteoarthritis	715	M15-M19, M47
TTDR00698	Platelet endothelial cell adhesion molecule	Colorectal cancer	153, 154	C18-C21
TTDR00698	Platelet endothelial cell adhesion molecule	Lung cancer	162	C33-C34
TTDR00699	Integrin alpha-M	Closed head injury	800-879	S00.0S09
TTDR00700	DNA fragmentation factor 40 kDa subunit	Colon cancer	153, 154	C18-C21
TTDR00701	Immunoglobulin A1 protease	Infections caused by nontypeable H influenza	001-139, 487, 488	A00-B99, J10, J11
TTDR00702	Alkylhydroperoxidase AhpD	Tuberculosis	010-018	A15-A19
TTDR00703	Bacitracin transport ATP-binding protein bcrA	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDR00704	Plasmepsin 4	Parasitic diseases	.	.
TTDR00705	Dystroglycan	Congenital muscular dystrophy	359.0-359.1	G71.0
TTDR00705	Dystroglycan	Lissencephaly	.	.
TTDR00705	Dystroglycan	Ocular abnormalities	.	.
TTDR00706	40S ribosomal protein S12	Cancer	140-229	C00-C96
TTDR00707	Choriogonadotropin beta chain	Cancer	140-229	C00-C96
TTDR00708	65 kD membrane-associated NADH-fumarate reductase	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDR00709	Inositol polyphosphate 1-phosphatase	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDR00710	Diphosphoinositol polyphosphate phosphohydrolase 2	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDR00711	Gene A1	Allergic diseases	995.3	T78.4
TTDI00711	Methionine aminopeptidase-2	Autoimmune diseases	279	D84.9, M35.9
TTDI00711	Methionine aminopeptidase-2	Cancer	140-229	C00-C96
TTDI00711	Methionine aminopeptidase-2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00712	Membrane-bound transcription factor site-1 protease	Hyperlipidemia	272.0-272.4	E78
TTDR00713	Beta-catenin	Colorectal cancer	153, 154	C18-C21
TTDR00714	5T4 ONCOFETAL antigen	Breast cancer	174, 175, 217	C50, D24
TTDR00714	5T4 ONCOFETAL antigen	Lung cancer	162	C33-C34
TTDR00715	Glycosylphosphatidylinositol phosphoethanolamine transferase	Parasitic diseases	.	.
TTDR00716	Farnesyl-protein transferase	Amebiasis	6	A06
TTDR00716	Farnesyl-protein transferase	Cancer	140-229	C00-C96
TTDR00716	Farnesyl-protein transferase	Parasitic diseases	.	.
TTDR00717	Serine/threonine protein phosphatase PP1-alpha 1 catalytic subunit	Cancer	140-229	C00-C96
TTDR00718	HPIV-1 hemagglutinin-neuraminidase glycoprotein	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00720	UPF0090 protein SP0552	Streptococcus pneumoniae infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
TTDR00721	Methionine aminopeptidase 2	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00721	Methionine aminopeptidase 2	Cancer	140-229	C00-C96
TTDR00721	Methionine aminopeptidase 2	Mesothelioma	163	C45
TTDR00722	L-selectin	Asthma	493	J45
TTDR00723	2C-Methyl-D-erythritol 2,4-cyclodiphosphate synthase	Malaria	84	B50-B54
TTDR00725	DNA: NF2 gene promoter	Schwannoma	237.73	Q85.03
TTDR00726	Signal peptidase I	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00727	Perilipin	Obesity	278	E66
TTDR00728	Contactin 2	Malignant gliomas	191	C71
TTDR00729	DNA: squamous cell carcinoma antigen SCCA1 promoter	Squamous cell carcinoma	199	C44
TTDR00730	Mucin 1	Breast cancer	174, 175, 217	C50, D24
TTDR00730	Mucin 1	Cancer	140-229	C00-C96
TTDR00730	Mucin 1	Immune disease	.	.
TTDR00730	Mucin 1	Papillary thyroid carcinomas	.	.
TTDR00731	P2Y purinoceptor 6	Cystic fibrosis gallbladder disease	188, 277.0, 574-575, 709.2	C67, E84, K80-K82, L90.5
TTDR00732	Arginase II, mitochondrial	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR00732	Arginase II, mitochondrial	Sexual arousal disorders	302.72	F52.22
TTDR00733	Transmembrane protease, serine 2	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00734	Complement receptor type 1	Malaria	84	B50-B54
TTDR00735	Phosphatidylinositol 3-kinase CaVps34p	Fungal diseases	110-118	B35-B49
TTDR00736	Macrophage scavenger receptor class B type I	Atherosclerosis	414.0, 440	I70
TTDR00737	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2	Neoplasms	140-239	C00-D48
TTDR00738	Human T-cell leukemia virus type-1 proteinase	Human T-lymphotropic virus infections	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00739	Superoxide dismutase [Mn]	Cancer	140-229	C00-C96
TTDR00739	Superoxide dismutase [Mn]	Colon cancer	153, 154	C18-C21
TTDR00740	Acylamino-acid-releasing enzyme	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDR00741	Signal transduction protein CBL	Malignancies	140-239	C00-C96
TTDR00742	Membrane copper amine oxidase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00743	Cytokine growth-related oncogene-alpha	Nasal polyposis	471	J33
TTDR00744	Trans-acting T-cell specific transcription factor GATA-3	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDR00745	Advanced glycosylation end product-specific receptor	Amyloidosis	277.3	E85
TTDR00746	Phosphomannomutase/phosphoglucomutase	P. aeruginosa infections	001-139	A00-B99
TTDR00747	Flavohemoglobin	Microbial infections	001-139	A00-B99
TTDI00747	Stearoyl CoA desaturase-1	Acne vulgaris	706.1	L70.0
TTDI00747	Stearoyl CoA desaturase-1	Dermatological disease	.	L00-L99
TTDI00747	Stearoyl CoA desaturase-1	Diabetes mellitus type 2	250	E11
TTDI00747	Stearoyl CoA desaturase-1	Gallstone	.	K82.9
TTDI00747	Stearoyl CoA desaturase-1	Lipid metabolism disorder	.	E75-E78
TTDI00747	Stearoyl CoA desaturase-1	Obesity	278	E66
TTDR00748	2-amino-4-hydroxy-6- hydroxymethyldihydropteridine pyrophosphokinase	Infections	001-139	A00-B99
TTDR00748	2-amino-4-hydroxy-6- hydroxymethyldihydropteridine pyrophosphokinase	Microbial infections	001-139	A00-B99
TTDR00748	2-amino-4-hydroxy-6- hydroxymethyldihydropteridine pyrophosphokinase	Parasitic diseases	.	.
TTDR00749	G-quadruplex DNA	Cancer	140-229	C00-C96
TTDR00750	Melanoma-associated antigen 3	Head and neck squamous cell carcinomas	199	C44
TTDR00750	Melanoma-associated antigen 3	Intrahepatic cholangiocarcinoma	155.1, 156.1	C22.1
TTDR00750	Melanoma-associated antigen 3	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR00751	CD9 antigen	Angiogenesis	.	.
TTDR00752	Myelin-associated/oligodendrocyte basic protein	Multiple sclerosis	340	G35
TTDR00753	Glucosamine-6-phosphate synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00753	Glucosamine-6-phosphate synthase	Fungal diseases	110-118	B35-B49
TTDR00754	Mitotic checkpoint protein	Lung cancer	162	C33-C34
TTDR00755	Metabotropic glutamate receptor 8	Analgesics	338	R52
TTDR00755	Metabotropic glutamate receptor 8	Epilepsy	290-319, 345	F01-F99, G40
TTDR00755	Metabotropic glutamate receptor 8	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR00756	Homeobox protein Hox-B13	Advanced prostate cancer	140-229, 185	C00-C96, C61
TTDR00757	Fatty-acyl-CoA synthase	Malaria	84	B50-B54
TTDR00758	Pyruvate:ferredoxin oxidoreductase	Anaerobic pathogens	.	.
TTDR00759	Xaa-Pro dipeptidase	Neoplastic diseases	.	.
TTDR00761	Subtilisin-like protease	Malaria	84	B50-B54
TTDR00762	3-dehydroquinate synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00762	3-dehydroquinate synthase	Fungal diseases	110-118	B35-B49
TTDR00763	C-C chemokine receptor type 8	Allergic diseases	995.3	T78.4
TTDR00764	Haemagglutinin	Influenza A virus infections	487, 488	J10, J11
TTDR00765	Tumor-associated calcium signal transducer 1	Colorectal cancer	153, 154	C18-C21
TTDR00766	Iron-transporter ferric ion-binding protein	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00767	Tryparedoxin	Trypanosomiasis	086.5-086	B56-B57
TTDR00769	Cysteine proteinase	Malaria	84	B50-B54
TTDR00769	Cysteine proteinase	Parasitic diseases	.	.
TTDR00771	Glycine receptor alpha-1 chain	Convulsions	780.3	R56.0
TTDR00771	Glycine receptor alpha-1 chain	Depression	311	F32
TTDR00773	Melanoma-associated antigen 4	Cancer	140-229	C00-C96
TTDR00774	GMP synthase [glutamine-hydrolyzing]	Cancer	140-229	C00-C96
TTDR00775	Gamma crystallin M2	Motor disorder	.	.
TTDR00776	Solute carrier family 2, facilitated glucose transporter, member 4	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00777	Neuropeptide Y	Heart failure	410, 428	I21, I22, I50
TTDR00777	Neuropeptide Y	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00777	Neuropeptide Y	Metabolic disease	270-279	E70-E89
TTDR00777	Neuropeptide Y	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00777	Neuropeptide Y	Obesity	278	E66
TTDR00778	Negative factor	Human immunodeficiency virus infection	279.3	D84.9
TTDR00779	69 kDa islet cell autoantigen	Insulin-dependent diabetes mellitus	250	E08-E13
TTDR00780	Interleukin-8 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00780	Interleukin-8 receptor	Psoriasis	696	L40
TTDR00781	Guanosine phosphotransferase	Parasitic diseases	.	.
TTDR00783	Deoxyribonucleoside phosphotransferase	Trichomoniasis	131	A59
TTDR00784	Aminopeptidase N	Coronaviruses infections	001-139	A00-B99
TTDR00784	Aminopeptidase N	Severe acute respiratory syndrome	.	.
TTDR00784	Aminopeptidase N	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00785	3,4-dihydroxy-2-butanone-4-phosphate synthase	Microbial infections	001-139	A00-B99
TTDR00786	G1/S-specific cyclin E1	Hepatocellular carcinoma	155	C22.0
TTDR00787	Endothelium-derived hyperpolarizing factor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR00788	Fibroblast-specific protein-1	Breast cancer	174, 175, 217	C50, D24
TTDR00789	Calgranulin A	Inflammatory arthritis	710-719	M00-M25
TTDR00790	Calgranulin B	Inflammatory arthritis	710-719	M00-M25
TTDR00792	Growth arrest and DNA-damage-inducible protein GADD45 beta	Hepatocellular carcinoma	155	C22.0
TTDR00793	Zinc finger protein OZF	Colorectal cancer	153, 154	C18-C21
TTDR00794	Myosin light chain kinase, smooth muscle and non-muscle isozymes	Lung injury	.	S00-T98
TTDR00795	Angiopoietin-related protein 4	Ischemic tumor; Solid tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00796	VDUP1 protein	Melanoma	172.9	C43
TTDR00797	Trypanothione synthetase	Chagas' disease	86	B57
TTDR00797	Trypanothione synthetase	Parasitic diseases	.	.
TTDR00798	Calprotectin	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00799	Adiponectin	Atherosclerotic cardiovascular disease	390-459	I00-I99
TTDR00799	Adiponectin	Dyslipidemia	272	E78
TTDR00800	Polyphosphate kinase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00802	Prostaglandin D2 receptor	Allergic diseases	995.3	T78.4
TTDR00803	Calgranulin D	Chronic airway inflammation	460-519	J00-J99
TTDR00803	Calgranulin D	Chronic arthritis	710-719	M00-M25
TTDR00804	Galectin-3	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR00805	Choline kinase	Cancer	140-229	C00-C96
TTDR00805	Choline kinase	Proliferative diseases	.	.
TTDR00805	Choline kinase	Ras-dependent tumourigenesis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00806	Presynaptic density protein 95	Analgesics	338	R52
TTDR00806	Presynaptic density protein 95	Chronic neuropathic pain	338, 356.0, 356.8, 530,780	G64, G90.0, K21, R52, G89
TTDR00806	Presynaptic density protein 95	Opioid dependence	304	F11.2
TTDR00807	Cell surface glycoprotein MUC18	Angiogenesis	.	.
TTDR00807	Cell surface glycoprotein MUC18	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00808	Stromal cell-derived factor 1	Breast cancer	174, 175, 217	C50, D24
TTDR00808	Stromal cell-derived factor 1	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00809	DNA mismatch repair protein MSH2	Huntington's disease	294.1, 333.4	F02.2, G10
TTDR00810	DNA-binding protein inhibitor ID-2	Allergic diseases	995.3	T78.4
TTDR00811	Estradiol 17 beta-dehydrogenase 4	Stiff-man syndrome	333.91	G25.82
TTDR00812	Myotubularin-related protein 1	Myotonic dystrophy	.	G71.1
TTDR00813	Toll-like receptor 2	Skin diseases	.	.
TTDR00814	S-phase kinase-associated protein 2	Gastric carcinoma	151	C16
TTDR00814	S-phase kinase-associated protein 2	Small cell lung cancer	162.9	C34.90
TTDR00814	S-phase kinase-associated protein 2	Squamous cell carcinoma	199	C44
TTDR00815	Growth/differentiation factor 15	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI00816	Glutathione reductase	Asthma	493	J45
TTDI00816	Glutathione reductase	Inflammatory bowel disease	555, 556	K50, K51
TTDI00816	Glutathione reductase	Vascular disease	325, 430-459	G45-G46, I60-I95
TTDR00816	Protease II	Microbial infections	001-139	A00-B99
TTDR00817	Orphan nuclear receptor SHP	Endometrial cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
TTDR00818	Nucleocapsid protein, NCP7, NC71	Human immunodeficiency virus infection	279.3	D84.9
TTDR00819	Mothers against decapentaplegic homolog 3	Lung fibrosis	709.2	L90.5
TTDR00820	WNT1 inducible signaling pathway protein 3 variant	Colorectal cancer	153, 154	C18-C21
TTDR00821	Metabotropic glutamate receptor 7	Convulsions	780.3	R56.0
TTDR00822	Cyclin-dependent kinase 6 inhibitor	Autoimmune diseases	279	D84.9, M35.9
TTDR00823	Growth/differentiation factor 8	Cachexia	799.4	R64
TTDR00823	Growth/differentiation factor 8	Endocrine disorder	.	.
TTDR00823	Growth/differentiation factor 8	Immune disease	.	.
TTDR00823	Growth/differentiation factor 8	Metabolic disease	270-279	E70-E89
TTDR00823	Growth/differentiation factor 8	Muscular atrophy	728.2	M62.5
TTDR00823	Growth/differentiation factor 8	Sarcopenia	.	M62.9
TTDR00823	Growth/differentiation factor 8	Skeletal muscle wasting	.	.
TTDR00824	Neuroendocrine convertase 1	Cancer	140-229	C00-C96
TTDR00824	Neuroendocrine convertase 1	Malignant gliomas	191	C71
TTDR00825	Neuroendocrine convertase 2	Cancer	140-229	C00-C96
TTDR00825	Neuroendocrine convertase 2	Malignant gliomas	191	C71
TTDR00826	Histidine kinase	Fungal diseases	110-118	B35-B49
TTDR00827	Phosphoribosylaminoimidazole carboxylase	Fungal diseases	110-118	B35-B49
TTDR00828	Deoxyribonuclease I	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00829	Fascin	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00830	Vascular endothelial-cadherin	Tumor angiogenesis and metastasis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00831	Apolipoprotein(a)	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00831	Apolipoprotein(a)	Neurodegenerative diseases	330-337	G30-G32
TTDR00832	Olfactory receptor 51E2	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00833	U6 snRNA-associated Sm-like protein LSm1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00834	ADM	Angiogenesis	.	.
TTDR00834	ADM	Cancer	140-229	C00-C96
TTDR00834	ADM	Diabetic complications	250	E08-E13
TTDR00834	ADM	Tumors (androgen sensitive)	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00838	Fatty acid transport protein	Insulin resistance	.	E00-E90
TTDR00838	Fatty acid transport protein	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR00838	Fatty acid transport protein	Obesity	278	E66
TTDR00839	Kexin-like serine endoprotease	P. carinii pneumonia	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
TTDR00840	Fos-related antigen 1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00841	Elav-like protein 1	Paraneoplastic encephalomyelitis	.	.
TTDR00842	Ets-domain protein elk-3	Candida vaginitis	616.1	N76.0-N76.1
TTDR00843	Elongation factor 2	Fungal diseases	110-118	B35-B49
TTDR00844	Leukosialin	Atherosclerosis	414.0, 440	I70
TTDR00844	Leukosialin	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00845	Protein tyrosine phosphatase	Atherosclerosis	414.0, 440	I70
TTDR00845	Protein tyrosine phosphatase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00845	Protein tyrosine phosphatase	Tumor angiogenesis and metastasis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00846	Beta-chimaerin	Phorbol ester tumor	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00847	ADAM 17	Inflammatory bowel disease	555, 556	K50, K51
TTDR00847	ADAM 17	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00847	ADAM 17	Neuroimmunological diseases	.	.
TTDR00848	Deoxyhypusine synthase	Cancer	140-229	C00-C96
TTDR00849	Lantibiotic mersacidin	Methicillin-resistant S. aureus infection	001-139	A00-B99
TTDR00850	Cd28 receptor	Immunosuppression	.	.
TTDR00851	Angiotensin converting enzyme-like protein	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00852	Sterol regulatory element binding protein-1	Diabetic dyslipidemia	250, 272	E08-E13, E78
TTDR00853	Biphenyl hydrolase-related protein	Herpes virus infection	001-139, 042-075	A00-B99, A80-A99, B00-B34
TTDR00854	Membrane-associated lectin type-C	Cutaneous leishmaniasis	085.1-085.4	B55.1
TTDR00854	Membrane-associated lectin type-C	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
TTDR00854	Membrane-associated lectin type-C	Visceral leishmaniasis	085.0, 110-118	B35-B49, B55.0
TTDR00855	Interleukin-20	Inflammatory skin disorder	.	.
TTDR00856	Follistatin-related protein 3	Malignant blood disorders	.	.
TTDR00857	Coronavirus main proteinase	Severe acute respiratory syndrome	.	.
TTDR00858	Tyrosine-protein kinase itk/tsk	Asthma	493	J45
TTDR00859	Protective antigen	Anthrax infection	001-139, 022	A00-B99, A22
TTDR00860	Mammaglobin A	Breast cancer	174, 175, 217	C50, D24
TTDR00861	Lectin-like oxidized ldl receptor	Endotoxin-induced inflammation	.	.
TTDR00862	Aspartate-semialdehyde dehydrogenase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00862	Aspartate-semialdehyde dehydrogenase	Fungal diseases	110-118	B35-B49
TTDI00862	Dihydroorotate dehydrogenase	Flavivirus infection	.	A86
TTDI00862	Dihydroorotate dehydrogenase	Immune disorder	.	D80-D89
TTDI00862	Dihydroorotate dehydrogenase	Multiple sclerosis	340	G35
TTDI00862	Dihydroorotate dehydrogenase	Plasmodium falciparum infection	.	B54
TTDI00862	Dihydroorotate dehydrogenase	Plasmodium infection	.	B54
TTDI00862	Dihydroorotate dehydrogenase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00863	Organic cation transporter 6	Leukemia	208.9	C91-C95
TTDR00864	Glutathionylspermidine synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00864	Glutathionylspermidine synthase	Parasitic diseases	.	.
TTDR00865	UDP-3-O-[3-hydroxymyristoyl] n-acetylglucosamine deacetylase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00866	Lanosterol synthase	Hypercholesterolemia	272	E78.0
TTDR00867	Galanin	Anxiety disorders	300	F40-F42
TTDR00869	ORF74 protein	Kaposi's sarcoma	176	C46
TTDR00870	GDP-mannose transporter	Fungal diseases	110-118	B35-B49
TTDR00871	Cystathionine gamma-synthase	Microbial infections	001-139	A00-B99
TTDR00872	Riboflavin synthase	Infections	001-139	A00-B99
TTDR00872	Riboflavin synthase	Microbial infections	001-139	A00-B99
TTDR00873	DNA-repair protein complementing xp-a cells	Cancer	140-229	C00-C96
TTDR00874	Dopachrome tautomerase	Malignant gliomas	191	C71
TTDR00874	Dopachrome tautomerase	Melanoma	172.9	C43
TTDR00874	Dopachrome tautomerase	Tyrosinase-positive melanomas	172	C43
TTDR00875	Hepatoma derived growth factor	Cancer	140-229	C00-C96
TTDR00876	Airway trypsin-like protease	Chronic airway diseases	490-492, 493, 494-496	J40-J44, J45, J47
TTDR00877	Peroxysome proliferator-activated receptor gamma 2	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR00878	Makorin 1	Polycystic kidney disease	753.1	Q61
TTDR00879	Sorbitol dehydrogenase	Diabetic complications	250	E08-E13
TTDR00879	Sorbitol dehydrogenase	Myocardial ischemia	410, 459.89	I21, I22, I99.8
TTDR00880	Acyl-CoA desaturase 1	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00883	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 1	Asthma	493	J45
TTDR00884	Tyrosine-protein kinase 6	Breast cancer	174, 175, 217	C50, D24
TTDR00884	Tyrosine-protein kinase 6	Cancer	140-229	C00-C96
TTDR00884	Tyrosine-protein kinase 6	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00884	Tyrosine-protein kinase 6	Prostate tumor	185	C61
TTDR00885	Transcription factor E2F2	Proliferative diseases	.	.
TTDR00886	Cathepsin B	Acute otitis media	381.0, 381.1, 381.2, 381.3, 381.4	H65, H66, H67
TTDR00886	Cathepsin B	Arthritis	710-719	M00-M25
TTDR00886	Cathepsin B	Ischemia	459.89	I99.8
TTDR00886	Cathepsin B	Tumor angiogenesis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00887	CASP8 and FADD-like apoptosis regulator	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00887	CASP8 and FADD-like apoptosis regulator	Cancer	140-229	C00-C96
TTDR00887	CASP8 and FADD-like apoptosis regulator	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00887	CASP8 and FADD-like apoptosis regulator	Multiple sclerosis	340	G35
TTDR00887	CASP8 and FADD-like apoptosis regulator	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00888	Gremlin	Renal diseases	580-599	N00-N39
TTDR00889	ADAM 33	Asthma	493	J45
TTDR00890	Early activation antigen CD69	Arthritis	710-719	M00-M25
TTDR00891	Kinase suppressor of ras-1	Tumor angiogenesis	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00892	Cell surface A33 antigen	Colon cancer	153, 154	C18-C21
TTDR00892	Cell surface A33 antigen	Gastrointestinal cancers	150-159	C15-C26
TTDR00893	Suppressor of cytokine signaling 3	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00894	Poly(ADP-ribose) glycohydrolase	Ischemia reperfusion injuries	459.89	I99.8
TTDR00894	Poly(ADP-ribose) glycohydrolase	Septic shock-like syndrome induced by zymosan	.	.
TTDR00895	NH(3)-dependent NAD(+) synthetase	Bacillus subtilis infections	001-139	A00-B99
TTDR00895	NH(3)-dependent NAD(+) synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00897	DNA-directed RNA polymerase II 19 kDa polypeptide	Renal cell carcinoma	189	C64
TTDR00897	DNA-directed RNA polymerase II 19 kDa polypeptide	Von Hippel-Lindau tumor; Hereditary VHL disease	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00898	DNA ligase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00899	Na+-coupled citrate transporter protein	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDR00900	Serine/threonine protein phosphatase 1	Human immunodeficiency virus infection	279.3	D84.9
TTDR00901	JUN activation domain binding protein	Breast cancer	174, 175, 217	C50, D24
TTDR00902	Short transient receptor potential channel 3	Immune disease	.	.
TTDR00903	Potassium voltage-gated channel subfamily A member 3	Autoimmune diseases	279	D84.9, M35.9
TTDR00903	Potassium voltage-gated channel subfamily A member 3	Immunosuppression	.	.
TTDR00903	Potassium voltage-gated channel subfamily A member 3	Multiple sclerosis	340	G35
TTDR00903	Potassium voltage-gated channel subfamily A member 3	T cell-mediated autoimmune diseases	279.4	D84.9, M35.9
TTDR00905	Ubiquitin-protein ligase E3A	Human papillomavirus positive cancers	140-229	C00-C96
TTDR00906	Munc13	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00907	40 kDa peptidyl-prolyl cis-trans isomerase	Neurodegenerative diseases	330-337	G30-G32
TTDR00908	Gamma-aminobutyric acid C receptor	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDR00908	Gamma-aminobutyric acid C receptor	Sleeping sickness	.	.
TTDR00908	Gamma-aminobutyric acid C receptor	Visual disorders	.	.
TTDR00909	Endoprotease bli-4	Helminth infection	001-139	A00-B99
TTDR00910	6-phosphogluconate dehydrogenase, decarboxylating	Trichomoniasis	131	A59
TTDR00910	6-phosphogluconate dehydrogenase, decarboxylating	Trypanosomiasis	086.5-086	B56-B57
TTDR00911	Oxysterols receptor LXR	Atherosclerosis	414.0, 440	I70
TTDR00911	Oxysterols receptor LXR	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR00911	Oxysterols receptor LXR	Dyslipidemia	272	E78
TTDR00911	Oxysterols receptor LXR	Low high density lipoprotein syndromes	.	.
TTDR00912	Gamma-synuclein	Breast cancer	174, 175, 217	C50, D24
TTDR00913	Adipocyte-derived leucine aminopeptidase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00914	Human leukocyte antigen class II	Hematologic malignancies	200-209	C81-C96
TTDR00914	Human leukocyte antigen class II	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR00915	Bax inhibitor-1	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00916	M1-family aminopeptidase	Malaria	84	B50-B54
TTDR00917	Hormone sensitive lipase	Lipid metabolic disorders	270-279	E70-E89
TTDR00917	Hormone sensitive lipase	Obesity	278	E66
TTDR00918	Islet-specific glucose-6-phosphatase catalytic subunit-related protein	Insulin-dependent diabetes mellitus	250	E08-E13
TTDR00919	Latent membrane protein 1	Epstein-barr virus-associated malignancies	075, 140-239	B27, C00-C96
TTDR00920	ADAM 8	Allergy	995.3	T78.4
TTDR00920	ADAM 8	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00921	Small inducible cytokine A3	B-cell lymphoma	202.8	C85.1
TTDR00922	DNA repair protein RAD51 homolog 1	Small cell lung cancer	162.9	C34.90
TTDR00924	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	Cancer	140-229	C00-C96
TTDR00925	Heparin-binding growth factor 1	Hepatic fibrosis	709.2	L90.5
TTDR00926	Vascular endothelial growth factor B	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00927	Lymphocyte antigen 96	Endotoxin-mediated diseases	.	.
TTDR00928	Mitogen-activated protein kinase 10	Ischemic stroke	434.91	I61-I63
TTDR00928	Mitogen-activated protein kinase 10	Neurological diseases	320-359	G00-G99
TTDR00929	Thymidine monophosphate kinase	Tuberculosis	010-018	A15-A19
TTDR00930	PI3K delta	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI00931	DHFR	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI00931	DHFR	Cancer	140-229	C00-C96
TTDI00931	DHFR	Fungal infection	110-118	B35-B49
TTDI00931	DHFR	Plasmodium falciparum infection	.	B54
TTDI00931	DHFR	Rheumatold arthritis	714	M05-M06
TTDI00931	DHFR	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00932	YihA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00933	TNF receptor associated factor	Autoimmune diseases	279	D84.9, M35.9
TTDR00933	TNF receptor associated factor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI00934	RNA polymerase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI00934	RNA polymerase	Cancer	140-229	C00-C96
TTDI00934	RNA polymerase	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI00934	RNA polymerase	Influenza virus infections	487, 488	J10, J11
TTDI00934	RNA polymerase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI00934	RNA polymerase	Picornavirus infection	.	A00-B99
TTDI00934	RNA polymerase	Under research	.	.
TTDR00934	Tumor necrosis factor receptor superfamily member 17	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDR00935	Tumor necrosis factor receptor superfamily member 13B	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDR00936	Tumor necrosis factor receptor superfamily member 13C	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDR00937	F-box and WD-40 domain protein 7	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR00938	Neutrophil cytosol factor 1	Atherosclerosis	414.0, 440	I70
TTDR00938	Neutrophil cytosol factor 1	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR00938	Neutrophil cytosol factor 1	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR00939	Toll-like receptor	Allergy	995.3	T78.4
TTDR00939	Toll-like receptor	Autoimmune diseases	279	D84.9, M35.9
TTDR00939	Toll-like receptor	Cancer	140-229	C00-C96
TTDR00939	Toll-like receptor	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDR00940	Fc receptor	Allergy	995.3	T78.4
TTDR00940	Fc receptor	Autoimmune diseases	279	D84.9, M35.9
TTDR00940	Fc receptor	Cancer	140-229	C00-C96
TTDR00941	SLC38	Neoplasms	140-239	C00-D48
TTDR00943	Peptide YY	Obesity	278	E66
TTDR00944	High density lipoprotein	Atherosclerosis	414.0, 440	I70
TTDR00944	High density lipoprotein	Atherosclerotic cardiovascular disease	390-459	I00-I99
TTDR00945	Phosphoribosylaminoimidazolecarboxamide formyltransferase	Cancer	140-229	C00-C96
TTDR00946	Glycoprotein Ib-IX-V receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR00946	Glycoprotein Ib-IX-V receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR00947	Coagulation factor VII	Coagulative disorders	286	D65-D69
TTDR00948	Protein phosphatase 1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00948	Protein phosphatase 1	Cancer	140-229	C00-C96
TTDR00948	Protein phosphatase 1	Heart failure	410, 428	I21, I22, I50
TTDR00948	Protein phosphatase 1	Human immunodeficiency virus infection	279.3	D84.9
TTDR00949	Elongation factor 1-alpha	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDR00950	Kynureninase	AIDS related dementia	042, 290-294	B20, F01-F07
TTDR00950	Kynureninase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR00950	Kynureninase	Huntington's disease	294.1, 333.4	F02.2, G10
TTDR00951	CAMP-specific 3',5'-cyclic phosphodiesterase 4	Asthma	493	J45
TTDR00952	Penicillin-binding protein 1A	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00953	DNA fragmentation factor alpha subunit	Colon cancer	153, 154	C18-C21
TTDR00955	Dihydrolipoamide dehydrogenase, mitochondrial	Chagas' disease	86	B57
TTDR00956	CTP synthase	Acute T-lymphoid leukemia	208.9	C91-C95
TTDR00956	CTP synthase	Acute non-lymphocytic leukaemia	208.9	C91-C95
TTDR00956	CTP synthase	Malaria	84	B50-B54
TTDR00956	CTP synthase	Sleeping sickness	.	.
TTDR00956	CTP synthase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR00956	CTP synthase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI00956	Thioredoxin reductase	Cancer	140-229	C00-C96
TTDI00956	Thioredoxin reductase	Mycobacterium tuberculosis infection	.	A15-A19
TTDR00957	Adenosylhomocysteinase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR00958	Purine nucleoside kinase	Trypanosomatid infections	001-139	A00-B99
TTDR00959	5'-methylthioadenosine phosphorylase	T cell leukemias	208.9	C91-C95
TTDR00960	Caspase	Heart failure	410, 428	I21, I22, I50
TTDR00961	Calcitonin gene-related peptide receptor	Migraine	346	G43
TTDR00961	Calcitonin gene-related peptide receptor	Primary headache disorders	339, 784.0	G43-G44, R51
TTDR00962	Cytochrome c oxidase copper chaperone	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR00963	Solute carrier family 2, facilitated glucose transporter, member 1	Cervical cancer	140-229, 180	C00-C96, C53
TTDR00964	Transforming protein RhoB	Cancer	140-229	C00-C96
TTDR00964	Transforming protein RhoB	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDR00964	Transforming protein RhoB	Macular degeneration	362.5	H35.3
TTDR00965	Metabotropic glutamate receptor 4	Parkinson's disease	332	F02.3, G20
TTDI00965	Squalene epoxidase	Coronary artery disease	410-414, 429.2	I20-I25
TTDI00965	Squalene epoxidase	Hypercholesterolaemia	.	E78.0
TTDI00965	Squalene epoxidase	Onychomycosis	.	B35.1
TTDR00966	Keratin, type I cytoskeletal 19	Hepatocellular carcinoma	155	C22.0
TTDR00967	DNA-(apurinic or apyrimidinic site) lyase	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00967	DNA-(apurinic or apyrimidinic site) lyase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI00967	Tubulin beta-1 chain	Cancer	140-229	C00-C96
TTDI00967	Tubulin beta-1 chain	Lung cancer	162	C33-C34
TTDR00968	Mitogen-activated protein kinase kinase kinase 5	Cardiac diseases	390-459	I00-I99
TTDR00968	Mitogen-activated protein kinase kinase kinase 5	Malignant fibrous histiocytomas	.	.
TTDR00969	Cell division protein FtsZ	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00970	DNA polymerase/reverse transcriptase	Hepatitis B infection	070.2, 070.3	B16, B18.0, B18.1
TTDR00971	Similar to dipeptidyl aminopeptidase-like protein	Asthma	493	J45
TTDR00972	Cytidylate kinase	Streptococcus pneumoniae infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
TTDR00973	Neuropeptide Y receptor	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR00975	Glandular kallikrein 1	Asthma	493	J45
TTDR00975	Glandular kallikrein 1	Pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDR00975	Glandular kallikrein 1	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR00976	CAMP-dependent protein kinase, catalytic subunit	Prostate cancer	140-229, 185	C00-C96, C61
TTDR00977	CAMP-dependent protein kinase type I-alpha regulatory chain	Cancer	140-229	C00-C96
TTDR00978	CAMP-dependent protein kinase type II-beta regulatory chain	Obesity	278	E66
TTDR00979	Adenylate cyclase	Heart failure	410, 428	I21, I22, I50
TTDR00980	28-kDa cysteine proteinase	Malaria	84	B50-B54
TTDR00981	Lymphocyte antigen Ly-6D	Squamous cell carcinoma	199	C44
TTDR00982	Cruzipain	Chagas' disease	86	B57
TTDR00982	Cruzipain	Trypanolytic infections	001-139	A00-B99
TTDR00983	Maspin	Breast cancer	174, 175, 217	C50, D24
TTDR00984	Phosphatidylcholine-specific phospholipase C	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00985	Guanine nucleotide-binding protein G(q), alpha subunit	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDR00985	Guanine nucleotide-binding protein G(q), alpha subunit	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR00985	Guanine nucleotide-binding protein G(q), alpha subunit	Unstable angina	411.1	I20.0
TTDR00986	Heat shock protein 40	Polyglutamine diseases	.	.
TTDR00987	Long transient receptor potential channel 2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00988	Short transient receptor potential channel 6	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR00989	mRNA of Methylenetetrahydrofolate reductase	Colon cancer	153, 154	C18-C21
TTDI00990	Farnesyl pyrophosphate synthase	Bone resorption	.	M80
TTDR00990	T cell receptor beta chain	Acute myelogenous leukemia	205	C92.0
TTDR00990	T cell receptor beta chain	Aplastic anemia	284	D60-D61
TTDR00990	T cell receptor beta chain	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR00991	Interferon consensus sequence binding protein	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDR00992	Chorismate synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR00992	Chorismate synthase	Fungal diseases	110-118	B35-B49
TTDR00992	Chorismate synthase	Parasitic diseases	.	.
TTDR00993	Fructosamine-3-kinase	Diabetic complications	250	E08-E13
TTDR00994	Herstatin	Bladder cancer	140-229, 188	C00-C96, C67
TTDR00995	Glyceraldehyde 3-phosphate dehydrogenase, muscle	Cancer	140-229	C00-C96
TTDR00996	Transmembrane 4 superfamily, member 2	Desmoplastic small round-cell tumor	140-199, 204.0, 210-229	C00-C75, C7A, C7B, C91.0, D10-D36, D3A
TTDR00997	Guanine nucleotide-binding protein beta subunit-like protein	Leishmania infections	001-139, 296.0, 296.4, 296.6	A00-B99, F30
TTDR00998	TGF-beta receptor type I	Cancer	140-229	C00-C96
TTDR00998	TGF-beta receptor type I	Fibrosis	709.2	L90.5
TTDR00999	T-cell leukemia/lymphoma protein 1A	Cancer	140-229	C00-C96
TTDR01000	CFP32	Tuberculosis	010-018	A15-A19
TTDR01001	Sodium/iodide cotransporter	Cancer	140-229	C00-C96
TTDR01002	Borna disease virus envelope glycoprotein	Borna disease	62.9	A83.9
TTDR01003	Insulin-like growth factor IA	Cancer	140-229	C00-C96
TTDR01004	ATP-citrate synthase	Hyperlipidemia	272.0-272.4	E78
TTDR01004	ATP-citrate synthase	Obesity	278	E66
TTDR01005	Mitogen-activated protein kinase kinase kinase 3	Cancer	140-229	C00-C96
TTDR01006	Caspase-9	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDR01006	Caspase-9	Brain injury associated with seizures	345.9, 780.3	G40, P90, R56
TTDR01007	Junction plakoglobin	Fibrosarcoma	.	.
TTDR01008	Epithelial-cadherin	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDR01010	Malignant melanoma metastasis-suppressor KiSS-1	Human reproductive syndromes	.	.
TTDR01011	CatSper	Male infertility asthenospermia	606, 628	N46, N97.0
TTDR01012	Polyketide synthase	Corynebacterineae infections	001-139	A00-B99
TTDR01013	PDZ domain containing-protein	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01014	Carnitine palmitoyltransferase-I	Obesity	278	E66
TTDI01014	Carnitine palmitoyltransferase-I	Psoriasis	696	L40
TTDR01015	Arginine deiminase	Microbial infections	001-139	A00-B99
TTDR01015	Arginine deiminase	Parasitic diseases	.	.
TTDR01016	Subtilisin-like protease 2	Malaria	84	B50-B54
TTDR01017	Development and differentiation enhancing factor-like 1	Hepatocellular carcinoma	155	C22.0
TTDR01018	Phosphopantetheine adenylyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01019	3-phosphoshikimate 1-carboxyvinyltransferase	Microbial infections	001-139	A00-B99
TTDR01020	27 kDa antigen Cfp30B	Tuberculosis	010-018	A15-A19
TTDR01021	88 kDa glycoprotein growth factor	Cancer	140-229	C00-C96
TTDR01022	AMP deaminase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR01023	Alpha v beta 5 integrin receptor	Arteriosclerosis	440	I70
TTDR01023	Alpha v beta 5 integrin receptor	Cancer	140-229	C00-C96
TTDR01023	Alpha v beta 5 integrin receptor	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDR01023	Alpha v beta 5 integrin receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01023	Alpha v beta 5 integrin receptor	Ophthalmic diseases	.	.
TTDR01023	Alpha v beta 5 integrin receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01023	Alpha v beta 5 integrin receptor	Restenosis	.	I51.89
TTDR01024	Anandamide amidase	Analgesics	338	R52
TTDR01024	Anandamide amidase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01025	Islet amyloid polypeptide	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR01026	Angiotensin-(1-7) receptor	Angina pectoris	413	I20
TTDR01026	Angiotensin-(1-7) receptor	Cardiac hypertrophy	429.3	I51.7
TTDR01026	Angiotensin-(1-7) receptor	Cardiac insufficiency	410	I21, I22
TTDR01026	Angiotensin-(1-7) receptor	Coronary heart disease	414	I25.1
TTDR01026	Angiotensin-(1-7) receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01027	Lethal factor	Anthrax infection	001-139, 022	A00-B99, A22
TTDR01028	Branched chain amino acid-dependent aminotransferase	Anxiety disorders	300	F40-F42
TTDR01028	Branched chain amino acid-dependent aminotransferase	Cerebral ischemia	459.89	I99.8
TTDR01028	Branched chain amino acid-dependent aminotransferase	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
TTDR01028	Branched chain amino acid-dependent aminotransferase	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Allergy	995.3	T78.4
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Asthma	493	J45
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Inflammatory bowel disease	555, 556	K50, K51
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Multiple sclerosis	340	G35
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Psoriasis	696	L40
TTDR01029	CAMP-specific 3',5'-cyclic phosphodiesterase 7	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR01030	Carboxypeptidase H	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDR01030	Carboxypeptidase H	Neurological diseases	320-359	G00-G99
TTDR01031	Cathepsin L	Autoimmune diseases	279	D84.9, M35.9
TTDR01031	Cathepsin L	Melanoma	172.9	C43
TTDR01032	Cathepsin F	Autoimmune diseases	279	D84.9, M35.9
TTDR01033	Tripeptidyl-peptidase II	Eating disorders	307.5	F50
TTDR01033	Tripeptidyl-peptidase II	Obesity	278	E66
TTDR01033	Tripeptidyl-peptidase II	Psychiatric illness	.	.
TTDR01034	Chlorine/potassium channel receptor	Erythema	695	L51-L54
TTDR01034	Chlorine/potassium channel receptor	Pruritus	698	L29
TTDR01034	Chlorine/potassium channel receptor	Skin itching	698	L29
TTDR01035	Bone morphogenetic protein 1	Fibrotic disease	709.2	L90.5
TTDR01036	Creatine kinase	Angina pectoris	413	I20
TTDR01036	Creatine kinase	Atherosclerosis	414.0, 440	I70
TTDR01036	Creatine kinase	Coronary atherosclerosis	414.0, 440	I70
TTDR01036	Creatine kinase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDR01036	Creatine kinase	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR01036	Creatine kinase	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
TTDR01036	Creatine kinase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR01038	Amiloride-sensitive sodium channel	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01039	FK506-binding protein 4	Neurological diseases	320-359	G00-G99
TTDR01041	Fructosamine oxidase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01041	Hemoglobin subunit beta	Beta thalassemia	.	D56.1
TTDR01042	Gamma-aminobutyric-acid receptor alpha-5 subunit	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01042	Gamma-aminobutyric-acid receptor alpha-5 subunit	Central nervous system diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
TTDR01042	Gamma-aminobutyric-acid receptor alpha-5 subunit	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDR01042	Gamma-aminobutyric-acid receptor alpha-5 subunit	Delirium	293	F05
TTDR01042	Gamma-aminobutyric-acid receptor alpha-5 subunit	Dementia	290-294, 331.0	F01-F07, G30
TTDR01044	Galanin receptor type 2	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01044	Galanin receptor type 2	Central nervous system diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
TTDR01044	Galanin receptor type 2	Cerebral hemorrhage	.	.
TTDR01044	Galanin receptor type 2	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01044	Galanin receptor type 2	Diarrhea	787.91	A09, K59.1
TTDR01044	Galanin receptor type 2	Eating disorders	307.5	F50
TTDR01044	Galanin receptor type 2	Obesity	278	E66
TTDR01045	Galanin receptor type 3	Central nervous system diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
TTDR01045	Galanin receptor type 3	Eating disorders	307.5	F50
TTDR01045	Galanin receptor type 3	Obesity	278	E66
TTDR01048	Somatotropin	Nutritional disorders	260-269	E40-E64
TTDR01048	Somatotropin	Skin diseases	.	.
TTDR01049	HIV-2 Protease	Human immunodeficiency virus infection	279.3	D84.9
TTDR01050	HNEAA81 receptor	Arthritis	710-719	M00-M25
TTDR01050	HNEAA81 receptor	Cancer	140-229	C00-C96
TTDR01050	HNEAA81 receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01050	HNEAA81 receptor	Ophthalmic diseases	.	.
TTDR01051	Human rhinovirus 3C protease	Human rhinovirus infection	001-139	A00-B99
TTDR01052	Homocitrate synthase	Fungal diseases	110-118	B35-B49
TTDR01053	Insulin receptor kinase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01053	Insulin receptor kinase	Hyperglycemia	790.29	R73.9
TTDR01053	Insulin receptor kinase	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
TTDR01053	Insulin receptor kinase	Insulin resistance	.	E00-E90
TTDR01053	Insulin receptor kinase	Ketoacidosis	.	.
TTDR01053	Insulin receptor kinase	Lipodystrophy	272.6	E88.1
TTDR01054	Integrin receptor	Arteriosclerosis	440	I70
TTDR01054	Integrin receptor	Cardiac infarction	410	I21, I22
TTDR01054	Integrin receptor	Circulatory disorders	.	I00-I99
TTDR01054	Integrin receptor	Coronary heart disease	414	I25.1
TTDR01054	Integrin receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01054	Integrin receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01054	Integrin receptor	Skeletal disorders	.	.
TTDR01054	Integrin receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR01056	Orexin receptor type 2	Gastrointestinal motility disorders	.	.
TTDR01056	Orexin receptor type 2	Nausea and vomiting	787, 787.0	R11
TTDR01057	Laminin beta-3 chain	Cancer	140-229	C00-C96
TTDR01059	Macrophage scavenger receptor types I and II	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01061	Metabotropic glutamate receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01061	Metabotropic glutamate receptor	Cognitive deficits	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, R41.3
TTDR01061	Metabotropic glutamate receptor	Neurodegenerative diseases	330-337	G30-G32
TTDR01061	Metabotropic glutamate receptor	Neurological diseases	320-359	G00-G99
TTDR01061	Metabotropic glutamate receptor	Psychosis	290-299	F20-F29
TTDR01061	Metabotropic glutamate receptor	Schizophrenia	295, 710.0	F20, M32
TTDR01062	Membrane-associated kinase	Cancer	140-229	C00-C96
TTDR01062	Membrane-associated kinase	Hyperproliferative disorders	.	.
TTDR01063	Methionyl-tRNA synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01064	Multidrug transporter	Bacterial and fungal resistance	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104, 110-118	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79, B35-B49
TTDR01064	Multidrug transporter	Cancer	140-229	C00-C96
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Cancer	140-229	C00-C96
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Compulsive disorders	300.3	F42
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Glaucoma	365	H40-H42
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Ischemia	459.89	I99.8
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Prostate diseases	.	.
TTDR01065	N-acetylated-alpha-linked acidic dipeptidase II	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDR01066	Myelin-associated glycoprotein	Injury to nervous tissue or neurons	.	.
TTDR01066	Myelin-associated glycoprotein	Neurodegenerative diseases	330-337	G30-G32
TTDR01067	Sphingomyelin phosphodiesterase 2	Cancer	140-229	C00-C96
TTDR01067	Sphingomyelin phosphodiesterase 2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01067	Sphingomyelin phosphodiesterase 2	Neurodegenerative diseases	330-337	G30-G32
TTDR01068	mRNA of PAI-1	Angiitis	466.2	M31.0
TTDR01068	mRNA of PAI-1	Cirrhosis	571.5, 571.6	K74.5, K74.6
TTDR01068	mRNA of PAI-1	Glomerulonephritis	580-582	N00, N01, N03, N18
TTDR01068	mRNA of PAI-1	Glomerulosclerosis	.	.
TTDR01068	mRNA of PAI-1	Heart failure	410, 428	I21, I22, I50
TTDR01068	mRNA of PAI-1	Interstitial fibrosis	709.2	L90.5
TTDR01068	mRNA of PAI-1	Pulmonary fibrosis	515, 516.3	J84.1
TTDR01069	Prostaglandin receptor	Bone disorders	710-739	M00-M99
TTDR01069	Prostaglandin receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01070	Geranylgeranyl transferase type I beta subunit	Myeloma disease	203	C90.0
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Atherosclerosis	414.0, 440	I70
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Coronary heart disease	414	I25.1
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Hypercholesterolemia	272	E78.0
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Hyperlipidemia	272.0-272.4	E78
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Hyperlipoproteinemia	272.0-272.4	E78
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR01072	Sterol regulatory element binding protein cleavage-activating protein	Obesity	278	E66
TTDR01073	Retinoic acid receptor RXR-alpha	Prostate cancer	140-229, 185	C00-C96, C61
TTDR01074	Retinoic acid receptor RXR-beta	Breast fibrocystic disease; Breast cancer	140-229	C00-C96
TTDR01075	Retinoic acid receptor RXR-gamma	Cancer	140-229	C00-C96
TTDR01076	Protein farnesyltransferase beta subunit	Cancer	140-229	C00-C96
TTDR01077	Retinoic acid receptor gamma-1	Breast fibrocystic disease; Breast cancer	140-229	C00-C96
TTDR01078	Retinoic acid receptor gamma-2	Breast fibrocystic disease; Breast cancer	140-229	C00-C96
TTDR01079	Pyruvate kinase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01079	Pyruvate kinase	Cancer	140-229	C00-C96
TTDR01079	Pyruvate kinase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01080	Serine/threonine protein kinase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01080	Serine/threonine protein kinase	Atherosclerosis	414.0, 440	I70
TTDR01080	Serine/threonine protein kinase	Cancer	140-229	C00-C96
TTDR01080	Serine/threonine protein kinase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01081	Protein kinase	Cancer	140-229	C00-C96
TTDR01081	Protein kinase	Colonic polyps	211.3	K63.5
TTDR01081	Protein kinase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01081	Protein kinase	Polycystic kidney disease	753.1	Q61
TTDR01082	Phenyl-protein transferase	Cancer	140-229	C00-C96
TTDR01083	Pyridoxin biosynthesis protein pyroA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01084	Pyridoxin biosynthesis protein SNZ1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01085	2,3-bisphosphoglycerate-independent phosphoglycerate mutase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01086	Phosphoenolpyruvate synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01087	Lysyl-tRNA synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01088	ATP/ADP translocase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01089	Orotidine 5'-phosphate decarboxylase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01090	Probable dihydroneopterin aldolase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01093	mRNA of beta-arrestin	Analgesics	338	R52
TTDR01093	mRNA of beta-arrestin	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDR01094	mRNA of c-fos	Clutamate neurotoxicity	.	.
TTDR01095	mRNA of CIRL-1	Oxidative cell injury	.	.
TTDR01096	mRNA of CIRL-3	Oxidative cell injury	.	.
TTDR01097	mRNA of Connexin 32	Oxidative cell injury	.	.
TTDR01098	mRNA of APP	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01100	DNA (cytosine-5)-methyltransferase 3B	Breast cancer	174, 175, 217	C50, D24
TTDR01101	Interleukin-2 receptor alpha chain	Acute allograft rejection	996.8	T86
TTDR01102	UDP-N-acetylenolpyruvylglucosamine reductase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01104	Interleukin-12 receptor beta-2 chain	Th cell responses melanoma	.	.
TTDR01105	Fibroblast growth factor-8	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01105	Fibroblast growth factor-8	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDR01105	Fibroblast growth factor-8	Neuropathy	356.0, 356.8	G64, G90.0
TTDR01105	Fibroblast growth factor-8	Parkinson's disease	332	F02.3, G20
TTDR01105	Fibroblast growth factor-8	Shionogi carcinoma	.	.
TTDR01105	Fibroblast growth factor-8	Tumors (androgen sensitive)	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01106	Breast cancer type 2 susceptibility protein	Breast cancer	174, 175, 217	C50, D24
TTDR01106	Breast cancer type 2 susceptibility protein	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR01107	Fanconi anemia group F protein	Head and neck squamous cell carcinomas	199	C44
TTDR01107	Fanconi anemia group F protein	Lung cancer	162	C33-C34
TTDR01107	Fanconi anemia group F protein	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR01107	Fanconi anemia group F protein	Oral cancer	140-146	C00-C08
TTDR01107	Fanconi anemia group F protein	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR01108	Myeloid differentiation primary response protein MyD88	Inflammatory joint diseases	.	.
TTDR01108	Myeloid differentiation primary response protein MyD88	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR01108	Myeloid differentiation primary response protein MyD88	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDR01109	Lipopolysaccharide-binding protein	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01110	Dual specificity protein kinase TTK	Cancer	140-229	C00-C96
TTDR01111	Abeta-binding alcohol dehydrogenase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01112	P-selectin glycoprotein ligand 1	Cutaneous vasculitis induced by immune complex deposition	446, 447.6	I77.6, I80, L95, M30-M31
TTDR01112	P-selectin glycoprotein ligand 1	IC-mediated diseases	.	.
TTDR01112	P-selectin glycoprotein ligand 1	Pulmonary fibrosis	515, 516.3	J84.1
TTDR01113	Diablo homolog, mitochondrial	Cancer	140-229	C00-C96
TTDR01114	Stanniocalcin 1	Breast cancer	174, 175, 217	C50, D24
TTDR01115	Cyclin E/cdk2	B-cell lymphoma	202.8	C85.1
TTDR01116	Ubiquitin carboxyl-terminal hydrolase 2	Prostate cancer	140-229, 185	C00-C96, C61
TTDR01117	Geminin	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01118	Transcription factor 7-like 2	Hepatocellular carcinoma	155	C22.0
TTDR01119	GPI transamidase component PIG-U	Bladder cancer	140-229, 188	C00-C96, C67
TTDR01120	Kallikrein 6	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01120	Kallikrein 6	Multiple sclerosis	340	G35
TTDR01121	Zinc finger protein 202	Atherosclerosis	414.0, 440	I70
TTDR01121	Zinc finger protein 202	Lipid metabolic disorders	270-279	E70-E89
TTDR01122	Mothers against decapentaplegic homolog 9	Breast cancer	174, 175, 217	C50, D24
TTDR01122	Mothers against decapentaplegic homolog 9	Colon cancer	153, 154	C18-C21
TTDR01123	Activation-inducible lymphocyte IMMUNOMEDIATORY molecule AILIM	Inflammatory bowel disease	555, 556	K50, K51
TTDR01124	Claudin-4	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR01125	Granulins	Prostate cancer	140-229, 185	C00-C96, C61
TTDR01126	C-Rel proto-oncogene protein	B-cell lymphoma	202.8	C85.1
TTDR01127	KSHV G protein-couple receptor	KSHV-mediated disease	.	.
TTDR01127	KSHV G protein-couple receptor	Kaposi's sarcoma	176	C46
TTDR01127	KSHV G protein-couple receptor	Primary effusion lymphoma	202.8	C81-C96
TTDR01128	Carcinoembryonic antigen-related cell adhesion molecule 6	Pancreatic adenocarcinoma	140-199	C00-C75, C7A, C7B
TTDR01128	Carcinoembryonic antigen-related cell adhesion molecule 6	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR01129	Protein tyrosine phosphatase short form	Cancer metastasis	140-229	C00-C96
TTDR01129	Protein tyrosine phosphatase short form	Colorectal cancer	153, 154	C18-C21
TTDR01130	Forkhead box protein M1	Hepatocellular carcinoma	155	C22.0
TTDR01131	Fibroleukin	Acute allograft rejection	996.8	T86
TTDR01132	Glucose 6-phosphate translocase	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDR01133	Ephrin type-B receptor 2	Colorectal cancer	153, 154	C18-C21
TTDR01134	Interferon regulatory factor 3	Septic shock	785.52	A41.9
TTDR01135	NGEP	Prostate cancer	140-229, 185	C00-C96, C61
TTDR01136	26S proteasome non-ATPase regulatory subunit 10	Hepatocellular carcinoma	155	C22.0
TTDR01137	17-beta-hydroxysteroid dehydrogenase 5	Prostate cancer	140-229, 185	C00-C96, C61
TTDR01138	Recoverin	Lung cancer	162	C33-C34
TTDR01139	Phosphoethanolamine N-methyltransferase	Malaria	84	B50-B54
TTDR01140	HIV-1 RNA	Human immunodeficiency virus infection	279.3	D84.9
TTDR01141	Ubiquitin carboxyl-terminal hydrolase isozyme L1	Parkinson's disease	332	F02.3, G20
TTDR01142	DNA-dependent protein kinase catalytic subunit	Leukemia	208.9	C91-C95
TTDR01143	Undecaprenyl pyrophosphate synthetase	Microbial infections	001-139	A00-B99
TTDR01144	Interleukin 11 receptor	Prostate cancer	140-229, 185	C00-C96, C61
TTDR01145	TRNA-dependent amidotransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01147	Adenine biosynthesis	Brain cancer	191, 225.0	C71, D33
TTDR01147	Transferrin receptor protein 1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01148	Lactotransferrin	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01148	Virus DNA	Herpes simplex virus infection	54	B00
TTDI01149	Beta-hydroxybutyrate	Memory loss	.	F03
TTDR01149	Receptor-type protein-tyrosine phosphatase zeta	Glioblastoma multiforme	191	C71
TTDI01150	Prolonging and increasing the activation of HSF1	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDR01150	Regenerating gene type IV 	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDR01151	Heat shock protein 20	Heart failure	410, 428	I21, I22, I50
TTDI01151	Inhibiting HIV-1 attachment	HIV-1 infections	001-139, 042	A00-B99, B20
TTDR01152	Epstein-Barr virus (Strain FF41) nuclear antigen gene	EBV-related cancers	140-229	C00-C96
TTDI01152	Nuclear transcription mechanisms that govern and regulate inflammation	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01153	Complement C3	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01153	HIV replication early phase	Acquired immune deficiency syndrome	42	B20
TTDI01154	Hydroxyapatite	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01154	Seprase	Atherogenesis	440	I70
TTDR01154	Seprase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01154	Seprase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01155	Inhibiting both TNF-alpha and IL-1 beta production	Arthritic	710-719	M00-M25
TTDR01155	Teratocarcinoma-derived growth factor 1	Cancer	140-229	C00-C96
TTDR01156	Histone deacetylase 2	Colon cancer	153, 154	C18-C21
TTDI01156	Inhibiting IL-1 synthesis and/or release	Asthma	493	J45
TTDI01157	Inhibiting the induction of nitric oxide synthase	Postoperative pain	.	G89
TTDR01157	Probable nicotinate-nucleotide adenylyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01158	Homeobox protein Hox-A7	Myeloid leukemia	208.9	C91-C95
TTDI01158	Micelle	Otitis media	.	H65-H67
TTDI01158	Micelle	Ulcer	531-534	K25-K27
TTDR01159	Low-density lipoprotein receptor-related protein 1	Proliferative vitreoretinopathy	.	.
TTDI01159	Mitochondrial gene transcription	Cancer	140-229	C00-C96
TTDI01160	Calcium flux	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01160	Transient receptor potential cation channel subfamily V member 4	Analgesics	338	R52
TTDR01160	Transient receptor potential cation channel subfamily V member 4	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01161	Reactive oxygen species	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDI01161	Reactive oxygen species	Asthma	493	J45
TTDR01161	Toxopain-1	Parasitic diseases	.	.
TTDI01162	Histamine and peptide leukotrienes release	Asthma	493	J45
TTDR01162	mRNA of platelet-derived growth factor receptor beta subunit	Liver fibrosis	571	K70.3, K71.7, K74
TTDR01163	GABA transporter-3	Neurological diseases	320-359	G00-G99
TTDI01163	Lipid peroxidation	Ischemia	459.89	I99.8
TTDI01163	Lipid peroxidation	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01164	IFN-gamma production	Inflammatory bowel disease	555, 556	K50, K51
TTDR01164	Proprotein convertase subtilisin/kexin type 9	Dyslipidemia	272	E78
TTDR01165	Platelet-activating factor receptor	Ocular allergy	360-379	H00-H59
TTDR01166	Chitin synthase 1	Fungal diseases	110-118	B35-B49
TTDI01166	Inducing a significant increase in cyclic AMP level	Cognition disorders	295	F20
TTDI01167	P-glycoprotein mediated multidrug resistance	Cancer	140-229	C00-C96
TTDI01168	Release of ACh	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01169	DNA topoisomerase 4 subunit A	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01169	Histamine release	Asthma	493	J45
TTDI01170	IgE-mediated histamine release	Asthma	493	J45
TTDR01170	Integrin beta-2	Ischemic stroke	434.91	I61-I63
TTDR01171	Hypoxia-inducible gene DDIT4	Diabetic macular oedema	362.07	E08.3, E09.3, E10.3, E11.3, E13.3
TTDI01171	Leukotriene biosynthesis	Asthma	493	J45
TTDI01172	Potential penetration	Ophthalmic disease	.	H00-H59
TTDR01172	mRNA of thymidylate synthase	Cancer	140-229	C00-C96
TTDI01173	Uptake of luminal sterol across the microvillus membrane	Hyperlipidemia	272.0-272.4	E78
TTDR01173	mRNA of MCL-1	Systemic mastocytosis	202.6, 757.33	C96.2, Q82.2
TTDI01174	HBV protein priming reaction and the packaging reaction	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR01174	mRNA of Tumour protein p53	Acute kidney injury	584	N17
TTDI01175	Potentiating dexamethasone-induced GR transcriptional activity	Cancer	140-229	C00-C96
TTDR01175	mRNA of HIV-1 Gag	AIDS	42	B20
TTDI01176	Ca2+ dependent or involving processes	Cognition disorders	295	F20
TTDR01176	Respiratory syncytial virus genomic RNA	Upper and lower respiratory tract disease	460-519	J00-J99
TTDI01177	Coccidia schizogony and gametogony processes	Isosporiasis	.	A07.3
TTDR01177	Gamma-aminobutyric-acid receptor alpha-2 subunit	Anxiety disorders	300	F40-F42
TTDR01177	Gamma-aminobutyric-acid receptor alpha-2 subunit	Disorders of initiating and maintaining sleep	710	M32
TTDI01178	Cyclin D1 synthesis	Hematopoietic	.	D50-D89
TTDR01178	Gamma-aminobutyric-acid receptor alpha-3 subunit	Anxiety disorders	300	F40-F42
TTDR01178	Gamma-aminobutyric-acid receptor alpha-3 subunit	Disorders of initiating and maintaining sleep	710	M32
TTDI01179	DNA synthesis	Cancer	140-229	C00-C96
TTDI01179	DNA synthesis	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01179	Sodium- and chloride-dependent GABA transporter 1	Convulsions	780.3	R56.0
TTDR01179	Sodium- and chloride-dependent GABA transporter 1	Psychosis	290-299	F20-F29
TTDR01180	Alpha-2C adrenergic receptor	Neuropsychiatric disorders	.	.
TTDR01180	Alpha-2C adrenergic receptor	Raynaud's syndrome	443	I73.0
TTDI01180	Downregulating angiotensin II-induced endothelin-1 gene expression	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01181	Histone synthesis	Cancer	140-229	C00-C96
TTDR01181	Plasma membrane H(+)-ATPase	Fungal diseases	110-118	B35-B49
TTDR01182	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Acne vulgaris	706.1	L70.0
TTDR01182	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Alopecia	704.09	L65.9
TTDR01182	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Benign prostatic hyperplasia	600	N40
TTDR01182	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Hirsutism	704.1	L68.0
TTDR01182	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Prostate cancer	140-229, 185	C00-C96, C61
TTDI01182	Inhibit the formation of beta-hematin by forming a complex with hemin	Plasmodium infection	.	B54
TTDR01183	3-oxo-5-alpha-steroid 4-dehydrogenase 2	Alopecia	704.09	L65.9
TTDR01183	3-oxo-5-alpha-steroid 4-dehydrogenase 2	Androgen-dependent diseases	.	.
TTDR01183	3-oxo-5-alpha-steroid 4-dehydrogenase 2	Benign prostatic hyperplasia	600	N40
TTDR01183	3-oxo-5-alpha-steroid 4-dehydrogenase 2	Prostate cancer	140-229, 185	C00-C96, C61
TTDI01183	Progesterone	Contraception	.	Z30
TTDR01184	Acetaldehyde dehydrogenase	Alcoholism	303	F10.2
TTDI01184	Prostaglandin metabolism	Cancer	140-229	C00-C96
TTDR01185	Aldehyde dehydrogenase, mitochondrial	Alcoholism	303	F10.2
TTDI01185	Superoxide anion	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDR01186	Betaine aldehyde dehydrogenase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01186	Second phase insulin secretion	Restenosis	.	I51.89
TTDR01187	Dihydropyrimidine dehydrogenase [NADP+]	Lung cancer	162	C33-C34
TTDI01187	Plasmodial phospholipid metabolism	Plasmodium falciparum infection	.	B54
TTDI01188	Bacterial protein synthesis	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01188	Bacterial protein synthesis	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
TTDI01188	Bacterial protein synthesis	Tuberculosis	010-018	A15-A19
TTDR01188	Corticosteroid receptor	Affective disorders	296	F30-F39
TTDI01189	Cell mediated immunity response	Bordetella pertussis infection	.	A37.0
TTDI01189	Cell mediated immunity response	HIV infection	001-139, 042	A00-B99, B20
TTDI01189	Cell mediated immunity response	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01189	Cell mediated immunity response	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01189	Cell mediated immunity response	Hepatitis E virus infection	.	B17.2
TTDI01189	Cell mediated immunity response	Infectious disease	001-139	A00-B99
TTDI01189	Cell mediated immunity response	Influenza virus infections	487, 488	J10, J11
TTDI01189	Cell mediated immunity response	Leishmania infection	.	B55.0
TTDI01189	Cell mediated immunity response	Plasmodium malariae infection	.	B50
TTDI01189	Cell mediated immunity response	Vaccination	.	.
TTDR01189	Corticosteroid receptor type I	Endocrine disorder	.	.
TTDR01190	Corticosteroid receptor type II	Endocrine disorder	.	.
TTDI01190	JAK-2/STAT-1 pathway	Cancer	140-229	C00-C96
TTDR01191	Retinoic acid receptor beta	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR01192	DNA topoisomerase II, beta isozyme	Cancer	140-229	C00-C96
TTDI01192	Phospholipids in bacterial cell membrane	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01193	Histamine H4 receptor	Allergic diseases	995.3	T78.4
TTDR01193	Histamine H4 receptor	Allergy	995.3	T78.4
TTDR01193	Histamine H4 receptor	Asthma	493	J45
TTDI01193	Tumour metastasis	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01194	5-hydroxytryptamine 1F receptor	Migraine	346	G43
TTDI01195	Cell cycle	Cancer	140-229	C00-C96
TTDR01195	Serotonin transporter	Depression	311	F32
TTDR01196	P2Y purinoceptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01196	P2Y purinoceptor	Liver fibrosis	571	K70.3, K71.7, K74
TTDR01196	P2Y purinoceptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01197	Signal transduction	Cancer	140-229	C00-C96
TTDI01197	Signal transduction	Leishmania infection	.	B55.0
TTDR01197	Thyrotropin-releasing hormone receptor	Alcohol dependence	303	F10.2
TTDR01197	Thyrotropin-releasing hormone receptor	Anxiety disorders	300	F40-F42
TTDI01198	Intracellular signaling, damage sensing, and DNA repair pathways responsible for DNA damage	Radiation sickness	990	T66
TTDR01198	Potassium channel subfamily K member 9	Cancer	140-229	C00-C96
TTDR01199	K-Cl cotransporter 3	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01199	Tumorigenesis	Prostate tumor	185	C61
TTDR01200	Cystine/glutamate transporter	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI01201	Inhibiting sodium/calcium ion exchange	Cerebral infarction	.	I63
TTDR01201	Pyridoxal kinase	Asthma	493	J45
TTDR01201	Pyridoxal kinase	Korsakov's alcoholic psychosis	290-299	F20-F29
TTDR01201	Pyridoxal kinase	Vitamin B6 deficiency	266.1	E53.1
TTDI01202	Fungal mitochondrial membrane	Mycoses	.	B49
TTDR01202	Inositol-1(or 4)-monophosphatase	Bipolar affective disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8	F31
TTDI01203	Ergosterol synthesis	Fungal infection	110-118	B35-B49
TTDR01203	Soluble epoxide hydrolase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01203	Soluble epoxide hydrolase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01203	Soluble epoxide hydrolase	Renal diseases	580-599	N00-N39
TTDR01204	Carboxypeptidase A	Arthritis	710-719	M00-M25
TTDR01204	Carboxypeptidase A	Cancer	140-229	C00-C96
TTDR01204	Carboxypeptidase A	Heart disease	390-429	I00-I52
TTDI01204	Improve mitochondrial function	Motor neurone disease	335.2	G12.2
TTDR01205	Leukotriene E4 receptor	Asthma	493	J45
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Asthma	493	J45
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Autoimmune diseases	279	D84.9, M35.9
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Fibrosing alveolitis	516.3	J84.1
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Inflammatory lung disease	.	.
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR01206	Inhibitor of nuclear factor kappa B kinase beta subunit	Transplant failure or rejection	.	.
TTDR01207	Endothelin receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01207	Endothelin receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01208	RNase P RNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01209	Hydroxy radical	Renal disease	.	N00-N29
TTDR01209	Probable arabinosyltransferase A	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01210	Probable arabinosyltransferase B	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01211	Arylamine N-acetyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01211	Arylamine N-acetyltransferase	Tuberculosis	010-018	A15-A19
TTDR01212	Malonyl-CoA:acyl carrier protein transacylase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01212	Malonyl-CoA:acyl carrier protein transacylase	Tuberculosis	010-018	A15-A19
TTDR01213	DNA helicase	Breast cancer	174, 175, 217	C50, D24
TTDR01214	Ephrin type-A receptor 2	Breast cancer	174, 175, 217	C50, D24
TTDR01214	Ephrin type-A receptor 2	Cancer	140-229	C00-C96
TTDR01214	Ephrin type-A receptor 2	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDR01214	Ephrin type-A receptor 2	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR01215	Microtubular protein	Cancer	140-229	C00-C96
TTDR01216	Platelet-derived growth factor	Cancer	140-229	C00-C96
TTDR01217	Beta platelet-derived growth factor receptor	Chronic myeloproliferative diseases	205.1, 238.4, 289.89, 289.9	D47.1
TTDR01217	Beta platelet-derived growth factor receptor	Ewing's sarcoma	170	C41
TTDI01217	Chaperonin	Cerebrovascular ischaemia	434.91	I61-I63
TTDR01218	BCR/ABL protein	Cancer	140-229	C00-C96
TTDR01218	BCR/ABL protein	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDR01218	BCR/ABL protein	Chronic myeloid leukemia	205.1	C92.1
TTDI01218	Microbial membrane	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
TTDI01219	Cytochrome P-450-dependent ergosterol synthesis	Fungal infections	110-118	B35-B49
TTDR01219	FIP1L1-PDGFRalpha kinase	Chronic eosinophilic leukemia	208.9	C91-C95
TTDR01219	FIP1L1-PDGFRalpha kinase	Hypereosinophilic syndrome	288.3	D72.1
TTDR01220	D1 dopamine receptor-interacting protein calcyon	Cocaine dependence	304.2, 311	F14.2, F32
TTDR01220	D1 dopamine receptor-interacting protein calcyon	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR01220	D1 dopamine receptor-interacting protein calcyon	Neuroleptic malignant syndrome	.	.
TTDR01220	D1 dopamine receptor-interacting protein calcyon	Respiratory diseases	.	.
TTDR01220	D1 dopamine receptor-interacting protein calcyon	Treatment-refractory psychoses	290-299	F20-F29
TTDI01220	Free radicals	Ischemia	459.89	I99.8
TTDR01221	Growth-arrest-specific protein 6	Endocrine disorder	.	.
TTDI01221	JAK-STAT pathway	Cancer	140-229	C00-C96
TTDI01222	Cytomegalovirus (CMV) replication	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR01222	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	Excessive collagen deposition	.	.
TTDR01222	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	Proliferative vitreoretinopathy	.	.
TTDI01223	Mast cell degranulation	Asthma	493	J45
TTDR01223	Preadipocyte factor	Eye inflammation	360-379	H00-H59
TTDR01224	Carbonic anhydrase I	Glaucoma	365	H40-H42
TTDR01224	Carbonic anhydrase I	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01224	Carbonic anhydrase I	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR01225	HIV aspartyl protease	Human immunodeficiency virus infection	279.3	D84.9
TTDR01225	HIV aspartyl protease	Retrovirus infections	001-139	A00-B99
TTDR01226	DNA-dependent DNA polymerase	Human immunodeficiency virus infection	279.3	D84.9
TTDR01227	Thyroid hormone receptor beta-1	Hyperlipidemia	272.0-272.4	E78
TTDR01227	Thyroid hormone receptor beta-1	Obesity	278	E66
TTDR01227	Thyroid hormone receptor beta-1	Thyroid hormone resistance syndrome	.	.
TTDR01227	Thyroid hormone receptor beta-1	Thyrotoxicosis hyperthyroidism	242.9	E05
TTDI01228	Bone metabolism	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01228	Sulfonylurea receptor 2B 	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01229	5'-Nucleotidase	Immune disease	.	.
TTDR01230	Cytochrome B	Malaria	84	B50-B54
TTDI01230	Ganglioside GD2	Melanoma	172.9	C43
TTDI01231	Galactose oligosaccharides and glycolipids	Fabry disease	272.7	E75.2
TTDR01231	Haem polymerase	Malaria	84	B50-B54
TTDR01232	Glutathione reductase, mitochondrial	Malaria	84	B50-B54
TTDR01232	Glutathione reductase, mitochondrial	Parasitic diseases	.	.
TTDI01232	Replacing the 17 beta-estradiol and progesterone hormones the body has stopped producing as the result of menopause	Endometriosis	617	N80
TTDR01233	Tissue-type plasminogen activator	Neurological diseases	320-359	G00-G99
TTDR01234	Granulocyte colony-stimulating factor	Neutropenia	288	D70
TTDI01234	Viral maturaton	HIV infections	001-139, 042	A00-B99, B20
TTDR01235	Catecholamine uptake	Obesity	278	E66
TTDI01235	Gene thrapy-delivered myostatin	Macular degeneration	362.5	H35.3
TTDI01236	AE-H	HIV infections	001-139, 042	A00-B99, B20
TTDR01236	Sulfonylurea receptor 1	Obesity	278	E66
TTDI01237	Hormone	Inflammatory bowel disease	555, 556	K50, K51
TTDI01237	Hormone	Multiple sclerosis	340	G35
TTDI01237	Hormone	Testosterone deficiency	.	E29.1
TTDR01237	Major prion protein	Prion diseases	.	.
TTDI01238	Cell differentiation	Hematological malignancies	200-209	C81-C96
TTDR01238	Tumor necrosis factor receptor superfamily member 1B	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR01239	Cholinergic receptor	Muscle contraction	.	.
TTDR01239	Cholinergic receptor	Schizophrenia	295, 710.0	F20, M32
TTDI01239	Galectin	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
TTDI01239	Galectin	Fibrosis	709.2	L90.5
TTDR01240	Glycinamide ribonucleotide formyltransferase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01240	Viral matration	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01241	HV MAG pDNA	HIV infections	001-139, 042	A00-B99, B20
TTDR01241	Tyrosine kinase	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01242	Fibrin	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDR01242	Fibrin	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01242	mRNA of HBV	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDR01243	Cytochrome p450 121	Tuberculosis	010-018	A15-A19
TTDI01243	Pseudomonas aeruginosa Psl exopolysaccharide	Pseudomonas infection	041.7, 482.1	B96.5, J15.1, P23.5
TTDR01244	24:1 cis-5 elongase 	Tuberculosis	010-018	A15-A19
TTDI01244	microbiome	Type 2 diabetes	250.00, 250.02	E11
TTDR01245	3-oxoacyl-[acyl-carrier-protein] synthase 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01245	3-oxoacyl-[acyl-carrier-protein] synthase 1	Tuberculosis	010-018	A15-A19
TTDI01245	meningococcal groups ACWY conjugate	Meningococcal infections	36.9	A39
TTDI01246	Haemophilus influenzae type B CRM 197 conjugate	Influenza virus infections	487, 488	J10, J11
TTDI01246	Haemophilus influenzae type B CRM 197 conjugate	Pneumococcal infections	001-139	A00-B99
TTDR01246	Lactoylglutathione lyase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01247	HIV-MAG DNA	HIV infections	001-139, 042	A00-B99, B20
TTDR01247	Nociceptin receptor	Analgesics	338	R52
TTDR01247	Nociceptin receptor	Anorexia nervosa	307.1	F50.0-F50.1
TTDR01247	Nociceptin receptor	Anxiety disorders	300	F40-F42
TTDR01247	Nociceptin receptor	Cerebral ischemia	459.89	I99.8
TTDR01247	Nociceptin receptor	Depression	311	F32
TTDR01247	Nociceptin receptor	Drug dependence	303-305	F10-F19
TTDR01247	Nociceptin receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDR01247	Nociceptin receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDR01247	Nociceptin receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDR01247	Nociceptin receptor	Neurogenic bladder	188	C67
TTDR01247	Nociceptin receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDR01247	Nociceptin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01248	Glutamatergc system	Schizophrenia	295, 710.0	F20, M32
TTDR01248	N-acylglucosamine 2-epimerase	Osteoarthritis	715	M15-M19, M47
TTDR01249	Pyridoxal phosphate phosphatase	Korsakov's alcoholic psychosis	290-299	F20-F29
TTDR01249	Pyridoxal phosphate phosphatase	Vitamin B6 deficiency	266.1	E53.1
TTDI01249	Recombinant tetravalent attenuated live dengue	Dengue	61	A90
TTDI01250	Inhibiting expression of interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor (TNF)	Ulcerative colitis	556	K51
TTDR01250	Serine/threonine-protein kinase Sgk1	Myelodisplastic syndrome	238.7	D46
TTDR01250	Serine/threonine-protein kinase Sgk1	Myeloid leukemia	208.9	C91-C95
TTDR01250	Serine/threonine-protein kinase Sgk1	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01251	Antigen-specific immunotherapeutic	Leukemia	208.9	C91-C95
TTDR01251	Vascular endothelial growth factor D	Cancer	140-229	C00-C96
TTDR01251	Vascular endothelial growth factor D	Macular degeneration	362.5	H35.3
TTDR01251	Vascular endothelial growth factor D	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01252	Stromelysin-3	Cancer	140-229	C00-C96
TTDR01252	Stromelysin-3	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR01252	Stromelysin-3	Oral cancer	140-146	C00-C08
TTDR01252	Stromelysin-3	Osteoarthritis	715	M15-M19, M47
TTDI01253	Basal lamina	Cancer	140-229	C00-C96
TTDR01253	Voltage-dependent calcium channel subunit alpha-2/delta-3	Analgesics	338	R52
TTDR01253	Voltage-dependent calcium channel subunit alpha-2/delta-3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01254	Activating key enzymes to regulate glucose metabolism	Metabolic disorders	270-279	E70-E89
TTDR01254	Voltage-gated sodium channel subunit alpha Nav1.9	Analgesics	338	R52
TTDR01254	Voltage-gated sodium channel subunit alpha Nav1.9	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01255	Inhibiting IL-1/TNF alpha synthesis	Rheumatold arthritis	714	M05-M06
TTDR01255	Voltage-gated sodium channel subunit alpha Nav1.3	Analgesics	338	R52
TTDR01255	Voltage-gated sodium channel subunit alpha Nav1.3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01256	Acid-sensing ion channel ASIC1a/ASIC1b	Analgesics	338	R52
TTDR01256	Acid-sensing ion channel ASIC1a/ASIC1b	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01256	Cholinergic activityy	Cognition disorders	295	F20
TTDR01257	Acid-sensing ion channel ASIC3	Analgesics	338	R52
TTDR01257	Acid-sensing ion channel ASIC3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01257	Gastric emptying	Obesity	278	E66
TTDI01258	Hydroxyl radicals and superoxide anions	Immuno-stimulant	.	C00-C97
TTDR01258	Transient receptor potential cation channel subfamily V member 3	Analgesics	338	R52
TTDR01258	Transient receptor potential cation channel subfamily V member 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01259	Glutamate [NMDA] receptor subunit zeta-1	Analgesics	338	R52
TTDR01259	Glutamate [NMDA] receptor subunit zeta-1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01259	Mediator release	Asthma	493	J45
TTDR01260	Neuronal acetylcholine receptor subunit alpha-5	Analgesics	338	R52
TTDR01260	Neuronal acetylcholine receptor subunit alpha-5	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01260	Neutrophil adhesion	Asthma	493	J45
TTDI01261	Hantavirus	Hantavirus infection	.	B33.4
TTDR01261	P2X purinoceptor 4	Analgesics	338	R52
TTDR01261	P2X purinoceptor 4	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01262	Cyclooxygenase-3	Analgesics	338	R52
TTDR01262	Cyclooxygenase-3	Chronic inflammatory diseases	.	.
TTDR01262	Cyclooxygenase-3	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01262	Cyclooxygenase-3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01262	Rotavirus toxin	Diarrhea	787.91	A09, K59.1
TTDI01263	Gram-positive bacteria	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01263	Protein-tyrosine phosphatase, non-receptor type 11	Cancer	140-229	C00-C96
TTDR01263	Protein-tyrosine phosphatase, non-receptor type 11	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDR01263	Protein-tyrosine phosphatase, non-receptor type 11	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01264	Interleukin-13 receptor alpha-1 chain	Glioblastoma multiforme	191	C71
TTDI01264	Secretion of growth hormone	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01265	Malaria DNA	Malaria	84	B50-B54
TTDR01265	Receptor protein-tyrosine kinase erbB-3	Advanced non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDR01265	Receptor protein-tyrosine kinase erbB-3	Lung adenocarcinomas	140-199	C00-C75, C7A, C7B
TTDI01266	Glycolysis	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01266	Neutrophil collagenase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01266	Neutrophil collagenase	Osteoarthritis	715	M15-M19, M47
TTDR01266	Neutrophil collagenase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01266	Neutrophil collagenase	Rheumatoid arthritis	710-719, 714	M05-M06
TTDR01266	Neutrophil collagenase	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01267	Beta-lactoglobulin-1	Rheumatoid arthritis	710-719, 714	M05-M06
TTDI01268	Inhibiting pro-inflammatory cytokines (IL-1b, MCP-1, IL-6 and IL-10)	Autoimmune diseases	279	D84.9, M35.9
TTDR01268	mRNA of Huntingtin protein	Hepatitis C infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDI01269	Cationic airway liquid	Respiratory disease	.	J00-J99
TTDR01269	Corticosteroid 11-beta-dehydrogenase, isozyme 2	Tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01270	ATP-sensitive inward rectifier potassium channel 11	Non-insulin-dependent diabetes mellitus	250	E08-E13
TTDI01270	mRNA of lentivirus	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01271	HIV-1 ribonucleic acid	HIV-1 infections	001-139, 042	A00-B99, B20
TTDR01271	Serine protease	Asthma	493	J45
TTDR01271	Serine protease	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01271	Serine protease	Chronic tendon injury	.	.
TTDR01271	Serine protease	Hypotension	458, 796.3	I95
TTDR01271	Serine protease	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01272	HCV nucleoside	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDR01272	Hepatitis C Virus RNA-dependent RNA Polymerase	Cancer	140-229	C00-C96
TTDR01272	Hepatitis C Virus RNA-dependent RNA Polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR01273	Pregnane X receptor	Anxiety disorders	300	F40-F42
TTDR01273	Pregnane X receptor	Depression	311	F32
TTDR01273	Pregnane X receptor	Eye inflammation	360-379	H00-H59
TTDR01273	Pregnane X receptor	Multiple sclerosis	340	G35
TTDR01274	Acid-sensing ion channel	Pain; CNS diseases	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 338, 340, 344.1, 344.81, 348.0,780	A83-A86, B94.1, F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0, R52, G89
TTDR01275	Activin	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01276	AP endonuclease APE1	Melanoma; Glioma	172, 191	C43, C71
TTDI01276	Non-retinoid visual cycle	Age related macular degeneration	.	H35.30
TTDR01278	Aquaporin 3 	Squamous cell carcinoma 	199	C44
TTDI01278	Synthetic peptide-based	Multiple sclerosis	340	G35
TTDI01279	Mistletoe lectin	Cancer	140-229	C00-C96
TTDR01280	Beta2-microglobulin 	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR01281	CCCH tandem zinc finger protein ZFP36L1	Chronic myeloproliferative disorders	205.1, 238.4, 289.89, 289.9	D47.1
TTDI01281	TNF-alpha synthesis	Cancer	140-229	C00-C96
TTDR01282	CCN1 	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI01282	Inhibiting the expression of inducible nitric oxide synthase (iNOS)	Diarrhea	787.91	A09, K59.1
TTDR01283	CD147	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDR01284	CD248	Arthritis	710-719	M00-M25
TTDI01285	Activity of important signaling molecules (pAKT) involved in chemoresistance	Cancer	140-229	C00-C96
TTDR01285	Cell division cycle 7 kinase	Solid tumors; Hematologic malignancies	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDR01286	Chondroitin sulfate proteoglycan 4	Triple-negative breast cancer	174, 175	C50
TTDI01286	Inhibiting expression of pro-inflammatory cytokines (IL-1beta, IL-6, IL-12, TNF-alpha and IL-10)	Autoimmune diseases	279	D84.9, M35.9
TTDR01287	Dickkopf-1	Myeloma bone disease	203	C90.0
TTDI01287	Potassium	Hyperkalemia	.	E87.5
TTDR01288	Dynactin-Associated Protein	Cancer	140-229	C00-C96
TTDI01288	Reducing beta-glucuronidase level	Periodontal disease	.	K05
TTDI01289	Binding to a specific neuroepithelial receptor	Premenstrual syndrome	.	N94.3
TTDR01290	Elongation factor 1A 	Melanoma	172.9	C43
TTDI01290	Increasing unstimulated AM release of both TNF and IL-10	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01291	Entamoeba histolytica cysteine proteinase EhCP4	Amebiasis induced by E. histolytica	6	A06
TTDI01291	Voltage-gated ion channel	Asthma	493	J45
TTDR01292	Eukaryotic translation initiation factor 5A-1	Diabetic inflammation	250	E08-E13
TTDI01292	Expression of inflammation cytokines including TNF-alpha, IL-1beta and IL-6	Inflammatory bowel disease	555, 556	K50, K51
TTDR01293	Ferritin	Opioid-induced neuropathology	.	.
TTDR01294	Forkhead box O	Diabetes; cancer	140-229, 250	C00-C96, E08-E13
TTDR01295	G protein-coupled estrogen receptor 1	ER-positive breast Cancer	140-229, 174, 175	C00-C96, C50
TTDI01295	HIV transmission	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01296	G Protein-Coupled Receptor 87	Cancer	140-229	C00-C96
TTDR01297	GlgE	Tuberculosis	010-018	A15-A19
TTDR01298	Gli1	Brain gliomas	191	C71
TTDR01299	Heat shock protein 47	Inflammatory bowel disease	555, 556	K50, K51
TTDR01300	Helicobacter pylori  Heat-shock protein A	Ulcer induced by H. pylori infection	001-139	A00-B99
TTDR01301	Histone H2A 	Breast cancer 	174, 175	C50
TTDI01302	Gluten	Celiac disease	579	K90.0
TTDR01302	Interleukin-2-inducible T cell kinase	Inflammatory disorders	.	.
TTDI01303	Hexim1 kinase	HIV infections	001-139, 042	A00-B99, B20
TTDR01303	Liver receptor homologue-1	Cancer	140-229	C00-C96
TTDI01304	Genes involved in the insulin signaling pathway during the differentiation of monocyte-derived stem cells (MDSCs)	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01304	MicroRNA miR-191	Hepatocellular carcinoma	155	C22.0
TTDR01305	Mitochondrial Na+/Ca2+ exchanger	Neurodegenerative diseases	330-337	G30-G32
TTDI01305	Poxvirus enzyme	Virus infection	.	B03
TTDI01306	Enhancing the inclusion of exon 7 in the splicing of SMN2 pre-messenger RNA (premRNA) and restored normal SMN protein levels	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
TTDR01306	Mitochondrial/Cell-Surface Protein p32/gC1qR	Breast cancer	174, 175, 217	C50, D24
TTDR01307	Olfactomedin 4	Myeloid leukemia	208.9	C91-C95
TTDR01308	Orphan G protein-coupled receptor Gpr88	Psychiatric disorders	290-319	F01-F99
TTDI01308	Protein synthesis	Cancer	140-229	C00-C96
TTDI01309	Inhibiting vascular cell adhesion molecule expression	Atherosclerosis	414.0, 440	I70
TTDR01309	Periostin	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI01310	Leukocyte	Inflammatory disorders	.	.
TTDR01310	Phosphodiesterase 8	Inflammatory disorders	.	.
TTDI01311	Nitric oxide	Diabetes mellitus type 2	250	E11
TTDR01311	Pituitary adenylate cyclase-activating polypeptide type I receptor 	Migraine	346	G43
TTDR01312	Plasmodium Dihydroorotate Dehydrogenase	Malaria	84	B50-B54
TTDI01312	Two specific enzymes that are active in the skin	Psoriatic disorders	696	L40
TTDI01313	PK modulator	Hereditary angioedema	277.6	D84.1
TTDR01313	Plasmodium falciparum plasmepsin V	Malaria	84	B50-B54
TTDI01314	Cyclic pyranopterin monophosphate	Molybdenum cofactor deficiency	.	E00-E90
TTDR01314	Prolyl hydroxylase domain 2	Cancer	140-229	C00-C96
TTDI01315	HIV maturation	HIV-1 infections	001-139, 042	A00-B99, B20
TTDR01315	Prostaglandin E receptor EP4	Prostate cancer	140-229, 185	C00-C96, C61
TTDI01316	Brain membranes	Epileptic seizure	.	G40,R56
TTDR01316	Prostate apoptosis response-4	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI01317	Multidrug-resistance	Cancer	140-229	C00-C96
TTDR01317	Protein kinase D	Cancer	140-229	C00-C96
TTDI01318	Bile acid	Hyperlipidemia	272.0-272.4	E78
TTDR01318	Pseudomonas aeruginosa  KerV	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01319	Poly-N-acetyl glucosamine	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01319	Rabl3 	Cancer	140-229	C00-C96
TTDR01320	Receptor protein tyrosine kinase TYRO3	Melanoma	172.9	C43
TTDI01321	Inhibiting platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDR01321	Roundabout homolog 1	Choroidal or retinal angiogenesis	.	.
TTDR01322	Salmonella enterica 27-kDa outer membrane protein T2544	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01323	Salt inducible kinase 2	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDR01324	Serine Racemase	Neurodegenerations; Epilepsy; Neuropathic pain; Drug addiction; Schizophrenia	295, 303-304, 330-337, 338, 345, 356.0, 356.8,780	F10-F19, F20, G30-G32, G40, G64, G90.0, R52, G89
TTDI01324	T cell	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
TTDI01325	Hypoxic cell	Cancer	140-229	C00-C96
TTDR01325	Serine/threonine-protein kinase Nek6	Cancer	140-229	C00-C96
TTDR01326	Small conductance calcium-activated potassium channel	Parkinson's disease	332	F02.3, G20
TTDI01326	T-cells	Asthma	493	J45
TTDR01327	Sprouty 1	Cancer	140-229	C00-C96
TTDI01327	Stem cell	Metachromatic leukodystrophy	.	E75.25
TTDI01327	Stem cell	WiskottCAldrich syndrome	.	D82.0
TTDR01328	Ste20-Related Proline/Alanine-Rich Kinase 	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01328	Stem or T cell	Anemia	280-285	D50-D64
TTDI01328	Stem or T cell	Autoimmune diseases	279	D84.9, M35.9
TTDI01328	Stem or T cell	Breast cancer	174, 175, 217	C50, D24
TTDI01328	Stem or T cell	Chronic myeloid leukemia	205.1	C92.1
TTDI01328	Stem or T cell	Colon cancer	153, 154	C18-C21
TTDI01328	Stem or T cell	Congestive heart failure	428, 428.0	I50
TTDI01328	Stem or T cell	Fecal incontinence	.	R15
TTDI01328	Stem or T cell	Insulin dependent diabetes	.	E10
TTDI01328	Stem or T cell	Melanoma	172.9	C43
TTDI01328	Stem or T cell	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI01328	Stem or T cell	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI01328	Stem or T cell	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01328	Stem or T cell	Osteonecrosis	733.4	M87
TTDI01328	Stem or T cell	Peripheral arterial occlusive disease	.	I73.9
TTDI01328	Stem or T cell	Peripheral vascular disorders	.	I73.9
TTDI01328	Stem or T cell	Retinitis pigmentosa	.	H35.5
TTDI01328	Stem or T cell	Rheumatold arthritis	714	M05-M06
TTDI01328	Stem or T cell	Stress urinary incontinence	.	N39.3
TTDI01328	Stem or T cell	Transplant rejection	279.5, 996	D89.8, T86
TTDI01328	Stem or T cell	Urea cycle disorders	270.6	E72.2
TTDI01329	Allogeneic B7.1/HLA-A1 transfected tumor cell	Sarcoma	202.8	C81-C96
TTDI01330	Cancer cell	Cancer	140-229	C00-C96
TTDR01330	TRESK background K(+) channel	T-cell mediated immune dysfunction	279.1	D83.1
TTDI01331	Cathelicidin	HIV infections	001-139, 042	A00-B99, B20
TTDR01331	Tryptophan hydroxylase	Depressive disorders	296, 710.0	F30-F39, M32
TTDI01332	Glycosyltransferase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01332	Glycosyltransferase	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
TTDR01332	Tyrosine kinase non-receptor 2	Ewing's sarcoma	170	C41
TTDI01333	ATM serine protein kinase	Cancer	140-229	C00-C96
TTDR01333	Ubiquitin-activating enzyme E1	Leukemia	208.9	C91-C95
TTDI01334	Exo-alpha sialidase	Acne vulgaris	706.1	L70.0
TTDI01334	Exo-alpha sialidase	Influenza virus infections	487, 488	J10, J11
TTDR01334	Ubiquitin-activating enzyme E2	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI01335	Heterotrimeric G-protein	Cancer	140-229	C00-C96
TTDR01335	Western equine encephalitis virus envelope protein E1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01336	SOS gene	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01336	WNT1-inducible-signaling pathway protein 1	Osteoarthritis	715	M15-M19, M47
TTDI01337	Bombesin bb3 receptor	Obesity	278	E66
TTDR01337	Histone Deacetylase 8	Cancer	140-229	C00-C96
TTDR01337	Histone Deacetylase 8	Under research	.	.
TTDI01338	DNA binding protein	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01338	Histone Deacetylase 10	Cancer	140-229	C00-C96
TTDR01338	Histone Deacetylase 10	Under research	.	.
TTDI01339	Calcium-calmodulin dependent kinase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01340	Phospho MurNAc pentapeptide transferase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01340	Phospho MurNAc pentapeptide transferase	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01340	mRNA of Ubiquitin Protein Ligase WWP2	Under research	.	.
TTDI01341	Ubiquitin ligase	Cancer	140-229	C00-C96
TTDR01341	mRNA of human E2F transcription factor 3	Under research	.	.
TTDI01342	Imidazoline I2 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01342	mRNA of Human ADAM10	Rheumatold arthritis	714	M05-M06
TTDR01342	mRNA of Human ADAM10	Under research	.	.
TTDI01343	RNA polymerase I	Cancer	140-229	C00-C96
TTDR01343	mRNA of Smad7	Crohn's disease	555	K50
TTDR01343	mRNA of Smad7	Under research	.	.
TTDR01344	mRNA of Inhibitor-kappa B Kinase-alpha	Under research	.	.
TTDI01345	Diacylglycerol O-acyltransferase	Lipid metabolism disorder	.	E75-E78
TTDR01345	mRNA of PDK-1	Under research	.	.
TTDI01346	Pleckstrin homology domain protein	Cancer	140-229	C00-C96
TTDR01346	mRNA of human RIP2	Under research	.	.
TTDI01347	Glycerol-3-phosphate O-acyltransferase	Obesity	278	E66
TTDR01347	mRNA of MADH6	Under research	.	.
TTDI01348	Glutamate racemase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01348	Glutamate racemase	Helicobacter pylori infection	41.86	B96.81
TTDR01348	mRNA of influenza A hemagglutinin	Under research	.	.
TTDI01349	SGK-1 protein kinase	Prostate tumor	185	C61
TTDR01349	mRNA of Influenza polymerase 3	Under research	.	.
TTDI01350	Transient receptor potential channel	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
TTDI01350	Transient receptor potential channel	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01350	Transient receptor potential channel	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01350	Transient receptor potential channel	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01350	Transient receptor potential channel	Overactive bladder disorder	188, 596.51	C67, N32.81
TTDI01350	Transient receptor potential channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01350	mRNA of influenza A matrix protein	Under research	.	.
TTDI01351	cAMP	Graft-versus host disease	.	T86.0
TTDR01351	mRNA of human zinc finger protein-217	Under research	.	.
TTDI01352	Helicase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01352	Helicase	Herpes simplex virus infection	54	B00
TTDI01352	Helicase	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01352	mRNA of mouse diacylglycerol acyltransferase 1	Under research	.	.
TTDI01353	Eukaryotic initiation 2 alpha kinase 1	Anemia	280-285	D50-D64
TTDR01353	mRNA of human acyl CoA cholesterol acyl-transferase-2	Malignant adrenal gland cancer	.	C74.0
TTDR01353	mRNA of human acyl CoA cholesterol acyl-transferase-2	Under research	.	.
TTDI01354	TNF-like receptor-2	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDR01354	mRNA of influenza A nucleoprotein	Under research	.	.
TTDI01355	Hemolysin alpha	Bacillus anthracis infection	.	A22
TTDI01356	Itk tyrosine kinase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01356	Itk tyrosine kinase	Leukemia	208.9	C91-C95
TTDI01356	Itk tyrosine kinase	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01356	mRNA of H-ras	Breast cancer	174, 175, 217	C50, D24
TTDR01356	mRNA of H-ras	Cancer	140-229	C00-C96
TTDR01356	mRNA of H-ras	Under research	.	.
TTDI01357	Mycolic acid synthase	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01357	mRNA of human apolipoprotein A	Under research	.	.
TTDI01358	Uncharacterized KIAA protein	Cancer	140-229	C00-C96
TTDI01359	Sensor protein qseC	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01359	mRNA of BPV-1 E2	Under research	.	.
TTDI01360	LIM kinase-2	Glaucoma	365	H40-H42
TTDR01360	mRNA of human apolipoprotein B	Cancer	140-229	C00-C96
TTDR01360	mRNA of human apolipoprotein B	Hepatocellular carcinoma	155	C22.0
TTDR01360	mRNA of human apolipoprotein B	Hypercholesterolemia	272	E78.0
TTDR01360	mRNA of human apolipoprotein B	Under research	.	.
TTDI01361	CDC25 associated kinase-1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01361	mRNA of HER2	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01361	mRNA of HER2	Under research	.	.
TTDI01362	Malonyl CoA decarboxylase	Obesity	278	E66
TTDR01362	mRNA of integrin beta 3	Angina	413	I20
TTDR01362	mRNA of integrin beta 3	Arteriosclerosis	440	I70
TTDR01362	mRNA of integrin beta 3	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01362	mRNA of integrin beta 3	Peripheral vascular disease	443.9	I73.9
TTDR01362	mRNA of integrin beta 3	Restenosis	.	I51.89
TTDR01362	mRNA of integrin beta 3	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
TTDR01362	mRNA of integrin beta 3	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR01362	mRNA of integrin beta 3	Under research	.	.
TTDI01363	Ttk protein kinase	Cancer	140-229	C00-C96
TTDR01363	mRNA of c-jun	Under research	.	.
TTDI01364	DYRK-1 alpha protein kinase	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDR01364	mRNA of HPV-18 E6 (start codon regions)	Under research	.	.
TTDI01365	TLR	Autoimmune diseases	279	D84.9, M35.9
TTDI01365	TLR	Cancer	140-229	C00-C96
TTDI01365	TLR	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
TTDI01365	TLR	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01365	TLR	Otitis media	.	H65-H67
TTDI01365	TLR	Under research	.	.
TTDR01365	mRNA of HPV-18 E7 (start codon regions)	Under research	.	.
TTDI01366	Mixed lineage kinase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01366	mRNA of HPV E2 transactivator protein	Papillomavirus infections	.	B97.7
TTDR01366	mRNA of HPV E2 transactivator protein	Under research	.	.
TTDI01367	Calcium dependent protein kinase 1	Plasmodium falciparum infection	.	B54
TTDR01367	mRNA of HCMV DNA polymerase	Under research	.	.
TTDI01368	Lysine specific demethylase gene	Cancer	140-229	C00-C96
TTDR01368	mRNA of hnRNP A1	Under research	.	.
TTDI01369	Phosphatonin receptor	Hyperphosphatemia	275.3	E22.1
TTDR01369	mRNA of human 5-lipoxygenase	Asthma	493	J45
TTDR01369	mRNA of human 5-lipoxygenase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDR01369	mRNA of human 5-lipoxygenase	Under research	.	.
TTDI01370	Nuclear transcription factor Y	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01370	Nuclear transcription factor Y	Cancer	140-229	C00-C96
TTDR01370	mRNA of A-Raf	Autoimmune diseases	279	D84.9, M35.9
TTDR01370	mRNA of A-Raf	Cancer	140-229	C00-C96
TTDR01370	mRNA of A-Raf	Parkinson's disease	332	F02.3, G20
TTDR01370	mRNA of A-Raf	Polycystic kidney disease	753.1	Q61
TTDR01370	mRNA of A-Raf	Psoriasis	696	L40
TTDR01370	mRNA of A-Raf	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01370	mRNA of A-Raf	Under research	.	.
TTDI01371	RAC1 GTPase	Cancer	140-229	C00-C96
TTDR01371	mRNA of integrin alpha-4	Multiple sclerosis	340	G35
TTDR01371	mRNA of integrin alpha-4	Under research	.	.
TTDI01372	Shikimate kinase	Mycobacterium infection	.	A31
TTDR01372	mRNA of human Macrophage migration inhibitory factor	Under research	.	.
TTDI01373	Tyro3 tyrosine kinase receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDR01373	mRNA of B-Raf	Autoimmune diseases	279	D84.9, M35.9
TTDR01373	mRNA of B-Raf	Cancer	140-229	C00-C96
TTDR01373	mRNA of B-Raf	Parkinson's disease	332	F02.3, G20
TTDR01373	mRNA of B-Raf	Polycystic kidney disease	753.1	Q61
TTDR01373	mRNA of B-Raf	Psoriasis	696	L40
TTDR01373	mRNA of B-Raf	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01373	mRNA of B-Raf	Under research	.	.
TTDI01374	Epoxide hydrolase-2	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01374	mRNA of E-selectin	Under research	.	.
TTDI01375	Other protein kinase family	Choroidal neovascularization	.	H35
TTDR01375	mRNA of PKA Catalytic Subunit C-alpha	Under research	.	.
TTDI01376	Succinate dehydrogenase	Cancer	140-229	C00-C96
TTDR01376	mRNA of human C/EBP beta	Under research	.	.
TTDI01377	COT protein kinase	Rheumatold arthritis	714	M05-M06
TTDR01377	mRNA of human VCAM-1	Under research	.	.
TTDI01378	Gene target	Cancer	140-229	C00-C96
TTDI01378	Gene target	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDR01378	mRNA of Nucleolin	Under research	.	.
TTDI01379	Undecaprenyl diphosphate synthetase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01379	mRNA of human PKC-eta	HIV infections	001-139, 042	A00-B99, B20
TTDR01379	mRNA of human PKC-eta	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01379	mRNA of human PKC-eta	Under research	.	.
TTDI01380	Vacuolar hydrogen ATPase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDR01380	mRNA of Human Fas	Under research	.	.
TTDI01381	JAM	Cancer	140-229	C00-C96
TTDR01381	mRNA of CD40	Under research	.	.
TTDI01382	Anti-mullerian hormone II receptor	Cancer	140-229	C00-C96
TTDR01382	mRNA of HCV core protein	Under research	.	.
TTDI01383	Urokinase plasminogen receptor	Cancer	140-229	C00-C96
TTDI01383	Urokinase plasminogen receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDR01383	mRNA of G-alpha-11	Under research	.	.
TTDI01384	Adrenomedullin receptor	Pulmonary hypertension	416	I27.0, I27.2
TTDR01384	mRNA of B7 protein (translation initiation codon region)	Under research	.	.
TTDI01385	Opsin GPCR gene	Achromatopsia	.	H53.51
TTDR01385	mRNA of MEK2	Under research	.	.
TTDI01386	Adenylate cyclase 5	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01386	mRNA of PPAR-gamma	Diabetes mellitus type 1	250	E10
TTDR01386	mRNA of PPAR-gamma	Hyperlipidemia	272.0-272.4	E78
TTDR01386	mRNA of PPAR-gamma	Metabolic disorders	270-279	E70-E89
TTDR01386	mRNA of PPAR-gamma	Under research	.	.
TTDI01387	ADAM	Cancer	140-229	C00-C96
TTDR01387	mRNA of STAT3	Cancer	140-229	C00-C96
TTDR01387	mRNA of STAT3	Cancers	140-239	C00-C96
TTDR01387	mRNA of STAT3	Under research	.	.
TTDI01388	Merozoite surface protein	Plasmodium falciparum infection	.	B54
TTDI01388	Merozoite surface protein	Plasmodium infection	.	B54
TTDR01388	mRNA of human cot oncogene	Under research	.	.
TTDI01389	AIMP multisynthetase complex protein 2	Lung cancer	162	C33-C34
TTDR01389	mRNA of CD86	Under research	.	.
TTDI01390	Alpha crystallin	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01390	mRNA of PI3K p110 beta	Under research	.	.
TTDI01391	Synuclein alpha	Parkinson's disease	332	F02.3, G20
TTDR01391	mRNA of human Jun-N-terminal kinase-2 (JNK2)	Cancer	140-229	C00-C96
TTDR01391	mRNA of human Jun-N-terminal kinase-2 (JNK2)	Under research	.	.
TTDI01392	Lactalbumin alpha	Breast cancer	174, 175, 217	C50, D24
TTDR01392	mRNA of P120	Under research	.	.
TTDI01393	Amyloid beta A4 binding protein	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01393	mRNA of Human FasL	Under research	.	.
TTDI01394	Complement Factor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01394	Complement Factor	Reperfusion injury	.	I00-I99
TTDR01394	mRNA of human glycogen synthase kinase 3 alpha	Under research	.	.
TTDI01395	Immunoglobulin gamma Fc receptor IIB	Autoimmune diseases	279	D84.9, M35.9
TTDI01396	HERV-W 3q26.32 ancestral Gag protein	Multiple sclerosis	340	G35
TTDI01396	HERV-W 3q26.32 ancestral Gag protein	Schizophrenia	295, 710.0	F20, M32
TTDR01396	mRNA of human caspase 6	Under research	.	.
TTDI01397	Lin 28 homolog A	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDR01397	mRNA of PTEN	Non-insulin dependent diabetes	.	E11.9
TTDR01397	mRNA of PTEN	Under research	.	.
TTDI01398	Staphylococcus enterotoxin B	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01398	Staphylococcus enterotoxin B	Staphylococcus aureus infection	001-139	A00-B99
TTDR01398	mRNA of RhoA	Under research	.	.
TTDI01399	Autophagy protein	Cancer	140-229	C00-C96
TTDR01399	mRNA of Human mdm2	Cancer	140-229	C00-C96
TTDR01399	mRNA of Human mdm2	Under research	.	.
TTDI01400	L-Lysine oxidase	Cancer	140-229	C00-C96
TTDR01400	mRNA of human E2F transcription factor 1	Under research	.	.
TTDI01401	Channel rhodopsin gene	Retinitis pigmentosa	.	H35.5
TTDI01401	Channel rhodopsin gene	Retinopathy	362.0-362.2	H35-H35.2
TTDR01401	mRNA of PKC-epsilon	HIV infections	001-139, 042	A00-B99, B20
TTDR01401	mRNA of PKC-epsilon	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01401	mRNA of PKC-epsilon	Under research	.	.
TTDI01402	Ectonucleotide pyrophosphatase-PDE-2	Cancer	140-229	C00-C96
TTDR01402	mRNA of Protein kinase C-theta	HIV infections	001-139, 042	A00-B99, B20
TTDR01402	mRNA of Protein kinase C-theta	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01402	mRNA of Protein kinase C-theta	Under research	.	.
TTDI01403	AXL tyrosine kinase receptor family	Cancer	140-229	C00-C96
TTDR01403	mRNA of PKC-zeta	Under research	.	.
TTDI01404	Heparan sulfate proteoglycan protein	Angiogenesis disorder	.	I00-I99
TTDI01404	Heparan sulfate proteoglycan protein	Wound healing	.	T14.0-T14.1
TTDR01404	mRNA of PKC-delta	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDR01404	mRNA of PKC-delta	HIV infections	001-139, 042	A00-B99, B20
TTDR01404	mRNA of PKC-delta	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01404	mRNA of PKC-delta	Under research	.	.
TTDI01405	Rho GTPase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDR01405	mRNA of Bcl-x	Under research	.	.
TTDI01406	H19 gene	Cancer	140-229	C00-C96
TTDR01406	mRNA of human forkhead box O1A	Under research	.	.
TTDI01407	Bcl-6 protein	Diffuse large b-cell lymphoma	200.0, 202.8, 203.0	C81-C96, C83.3, C85.1, C90.0
TTDR01407	mRNA of Human FAP-1	Under research	.	.
TTDI01408	Bacterial quorum sensing protein	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01408	Bacterial quorum sensing protein	Staphylococcus aureus infection	001-139	A00-B99
TTDR01408	mRNA of Dual specific phosphatase 8	Under research	.	.
TTDI01409	IGF binding protein	Psoriasis	696	L40
TTDR01409	mRNA of MEKK1	Under research	.	.
TTDI01410	Bmx tyrosine kinase	Cancer	140-229	C00-C96
TTDR01410	mRNA of Apoptosis-2	Under research	.	.
TTDI01411	Branched amino acid aminotransferase 1	Cancer	140-229	C00-C96
TTDR01411	mRNA of eIF4E-BP2	Cancer	140-229	C00-C96
TTDI01412	Casein kinase I	Cancer	140-229	C00-C96
TTDR01412	mRNA of human ARA70	Under research	.	.
TTDI01413	Cation channel sperm protein	Contraception	.	Z30
TTDR01413	mRNA of Caspase 8	Rheumatold arthritis	714	M05-M06
TTDR01413	mRNA of Caspase 8	Under research	.	.
TTDI01414	Chondroitin ABC endolyase 1	Spinal cord injuries	952	S14, S24, S34
TTDR01414	mRNA of HER4	Under research	.	.
TTDI01415	Heat shock protein	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
TTDI01415	Heat shock protein	Condyloma	.	A51.3
TTDI01415	Heat shock protein	Meningococcal infections	36.9	A39
TTDI01415	Heat shock protein	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01415	Heat shock protein	Neisseria meningitidis infection	001-139, 041.5, 487, 488	A00-B99, A49.2, J10, J11
TTDI01415	Heat shock protein	Streptococcus pneumoniae infection	480-486, 770.0	J12, J13, J14, J15, J16, J17, J18, P23
TTDR01415	mRNA of Smad	Under research	.	.
TTDI01416	ATP-dependent Clp protease	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01416	mRNA of HIF1-alpha	Under research	.	.
TTDI01417	Type II TNF receptor	Under research	.	.
TTDR01417	mRNA of human dual specific phosphatase 5	Under research	.	.
TTDI01418	Death associated protein kinase	Cerebrovascular ischaemia	434.91	I61-I63
TTDR01418	mRNA of Human Syntaxin 4 Interacting Protein	Under research	.	.
TTDI01419	Ankyrin	Autoimmune diseases	279	D84.9, M35.9
TTDR01419	mRNA of human E2A-Pbx1	Under research	.	.
TTDI01420	K-Ras GTPase	Cancer	140-229	C00-C96
TTDR01420	mRNA of Aurora B	Cancer	140-229	C00-C96
TTDR01420	mRNA of Aurora B	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDR01420	mRNA of Aurora B	Under research	.	.
TTDI01421	Chromosomal replication initiator dnaA	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDR01421	mRNA of cytohesin-2	Under research	.	.
TTDI01422	TNF receptor 21	Multiple sclerosis	340	G35
TTDR01422	mRNA of human MEKK3	Under research	.	.
TTDI01423	Sp1 transcription factor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDR01423	mRNA of HIF2-alpha	Solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01424	Natural cytotoxic triggering receptor 1	Insulin dependent diabetes	.	E10
TTDR01424	mRNA of Dual specific phosphatase 9	Under research	.	.
TTDI01425	Transcription factor gene	HIV infections	001-139, 042	A00-B99, B20
TTDR01425	mRNA of Ubiquitin Protein Ligase WWP1	Under research	.	.
TTDI01426	Elongation factor 1 alpha	Parasitic infection	.	B89
TTDR01426	mRNA of human IL-1 receptor-associated kinase-4	Under research	.	.
TTDI01427	Enoyl ACP reductase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01427	Enoyl ACP reductase	Plasmodium falciparum infection	.	B54
TTDR01427	mRNA of human helicase-moi	Under research	.	.
TTDI01428	Falcipain	Plasmodium infection	.	B54
TTDR01428	mRNA of influenza A neuraminidase	Under research	.	.
TTDI01429	Albumin	Ocular disease	.	H00-H59
TTDR01429	mRNA of influenza A polymerase 1	Under research	.	.
TTDI01430	Epimerase	Wound healing	.	T14.0-T14.1
TTDR01430	mRNA of human Jagged2	Under research	.	.
TTDI01431	Gamma glutamyltranspeptidase	Under research	.	.
TTDR01431	mRNA of AkT-3	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDR01431	mRNA of AkT-3	Under research	.	.
TTDI01432	GATA 3 transcription factor	Asthma	493	J45
TTDR01432	mRNA of human MEKK2	Under research	.	.
TTDI01433	Glycogen synthase kinase	Neurodegenerative diseases	330-337	G30-G32
TTDR01433	mRNA of Talin	Under research	.	.
TTDI01434	Granulin ligand	Cancer	140-229	C00-C96
TTDR01434	mRNA of RANK	Under research	.	.
TTDI01435	Class A orphan GPCR	Central nervous system disease	.	G00-G99
TTDI01435	Class A orphan GPCR	Metabolic disorders	270-279	E70-E89
TTDI01435	Class A orphan GPCR	Sleep disorders	307.4, 327, 780.5	F51, G47
TTDR01435	Sigma 2-type opioid receptor	Melanoma; Prostate cancer; Pancreatic cancer	140-229, 157, 172, 185	C00-C96, C25, C43, C61
TTDI01436	Class A GPCR	Non-insulin dependent diabetes	.	E11.9
TTDR01436	mRNA of glucocorticoid receptor	Type 2 Diabetes	250.00, 250.02	E11
TTDI01437	Mechanosensitive channel	Duchenne dystrophy	.	G71.0
TTDR01437	mRNA of Protein tyrosine phosphatase-1B	Type 2 Diabetes	250.00, 250.02	E11
TTDI01438	GTPase	Cancer	140-229	C00-C96
TTDR01438	mRNA of FGFR4	Obesity	278	E66
TTDI01439	A-G adenine DNA glycosylase	Cancer	140-229	C00-C96
TTDI01439	A-G adenine DNA glycosylase	Mycobacterium tuberculosis infection	.	A15-A19
TTDR01439	mRNA of proprotein convertase subtilisin/kexin type 9	Coronary artery disease	410-414, 429.2	I20-I25
TTDR01439	mRNA of proprotein convertase subtilisin/kexin type 9	Hypercholesterolemia	272	E78.0
TTDI01440	PMS2L gene	Cancer	140-229	C00-C96
TTDR01440	TGR5	Type 2 Diabetes	250.00, 250.02	E11
TTDI01441	DNA RNA polymerase II subunit RPB11	Cancer	140-229	C00-C96
TTDR01441	Staphylococcus aureus Quinolone resistance protein norA	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01442	Chemokine CC22 ligand	Immune disorder	.	D80-D89
TTDR01442	Cytochrome P450 2B2	Hypothalamic-pituitary ACTH function	.	.
TTDI01443	Chemokine CC23 ligand	Immune disorder	.	D80-D89
TTDR01443	Cytochrome P450 2A6	Hypothalamic-pituitary ACTH function	.	.
TTDI01444	CXC11 chemokine ligand	Immune disorder	.	D80-D89
TTDR01444	Cytochrome P450 2B6	Hypothalamic-pituitary ACTH function	.	.
TTDR01445	Cytochrome P450 2A5	Hypothalamic-pituitary ACTH function	.	.
TTDI01445	Thioredoxin domain-contained protein 12	Cancer	140-229	C00-C96
TTDR01446	Clostridium histolyticum Collagenase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01446	NTT4 neurotransmitter transporter	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01447	TREM receptor 2	Bone disease	.	M00-M99
TTDI01448	Hypoxia inducible factor	Renal cell carcinoma	189	C64
TTDI01449	JmjC histone demethylation protein 2C	Cancer	140-229	C00-C96
TTDI01450	TNFSF14 gene	Cancer	140-229	C00-C96
TTDI01451	Adrenomedullin ligand	Ischemia	459.89	I99.8
TTDI01451	Adrenomedullin ligand	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01452	Immunoglobulin gamma Fc receptor II	B-cell lymphoma	202.8	C85.1
TTDI01453	Trans acting transcription protein ICP0	Herpes simplex virus infection	54	B00
TTDI01454	Type I IL-1 receptor	Gout	274.00274.1274.8274.9	M10
TTDI01455	SMAD	Inflammatory bowel disease	555, 556	K50, K51
TTDI01456	SREBP transcription factor 2	Atherosclerosis	414.0, 440	I70
TTDI01457	IRAK-4 protein kinase	Diffuse large b-cell lymphoma	200.0, 202.8, 203.0	C81-C96, C83.3, C85.1, C90.0
TTDI01458	S100 calcium binding protein	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01458	S100 calcium binding protein	Leukemia	208.9	C91-C95
TTDI01458	S100 calcium binding protein	Neutropenia	288	D70
TTDI01459	Isocitrate dehydrogenase	Cancer	140-229	C00-C96
TTDI01460	Scavenger receptor B1	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01461	JmjC histone demethylation protein	Cancer	140-229	C00-C96
TTDI01462	WW domain containing protein	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI01463	Triosephosphate dehydrogenase	Cancer	140-229	C00-C96
TTDI01463	Triosephosphate dehydrogenase	Multiple sclerosis	340	G35
TTDI01464	Leucine rich serine threonine kinase 2	Parkinson's disease	332	F02.3, G20
TTDI01465	Ligase	Cancer	140-229	C00-C96
TTDI01466	Delta-like protein ligand 1	Cancer	140-229	C00-C96
TTDI01467	UDP N Acetylglucosamine Acyltransferase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01467	UDP N Acetylglucosamine Acyltransferase	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01468	Lysine specific demethylase	Cancer	140-229	C00-C96
TTDI01469	Cathepsin	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01469	Cathepsin	Cancer	140-229	C00-C96
TTDI01470	Frizzled receptor	Cancer	140-229	C00-C96
TTDI01471	PB2 gene	Influenza virus infections	487, 488	J10, J11
TTDI01472	Metallothionein	Brain injury	.	S09.90
TTDI01473	IRE1 protein kinase	Autoimmune diseases	279	D84.9, M35.9
TTDI01474	Methylthioadenosine nucleosidase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01475	CD24 gene	Multiple sclerosis	340	G35
TTDI01476	Streptococcus exotoxin	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01477	Hepatitis virus structural protein	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01478	Elongation factor kinase 2	Cancer	140-229	C00-C96
TTDI01479	Mitochondrial NADP transhydrogenase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01480	Neuregulin ligand	Schizophrenia	295, 710.0	F20, M32
TTDI01481	Flavivirus NS3 protease	Flavivirus infection	.	A86
TTDI01482	Dengue virus 1 NS3 protease	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
TTDI01483	Ligand gated ion channel receptor	Ataxia	.	R26.0
TTDI01484	Galanin ligand	Epilepsy	290-319, 345	F01-F99, G40
TTDI01485	Eukaryotic initiation 2 alpha kinase 3	Cancer	140-229	C00-C96
TTDI01486	PAK protein kinase	Autism	299	F84.0
TTDI01486	PAK protein kinase	Cancer	140-229	C00-C96
TTDI01487	Thymidine kinase 1	Cancer	140-229	C00-C96
TTDI01487	Thymidine kinase 1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01488	Orphan nuclear receptor	Cancer	140-229	C00-C96
TTDI01489	Pancreas duodenum homeobox 1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI01490	Stathmin-1	Breast cancer	174, 175, 217	C50, D24
TTDI01491	Ras related C3 botulinum substrate	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI01492	Plasmodium subtilisin like protease	Plasmodium falciparum infection	.	B54
TTDI01493	Lysostaphin	Staphylococcus aureus infection	001-139	A00-B99
TTDI01494	Plasmepsin V	Plasmodium infection	.	B54
TTDI01495	Defensin	Fungal infection	110-118	B35-B49
TTDI01495	Defensin	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01496	Bifunctional polynucleotide phosphatase	Cancer	140-229	C00-C96
TTDI01497	Protein tyrosine phosphatase IVA3	Metastasis	.	C00-C97
TTDI01498	Ptk6 tyrosine kinase	Cancer	140-229	C00-C96
TTDI01499	LIM kinase	Cancer	140-229	C00-C96
TTDI01500	C-type lectin domain protein	HIV infections	001-139, 042	A00-B99, B20
TTDI01501	Pleiotropic drug resistance transporter	Cancer	140-229	C00-C96
TTDI01502	Protein recA	Escherichia coli infection	.	A00-B99
TTDI01503	Melanoma derived growth regulator	Articular cartilage disorders	.	M24.10
TTDI01503	Melanoma derived growth regulator	Osteoarthritis	715	M15-M19, M47
TTDI01503	Melanoma derived growth regulator	Spinal disease	.	G95.9
TTDI01504	Zinc alpha-2 glycoprotein precursor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01505	Retinoid Z receptor gamma	Autoimmune diseases	279	D84.9, M35.9
TTDI01506	Dengue virus protease	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
TTDI01507	Bacterial ribosome recycling factor	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01508	Ribonuclease HII	Autoimmune diseases	279	D84.9, M35.9
TTDI01509	Retinoid Z receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01510	Ntrkr1 tyrosine kinase receptor	Chronic lymphocytic leukaemia	204.1, 208.9	C91-C95, C91.1
TTDI01511	Ros1 tyrosine kinase receptor	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDI01512	RPL15 gene	Retinitis pigmentosa	.	H35.5
TTDI01513	ID DNA-binding protein inhibitor	Cancer	140-229	C00-C96
TTDI01514	Lung surfactant associated protein D	Lung inflammation	.	D86
TTDI01515	STAT	Leukopenia	.	D72.819
TTDI01516	CHST15 gene	Pyloric stenosis	.	K31.1
TTDI01517	TAP1 gene	Cancer	140-229	C00-C96
TTDI01518	Annexin	Heart disease	390-429	I00-I52
TTDI01519	NFKB gene	Herpesvirus infection	.	B00
TTDI01520	Leukocyte Ig-like receptor-3	Autoimmune diseases	279	D84.9, M35.9
TTDI01521	Leukocyte Ig-like receptor-5	Cancer	140-229	C00-C96
TTDI01522	Toxic shock syndrome toxin 1	Endotoxic shock	.	R57.8
TTDI01523	Immunoglobulin gamma Fc receptor IIA	Autoimmune diseases	279	D84.9, M35.9
TTDI01524	Eukaryotic initiation 2 alpha kinase 2	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01525	esaT6 gene	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01526	Tyk2 tyrosine kinase	Autoimmune diseases	279	D84.9, M35.9
TTDI01527	P2X purinoceptor	Asthma	493	J45
TTDI01528	CACNA1H calcium channel subunit	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01529	Wnk protein kinase	Cancer	140-229	C00-C96
TTDI01530	Wnk 1 protein kinase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01531	WNT gene	Cancer	140-229	C00-C96
TTDI01532	Heparan sulfate 6 O-sulfotransferase	Cancer	140-229	C00-C96
TTDI01533	SLC6A gene	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01535	Regulatory protein gene	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01536	NADPH oxidase gene	Chronic granulomatous disease	288.1	D71
TTDI01537	Cyclic nucleotide	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01541	ERK pathway	Cognition disorders	295	F20
TTDI01542	JNK pathway	Cognition disorders	295	F20
TTDI01543	Cyclin D1/E2F pathway	Platelet aggregatory	.	D69.1
TTDI01544	Energy metabolism pathway	Coagulation	.	I80-I82
TTDI01545	NF-kB pathway	Fungal infections	110-118	B35-B49
TTDI01546	Pleiotropic pathway	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01547	Hedgehog pathway	Cancer	140-229	C00-C96
TTDI01548	Wnt pathway	Osteoarthritis	715	M15-M19, M47
TTDI01549	Wnt signalling pathway	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
TTDI01550	Akt-mToR pathway	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01551	signal transduction pathway	Cancer	140-229	C00-C96
TTDI01552	Virus capside protein	HIV infections	001-139, 042	A00-B99, B20
TTDI01553	Wnt ligand	Bone disease	.	M00-M99
TTDI01553	Wnt ligand	Cancer	140-229	C00-C96
TTDI01553	Wnt ligand	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01553	Wnt ligand	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI01553	Wnt ligand	Scar tissue	.	L00-L99
TTDI01554	Immune checkpoint	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01555	Leukotriene receptor	Allergy	995.3	T78.4
TTDI01555	Leukotriene receptor	Asthma	493	J45
TTDI01555	Leukotriene receptor	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01555	Leukotriene receptor	Cardiotonic	.	I50
TTDI01555	Leukotriene receptor	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDI01556	Mucin	Gastrointestinal infection	.	A09.0
TTDI01556	Mucin	Ocular disease	.	H00-H59
TTDI01556	Mucin	Xerophthalmia	.	E50.6-E50.7
TTDI01557	Class B GPCR	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01557	Class B GPCR	HIV infections	001-139, 042	A00-B99, B20
TTDI01557	Class B GPCR	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01557	Class B GPCR	Psoriasis	696	L40
TTDI01558	Urate transporter	Hyperuricosuria	.	E79
TTDI01559	Cytokine receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01559	Cytokine receptor	Arthritis	710-719	M00-M25
TTDI01559	Cytokine receptor	Asthma	493	J45
TTDI01559	Cytokine receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI01559	Cytokine receptor	Cancer	140-229	C00-C96
TTDI01559	Cytokine receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI01559	Cytokine receptor	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01559	Cytokine receptor	Hypereosinophilic syndrome	288.3	D72.1
TTDI01559	Cytokine receptor	Infectious disease	001-139	A00-B99
TTDI01559	Cytokine receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDI01559	Cytokine receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01559	Cytokine receptor	Ocular disease	.	H00-H59
TTDI01559	Cytokine receptor	Plasmodium infection	.	B54
TTDI01559	Cytokine receptor	Psoriasis	696	L40
TTDI01559	Cytokine receptor	Rheumatold arthritis	714	M05-M06
TTDI01559	Cytokine receptor	Septic shock	785.52	A41.9
TTDI01559	Cytokine receptor	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDI01559	Cytokine receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01560	Protein tyrosine kinase	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI01560	Protein tyrosine kinase	Age related macular degeneration	.	H35.30
TTDI01560	Protein tyrosine kinase	Brain injury	.	S09.90
TTDI01560	Protein tyrosine kinase	Cancer	140-229	C00-C96
TTDI01560	Protein tyrosine kinase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01560	Protein tyrosine kinase	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01560	Protein tyrosine kinase	Multiple sclerosis	340	G35
TTDI01560	Protein tyrosine kinase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01560	Protein tyrosine kinase	Psoriasis	696	L40
TTDI01560	Protein tyrosine kinase	Scleroderma	701.0710.1	L94.0-L94.1, M34
TTDI01561	Unspecified enzyme	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01561	Unspecified enzyme	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01561	Unspecified enzyme	Cancer	140-229	C00-C96
TTDI01561	Unspecified enzyme	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01561	Unspecified enzyme	Cerebral infarction	.	I63
TTDI01561	Unspecified enzyme	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01561	Unspecified enzyme	Colorectal cancer	153, 154	C18-C21
TTDI01561	Unspecified enzyme	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
TTDI01561	Unspecified enzyme	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01561	Unspecified enzyme	Diabetic cataract	.	E10.36,E11.36
TTDI01561	Unspecified enzyme	Exocrine pancreatic insufficiency	.	K86.8
TTDI01561	Unspecified enzyme	Gout	274.00274.1274.8274.9	M10
TTDI01561	Unspecified enzyme	Haematological malignancies	200-209	C81-C96
TTDI01561	Unspecified enzyme	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01561	Unspecified enzyme	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01561	Unspecified enzyme	Hyperbilirubinemia	.	E80.6
TTDI01561	Unspecified enzyme	Hyperoxaluria	.	E74.8
TTDI01561	Unspecified enzyme	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01561	Unspecified enzyme	Keratosis	.	L57.0
TTDI01561	Unspecified enzyme	Lysosomal storage disease	.	E75-E77
TTDI01561	Unspecified enzyme	MRSA infection	41.12	A49.02
TTDI01561	Unspecified enzyme	Metabolic disorders	270-279	E70-E89
TTDI01561	Unspecified enzyme	Mycobacterium infection	.	A31
TTDI01561	Unspecified enzyme	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01561	Unspecified enzyme	Nervous system disease	.	G00-G99
TTDI01561	Unspecified enzyme	Neurodegenerative diseases	330-337	G30-G32
TTDI01561	Unspecified enzyme	Obesity	278	E66
TTDI01561	Unspecified enzyme	Onchocerciasis	.	B73
TTDI01561	Unspecified enzyme	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01561	Unspecified enzyme	Parkinson's disease	332	F02.3, G20
TTDI01561	Unspecified enzyme	Peritoneal cancer	140-229, 158	C00-C96, C48.1-C48.2
TTDI01561	Unspecified enzyme	Picornavirus infection	.	A00-B99
TTDI01561	Unspecified enzyme	Prostate tumor	185	C61
TTDI01561	Unspecified enzyme	Retrovirus infection	.	B33.3
TTDI01561	Unspecified enzyme	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01561	Unspecified enzyme	Under research	.	.
TTDI01561	Unspecified enzyme	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01562	Sodium, potassium transport	Diuretic	.	Y54.5
TTDI01563	Purinoceptor	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDI01563	Purinoceptor	Glaucoma	365	H40-H42
TTDI01563	Purinoceptor	Non-insulin dependent diabetes	.	E11.9
TTDI01564	Protein prenyltransferase	Cancer	140-229	C00-C96
TTDI01565	Matrix metalloprotease	Arthritis	710-719	M00-M25
TTDI01565	Matrix metalloprotease	Atherosclerosis	414.0, 440	I70
TTDI01565	Matrix metalloprotease	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01565	Matrix metalloprotease	Bone disease	.	M00-M99
TTDI01565	Matrix metalloprotease	Cancer	140-229	C00-C96
TTDI01565	Matrix metalloprotease	Dermatological disease	.	L00-L99
TTDI01565	Matrix metalloprotease	Endotoxic shock	.	R57.8
TTDI01565	Matrix metalloprotease	Inflammatory bowel disease	555, 556	K50, K51
TTDI01565	Matrix metalloprotease	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01565	Matrix metalloprotease	Osteoarthritis	715	M15-M19, M47
TTDI01565	Matrix metalloprotease	Rheumatold arthritis	714	M05-M06
TTDI01566	Actin polymerization	Restenosis	.	I51.89
TTDI01567	Interferon receptor	Arteriosclerosis	440	I70
TTDI01567	Interferon receptor	Cancer	140-229	C00-C96
TTDI01567	Interferon receptor	HIV infections	001-139, 042	A00-B99, B20
TTDI01567	Interferon receptor	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01567	Interferon receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01567	Interferon receptor	Respiratory disease	.	J00-J99
TTDI01567	Interferon receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01568	ATPase	Angina	413	I20
TTDI01568	ATPase	Cancer	140-229	C00-C96
TTDI01568	ATPase	Cognition disorders	295	F20
TTDI01569	Endonuclease	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01569	Endonuclease	Cancer	140-229	C00-C96
TTDI01569	Endonuclease	Heart disease	390-429	I00-I52
TTDI01569	Endonuclease	Herpesvirus infection	.	B00
TTDI01569	Endonuclease	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01569	Endonuclease	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01569	Endonuclease	Schizophrenia	295, 710.0	F20, M32
TTDI01569	Endonuclease	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01570	Phosphodiesterase (PDE)	Asthma	493	J45
TTDI01570	Phosphodiesterase (PDE)	Bronchodilator	493	J45
TTDI01570	Phosphodiesterase (PDE)	Cardiac failure	.	I50
TTDI01570	Phosphodiesterase (PDE)	Cardiotonic	.	I50
TTDI01570	Phosphodiesterase (PDE)	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01570	Phosphodiesterase (PDE)	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01570	Phosphodiesterase (PDE)	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDI01570	Phosphodiesterase (PDE)	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01570	Phosphodiesterase (PDE)	Septic shock	785.52	A41.9
TTDI01571	Chloride channel	Cancer	140-229	C00-C96
TTDI01571	Chloride channel	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI01571	Chloride channel	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDI01571	Chloride channel	Glioma	140-199, 183, 191, 210-229	C00-C75, C56, C71, C7A, C7B, D10-D36, D3A
TTDI01571	Chloride channel	Onchocerciasis	.	B73
TTDI01572	Ribonuclease P	Cancer	140-229	C00-C96
TTDI01572	Ribonuclease P	Psoriasis	696	L40
TTDI01574	FK506 binding protein	Cancer	140-229	C00-C96
TTDI01574	FK506 binding protein	Fungal infection	110-118	B35-B49
TTDI01574	FK506 binding protein	Hyperuricosuria	.	E79
TTDI01574	FK506 binding protein	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01574	FK506 binding protein	Psoriasis	696	L40
TTDI01575	HCMV terminase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01576	HCV replication enzyme	Hepatitis virus infection	573.3	K75.9
TTDI01577	Isomerase	Angina	413	I20
TTDI01577	Isomerase	Bronchodilator	493	J45
TTDI01578	Transferase	Arthritis	710-719	M00-M25
TTDI01578	Transferase	Cancer	140-229	C00-C96
TTDI01578	Transferase	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01579	Unspecified protein kinase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01579	Unspecified protein kinase	Asthma	493	J45
TTDI01579	Unspecified protein kinase	Autoimmune diseases	279	D84.9, M35.9
TTDI01579	Unspecified protein kinase	Cancer	140-229	C00-C96
TTDI01579	Unspecified protein kinase	Hepatocellular carcinoma	155	C22.0
TTDI01579	Unspecified protein kinase	Infectious disease	001-139	A00-B99
TTDI01579	Unspecified protein kinase	Melanoma	172.9	C43
TTDI01579	Unspecified protein kinase	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01579	Unspecified protein kinase	Plasmodium falciparum infection	.	B54
TTDI01579	Unspecified protein kinase	Rheumatold arthritis	714	M05-M06
TTDI01579	Unspecified protein kinase	Under research	.	.
TTDI01580	Polymorphonuclear neutrophil adhesion	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDI01581	Cell adhesion molecule	Asthma	493	J45
TTDI01581	Cell adhesion molecule	Cancer	140-229	C00-C96
TTDI01581	Cell adhesion molecule	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01581	Cell adhesion molecule	Cerebrovascular disorders	.	I60-I69
TTDI01581	Cell adhesion molecule	Deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
TTDI01581	Cell adhesion molecule	Graft-versus host disease	.	T86.0
TTDI01581	Cell adhesion molecule	Infectious disease	001-139	A00-B99
TTDI01581	Cell adhesion molecule	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01581	Cell adhesion molecule	Melanoma	172.9	C43
TTDI01581	Cell adhesion molecule	Neurodegenerative diseases	330-337	G30-G32
TTDI01581	Cell adhesion molecule	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01581	Cell adhesion molecule	Rheumatold arthritis	714	M05-M06
TTDI01582	Ionotropic glutamate receptor	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01582	Ionotropic glutamate receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01582	Ionotropic glutamate receptor	Parkinson's disease	332	F02.3, G20
TTDI01583	Thiol group of protein	Inflammatory bowel disease	555, 556	K50, K51
TTDI01584	Polymerase	Pediatric cancer	140-229	C00-C96
TTDI01585	MAP kinase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01585	MAP kinase	Cancer	140-229	C00-C96
TTDI01585	MAP kinase	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01585	MAP kinase	Dermatitis	692.9	L20-L30
TTDI01585	MAP kinase	Keratosis	.	L57.0
TTDI01585	MAP kinase	Melanoma	172.9	C43
TTDI01585	MAP kinase	Non-insulin dependent diabetes	.	E11.9
TTDI01585	MAP kinase	Osteoarthritis	715	M15-M19, M47
TTDI01585	MAP kinase	Psoriasis	696	L40
TTDI01586	Bacterial enoyl-acyl carrier reductase (PfENR)	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01586	Bacterial enoyl-acyl carrier reductase (PfENR)	Plasmodium falciparum infection	.	B54
TTDI01587	Unspecified receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01587	Unspecified receptor	Articular cartilage disorders	.	M24.10
TTDI01587	Unspecified receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI01587	Unspecified receptor	Bone disease	.	M00-M99
TTDI01587	Unspecified receptor	Breast cancer	174, 175, 217	C50, D24
TTDI01587	Unspecified receptor	Cancer	140-229	C00-C96
TTDI01587	Unspecified receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01587	Unspecified receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDI01587	Unspecified receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDI01587	Unspecified receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01587	Unspecified receptor	Ischemia	459.89	I99.8
TTDI01587	Unspecified receptor	Multiple sclerosis	340	G35
TTDI01587	Unspecified receptor	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI01587	Unspecified receptor	Neurodegenerative diseases	330-337	G30-G32
TTDI01587	Unspecified receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01587	Unspecified receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01587	Unspecified receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01587	Unspecified receptor	Proctitis	.	K51.2,K62.7,K62.8
TTDI01587	Unspecified receptor	Pulmonary disease	460-519	J00-J99
TTDI01587	Unspecified receptor	Restenosis	.	I51.89
TTDI01587	Unspecified receptor	Skin burns	940-949	T20-T31
TTDI01587	Unspecified receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01587	Unspecified receptor	Ulcerative colitis	556	K51
TTDI01587	Unspecified receptor	Wound healing	.	T14.0-T14.1
TTDI01588	Peptidyltransferase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01589	Unspecified GPCR	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01589	Unspecified GPCR	Anxiety disorder	300, 311	F32, F40-F42
TTDI01589	Unspecified GPCR	Cancer	140-229	C00-C96
TTDI01589	Unspecified GPCR	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01589	Unspecified GPCR	Central nervous system disease	.	G00-G99
TTDI01589	Unspecified GPCR	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI01589	Unspecified GPCR	Dermatological disease	.	L00-L99
TTDI01589	Unspecified GPCR	Emesis	787	R11
TTDI01589	Unspecified GPCR	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDI01589	Unspecified GPCR	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01589	Unspecified GPCR	Influenza virus infections	487, 488	J10, J11
TTDI01589	Unspecified GPCR	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDI01589	Unspecified GPCR	Male sexual dysfunction	.	N52.9
TTDI01589	Unspecified GPCR	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI01589	Unspecified GPCR	Overactive bladder disorder	188, 596.51	C67, N32.81
TTDI01589	Unspecified GPCR	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01589	Unspecified GPCR	Parkinson's disease	332	F02.3, G20
TTDI01589	Unspecified GPCR	Prostate hyperplasia	.	N40
TTDI01589	Unspecified GPCR	Respiratory disorder	518.81	J96
TTDI01589	Unspecified GPCR	Retinitis pigmentosa	.	H35.5
TTDI01589	Unspecified GPCR	Rosacea	.	L71
TTDI01589	Unspecified GPCR	Schizophrenia	295, 710.0	F20, M32
TTDI01589	Unspecified GPCR	Under research	.	.
TTDI01590	Hydrolase	Atherosclerosis	414.0, 440	I70
TTDI01590	Hydrolase	Gout	274.00274.1274.8274.9	M10
TTDI01590	Hydrolase	Leishmania infection	.	B55.0
TTDI01591	Prostanoid receptor	Alopecia	704.09	L65.9
TTDI01591	Prostanoid receptor	Cancer	140-229	C00-C96
TTDI01591	Prostanoid receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDI01591	Prostanoid receptor	Glaucoma	365	H40-H42
TTDI01591	Prostanoid receptor	Inner ear disease	.	H80-H83
TTDI01591	Prostanoid receptor	Ocular hypertension	365.04	H40.0
TTDI01591	Prostanoid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01591	Prostanoid receptor	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
TTDI01591	Prostanoid receptor	Psoriasis	696	L40
TTDI01591	Prostanoid receptor	Scar tissue	.	L00-L99
TTDI01591	Prostanoid receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
TTDI01591	Prostanoid receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01592	Peptidase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01593	Lyase	Cancer	140-229	C00-C96
TTDI01593	Lyase	Entamoeba histolytica infection	.	A06
TTDI01595	Herpesvirus DNA polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01596	Intracellular reductase	Diagnosis	331	G30,I73.9
TTDI01597	Lipoxygenase	Arthritic	710-719	M00-M25
TTDI01597	Lipoxygenase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDI01598	Neutrophil	Rhinitis	472.0, 477	J00, J30, J31.0
TTDI01599	Polyamine	Cancer	140-229	C00-C96
TTDI01600	Nuclear receptor	Arthritic	710-719	M00-M25
TTDI01600	Nuclear receptor	Non-insulin dependent diabetes	.	E11.9
TTDI01601	AdoHcy hydrolase	Arthritic	710-719	M00-M25
TTDI01602	Gap junction protein	Cardiac arrhythmias	427	I47-I49
TTDI01603	Glucosidase	Diabetes	250	E08-E13
TTDI01604	Rhinovirus protein 1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01605	NADPH oxidase	Arthritic	710-719	M00-M25
TTDI01605	NADPH oxidase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01605	NADPH oxidase	Motor neurone disease	335.2	G12.2
TTDI01605	NADPH oxidase	Ocular disease	.	H00-H59
TTDI01606	Nucleoside transporter	Cardiac arrhythmias	427	I47-I49
TTDI01607	Rhinovirus capsid protein	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01608	Vesicular monoamine transporter	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDI01609	Cholesterol transporter	Hyperlipidemia	272.0-272.4	E78
TTDI01610	IgE-regulated calcium channels	Asthma	493	J45
TTDI01611	Prostaglandin synthetase	Inflammation	.	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, R52, G89
TTDI01612	Ion channel	Arthritis	710-719	M00-M25
TTDI01612	Ion channel	Autoimmune diseases	279	D84.9, M35.9
TTDI01612	Ion channel	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
TTDI01612	Ion channel	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01612	Ion channel	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
TTDI01612	Ion channel	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI01612	Ion channel	Coronavirus infection	.	B34.2
TTDI01612	Ion channel	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
TTDI01612	Ion channel	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01612	Ion channel	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01612	Ion channel	Influenza virus infections	487, 488	J10, J11
TTDI01612	Ion channel	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI01612	Ion channel	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01612	Ion channel	Noise induced hearing loss	.	H90-H95
TTDI01612	Ion channel	Respiratory disease	.	J00-J99
TTDI01612	Ion channel	Sickle-cell anemia	280-285	D50-D64
TTDI01613	Splicing factor	Cancer	140-229	C00-C96
TTDI01614	Aminotransferase	Liver disease	570-574	K70-K77
TTDI01615	Plasma protein	Trypanosomiasis	086.5-086	B56-B57
TTDI01616	Fungal enzyme	Fungal infection	110-118	B35-B49
TTDI01617	Chemokine ligand	Asthma	493	J45
TTDI01617	Chemokine ligand	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01617	Chemokine ligand	Scar tissue	.	L00-L99
TTDI01618	Voltage-dependent calcium channel	Muscle spasm	.	M62.838
TTDI01618	Voltage-dependent calcium channel	Parkinson's disease	332	F02.3, G20
TTDI01619	Transcription factor	Papillomavirus infections	.	B97.7
TTDI01619	Transcription factor	Viral encephalitis	.	A86
TTDI01621	Retinal isomerase	Restless legs syndrome	.	G25.81
TTDI01622	58-kDa acetaminophen binding protein	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01623	Bacterial ribosome	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01623	Bacterial ribosome	Influenza virus infections	487, 488	J10, J11
TTDI01625	Methyltransferase	Cancer	140-229	C00-C96
TTDI01625	Methyltransferase	Leukemia	208.9	C91-C95
TTDI01625	Methyltransferase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01626	Lysosphingolipid receptor	Cancer	140-229	C00-C96
TTDI01627	Rhinovirus capsid	Rhinovirus infection	.	J20.6?
TTDI01628	DNA-directed DNA polymerase	Cancer	140-229	C00-C96
TTDI01629	Enzyme	Acute intermittent (hepatic) porphyria	.	E80.21
TTDI01629	Enzyme	Female genital tract inflammation	.	N73.9
TTDI01629	Enzyme	HIV infections	001-139, 042	A00-B99, B20
TTDI01630	DNA RNA polymerase	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01631	Neuropeptide recptor	Type 1 diabetes	250, 250.01	E08-E13, E10
TTDI01632	Ribonuclease	Acute promyelocytic leukemia	205	C92.4
TTDI01632	Ribonuclease	Cancer	140-229	C00-C96
TTDI01632	Ribonuclease	Cervical cancer	140-229, 180	C00-C96, C53
TTDI01632	Ribonuclease	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01633	Immunoglobulin Fc receptor	Ischemic heart diseases	410-414	I20-I25
TTDI01633	Immunoglobulin Fc receptor	Pemphigus	.	L10.0
TTDI01634	T cell receptor	Multiple sclerosis	340	G35
TTDI01635	Aminopeptidase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01635	Aminopeptidase	Plasmodium falciparum infection	.	B54
TTDI01638	Outer membrane protein	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01638	Outer membrane protein	Haemophilus influenzae prophylaxis	487, 488	J10, J11
TTDI01639	Hydroxylase	Dermatological disease	.	L00-L99
TTDI01639	Hydroxylase	Inflammatory bowel disease	555, 556	K50, K51
TTDI01639	Hydroxylase	Neurodegenerative diseases	330-337	G30-G32
TTDI01640	Hematopoietic cell phosphatase	Cancer	140-229	C00-C96
TTDI01641	Cytochrome P450 3	HIV infections	001-139, 042	A00-B99, B20
TTDI01643	HLA antigen	Autoimmune diseases	279	D84.9, M35.9
TTDI01643	HLA antigen	Breast cancer	174, 175, 217	C50, D24
TTDI01643	HLA antigen	Celiac disease	579	K90.0
TTDI01643	HLA antigen	Infectious disease	001-139	A00-B99
TTDI01643	HLA antigen	Multiple sclerosis	340	G35
TTDI01644	T-cell receptor	Multiple sclerosis	340	G35
TTDI01644	T-cell receptor	Psoriatic disorders	696	L40
TTDI01645	HRV 3C protease	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01646	LPS receptor	Septic shock	785.52	A41.9
TTDI01647	Major histocompatibility complex	Acquired immune deficiency syndrome	42	B20
TTDI01647	Major histocompatibility complex	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01649	HLA class II antigen	Allergy	995.3	T78.4
TTDI01649	HLA class II antigen	Autoimmune diseases	279	D84.9, M35.9
TTDI01649	HLA class II antigen	Brain injury	.	S09.90
TTDI01649	HLA class II antigen	Cancer	140-229	C00-C96
TTDI01649	HLA class II antigen	Celiac disease	579	K90.0
TTDI01649	HLA class II antigen	HIV infections	001-139, 042	A00-B99, B20
TTDI01649	HLA class II antigen	Influenza virus infections	487, 488	J10, J11
TTDI01649	HLA class II antigen	Insulin dependent diabetes	.	E10
TTDI01649	HLA class II antigen	Leukemia	208.9	C91-C95
TTDI01649	HLA class II antigen	Optic neuritis	.	H46
TTDI01649	HLA class II antigen	Rheumatold arthritis	714	M05-M06
TTDI01649	HLA class II antigen	Uveitis	364	H20
TTDI01650	Receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI01650	Receptor	Kidney transplant rejection	996.81	T86.1
TTDI01650	Receptor	Oral mucositis	528	K12.3
TTDI01652	Bone morphogenetic protein ligand	Renal disease	.	N00-N29
TTDI01653	Regulatory protein	Arthritis	710-719	M00-M25
TTDI01653	Regulatory protein	Autoimmune diseases	279	D84.9, M35.9
TTDI01653	Regulatory protein	Bone marrow transplantation	279.5, 996	D89.8, T86
TTDI01653	Regulatory protein	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
TTDI01653	Regulatory protein	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01653	Regulatory protein	Graft-versus host disease	.	T86.0
TTDI01653	Regulatory protein	HIV infections	001-139, 042	A00-B99, B20
TTDI01653	Regulatory protein	Melanoma	172.9	C43
TTDI01654	NAD-dehydrogenase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01655	HPV antigens	Cervical cancer	140-229, 180	C00-C96, C53
TTDI01656	Surface antigen preferentially overexpressed on multiple myeloma (MM) cells	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI01657	Zinc-finger proteins (ZFP)	Acne vulgaris	706.1	L70.0
TTDI01658	G-protein-coupled receptor	Depression	311	F32
TTDI01660	Antigens on activated T-cells	Transplant rejection	279.5, 996	D89.8, T86
TTDI01661	Capsid-SP1 cleavage site in HIV Gag protein	HIV infections	001-139, 042	A00-B99, B20
TTDI01662	Sodium calcium channel	Epilepsy	290-319, 345	F01-F99, G40
TTDI01663	Synthetic multi-antigen DNA	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01664	Interferon ligand	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01664	Interferon ligand	Papillomavirus infections	.	B97.7
TTDI01665	Nucleoside DNA polymerase	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
TTDI01666	Ubiquitin-activating enzyme	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01667	Humanized IgG2	Sickle-cell disease	282.6	D57
TTDI01668	Immunoglobulin G1 (IgG1)	Influenza virus infections	487, 488	J10, J11
TTDI01669	Fibrolase	Peripheral vascular disease	443.9	I73.9
TTDI01670	Helicase-primase	Herpes simplex virus infection	54	B00
TTDI01671	Unspecified protease	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI01671	Unspecified protease	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01671	Unspecified protease	Cancer	140-229	C00-C96
TTDI01671	Unspecified protease	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI01672	Unspecified hormone	Cancer	140-229	C00-C96
TTDI01672	Unspecified hormone	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01672	Unspecified hormone	Obesity	278	E66
TTDI01672	Unspecified hormone	Parkinson's disease	332	F02.3, G20
TTDI01672	Unspecified hormone	Premenstrual syndrome	.	N94.3
TTDI01672	Unspecified hormone	Under research	.	.
TTDI01673	17-beta-hydroxysteroid dehydrogenase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01674	Esterase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01675	Glycosidase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01675	Glycosidase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01676	Viral envelope glycoprotein	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01676	Viral envelope glycoprotein	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01676	Viral envelope glycoprotein	Metapneumovirus infection	.	J12.3
TTDI01677	Carbohydrate antigen Lewis Y	Cancer	140-229	C00-C96
TTDI01678	Phosphatase	Cancer	140-229	C00-C96
TTDI01679	Nuclear hormone receptor	Endocrine disease	.	E00-E35
TTDI01680	24-hydroxylase	Cancer	140-229	C00-C96
TTDI01681	Serum protein	Acquired hemolytic anemia	.	D59.9
TTDI01681	Serum protein	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01681	Serum protein	Asthma	493	J45
TTDI01681	Serum protein	Influenza virus infections	487, 488	J10, J11
TTDI01681	Serum protein	Kidney diseases	580-589	N00-N29
TTDI01681	Serum protein	Motor neurone disease	335.2	G12.2
TTDI01681	Serum protein	Spinal cord injuries	952	S14, S24, S34
TTDI01681	Serum protein	Under research	.	.
TTDI01682	Proteoglycanase	Arthritic	710-719	M00-M25
TTDI01683	Tuftsin receptor	Diagnosis	331	G30,I73.9
TTDI01684	Oxalate oxidase	Hyperoxaluria	.	E74.8
TTDI01685	Anthrax toxin	Anthrax	22	A22
TTDI01685	Anthrax toxin	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDI01686	Inhibitor of apoptosis (IAP)	Autoimmune diseases	279	D84.9, M35.9
TTDI01686	Inhibitor of apoptosis (IAP)	Cancer	140-229	C00-C96
TTDI01687	Motoneuronotrophic factor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01688	Tumor-associated peptide	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDI01690	Allergen	Allergy	995.3	T78.4
TTDI01691	Phosphoric diester hydrolase	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01691	Phosphoric diester hydrolase	Trypanosomiasis	086.5-086	B56-B57
TTDI01692	Deoxyribonuclease	Cancer	140-229	C00-C96
TTDI01692	Deoxyribonuclease	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDI01693	IgG2a	Cancer pain	140-229, 338,780	C00-C96, R52, G89
TTDI01694	Pseudomonas outer membrane protein	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01695	Major pollen antigen	Allergy	995.3	T78.4
TTDI01696	Protein of eimeria protozoan	Cancer	140-229	C00-C96
TTDI01697	Sphingomyelinase	Dermatitis	692.9	L20-L30
TTDI01697	Sphingomyelinase	Niemann-Pick disease	.	E75.249
TTDI01698	T-cell ligand	Multile sclerosis	.	G35
TTDI01699	Thymulin	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01701	Endopeptidase	Diarrhea	787.91	A09, K59.1
TTDI01701	Endopeptidase	Overactive bladder disorder	188, 596.51	C67, N32.81
TTDI01702	Major pollen allergen Bet-v-1	Allergy	995.3	T78.4
TTDI01703	Birch pollen allergen	Allergy	995.3	T78.4
TTDI01705	Pancreatic beta cell growth factor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01705	Pancreatic beta cell growth factor	Insulin dependent diabetes	.	E10
TTDI01706	Galactosyltransferase	Atherosclerosis	414.0, 440	I70
TTDI01706	Galactosyltransferase	Breast cancer	174, 175, 217	C50, D24
TTDI01706	Galactosyltransferase	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
TTDI01706	Galactosyltransferase	Melanoma	172.9	C43
TTDI01706	Galactosyltransferase	Non-small-cell lung cancer	162, 183	C33, C34, C56
TTDI01707	Telomere	Cancer	140-229	C00-C96
TTDI01708	ATP binding cassette	Metabolic disorders	270-279	E70-E89
TTDI01708	ATP binding cassette	Toxicity	.	T36-T50,T51-T65
TTDI01709	Transporter	Toxicity	.	T36-T50,T51-T65
TTDI01710	p40	Psoriasis	696	L40
TTDI01713	Thrombospondin relate anonymous protein	Plasmodium infection	.	B54
TTDI01714	Bothrops atrox serine protease	Bleeding	444, 453	I74, I80-I82
TTDI01715	Mite allergen	Asthma	493	J45
TTDI01716	Inducing anti-tumor immune responses by human lymphocyte	Breast cancer	174, 175, 217	C50, D24
TTDI01717	L-type calcium channel	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01718	Hepatitis B structural protein	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01719	Grass pollen allergen	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDI01720	Antigens of many solid tumor types	Colorectal cancer	153, 154	C18-C21
TTDI01723	GDF	Metabolic disorders	270-279	E70-E89
TTDI01724	Interleukin receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI01725	Unspecified transcription factor	Congestive heart failure	428, 428.0	I50
TTDI01725	Unspecified transcription factor	Hearing disorder	.	H90.5
TTDI01726	Laminin	Muscular dystrophy	.	G71.0
TTDI01727	Unspecified transporter protein	Cholesterol metabolism disorder	.	E70-E88
TTDI01727	Unspecified transporter protein	Toxicity	.	T36-T50,T51-T65
TTDI01728	Mas-related G-protein coupled receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01729	Aspartic protease	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01730	EPH family tyrosine kinase	Cancer	140-229	C00-C96
TTDI01731	rhIgG1k	Sickle-cell disease	282.6	D57
TTDI01732	Transaminase	Obesity	278	E66
TTDI01733	Immunoglobulin gamma Fc receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI01733	Immunoglobulin gamma Fc receptor	Cancer	140-229	C00-C96
TTDI01734	Alpha-secretase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01735	Nuclease	Autoimmune diseases	279	D84.9, M35.9
TTDI01736	Unspecified cell adhesion molecule	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDI01737	Unspecified regulatory protein	Cancer	140-229	C00-C96
TTDI01738	Viral protein	Influenza A virus infections	487, 488	J10, J11
TTDI01739	Zinc finger protein transcription factor	Age related macular degeneration	.	H35.30
TTDI01739	Zinc finger protein transcription factor	Cancer	140-229	C00-C96
TTDI01740	Fibroblast growth factor	Cancer	140-229	C00-C96
TTDI01740	Fibroblast growth factor	Skin burns	940-949	T20-T31
TTDI01741	Folate binding protein-E39	Endometrial cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
TTDI01742	Bacteria topoisomerase	Acquired immune deficiency syndrome	42	B20
TTDI01743	5-HT 2 receptor	Aggressive non-Hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C96, C82-C85, C91-C95
TTDI01743	5-HT 2 receptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01743	5-HT 2 receptor	Arthritis	710-719	M00-M25
TTDI01743	5-HT 2 receptor	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01743	5-HT 2 receptor	Depression	311	F32
TTDI01743	5-HT 2 receptor	Gastrointestinal disease	.	K00-K93
TTDI01743	5-HT 2 receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01743	5-HT 2 receptor	Migraine	346	G43
TTDI01743	5-HT 2 receptor	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDI01743	5-HT 2 receptor	Pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDI01743	5-HT 2 receptor	Peripheral vascular disease	443.9	I73.9
TTDI01743	5-HT 2 receptor	Psychotic disorders	290-299	F20-F29
TTDI01743	5-HT 2 receptor	Schizophrenia	295, 710.0	F20, M32
TTDI01743	5-HT 2 receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
TTDI01746	Interleukin-12 ligand	Breast cancer	174, 175, 217	C50, D24
TTDI01746	Interleukin-12 ligand	Cancer	140-229	C00-C96
TTDI01746	Interleukin-12 ligand	Cutaneous T-cell lymphoma	202.1, 202.2, 202.8, 208.9	C81-C96, C84.0, C84.1, C91-C95
TTDI01746	Interleukin-12 ligand	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDI01746	Interleukin-12 ligand	Malignant melanoma	172, 208.9	C43, C91-C95
TTDI01746	Interleukin-12 ligand	Prostate tumor	185	C61
TTDI01747	VEGF ligand	Age-related macular degeneration	362.5	H35.3
TTDI01747	VEGF ligand	Cancer	140-229	C00-C96
TTDI01747	VEGF ligand	Macular degeneration	362.5	H35.3
TTDI01748	JAK tyrosine kinase	Ankylosing spondylitis	720	M08.1, M45
TTDI01748	JAK tyrosine kinase	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDI01749	Muscarinic receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDI01749	Muscarinic receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01749	Muscarinic receptor	Amnesia	.	F04
TTDI01749	Muscarinic receptor	Asthma	493	J45
TTDI01749	Muscarinic receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI01749	Muscarinic receptor	Cognition disorders	295	F20
TTDI01749	Muscarinic receptor	Glaucoma	365	H40-H42
TTDI01749	Muscarinic receptor	Interstitial cystitis	.	N30.1
TTDI01749	Muscarinic receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDI01749	Muscarinic receptor	Neurodegenerative diseases	330-337	G30-G32
TTDI01749	Muscarinic receptor	Overactive bladder disorder	188, 596.51	C67, N32.81
TTDI01749	Muscarinic receptor	Peptic ulcer	531-534	K25-K27
TTDI01749	Muscarinic receptor	Pollakiuria	.	R35
TTDI01749	Muscarinic receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDI01749	Muscarinic receptor	Xerostomia	527.7	K11.7, R68.2
TTDI01750	Alpha 2 adrenoceptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01750	Alpha 2 adrenoceptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01750	Alpha 2 adrenoceptor	Asthma	493	J45
TTDI01750	Alpha 2 adrenoceptor	Attention deficit hyperactivity disorder	314.00, 314.01	F90
TTDI01750	Alpha 2 adrenoceptor	Depression	311	F32
TTDI01750	Alpha 2 adrenoceptor	Diabetes	250	E08-E13
TTDI01750	Alpha 2 adrenoceptor	Glaucoma	365	H40-H42
TTDI01750	Alpha 2 adrenoceptor	Heart failure	410, 428	I21, I22, I50
TTDI01750	Alpha 2 adrenoceptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01750	Alpha 2 adrenoceptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDI01750	Alpha 2 adrenoceptor	Male sexual disorders	.	F52
TTDI01750	Alpha 2 adrenoceptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01750	Alpha 2 adrenoceptor	Ocular hypertension	365.04	H40.0
TTDI01750	Alpha 2 adrenoceptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01750	Alpha 2 adrenoceptor	Peptic ulcer	531-534	K25-K27
TTDI01750	Alpha 2 adrenoceptor	Poison intoxication	.	T36-T50
TTDI01750	Alpha 2 adrenoceptor	Prostate disease	.	N42.9
TTDI01750	Alpha 2 adrenoceptor	Prostate disorder	.	N40-N42
TTDI01751	Angiotensin II receptor	Anemia	280-285	D50-D64
TTDI01751	Angiotensin II receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01751	Angiotensin II receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01752	Nicotinic ACh receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01752	Nicotinic ACh receptor	Anesthesia	338	R52
TTDI01752	Nicotinic ACh receptor	Asthma	493	J45
TTDI01752	Nicotinic ACh receptor	Attention deficit hyperactivity disorder	314.00, 314.01	F90
TTDI01752	Nicotinic ACh receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI01752	Nicotinic ACh receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDI01752	Nicotinic ACh receptor	HIV infections	001-139, 042	A00-B99, B20
TTDI01752	Nicotinic ACh receptor	Muscle spasm	.	M62.838
TTDI01752	Nicotinic ACh receptor	Nicotine dependence	305.1	F17
TTDI01752	Nicotinic ACh receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01752	Nicotinic ACh receptor	Parkinson's disease	332	F02.3, G20
TTDI01752	Nicotinic ACh receptor	Pollakiuria	.	R35
TTDI01753	Acetyl CoA carboxylase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01753	Acetyl CoA carboxylase	Fungal infection	110-118	B35-B49
TTDI01753	Acetyl CoA carboxylase	Metabolic disorders	270-279	E70-E89
TTDI01753	Acetyl CoA carboxylase	Obesity	278	E66
TTDI01753	Acetyl CoA carboxylase	Parkinson's disease	332	F02.3, G20
TTDI01753	Acetyl CoA carboxylase	Sebaceous gland disease	.	L73.8
TTDI01754	Plasminogen activator inhibitor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01754	Plasminogen activator inhibitor	Atherosclerosis	414.0, 440	I70
TTDI01754	Plasminogen activator inhibitor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
TTDI01754	Plasminogen activator inhibitor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01755	Acetylcholine receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDI01755	Acetylcholine receptor	Brain diseases	.	G00-G99
TTDI01755	Acetylcholine receptor	Central and peripheral nervous diseases	.	G96.9
TTDI01755	Acetylcholine receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI01755	Acetylcholine receptor	Cognition disorders	295	F20
TTDI01755	Acetylcholine receptor	Colitis	556.9	K50-K52
TTDI01755	Acetylcholine receptor	Dysmenorrhea	625.3	N94.4-N94.6
TTDI01755	Acetylcholine receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDI01755	Acetylcholine receptor	Myasthenia gravis	358	G70.0
TTDI01755	Acetylcholine receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01755	Acetylcholine receptor	Stomach ulcer	.	K25-K27
TTDI01755	Acetylcholine receptor	Under research	.	.
TTDI01755	Acetylcholine receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDI01756	Beta adrenoceptor	Angina	413	I20
TTDI01756	Beta adrenoceptor	Asthma	493	J45
TTDI01756	Beta adrenoceptor	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
TTDI01756	Beta adrenoceptor	Diabetes	250	E08-E13
TTDI01756	Beta adrenoceptor	Glaucoma	365	H40-H42
TTDI01756	Beta adrenoceptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01756	Beta adrenoceptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDI01757	Sodium hydrogen exchanger	Angina pectoris	413	I20
TTDI01757	Sodium hydrogen exchanger	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01757	Sodium hydrogen exchanger	Ischemia	459.89	I99.8
TTDI01757	Sodium hydrogen exchanger	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI01758	Na+ K+ ATPase	Cardiotonic	.	I50
TTDI01758	Na+ K+ ATPase	Heart arrhythmia	.	I47-I49
TTDI01758	Na+ K+ ATPase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01759	NK receptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01759	NK receptor	Cancer	140-229	C00-C96
TTDI01759	NK receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01760	Gelatinase	Colorectal cancer	153, 154	C18-C21
TTDI01761	Phospholipase C	Cancer	140-229	C00-C96
TTDI01761	Phospholipase C	Herpes simplex virus infection	54	B00
TTDI01761	Phospholipase C	Leukemia	208.9	C91-C95
TTDI01762	Alpha 1 adrenoceptor	Angina	413	I20
TTDI01762	Alpha 1 adrenoceptor	Cardiac arrhythmias	427	I47-I49
TTDI01762	Alpha 1 adrenoceptor	Congestive heart failure	428, 428.0	I50
TTDI01762	Alpha 1 adrenoceptor	Depression	311	F32
TTDI01762	Alpha 1 adrenoceptor	Diabetes	250	E08-E13
TTDI01762	Alpha 1 adrenoceptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDI01762	Alpha 1 adrenoceptor	Fecal incontinence	.	R15
TTDI01762	Alpha 1 adrenoceptor	Glaucoma	365	H40-H42
TTDI01762	Alpha 1 adrenoceptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01762	Alpha 1 adrenoceptor	Peripheral vascular disease	443.9	I73.9
TTDI01762	Alpha 1 adrenoceptor	Prostate disease	.	N42.9
TTDI01762	Alpha 1 adrenoceptor	Prostate disorder	.	N40-N42
TTDI01762	Alpha 1 adrenoceptor	Prostate hyperplasia	.	N40
TTDI01762	Alpha 1 adrenoceptor	Psychotic disorders	290-299	F20-F29
TTDI01762	Alpha 1 adrenoceptor	Urinary incontinence	788.3	N39.3, N39.4, R32
TTDI01763	ACTH releasing factor receptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01763	ACTH releasing factor receptor	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
TTDI01763	ACTH releasing factor receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01764	Alpha adrenoceptor	Alcohol use disorders	303	F10.2
TTDI01764	Alpha adrenoceptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
TTDI01764	Alpha adrenoceptor	Contusion	.	S36.220S
TTDI01764	Alpha adrenoceptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDI01764	Alpha adrenoceptor	Erythema	695	L51-L54
TTDI01764	Alpha adrenoceptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01764	Alpha adrenoceptor	Hypotension	458, 796.3	I95
TTDI01764	Alpha adrenoceptor	Obesity	278	E66
TTDI01764	Alpha adrenoceptor	Ocular disease	.	H00-H59
TTDI01764	Alpha adrenoceptor	Prostate hyperplasia	.	N40
TTDI01765	Fibrinogen	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01766	Melatonin receptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01766	Melatonin receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDI01766	Melatonin receptor	Sleep disorders	307.4, 327, 780.5	F51, G47
TTDI01766	Melatonin receptor	Under research	.	.
TTDI01767	Ras GTPase	Cancer	140-229	C00-C96
TTDI01767	Ras GTPase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI01767	Ras GTPase	Prostate tumor	185	C61
TTDI01768	Integrin alpha-5/beta-1	Cancer	140-229	C00-C96
TTDI01768	Integrin alpha-5/beta-1	Melanoma	172.9	C43
TTDI01768	Integrin alpha-5/beta-1	Ocular disease	.	H00-H59
TTDI01768	Integrin alpha-5/beta-1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01769	Bradykinin receptor	Asthma	493	J45
TTDI01769	Bradykinin receptor	Cancer	140-229	C00-C96
TTDI01770	Nitric oxide synthase	Brain injury	.	S09.90
TTDI01770	Nitric oxide synthase	Migraine	346	G43
TTDI01770	Nitric oxide synthase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI01770	Nitric oxide synthase	Pulmonary hypertension	416	I27.0, I27.2
TTDI01771	Inosine monophosphate dehydrogenase	Cancer	140-229	C00-C96
TTDI01771	Inosine monophosphate dehydrogenase	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01771	Inosine monophosphate dehydrogenase	Inflammatory bowel disease	555, 556	K50, K51
TTDI01771	Inosine monophosphate dehydrogenase	Transplant rejection	279.5, 996	D89.8, T86
TTDI01772	CC chemokine receptor	Asthma	493	J45
TTDI01772	CC chemokine receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01773	Selectin	Allergy	995.3	T78.4
TTDI01773	Selectin	Asthma	493	J45
TTDI01773	Selectin	Cancer	140-229	C00-C96
TTDI01773	Selectin	Ischemia	459.89	I99.8
TTDI01774	GABA A receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01774	GABA A receptor	Anesthesia	338	R52
TTDI01774	GABA A receptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01774	GABA A receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDI01774	GABA A receptor	Epileptic seizure	.	G40,R56
TTDI01774	GABA A receptor	General anesthesia	338	R52
TTDI01774	GABA A receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDI01774	GABA A receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDI01774	GABA A receptor	Neurodegenerative diseases	330-337	G30-G32
TTDI01774	GABA A receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01774	GABA A receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01774	GABA A receptor	Panic disorder	300.01, 300.21	F41.0
TTDI01774	GABA A receptor	Premenstrual syndrome	.	N94.3
TTDI01775	MEK protein kinase	Cancer	140-229	C00-C96
TTDI01775	MEK protein kinase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01776	Phosphodiesterase (PDE) 7	Central nervous system disease	.	G00-G99
TTDI01776	Phosphodiesterase (PDE) 7	Immune disorder	.	D80-D89
TTDI01777	Aurora protein kinase	Cancer	140-229	C00-C96
TTDI01778	Bombesin receptor	Breast cancer	174, 175, 217	C50, D24
TTDI01778	Bombesin receptor	Cancer	140-229	C00-C96
TTDI01778	Bombesin receptor	Carcinoma	230-234	D00-D09
TTDI01779	Notch receptor	Cancer	140-229	C00-C96
TTDI01779	Notch receptor	Neurodegenerative diseases	330-337	G30-G32
TTDI01779	Notch receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01780	VEGF receptor	Age related macular degeneration	.	H35.30
TTDI01780	VEGF receptor	Angina	413	I20
TTDI01780	VEGF receptor	Angiogenesis disorder	.	I00-I99
TTDI01780	VEGF receptor	Atherosclerosis	414.0, 440	I70
TTDI01780	VEGF receptor	Cancer	140-229	C00-C96
TTDI01780	VEGF receptor	Colorectal cancer	153, 154	C18-C21
TTDI01780	VEGF receptor	Coronary artery disease	410-414, 429.2	I20-I25
TTDI01780	VEGF receptor	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
TTDI01780	VEGF receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDI01780	VEGF receptor	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
TTDI01780	VEGF receptor	Macular degeneration	362.5	H35.3
TTDI01780	VEGF receptor	Musculoskeletal disease	.	M00-M99
TTDI01780	VEGF receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01780	VEGF receptor	Ocular disease	.	H00-H59
TTDI01780	VEGF receptor	Psoriasis	696	L40
TTDI01780	VEGF receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01781	Integrin alpha-V/beta-5	Acute lung injury	518	J80
TTDI01781	Integrin alpha-V/beta-5	Ocular disease	.	H00-H59
TTDI01781	Integrin alpha-V/beta-5	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01782	Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)	Malaria	84	B50-B54
TTDI01783	Luteinizing hormone-releasing hormone	Prostate cancer	140-229, 185	C00-C96, C61
TTDI01784	Adenosine A2 receptor	Hyperlipidemia	272.0-272.4	E78
TTDI01785	Leukotriene B4 receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDI01786	Integrin alpha-2/beta-1	Cancer	140-229	C00-C96
TTDI01786	Integrin alpha-2/beta-1	Inflammatory bowel disease	555, 556	K50, K51
TTDI01786	Integrin alpha-2/beta-1	Multile sclerosis	.	G35
TTDI01786	Integrin alpha-2/beta-1	Multiple sclerosis	340	G35
TTDI01789	Integrin alpha-5/beta-3	Cancer	140-229	C00-C96
TTDI01789	Integrin alpha-5/beta-3	Renal cancer	140-229, 189	C00-C96, C64
TTDI01790	Integrin alpha-V/beta-1	Renal cancer	140-229, 189	C00-C96, C64
TTDI01791	KCNQ voltage-gated potassium channel	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01792	Tryptophan 5-hydroxylase	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
TTDI01793	Heme oxygenase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01794	PIM protein kinase	Cancer	140-229	C00-C96
TTDI01794	PIM protein kinase	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI01795	Integrin alpha-5/beta-5	Cancer	140-229	C00-C96
TTDI01796	Interleukin-17 ligand	Bacillus anthracis infection	.	A22
TTDI01796	Interleukin-17 ligand	Rheumatold arthritis	714	M05-M06
TTDI01797	Integrin alpha-4/beta-1	Arthritic	710-719	M00-M25
TTDI01797	Integrin alpha-4/beta-1	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01797	Integrin alpha-4/beta-1	Inflammatory disorders	.	.
TTDI01798	Tankyrase	Breast cancer	174, 175, 217	C50, D24
TTDI01798	Tankyrase	Cancer	140-229	C00-C96
TTDI01799	Interferon alpha ligand	Autoimmune diseases	279	D84.9, M35.9
TTDI01799	Interferon alpha ligand	Bladder cancer	140-229, 188	C00-C96, C67
TTDI01799	Interferon alpha ligand	Cancer	140-229	C00-C96
TTDI01799	Interferon alpha ligand	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDI01799	Interferon alpha ligand	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
TTDI01799	Interferon alpha ligand	HIV infections	001-139, 042	A00-B99, B20
TTDI01799	Interferon alpha ligand	Hairy cell leukemia	202.4	C91.4
TTDI01799	Interferon alpha ligand	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDI01799	Interferon alpha ligand	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01799	Interferon alpha ligand	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01799	Interferon alpha ligand	Hepatitis virus infection	573.3	K75.9
TTDI01799	Interferon alpha ligand	Hepatocellular carcinoma	155	C22.0
TTDI01799	Interferon alpha ligand	Infectious disease	001-139	A00-B99
TTDI01799	Interferon alpha ligand	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDI01799	Interferon alpha ligand	Under research	.	.
TTDI01800	Interleukin-3 receptor	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI01800	Interleukin-3 receptor	Bone marrow transplantation	279.5, 996	D89.8, T86
TTDI01800	Interleukin-3 receptor	Human immunodeficiency virus infection	279.3	D84.9
TTDI01800	Interleukin-3 receptor	Immune disorder	.	D80-D89
TTDI01800	Interleukin-3 receptor	Rheumatold arthritis	714	M05-M06
TTDI01801	Cyclin D	Ischemic heart diseases	410-414	I20-I25
TTDI01802	Estrogen related receptor	Breast cancer	174, 175, 217	C50, D24
TTDI01803	Galanin receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01803	Galanin receptor	Epilepsy	290-319, 345	F01-F99, G40
TTDI01803	Galanin receptor	Pancreatitis	577.0-577.1	K85, K86.0K86.1
TTDI01804	CXCR chemokine	Bone marrow transplantation	279.5, 996	D89.8, T86
TTDI01805	Integrin alpha-1/beta-1	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01806	Orexin receptor	Anxiety disorder	300, 311	F32, F40-F42
TTDI01806	Orexin receptor	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10, I11, I12, I13, I15, I50
TTDI01806	Orexin receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
TTDI01807	Trk receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01808	Interleukin-23 ligand	Asthma	493	J45
TTDI01808	Interleukin-23 ligand	Crohn's disease	555	K50
TTDI01808	Interleukin-23 ligand	Rheumatold arthritis	714	M05-M06
TTDI01809	Integrin alpha-1/beta-3	Bone metastases	198.5	C79.51
TTDI01810	Tumor suppressor candidate	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI01811	Na-K-Cl symporter	Chronic heart failure	428	I50
TTDI01817	Bone morphogenetic protein receptor	Articular cartilage disorders	.	M24.10
TTDI01817	Bone morphogenetic protein receptor	Obesity	278	E66
TTDI01817	Bone morphogenetic protein receptor	Prostate tumor	185	C61
TTDI01817	Bone morphogenetic protein receptor	Renal disease	.	N00-N29
TTDI01817	Bone morphogenetic protein receptor	Renal injury	.	N17.9
TTDI01818	Relaxin receptor	Cancer	140-229	C00-C96
TTDI01818	Relaxin receptor	Fibrosis	709.2	L90.5
TTDI01819	Natriuretic peptide receptor	Chronic heart failure	428	I50
TTDI01819	Natriuretic peptide receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01820	Aggrecanase	Osteoarthritis	715	M15-M19, M47
TTDI01821	Amiloride sensitive sodium channel	Respiratory disorder	518.81	J96
TTDI01822	ATP synthase	Cancer	140-229	C00-C96
TTDI01823	Bacteria ATP synthase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01824	Guanylate cyclase receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01824	Guanylate cyclase receptor	Ulcerative colitis	556	K51
TTDI01825	Histone acetyltransferase	Cancer	140-229	C00-C96
TTDI01826	Alkaline phosphatase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01826	Alkaline phosphatase	Renal failure	584, 585	N17, N18, N19
TTDI01826	Alkaline phosphatase	Ulcerative colitis	556	K51
TTDI01827	TRAIL receptor	Cancer	140-229	C00-C96
TTDI01828	Troponin I	Ocular disease	.	H00-H59
TTDI01832	The activation of 3 monoaminergic neural systems (serotonin, norepinephrine, and dopamine)	Depression	311	F32
TTDI01836	Meningococcal group b	Meningitis	320-322	G00-G03
TTDI01843	TNF alpha production	Peripheral vascular disease	443.9	I73.9
TTDI01844	Brain concentrations of gamma-aminobutyric acid (GABA)	Epilepsy	290-319, 345	F01-F99, G40
TTDI01846	Reduction of cumulative renal toxicity of cisplatin and toxic effects of radiation on normal oral tissues	Mucositis	.	K92.81
TTDI01849	Facilitating dopamine (DA) release, inhibiting monoamine oxidase type B (MAO-B) and DA (re) up-take and stimulating aromatic L-amino acid decarboxylase (AADC)	Migraine	346	G43
TTDI01851	Expression of STAT-3	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
TTDI01853	Tromboxane A2 synthesis	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01856	Synthesis of T(H2) cytokines	Allergy	995.3	T78.4
TTDI01858	Lymphoid cell	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI01859	Wnt/beta-catenin signaling pathway	Cancer	140-229	C00-C96
TTDI01863	H5N1 pandemic influenza virus	Influenza virus infections	487, 488	J10, J11
TTDI01869	Colony stimulating factor ligand	Aplastic anemia	284	D60-D61
TTDI01872	CD15	Appendicitis	.	K35
TTDI01874	Subcutaneous fluid administration for achieving hydration	Cancer	140-229	C00-C96
TTDI01874	Subcutaneous fluid administration for achieving hydration	Improving resorption of radiopaque agents	.	.
TTDI01875	Bacteria clostridium tetani	Clostridium tetani infection	001-139	A00-B99
TTDI01876	Bacteria corynebacterium diphtheriae	Clostridium tetani infection	001-139	A00-B99
TTDI01879	Acetylcholine release inhibitor and neuromuscular blockor	Cervical cancer	140-229, 180	C00-C96, C53
TTDI01885	Deamidation of asparagine	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
TTDI01893	Proteins on the surface of ulcers including albumin and fibrinogen to form stable insoluble complexes	Acne vulgaris	706.1	L70.0
TTDI01895	Fructose	Constipation	564	K59.0
TTDI01898	Glucosaminylmuramyl dipeptide	Infectious disease	001-139	A00-B99
TTDI01899	Oxidoreductase	Ulcerative colitis	556	K51
TTDI01900	Immunoglobulin	Bacillus anthracis infection	.	A22
TTDI01900	Immunoglobulin	Bone marrow transplantation	279.5, 996	D89.8, T86
TTDI01900	Immunoglobulin	Vaccination	.	.
TTDI01901	HBV immunoglobulin	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01906	Trace amine-associated receptor-1	Attention deficit hyperactivity disorder	314.00, 314.01	F90
TTDI01906	Trace amine-associated receptor-1	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDI01906	Trace amine-associated receptor-1	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
TTDI01909	GABA A receptor delta subunit	Anesthesia	338	R52
TTDI01909	GABA A receptor delta subunit	Anxiety disorder	300, 311	F32, F40-F42
TTDI01909	GABA A receptor delta subunit	Epilepsy	290-319, 345	F01-F99, G40
TTDI01909	GABA A receptor delta subunit	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDI01909	GABA A receptor delta subunit	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01910	Iron	Anemia	280-285	D50-D64
TTDI01910	Iron	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI01910	Iron	Iron deficiency anaemia	.	D50
TTDI01910	Iron	Malaria	84	B50-B54
TTDI01911	Human DNA	Breast cancer	174, 175, 217	C50, D24
TTDI01911	Human DNA	Cancer	140-229	C00-C96
TTDI01911	Human DNA	Crohn's disease	555	K50
TTDI01911	Human DNA	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDI01911	Human DNA	Head and neck cancer	140-149, 140-229	C00-C96, C07-C14, C32-C33
TTDI01911	Human DNA	Human immunodeficiency virus infection	279.3	D84.9
TTDI01911	Human DNA	Influenza A virus H5N1 infections	487, 488	J10, J11
TTDI01911	Human DNA	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
TTDI01911	Human DNA	Marburg virus disease	78.89	A98.3
TTDI01911	Human DNA	Meningitis	320-322	G00-G03
TTDI01911	Human DNA	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01911	Human DNA	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDI01911	Human DNA	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI01911	Human DNA	Peripheral vascular disease	443.9	I73.9
TTDI01911	Human DNA	Prostate cancer	140-229, 185	C00-C96, C61
TTDI01911	Human DNA	Skin disease	.	L00-L99
TTDI01911	Human DNA	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01912	Bacterial cell membrane	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI01912	Bacterial cell membrane	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01912	Bacterial cell membrane	Bacterial respiratory tract infection	.	J13,J15
TTDI01912	Bacterial cell membrane	Fungal infections	110-118	B35-B49
TTDI01912	Bacterial cell membrane	Infections disease	.	A00-B99
TTDI01912	Bacterial cell membrane	Methicillin-resistant staphylococcus aureus	.	B95.62
TTDI01912	Bacterial cell membrane	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01912	Bacterial cell membrane	Pseudomonas infection	041.7, 482.1	B96.5, J15.1, P23.5
TTDI01912	Bacterial cell membrane	Staphylococcus aureus infection	001-139	A00-B99
TTDI01913	Bacterial penicillin binding protein	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01914	Bacterial DNA gyrase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01914	Bacterial DNA gyrase	Bacterial respiratory tract infection	.	J13,J15
TTDI01914	Bacterial DNA gyrase	Fungal infection	110-118	B35-B49
TTDI01914	Bacterial DNA gyrase	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01914	Bacterial DNA gyrase	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01914	Bacterial DNA gyrase	Infections disease	.	A00-B99
TTDI01914	Bacterial DNA gyrase	Infectious disease	001-139	A00-B99
TTDI01914	Bacterial DNA gyrase	MRSA infection	41.12	A49.02
TTDI01914	Bacterial DNA gyrase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01914	Bacterial DNA gyrase	Otitis media	.	H65-H67
TTDI01914	Bacterial DNA gyrase	Pneumonia	.	J12,J13,J14,J15,J16,J17,J18
TTDI01914	Bacterial DNA gyrase	Respiratory tract inflammation	.	J00-J99
TTDI01914	Bacterial DNA gyrase	Staphylococcus aureus infection	001-139	A00-B99
TTDI01914	Bacterial DNA gyrase	Urinary tract infections	599	N39.0
TTDI01915	Bacteria 50S ribosomal subunit	Bacillus anthracis infection	.	A22
TTDI01915	Bacteria 50S ribosomal subunit	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01915	Bacteria 50S ribosomal subunit	Bacterial respiratory tract infection	.	J13,J15
TTDI01915	Bacteria 50S ribosomal subunit	Dermatological disease	.	L00-L99
TTDI01915	Bacteria 50S ribosomal subunit	Inflammatory bowel disease	555, 556	K50, K51
TTDI01915	Bacteria 50S ribosomal subunit	Skin infections	680-709	L00-L99
TTDI01916	Leukotriene CysLT2 receptor	Allergy	995.3	T78.4
TTDI01916	Leukotriene CysLT2 receptor	Asthma	493	J45
TTDI01917	Erythropoietin ligand	Anemia	280-285	D50-D64
TTDI01917	Erythropoietin ligand	Brain injury	.	S09.90
TTDI01917	Erythropoietin ligand	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01917	Erythropoietin ligand	Myasthenic syndrome	.	G73
TTDI01918	Folate receptor alpha	Breast cancer	174, 175, 217	C50, D24
TTDI01918	Folate receptor alpha	Cancer	140-229	C00-C96
TTDI01918	Folate receptor alpha	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01918	Folate receptor alpha	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI01918	Folate receptor alpha	Psoriasis	696	L40
TTDI01918	Folate receptor alpha	Renal cell carcinoma	189	C64
TTDI01918	Folate receptor alpha	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01919	Respiratory syncytial virus protein F	Respiratory syncytial virus 	001-139, 079.6	A00-B99, B97.4
TTDI01919	Respiratory syncytial virus protein F	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01920	HIV GAG protein	HIV infections	001-139, 042	A00-B99, B20
TTDI01920	HIV GAG protein	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01921	Interferon alpha 2 ligand	Basal cell cancer	140-229, 173	C00-C96, C44
TTDI01921	Interferon alpha 2 ligand	Bladder cancer	140-229, 188	C00-C96, C67
TTDI01921	Interferon alpha 2 ligand	Cancer	140-229	C00-C96
TTDI01921	Interferon alpha 2 ligand	Cervical intraepithelial neoplasia	233.1, 622.10	D06, N87
TTDI01921	Interferon alpha 2 ligand	Colorectal cancer	153, 154	C18-C21
TTDI01921	Interferon alpha 2 ligand	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01921	Interferon alpha 2 ligand	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01921	Interferon alpha 2 ligand	Melanoma	172.9	C43
TTDI01921	Interferon alpha 2 ligand	Mesothelioma	163	C45
TTDI01921	Interferon alpha 2 ligand	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01922	Interferon beta ligand	Acute lung injury	518	J80
TTDI01922	Interferon beta ligand	Atherosclerosis	414.0, 440	I70
TTDI01922	Interferon beta ligand	Autoimmune diseases	279	D84.9, M35.9
TTDI01922	Interferon beta ligand	Cancer	140-229	C00-C96
TTDI01922	Interferon beta ligand	Glioblastoma multiforme	191	C71
TTDI01922	Interferon beta ligand	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01922	Interferon beta ligand	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01922	Interferon beta ligand	Multiple sclerosis	340	G35
TTDI01922	Interferon beta ligand	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI01922	Interferon beta ligand	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01922	Interferon beta ligand	Type 2 diabetes	250.00, 250.02	E11
TTDI01922	Interferon beta ligand	Under research	.	.
TTDI01922	Interferon beta ligand	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI01923	Tubulin receptor	Cancer	140-229	C00-C96
TTDI01923	Tubulin receptor	Colorectal cancer	153, 154	C18-C21
TTDI01923	Tubulin receptor	Macular degeneration	362.5	H35.3
TTDI01923	Tubulin receptor	Mesothelioma	163	C45
TTDI01923	Tubulin receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01924	HIV envelope glycoprotein gp120	HIV infections	001-139, 042	A00-B99, B20
TTDI01924	HIV envelope glycoprotein gp120	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01924	HIV envelope glycoprotein gp120	Human immunodeficiency virus infection	279.3	D84.9
TTDI01926	Hepatitis C virus NS5B polymerase	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01926	Hepatitis C virus NS5B polymerase	Hepatitis virus infection	573.3	K75.9
TTDI01927	Hepatitis C virus protease	Cancer	140-229	C00-C96
TTDI01927	Hepatitis C virus protease	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01928	Leishmania donovani DNA topoisomerase I	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01929	Schistosoma mansoni purine nucleoside phosphorylase	Prostate cancer	140-229, 185	C00-C96, C61
TTDI01930	Bacterial 30S ribosomal subunit	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01930	Bacterial 30S ribosomal subunit	Bacterial pneumonia infection	.	J13,J15
TTDI01930	Bacterial 30S ribosomal subunit	Infectious disease	001-139	A00-B99
TTDI01933	ICAM-1	Allergic conjunctivitis	204.0, 372.0, 372.14, 995.3	C91.0, H10, H10.45, T78.4
TTDI01933	ICAM-1	Cancer	140-229	C00-C96
TTDI01933	ICAM-1	Hormone refractory prostate cancer	140-229, 185	C00-C96, C61
TTDI01933	ICAM-1	Inflammatory bowel disease	555, 556	K50, K51
TTDI01933	ICAM-1	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01933	ICAM-1	Ocular inflammation	.	H00-H59
TTDI01933	ICAM-1	Psoriasis	696	L40
TTDI01934	Protein tyrosine phosphatase-1B	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01934	Protein tyrosine phosphatase-1B	Diabetes mellitus type 2	250	E11
TTDI01934	Protein tyrosine phosphatase-1B	Metabolic disorders	270-279	E70-E89
TTDI01934	Protein tyrosine phosphatase-1B	Obesity	278	E66
TTDI01935	Interleukin-1 alpha ligand	Atherosclerosis	414.0, 440	I70
TTDI01935	Interleukin-1 alpha ligand	Cancer	140-229	C00-C96
TTDI01935	Interleukin-1 alpha ligand	Hematological disease	.	D50-D89
TTDI01935	Interleukin-1 alpha ligand	Osteoarthritis	715	M15-M19, M47
TTDI01936	Carnitine acyltransferase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01936	Carnitine acyltransferase	Ischemia	459.89	I99.8
TTDI01937	Phosphodiesterase (PDE) 1	Cancer	140-229	C00-C96
TTDI01937	Phosphodiesterase (PDE) 1	Central nervous system disease	.	G00-G99
TTDI01937	Phosphodiesterase (PDE) 1	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI01938	Immunoglobulin gamma Fc receptor III	Arthritis	710-719	M00-M25
TTDI01938	Immunoglobulin gamma Fc receptor III	Autoimmune diseases	279	D84.9, M35.9
TTDI01938	Immunoglobulin gamma Fc receptor III	Hodgkin's lymphoma	201, 202.8	C81, C81-C96
TTDI01938	Immunoglobulin gamma Fc receptor III	Immune disorder	.	D80-D89
TTDI01938	Immunoglobulin gamma Fc receptor III	Muscle weakness	.	M62.8
TTDI01938	Immunoglobulin gamma Fc receptor III	Nephritis	.	N00-N19,N25-N29
TTDI01939	Coagulation factor XIII	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01940	Endostatin	Cancer	140-229	C00-C96
TTDI01940	Endostatin	Corneal abrasion	.	S05.0
TTDI01940	Endostatin	Macular degeneration	362.5	H35.3
TTDI01942	Fungal 1,3-beta-glucan synthase	Aspergillosis	.	B44
TTDI01942	Fungal 1,3-beta-glucan synthase	Fungal infection	110-118	B35-B49
TTDI01943	Cytochrome P450 reductase	Breast cancer	174, 175, 217	C50, D24
TTDI01943	Cytochrome P450 reductase	Cancer	140-229	C00-C96
TTDI01943	Cytochrome P450 reductase	Dermatitis	692.9	L20-L30
TTDI01943	Cytochrome P450 reductase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01943	Cytochrome P450 reductase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01943	Cytochrome P450 reductase	Pruritus	698	L29
TTDI01944	Parathyroid hormone ligand	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI01944	Parathyroid hormone ligand	Parathyroid disease	.	E20-E21
TTDI01945	Microtubule-associated protein tau	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI01945	Microtubule-associated protein tau	Central nervous system disease	.	G00-G99
TTDI01945	Microtubule-associated protein tau	Cognitive impairment	331.83	G31.84
TTDI01945	Microtubule-associated protein tau	Neurodegenerative diseases	330-337	G30-G32
TTDI01946	Chymotrypsin	Cancer	140-229	C00-C96
TTDI01946	Chymotrypsin	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01946	Chymotrypsin	Pancreatic disease	.	K85-K86
TTDI01947	Amylin receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI01947	Amylin receptor	Diabetes mellitus type 2	250	E11
TTDI01947	Amylin receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI01947	Amylin receptor	Obesity	278	E66
TTDI01948	Deoxycytidine kinase	Cancer	140-229	C00-C96
TTDI01949	Protein kinase C iota	Cancer	140-229	C00-C96
TTDI01951	Phosphodiesterase (PDE) 7A	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01951	Phosphodiesterase (PDE) 7A	Psoriasis	696	L40
TTDI01952	Phosphodiesterase (PDE) 7B	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI01953	Immunoglobulin G	Allergy	995.3	T78.4
TTDI01953	Immunoglobulin G	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI01953	Immunoglobulin G	Autoimmune diseases	279	D84.9, M35.9
TTDI01953	Immunoglobulin G	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
TTDI01953	Immunoglobulin G	Filoviridae	.	A99
TTDI01953	Immunoglobulin G	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01954	E3 ubiquitin protein ligase COP1	Heart arrhythmia	.	I47-I49
TTDI01955	Streptokinase	Cerebrovascular ischaemia	434.91	I61-I63
TTDI01955	Streptokinase	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI01956	Histone deacetylase-3	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01957	T-cell surface glycoprotein CD8	Autoimmune diseases	279	D84.9, M35.9
TTDI01957	T-cell surface glycoprotein CD8	Cancer	140-229	C00-C96
TTDI01957	T-cell surface glycoprotein CD8	HIV infections	001-139, 042	A00-B99, B20
TTDI01957	T-cell surface glycoprotein CD8	Influenza virus infections	487, 488	J10, J11
TTDI01957	T-cell surface glycoprotein CD8	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01958	Fungal aureus leucyl-tRNA synthetase	Fungal infection	110-118	B35-B49
TTDI01958	Fungal aureus leucyl-tRNA synthetase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI01958	Fungal aureus leucyl-tRNA synthetase	Onychomycosis	.	B35.1
TTDI01958	Fungal aureus leucyl-tRNA synthetase	Urinary tract infections	599	N39.0
TTDI01959	HIV env	HIV infections	001-139, 042	A00-B99, B20
TTDI01959	HIV env	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI01960	Collagen I	Duchenne muscular dystrophy	359.1	G71.0
TTDI01960	Collagen I	Scleroderma	701.0710.1	L94.0-L94.1, M34
TTDI01961	Fibroblast growth factor-4	Angina	413	I20
TTDI01963	Phenylalanine hydroxylase	Autoimmune diseases	279	D84.9, M35.9
TTDI01963	Phenylalanine hydroxylase	Genetic disorder	.	Q00-Q99
TTDI01963	Phenylalanine hydroxylase	Hyperphenylalaninemia	.	E70.1
TTDI01963	Phenylalanine hydroxylase	Liver failure	.	K72.9
TTDI01963	Phenylalanine hydroxylase	Phenylketonuria	.	E70.0
TTDI01964	Coagulation factor XI	Blood clotting disorder	286	D65-D69
TTDI01964	Coagulation factor XI	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDI01964	Coagulation factor XI	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI01965	GABA B receptor subunit 2	Schizophrenia	295, 710.0	F20, M32
TTDI01966	Nuclear factor kappa B p105 subunit	Cancer	140-229	C00-C96
TTDI01967	Perlecan	Atherosclerosis	414.0, 440	I70
TTDI01969	Tryptophan 5-hydroxylase-1	Bone disease	.	M00-M99
TTDI01969	Tryptophan 5-hydroxylase-1	Carcinoid syndrome	.	E34.0
TTDI01969	Tryptophan 5-hydroxylase-1	Psychotic disorders	290-299	F20-F29
TTDI01971	Potassium channel KCa1.1	Alopecia	704.09	L65.9
TTDI01972	DNA topoisomerase II alpha	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI01973	Interleukin-10 receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDI01973	Interleukin-10 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01973	Interleukin-10 receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI01973	Interleukin-10 receptor	Scar tissue	.	L00-L99
TTDI01975	Glutamate receptor 4	Parkinson's disease	332	F02.3, G20
TTDI01976	Phosphate	Hyperphosphatemia	275.3	E22.1
TTDI01978	Fungal cell membrane	Fungal infection	110-118	B35-B49
TTDI01980	Calcium activated potassium KCNMA1 (maxiK) channel	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDI01981	Maxi K potassium channel	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
TTDI01982	Asparaginase	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
TTDI01982	Asparaginase	Cancer	140-229	C00-C96
TTDI01983	Bone morphogenetic protein-2 ligand	Bone development disorder	.	M89
TTDI01983	Bone morphogenetic protein-2 ligand	Bone injury	800-829	S02, S12, S22, S32, S42, S52, S62, S72, S82, S92
TTDI01983	Bone morphogenetic protein-2 ligand	Osteonecrosis	733.4	M87
TTDI01984	Varicella-zoster virus DNA polymerase	Herpes simplex virus infection	54	B00
TTDI01985	Duffy antigen chemokine receptor	Malaria	84	B50-B54
TTDI01986	Epidermal growth factor ligand	Oral mucositis	528	K12.3
TTDI01986	Epidermal growth factor ligand	Wound healing	.	T14.0-T14.1
TTDI01987	Endoplasmin	Autoimmune diseases	279	D84.9, M35.9
TTDI01987	Endoplasmin	HIV infections	001-139, 042	A00-B99, B20
TTDI01987	Endoplasmin	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI01987	Endoplasmin	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI01987	Endoplasmin	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI01988	Hepatitis B large envelope protein	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01989	Hyaluronic acid receptor	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI01989	Hyaluronic acid receptor	Cancer	140-229	C00-C96
TTDI01989	Hyaluronic acid receptor	Hematological malignancies	200-209	C81-C96
TTDI01989	Hyaluronic acid receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI01989	Hyaluronic acid receptor	Macular degeneration	362.5	H35.3
TTDI01989	Hyaluronic acid receptor	Pancytopenia	.	D61.81
TTDI01989	Hyaluronic acid receptor	Rheumatold arthritis	714	M05-M06
TTDI01990	Pattern recognition receptor NOD2	Autoimmune diseases	279	D84.9, M35.9
TTDI01990	Pattern recognition receptor NOD2	Bacillus anthracis infection	.	A22
TTDI01990	Pattern recognition receptor NOD2	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI01991	Prolyl 4-hydroxylase subunit alpha-1	Liver cirrhosis	.	K70.3,K71.7,K74
TTDI01991	Prolyl 4-hydroxylase subunit alpha-1	Transplant rejection	279.5, 996	D89.8, T86
TTDI01992	Blood group Rh(D) polypeptide	Anemia	280-285	D50-D64
TTDI01993	Kit ligand	Anemia	280-285	D50-D64
TTDI01994	Bifunctional aminoacyl tRNA synthetase	Duchenne muscular dystrophy	359.1	G71.0
TTDI01996	Bacterial 23S RNA of 50S ribosomal subunit	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI01999	Botulinum toxin A	Acne vulgaris	706.1	L70.0
TTDI01999	Botulinum toxin A	Clostridium botulinum infection	.	A05.1
TTDI01999	Botulinum toxin A	Intoxication	.	T36-T50
TTDI01999	Botulinum toxin A	Rhinitis	472.0, 477	J00, J30, J31.0
TTDI02000	Positive transcription elongation factor B (P-TEFb)	Cancer	140-229	C00-C96
TTDI02001	GDNF receptor	Central nervous system disease	.	G00-G99
TTDI02001	GDNF receptor	Parkinson's disease	332	F02.3, G20
TTDI02002	Glutaminase	Leukemia	208.9	C91-C95
TTDI02003	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel	Angina	413	I20
TTDI02003	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel	Cardiac arrhythmias	427	I47-I49
TTDI02005	Neural cell adhesion molecule	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02005	Neural cell adhesion molecule	Cancer	140-229	C00-C96
TTDI02005	Neural cell adhesion molecule	Spinal cord injuries	952	S14, S24, S34
TTDI02006	Sphingomyelin synthase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI02007	Uridine phosphorylase	Mucositis	.	K92.81
TTDI02008	CaM kinase II	Anxiety disorder	300, 311	F32, F40-F42
TTDI02008	CaM kinase II	Rheumatold arthritis	714	M05-M06
TTDI02010	HLA class II antigen DR10	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02011	Solute carrier family 3 member 2	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02012	NADH or NADPH oxidoreductase	Huntington's disease	294.1, 333.4	F02.2, G10
TTDI02013	Aryl hydrocarbon receptor	Cancer	140-229	C00-C96
TTDI02014	Cytosine deaminase	Cancer	140-229	C00-C96
TTDI02014	Cytosine deaminase	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDI02015	AKT2 protein kinase	Cancer	140-229	C00-C96
TTDI02016	AKT3 protein kinase	Cancer	140-229	C00-C96
TTDI02017	Plasmodium apical membrane protein	Plasmodium falciparum infection	.	B54
TTDI02017	Plasmodium apical membrane protein	Plasmodium infection	.	B54
TTDI02017	Plasmodium apical membrane protein	Plasmodium malariae infection	.	B50
TTDI02018	C-type natriuretic peptide ligand	Achondroplasia	756.4	Q77.4
TTDI02019	Annexin A5	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI02020	Apolipoprotein A-I	Aortic valve stenosis	.	I35.0,I06.0
TTDI02020	Apolipoprotein A-I	Atherosclerosis	414.0, 440	I70
TTDI02020	Apolipoprotein A-I	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI02020	Apolipoprotein A-I	Cholesterol metabolism disorder	.	E70-E88
TTDI02020	Apolipoprotein A-I	Hypercholesterolemia	272	E78.0
TTDI02020	Apolipoprotein A-I	Hyperlipidemia	272.0-272.4	E78
TTDI02021	Arylsulfatase A	Metachromatic leukodystrophy	.	E75.25
TTDI02023	Serine threonine protein kinase ATR	Cancer	140-229	C00-C96
TTDI02023	Serine threonine protein kinase ATR	Chronic lymphocytic leukaemia	204.1, 208.9	C91-C95, C91.1
TTDI02023	Serine threonine protein kinase ATR	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02025	Inhibitor of apoptosis protein 2	Cancer	140-229	C00-C96
TTDI02025	Inhibitor of apoptosis protein 2	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02026	Inhibitor of apoptosis protein 1	Cancer	140-229	C00-C96
TTDI02026	Inhibitor of apoptosis protein 1	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02028	Bactericidal permeability-increasing protein	Acne vulgaris	706.1	L70.0
TTDI02030	Bromodomain-containing protein 2	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDI02030	Bromodomain-containing protein 2	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDI02031	Bromodomain-containing protein 3	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDI02031	Bromodomain-containing protein 3	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDI02032	Bromodomain-containing protein 4	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDI02032	Bromodomain-containing protein 4	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDI02033	Bromodomain testis-specific protein	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDI02033	Bromodomain testis-specific protein	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDI02034	Cadherin-3	Cancer	140-229	C00-C96
TTDI02035	Catalase	Neurodegenerative diseases	330-337	G30-G32
TTDI02035	Catalase	Skin burns	940-949	T20-T31
TTDI02036	Eotaxin ligand	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI02037	RANTES ligand	Autoimmune diseases	279	D84.9, M35.9
TTDI02038	CD34	Breast cancer	174, 175, 217	C50, D24
TTDI02040	Cytidine deaminase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02041	Cyclin-dependent kinase-3	Hematological malignancies	200-209	C81-C96
TTDI02042	Complement Factor H	Autoimmune diseases	279	D84.9, M35.9
TTDI02042	Complement Factor H	Colon cancer	153, 154	C18-C21
TTDI02042	Complement Factor H	HIV infections	001-139, 042	A00-B99, B20
TTDI02042	Complement Factor H	Neisseria meningitidis infection	001-139, 041.5, 487, 488	A00-B99, A49.2, J10, J11
TTDI02042	Complement Factor H	Renal disease	.	N00-N29
TTDI02043	Mitochondrial 10 kDa heat shock protein	Autoimmune diseases	279	D84.9, M35.9
TTDI02044	Candida albicans chitin synthase 3	Candidiasis infection	001-139, 112	A00-B99, B37
TTDI02045	Claudin 18	Esophageal cancer	140-229, 150	C00-C96, C15
TTDI02046	Cytochrome P450 24	Hyperparathyroidism	252.02, 588.81	E21.1
TTDI02046	Cytochrome P450 24	Psoriasis	696	L40
TTDI02047	Cholesterol 24-hydroxylase	Glutamate excitotoxiity	.	T36-T65
TTDI02048	Thymic stromal lymphoprotein receptor	Asthma	493	J45
TTDI02050	CD55	Cancer	140-229	C00-C96
TTDI02050	CD55	Colorectal cancer	153, 154	C18-C21
TTDI02050	CD55	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDI02051	Retinoic acid-inducible gene-1 (RIG-1)	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDI02051	Retinoic acid-inducible gene-1 (RIG-1)	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02051	Retinoic acid-inducible gene-1 (RIG-1)	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02052	Beta defensin 2	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI02053	Dystrophin	Duchenne dystrophy	.	G71.0
TTDI02053	Dystrophin	Duchenne muscular dystrophy	359.1	G71.0
TTDI02054	Dopamine beta hydroxylase	Heart failure	410, 428	I21, I22, I50
TTDI02054	Dopamine beta hydroxylase	Parkinson's disease	332	F02.3, G20
TTDI02055	HLA class II antigen DQ-2 alpha	Diabetes mellitus type 1	250	E10
TTDI02057	Cholestenol delta-isomerase	Rheumatold arthritis	714	M05-M06
TTDI02058	Bacterial elongation factor Tu	Acne vulgaris	706.1	L70.0
TTDI02058	Bacterial elongation factor Tu	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI02059	EGR-1 transcription factor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI02061	Epha3 tyrosine kinase receptor	Hematological malignancies	200-209	C81-C96
TTDI02062	Epiregulin (EREG)	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
TTDI02063	Enhancer of zeste homolog 2	Cancer	140-229	C00-C96
TTDI02063	Enhancer of zeste homolog 2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02064	Major envelope protein p37	Virus infection	.	B03
TTDI02065	PFKFB3 kinase	Cancer	140-229	C00-C96
TTDI02065	PFKFB3 kinase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02066	Escherichia coli NADH-dependent enoyl-ACP reductase	Methicillin-resistant staphylococcus aureus	.	B95.62
TTDI02067	Staphylococcus aureus Enoyl ACP reductase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI02067	Staphylococcus aureus Enoyl ACP reductase	Methicillin-resistant staphylococcus aureus	.	B95.62
TTDI02067	Staphylococcus aureus Enoyl ACP reductase	Staphylococcus aureus infection	001-139	A00-B99
TTDI02068	Fc-epsilon-RII (CD23)	Allergy	995.3	T78.4
TTDI02068	Fc-epsilon-RII (CD23)	Leukaemia	204	C91.0
TTDI02069	Free fatty acid receptor 2	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI02069	Free fatty acid receptor 2	Lipid metabolism disorder	.	E75-E78
TTDI02070	FGF-18 ligand	Arthropathy	.	M00-M14
TTDI02071	FGF-21 ligand	Diabetes mellitus type 2	250	E11
TTDI02071	FGF-21 ligand	Metabolic disorders	270-279	E70-E89
TTDI02074	Galactoside 3(4)-L-fucosyltransferase	Fallopian tube cancer	.	C57.0,D28.2
TTDI02075	Frizzled-7 receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02076	Gastrin	Gastric cancer	140-229, 151, 188	C00-C96, C16, C67
TTDI02077	Human cytomegalovirus glycoprotein B	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
TTDI02078	Growth differentiation factor-5	Periodontal disease	.	K05
TTDI02079	Gelsolin	Multiple sclerosis	340	G35
TTDI02080	N-acetylmannosamine kinase	Myopathy	.	M60-M63
TTDI02081	Glioma pathogenesis-related protein 1	Glioma	140-199, 183, 191, 210-229	C00-C75, C56, C71, C7A, C7B, D10-D36, D3A
TTDI02081	Glioma pathogenesis-related protein 1	Prostate tumor	185	C61
TTDI02082	Glutamate decarboxylase	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDI02082	Glutamate decarboxylase	Parkinson's disease	332	F02.3, G20
TTDI02083	CD42b	Cerebrovascular ischaemia	434.91	I61-I63
TTDI02083	CD42b	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI02084	Glypican-3	Cancer	140-229	C00-C96
TTDI02084	Glypican-3	Hepatocellular carcinoma	155	C22.0
TTDI02085	Platelet glycoprotein VI	Arteriosclerosis	440	I70
TTDI02085	Platelet glycoprotein VI	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
TTDI02086	Mortalin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02087	78 kDa glucose-regulated protein	Breast cancer	174, 175, 217	C50, D24
TTDI02087	78 kDa glucose-regulated protein	Cancer	140-229	C00-C96
TTDI02087	78 kDa glucose-regulated protein	Melanoma	172.9	C43
TTDI02087	78 kDa glucose-regulated protein	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02088	Glutathione S-transferase P	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDI02089	Histone H1.3	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02090	Hepcidin	Anemia	280-285	D50-D64
TTDI02091	CD74	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02092	Staphylococcus aureus alpha hemolysin	Hospital-acquired pneumonia	.	J18.9
TTDI02092	Staphylococcus aureus alpha hemolysin	Mucolytic	.	J00-J99
TTDI02092	Staphylococcus aureus alpha hemolysin	Pneumonia due to Methicillin susceptible Staphylococcus aureus	.	J15.211
TTDI02093	Interleukin-15 receptor subunit alpha	Autoimmune diseases	279	D84.9, M35.9
TTDI02093	Interleukin-15 receptor subunit alpha	Cancer	140-229	C00-C96
TTDI02093	Interleukin-15 receptor subunit alpha	Virus infection	.	B03
TTDI02094	Isocitrate dehydrogenase [NADP] cytoplasmic	Hematological malignancies	200-209	C81-C96
TTDI02095	Isocitrate dehydrogenase (IDH2)	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02096	Interferon alpha 5 ligand	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02096	Interferon alpha 5 ligand	Infectious disease	001-139	A00-B99
TTDI02097	Interferon omega ligand	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02098	Kappa myeloma antigen (KMA)	Hematological malignancies	200-209	C81-C96
TTDI02099	Interleukin-21 receptor	Crohn's disease	555	K50
TTDI02099	Interleukin-21 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02100	Interleukin-31 ligand	Immune disorder	.	D80-D89
TTDI02101	Interleukin-33	Asthma	493	J45
TTDI02103	Staphylococcus aureus iron-regulated surface determinant protein B	Staphylococcus aureus infection	001-139	A00-B99
TTDI02104	Lysine specific histone demethylase 1	Cancer	140-229	C00-C96
TTDI02104	Lysine specific histone demethylase 1	Small-cell lung cancer	162, 202.8, 203.0, 208.9	C33, C34, C81-C96, C90.0, C91-C95
TTDI02105	CD158a	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02105	CD158a	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02106	CD158b1	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02106	CD158b1	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02107	Killer cell immunoglobulin-like receptor 2DL3	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02107	Killer cell immunoglobulin-like receptor 2DL3	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02109	Kruppel like factor 4	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02110	Pyruvate kinase M2	Cancer	140-229	C00-C96
TTDI02111	Lecithin-cholesterol acyltransferase	Acute coronary syndrome	411.1, 434.91, 437.6, 453, 671.5, 671.9	I20.0, I61-I63, I80-I82
TTDI02112	Yersinia pestis virulence associated V antigen	Yersinia infections	20	A20
TTDI02113	Leucine-rich repeat neuronal protein 1	Multiple sclerosis	340	G35
TTDI02114	Epstein-Barr virus Latent membrane protein 2	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02114	Epstein-Barr virus Latent membrane protein 2	Nasopharyngeal carcinoma	.	C11.9
TTDI02116	Lysophosphatidate-3 receptor	Fibrosis	709.2	L90.5
TTDI02118	Lysozyme	Upper respiratory infection	.	J00-06,J30-39
TTDI02119	MAPKAP kinase 2	Autoimmune diseases	279	D84.9, M35.9
TTDI02119	MAPKAP kinase 2	Fibrosis	709.2	L90.5
TTDI02119	MAPKAP kinase 2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02120	MART-1 melanoma antigen	Melanoma	172.9	C43
TTDI02122	Mannose binding protein	HIV infections	001-139, 042	A00-B99, B20
TTDI02122	Mannose binding protein	Infectious disease	001-139	A00-B99
TTDI02123	Melanocortin MC5 receptor	Acne vulgaris	706.1	L70.0
TTDI02123	Melanocortin MC5 receptor	Seborrhea	.	L21
TTDI02124	Tyrosine-protein kinase MELK	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02125	Mycobacterium tuberculosis membrane protein mmpL3	Asthma	493	J45
TTDI02126	CI Man-6-P receptor	Cancer	140-229	C00-C96
TTDI02126	CI Man-6-P receptor	Fibrosis	709.2	L90.5
TTDI02126	CI Man-6-P receptor	Scar tissue	.	L00-L99
TTDI02127	Mas-related gene 2 (MRGX2)	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI02129	Plasmodium falciparum merozoite surface protein 1	Plasmodium malariae infection	.	B50
TTDI02131	Myosin-7	Deafness	.	H90-H91
TTDI02132	Nicotinamide phosphoribosyltransferase	Cancer	140-229	C00-C96
TTDI02132	Nicotinamide phosphoribosyltransferase	Leukaemia	204	C91.0
TTDI02132	Nicotinamide phosphoribosyltransferase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02133	Respiratory syncytial virus N protein	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI02134	Notch-2 receptor	Cancer	140-229	C00-C96
TTDI02134	Notch-2 receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02135	Notch-3 receptor	Cancer	140-229	C00-C96
TTDI02135	Notch-3 receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02136	NADPH oxidase 4	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI02136	NADPH oxidase 4	Fibrosis	709.2	L90.5
TTDI02137	Nucleophosmin	Cancer	140-229	C00-C96
TTDI02140	TrkC receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02142	Pseudomonas PcrV protein type III	Infections disease	.	A00-B99
TTDI02142	Pseudomonas PcrV protein type III	Pseudomonas infection	041.7, 482.1	B96.5, J15.1, P23.5
TTDI02143	Membrane glycoprotein OX2	Autoimmune diseases	279	D84.9, M35.9
TTDI02143	Membrane glycoprotein OX2	Cancer	140-229	C00-C96
TTDI02144	Tumor antigen NGcGM3	Breast cancer	174, 175, 217	C50, D24
TTDI02145	PAK-4 protein kinase	Cancer	140-229	C00-C96
TTDI02146	Programmed cell death ligand 2	Cancer	140-229	C00-C96
TTDI02148	Phosphodiesterase (PDE) 9	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02148	Phosphodiesterase (PDE) 9	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI02148	Phosphodiesterase (PDE) 9	Genitourinary disorders	.	N00-N99
TTDI02149	Platelet-derived growth factor D	Nephropathy	.	N00-N29
TTDI02150	Opioid receptor sigma 2	Schizophrenia	295, 710.0	F20, M32
TTDI02151	PIM-3 protein kinase	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02153	Tumor expressed melanoma antigen	Melanoma	172.9	C43
TTDI02153	Tumor expressed melanoma antigen	Non-small-cell lung cancer	162, 183	C33, C34, C56
TTDI02154	Prominin 1	Cancer	140-229	C00-C96
TTDI02156	Glutaminyl cyclase	Dementia	290-294, 331.0	F01-F07, G30
TTDI02157	HIV REV protein	HIV infections	001-139, 042	A00-B99, B20
TTDI02157	HIV REV protein	Human immunodeficiency virus infection	279.3	D84.9
TTDI02159	Transforming protein RhoA	Bone disease	.	M00-M99
TTDI02159	Transforming protein RhoA	Cancer	140-229	C00-C96
TTDI02159	Transforming protein RhoA	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02160	Ribosome-inactivating protein alpha-trichosanthin	HIV infections	001-139, 042	A00-B99, B20
TTDI02161	Ring finger protein	Colorectal cancer	153, 154	C18-C21
TTDI02162	Rho associated protein kinase 2	Cancer	140-229	C00-C96
TTDI02162	Rho associated protein kinase 2	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI02162	Rho associated protein kinase 2	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI02162	Rho associated protein kinase 2	Glaucoma	365	H40-H42
TTDI02162	Rho associated protein kinase 2	Immune disorder	.	D80-D89
TTDI02162	Rho associated protein kinase 2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02162	Rho associated protein kinase 2	Rheumatold arthritis	714	M05-M06
TTDI02163	Roof plate-specific spondin 1	Gastrointestinal disease	.	K00-K93
TTDI02164	Reticulon 4	Nerve injury	.	T14.4
TTDI02166	S100 calcium binding protein A4	Breast cancer	174, 175, 217	C50, D24
TTDI02167	Sphingosine 1-phosphate receptor 5	Multiple sclerosis	340	G35
TTDI02168	Zinc transporter ZIP6	Breast cancer	174, 175, 217	C50, D24
TTDI02171	Semaphorin-4D	Multiple sclerosis	340	G35
TTDI02172	Sarcoglycan gamma	Duchenne muscular dystrophy	359.1	G71.0
TTDI02173	Sphingosine 1 phosphate lyase 1	Autoimmune diseases	279	D84.9, M35.9
TTDI02174	SH2 domain inositol phosphatase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI02174	SH2 domain inositol phosphatase	Non-insulin dependent diabetes	.	E11.9
TTDI02175	SLIT and NTRK-like family member 6 (SLITRK6)	Bladder cancer	140-229, 188	C00-C96, C67
TTDI02176	Survival motor neuron protein	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
TTDI02177	Mitochondrial manganese superoxide dismutase (MnSOD)	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI02179	Sphingosine kinase 1	Arteriosclerosis	440	I70
TTDI02179	Sphingosine kinase 1	Vascular disease	325, 430-459	G45-G46, I60-I95
TTDI02180	N-sulphoglucosamine sulphohydrolase	Sanfilippo syndrome	.	E76.2
TTDI02181	SPTBN1	Cancer	140-229	C00-C96
TTDI02182	Sequestosome-1 p62	Mucositis	.	K92.81
TTDI02183	Facilitates chromatin transcription complex (FACT)	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDI02183	Facilitates chromatin transcription complex (FACT)	Hepatocellular carcinoma	155	C22.0
TTDI02185	Fungi/Bacteria isoleucyl t-RNA synthetase	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI02186	Alpha-synuclein	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02186	Alpha-synuclein	Parkinson's disease	332	F02.3, G20
TTDI02187	Valosin-containing protein p97	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02188	Trefoil factor-1	Oral mucositis	528	K12.3
TTDI02190	TGF-beta type II receptor	Cancer	140-229	C00-C96
TTDI02190	TGF-beta type II receptor	Wound healing	.	T14.0-T14.1
TTDI02191	Toll-like receptor 5	Acute radiation syndrome	990	T66
TTDI02192	Toll-like receptor 6	Cancer	140-229	C00-C96
TTDI02192	Toll-like receptor 6	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02193	TNF related apoptosis inducing ligand	Brain cancer	191, 225.0	C71, D33
TTDI02193	TNF related apoptosis inducing ligand	Cancer	140-229	C00-C96
TTDI02193	TNF related apoptosis inducing ligand	Prostate tumor	185	C61
TTDI02193	TNF related apoptosis inducing ligand	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02194	OX40 ligand	Asthma	493	J45
TTDI02194	OX40 ligand	Infections disease	.	A00-B99
TTDI02194	OX40 ligand	Prostate cancer	140-229, 185	C00-C96, C61
TTDI02194	OX40 ligand	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02195	Fast skeletal muscle troponin complex	Muscular atrophy	728.2	M62.5
TTDI02196	TNF superfamily receptor 12A	Cancer	140-229	C00-C96
TTDI02196	TNF superfamily receptor 12A	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02197	Activation-inducible TNFR family receptor	Melanoma	172.9	C43
TTDI02197	Activation-inducible TNFR family receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02198	Lymphotoxin beta receptor	Cancer	140-229	C00-C96
TTDI02198	Lymphotoxin beta receptor	Rheumatold arthritis	714	M05-M06
TTDI02199	CD95	Cancer	140-229	C00-C96
TTDI02199	CD95	Cerebrovascular ischaemia	434.91	I61-I63
TTDI02199	CD95	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02199	CD95	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02199	CD95	Rheumatold arthritis	714	M05-M06
TTDI02199	CD95	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02200	Tumor susceptibility gene protein 101	Influenza virus infections	487, 488	J10, J11
TTDI02200	Tumor susceptibility gene protein 101	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI02201	Thrombospondin-1 ligand	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02202	Tumor suppressor candidate 2	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDI02202	Tumor suppressor candidate 2	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDI02203	DHICA oxidase	Malignant melanoma	172, 208.9	C43, C91-C95
TTDI02203	DHICA oxidase	Melanoma	172.9	C43
TTDI02204	Uteroglobin	Adult respiratory distress syndrome	518.5, 518.82	J80
TTDI02204	Uteroglobin	Asthma	493	J45
TTDI02204	Uteroglobin	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI02204	Uteroglobin	Autoimmune diseases	279	D84.9, M35.9
TTDI02204	Uteroglobin	Cancer	140-229	C00-C96
TTDI02204	Uteroglobin	Endometriosis	617	N80
TTDI02204	Uteroglobin	Metastasis	.	C00-C97
TTDI02204	Uteroglobin	Sinusitis	.	J01,J32
TTDI02205	Utrophin	Duchenne muscular dystrophy	359.1	G71.0
TTDI02207	Human papillomavirus E7 protein	Papillomavirus infections	.	B97.7
TTDI02207	Human papillomavirus E7 protein	Uterine cervix cancer	.	C53
TTDI02208	VIP 2 receptor	Asthma	493	J45
TTDI02208	VIP 2 receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI02208	VIP 2 receptor	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI02208	VIP 2 receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI02209	HIV p17 matrix protein	HIV infections	001-139, 042	A00-B99, B20
TTDI02210	Pituitary adenylate cyclase-activating polypeptide 38	Nerve injury	.	T14.4
TTDI02211	Pancreatic hormone ligand	Obesity	278	E66
TTDI02212	HIV p24 capsid protein	HIV infections	001-139, 042	A00-B99, B20
TTDI02212	HIV p24 capsid protein	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI02212	HIV p24 capsid protein	Sexually transmitted infection	.	A64
TTDI02213	HIV p7 nucleocapsid protein	Human immunodeficiency virus infection	279.3	D84.9
TTDI02214	Hepatitis C virus protein NS4B	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02215	Hepatitis C virus E2 glycoprotein	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02217	Melanoma-associated antigen C2	Non-small-cell lung cancer	162, 183	C33, C34, C56
TTDI02219	Beta-nerve growth factor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02220	Sarcoglycan alpha	Duchenne muscular dystrophy	359.1	G71.0
TTDI02220	Sarcoglycan alpha	Muscular dystrophy	.	G71.0
TTDI02221	Wiskott-Aldrich syndrome protein	WiskottCAldrich syndrome	.	D82.0
TTDI02222	ATP-binding cassette sub-family A member 4 (ABCA4)	Retinitis pigmentosa	.	H35.5
TTDI02223	Kinetochore protein Nuf2	Prostate tumor	185	C61
TTDI02224	Quinone oxidoreductase	Obesity	278	E66
TTDI02226	Hedgehog protein	Breast cancer	174, 175, 217	C50, D24
TTDI02226	Hedgehog protein	Cancer	140-229	C00-C96
TTDI02228	Insulin-like growth factor-1 ligand	Cancer	140-229	C00-C96
TTDI02229	Opioid growth factor receptor	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02229	Opioid growth factor receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02230	Mycobacterium tuberculosis antigen complex 85A	Mycobacterium tuberculosis infection	.	A15-A19
TTDI02231	Pyruvate dehydrogenase kinase isoform 2 (PDHK2)	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI02231	Pyruvate dehydrogenase kinase isoform 2 (PDHK2)	Pulmonary hypertension	416	I27.0, I27.2
TTDI02233	mRNA of influenza virus Env protein	Influenza virus infections	487, 488	J10, J11
TTDI02235	mRNA of VEGF	Age related macular degeneration	.	H35.30
TTDI02235	mRNA of VEGF	Macular degeneration	362.5	H35.3
TTDI02236	mRNA of CCR5	HIV infections	001-139, 042	A00-B99, B20
TTDI02236	mRNA of CCR5	Human immunodeficiency virus infection	279.3	D84.9
TTDI02237	mRNA of SYK	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02237	mRNA of SYK	B-cell lymphoma	202.8	C85.1
TTDI02237	mRNA of SYK	Chronic lymphocytic leukaemia	204.1, 208.9	C91-C95, C91.1
TTDI02239	mRNA of PLK1	Bladder cancer	140-229, 188	C00-C96, C67
TTDI02240	mRNA of ANGPTL3	Hyperlipidemia	272.0-272.4	E78
TTDI02242	mRNA of ebola virus VP35	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
TTDI02242	mRNA of ebola virus VP35	Marburg virus disease	78.89	A98.3
TTDI02245	mRNA of Insulin-like growth factor 1 receptor	Psoriatic disorders	696	L40
TTDI02246	mRNA of ebola virus VP24	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
TTDI02246	mRNA of ebola virus VP24	Marburg virus disease	78.89	A98.3
TTDI02248	mRNA of Transferrin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02255	mRNA of Caspase-2	Glaucoma	365	H40-H42
TTDI02256	mRNA of Beta 2 adrenoceptor	Ocular hypertension	365.04	H40.0
TTDI02257	mRNA of DMPK	Myotonic dystrophy	.	G71.1
TTDI02258	mRNA of NFkappaB	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDI02259	mRNA of Ribonucleotide reductase R2 component	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02260	mRNA of BCL-2	Cancer	140-229	C00-C96
TTDI02260	mRNA of BCL-2	Leukaemia	204	C91.0
TTDI02260	mRNA of BCL-2	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02261	mRNA of Plasma kallikrein	Hereditary angioedema	277.6	D84.1
TTDI02262	mRNA of CYP3A4	Anxiety disorder	300, 311	F32, F40-F42
TTDI02263	miR-34	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
TTDI02264	HCV MicroRNA-122 (miR-122)	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02265	mRNA of C-myc binding protein	Hepatocellular carcinoma	155	C22.0
TTDI02266	mRNA of Apolipoprotein A	Coronary artery disease	410-414, 429.2	I20-I25
TTDI02267	mRNA of marburg virus nucleoprotein NP	Marburg virus infection	.	A98.3
TTDI02268	mRNA of Myc proto-oncogene protein	Cancer	140-229	C00-C96
TTDI02268	mRNA of Myc proto-oncogene protein	Coronary artery disease	410-414, 429.2	I20-I25
TTDI02269	mRNA of STMN1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02270	mRNA of Keratin 6A	Pachyonychia	.	Q84.5
TTDI02271	ALK tyrosine kinase receptor	Advanced solid tumours	140-199, 183, 210-229	C00-C75, C56, C7A, C7B, D10-D36, D3A
TTDI02271	ALK tyrosine kinase receptor	Cancer	140-229	C00-C96
TTDI02271	ALK tyrosine kinase receptor	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02271	ALK tyrosine kinase receptor	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02271	ALK tyrosine kinase receptor	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
TTDI02271	ALK tyrosine kinase receptor	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDI02271	ALK tyrosine kinase receptor	Non-small-cell lung cancer	162, 183	C33, C34, C56
TTDI02271	ALK tyrosine kinase receptor	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDI02271	ALK tyrosine kinase receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02271	ALK tyrosine kinase receptor	Under research	.	.
TTDI02272	N-acetylgalactosamine 6 sulfatase	Morquio syndrome	.	E76.2
TTDI02272	N-acetylgalactosamine 6 sulfatase	Mucopolysaccharidosis	.	E76
TTDI02273	Lyn tyrosine kinase	Cancer	140-229	C00-C96
TTDI02275	Hyaluronidase	Edema	.	R60.9
TTDI02275	Hyaluronidase	Immunodeficiency	279.3	D84.9
TTDI02275	Hyaluronidase	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02286	Iduronate 2-sulfatase	Hunter syndrome	.	E76.1
TTDI02287	Proto-oncogene c-RAF	Cancer	140-229	C00-C96
TTDI02293	Alpha-mannosidase	Alpha-mannosidosis	.	E77.1
TTDI02293	Alpha-mannosidase	Muscular dystrophy	.	G71.0
TTDI02294	mRNA of Survival motor neuron protein	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
TTDI02295	Retinal pigment epithelium protein	Blindness	.	H53.6
TTDI02295	Retinal pigment epithelium protein	Ocular disease	.	H00-H59
TTDI02295	Retinal pigment epithelium protein	Retinopathy	362.0-362.2	H35-H35.2
TTDI02295	Retinal pigment epithelium protein	Vision disorder	.	H53
TTDI02295	Retinal pigment epithelium protein	Visual disturbances	.	H53
TTDI02296	Interleukin-29 ligand	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02296	Interleukin-29 ligand	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI02297	PI3K beta	Cancer	140-229	C00-C96
TTDI02297	PI3K beta	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02298	mRNA of Nuclear factor kappa B	Ulcerative colitis	556	K51
TTDI02299	mRNA of Insulin receptor substrate-1	Macular degeneration	362.5	H35.3
TTDI02300	mRNA of Dystrophin	Duchenne dystrophy	.	G71.0
TTDI02300	mRNA of Dystrophin	Duchenne muscular dystrophy	359.1	G71.0
TTDI02301	Mitochondrial complex I	Myocardial disease	.	I21-I22,I40-I42
TTDI02302	CD6	Diabetes mellitus type 1	250	E10
TTDI02303	Lysosomal acid lipase	Enzyme deficiency	.	E70-E90
TTDI02304	Bacterial DNA-directed RNA polymerase beta' chain	Infections disease	.	A00-B99
TTDI02306	mRNA of TGF beta-2 ligand	Brain cancer	191, 225.0	C71, D33
TTDI02306	mRNA of TGF beta-2 ligand	Cancer	140-229	C00-C96
TTDI02308	mRNA of BIRC5	Cancer	140-229	C00-C96
TTDI02309	Hepatitis C virus non-structural protein 5A	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02311	mRNA of AKT1	Cancer	140-229	C00-C96
TTDI02312	Leukocyte proteinase-3	Myeloid leukemia	208.9	C91-C95
TTDI02312	Leukocyte proteinase-3	Pulmonary arterial hypertension	416	I27.0, I27.2
TTDI02313	Proto-oncogene Mas	Adult respiratory distress syndrome	518.5, 518.82	J80
TTDI02313	Proto-oncogene Mas	Sarcoma	202.8	C81-C96
TTDI02317	PDGF-B ligand	Diabetic foot ulcer	707	L88-L89
TTDI02317	PDGF-B ligand	Macular degeneration	362.5	H35.3
TTDI02320	Glutamate decarboxylase 2	Diabetes mellitus type 1	250	E10
TTDI02323	Keratinocyte growth factor 2	Oral mucositis	528	K12.3
TTDI02323	Keratinocyte growth factor 2	Skin burns	940-949	T20-T31
TTDI02323	Keratinocyte growth factor 2	Wound healing	.	T14.0-T14.1
TTDI02324	Myelin basic protein	Multiple sclerosis	340	G35
TTDI02325	mRNA of p53	Hearing disorder	.	H90.5
TTDI02326	Chemokine receptor 3	Asthma	493	J45
TTDI02327	ADAM 10	Breast cancer	174, 175, 217	C50, D24
TTDI02327	ADAM 10	Cancer	140-229	C00-C96
TTDI02329	CMV 65kDa lower matrix phosphoprotein	Cytomegalovirus infection	001-139, 078.5	A00-B99, B25
TTDI02330	Tissue factor pathway inhibitor	Factor IX deficiency	.	D67
TTDI02330	Tissue factor pathway inhibitor	Sepsis	995.0, 995.91	A40, A41, T78.2
TTDI02331	Melanocytes lineage-specific antigen GP100	Melanoma	172.9	C43
TTDI02332	Picornavirus capsid protein VP1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI02333	X-linked inhibitor of apoptosis protein	Cancer	140-229	C00-C96
TTDI02333	X-linked inhibitor of apoptosis protein	Hematological malignancies	200-209	C81-C96
TTDI02333	X-linked inhibitor of apoptosis protein	Huntington's disease	294.1, 333.4	F02.2, G10
TTDI02333	X-linked inhibitor of apoptosis protein	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDI02333	X-linked inhibitor of apoptosis protein	Retinopathy	362.0-362.2	H35-H35.2
TTDI02335	Interleukin-24 ligand	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02336	Interleukin-23 receptor	Arthritis	710-719	M00-M25
TTDI02336	Interleukin-23 receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI02336	Interleukin-23 receptor	Cancer	140-229	C00-C96
TTDI02336	Interleukin-23 receptor	Immune disorder	.	D80-D89
TTDI02336	Interleukin-23 receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDI02336	Interleukin-23 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02338	Melanoma associated antigen 1	Breast cancer	174, 175, 217	C50, D24
TTDI02338	Melanoma associated antigen 1	Melanoma	172.9	C43
TTDI02339	MHC class II antigen DR (HLA-DR)	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02342	Gastric inhibitory polypeptide receptor	Diabetes mellitus type 2	250	E11
TTDI02342	Gastric inhibitory polypeptide receptor	Non-insulin dependent diabetes	.	E11.9
TTDI02344	mRNA of Ribonucleotide reductase R1 component	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02345	Enterobacteria phage shiga like toxin II B subunit	Escherichia coli infection	.	A00-B99
TTDI02348	Complement C1q subcomponent	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDI02349	Serine palmitoyltransferase	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02350	Fatty acid binding protein	Lipid metabolism disorder	.	E75-E78
TTDI02350	Fatty acid binding protein	Obesity	278	E66
TTDI02351	Apolipoprotein A-IV	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10, I11, I12, I13, I15, I50
TTDI02352	Cadherin-11	Metastasis	.	C00-C97
TTDI02353	Cathepsin V	Colorectal cancer	153, 154	C18-C21
TTDI02354	Complement Factor B	Age related macular degeneration	.	H35.30
TTDI02354	Complement Factor B	Asthma	493	J45
TTDI02354	Complement Factor B	Coronary artery disease	410-414, 429.2	I20-I25
TTDI02355	Complement factor I	Cerebrovascular ischaemia	434.91	I61-I63
TTDI02356	Chitinase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02357	Transcriptional repressor CTCFL	Breast cancer	174, 175, 217	C50, D24
TTDI02357	Transcriptional repressor CTCFL	Cancer	140-229	C00-C96
TTDI02359	Porphobilinogen deaminase	Acute intermittent (hepatic) porphyria	.	E80.21
TTDI02359	Porphobilinogen deaminase	Porphyria	277.1	E80.0-E80.2
TTDI02360	Laminin gamma-2 subunit	Cancer	140-229	C00-C96
TTDI02361	Leukemia inhibitory factor receptor	Infertility	628	N97.0
TTDI02362	Membrane cofactor protein	Breast cancer	174, 175, 217	C50, D24
TTDI02362	Membrane cofactor protein	Cancer	140-229	C00-C96
TTDI02363	Neurotrophin-4 ligand	Central nervous system disease	.	G00-G99
TTDI02363	Neurotrophin-4 ligand	Glaucoma	365	H40-H42
TTDI02363	Neurotrophin-4 ligand	Macular degeneration	362.5	H35.3
TTDI02364	D-amino acid oxidase	Cognitive impairment	331.83	G31.84
TTDI02365	Ras-related C3 botulinum toxin substrate 1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02366	Plasma retinol-binding protein	Retinopathy	362.0-362.2	H35-H35.2
TTDI02368	Alanine glyoxylate aminotransferase	Hyperoxaluria	.	E74.8
TTDI02369	Translationally controlled tumor protein	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDI02369	Translationally controlled tumor protein	Allergy	995.3	T78.4
TTDI02370	HIV virion infectivity factor	HIV infections	001-139, 042	A00-B99, B20
TTDI02370	HIV virion infectivity factor	HIV-1 infections	001-139, 042	A00-B99, B20
TTDI02371	Zap70 tyrosine kinase	Cancer	140-229	C00-C96
TTDI02371	Zap70 tyrosine kinase	Immune disorder	.	D80-D89
TTDI02371	Zap70 tyrosine kinase	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02372	Apoptosis regulator BAK	Heart failure	410, 428	I21, I22, I50
TTDI02373	Transferrin	Cancer	140-229	C00-C96
TTDI02373	Transferrin	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDI02374	Golgi alpha-mannosidase II	Cancer	140-229	C00-C96
TTDI02375	Complement factor P	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02376	Feto-acinar pancreatic protein (FAPP)	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02377	Epha4 tyrosine kinase receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02379	mRNA of influenza virus neuraminidase	Influenza virus infections	487, 488	J10, J11
TTDI02380	mRNA of TNF alpha ligand	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02383	mRNA of Protein kinase C alpha	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI02384	mRNA of Antigen KI-67	Bladder cancer	140-229, 188	C00-C96, C67
TTDI02385	mRNA of Abl	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDI02387	mRNA of BORIS	Breast cancer	174, 175, 217	C50, D24
TTDI02388	mRNA of TGF-alpha	Psoriasis	696	L40
TTDI02389	Radioactive plutonium, americium, and curium	Acute radiation syndrome	990	T66
TTDI02391	Mycobacterium tuberculosis aminoglycoside 2'-N-acetyltransferase	Mycobacterium tuberculosis infection	.	A15-A19
TTDI02392	Bcl 2 binding component 3	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI02393	Amphiregulin ligand	Psoriasis	696	L40
TTDI02395	FGF-14 ligand	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02396	CD160	Autoimmune diseases	279	D84.9, M35.9
TTDI02396	CD160	Ocular disease	.	H00-H59
TTDI02397	Killer cell immunoglobulin-like receptor 3DL2	Mycoses	.	B49
TTDI02398	CD58	Immune disorder	.	D80-D89
TTDI02399	Centrosomal protein	Cancer	140-229	C00-C96
TTDI02400	Anterior gradient protein 2 homolog	Cancer	140-229	C00-C96
TTDI02401	Bone marrow stromal antigen 2	Autoimmune diseases	279	D84.9, M35.9
TTDI02402	TRP cation channel M5	Non-insulin dependent diabetes	.	E11.9
TTDI02403	Desmoglein-3	Cancer	140-229	C00-C96
TTDI02404	Gap junction alpha-8 protein	Cancer	140-229	C00-C96
TTDI02405	Myosin-2	Reperfusion injury	.	I00-I99
TTDI02406	Tubulin beta-3 chain	Lung cancer	162	C33-C34
TTDI02407	Dysferlin	Myopathy	.	M60-M63
TTDI02408	Prostate derived ETS factor	Cancer	140-229	C00-C96
TTDI02412	Thioredoxin reductase 3	Schistosomiasis	120	B65
TTDI02413	Runt-related transcription factor 2	Bone disease	.	M00-M99
TTDI02413	Runt-related transcription factor 2	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI02414	Runt-related transcription factor 3	Cancer	140-229	C00-C96
TTDI02416	Secreted frizzled related protein-4	Cancer	140-229	C00-C96
TTDI02417	Botulinum toxin B	Clostridium botulinum infection	.	A05.1
TTDI02418	Botulinum toxin	Clostridium botulinum infection	.	A05.1
TTDI02418	Botulinum toxin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02418	Botulinum toxin	Toxicity	.	T36-T50,T51-T65
TTDI02419	E3 ubiquitin protein ligase CBLB	Cancer	140-229	C00-C96
TTDI02420	Myotubularin	Myopathy	.	M60-M63
TTDI02421	Sodium calcium exchanger 1	Multiple sclerosis	340	G35
TTDI02424	Aspartate beta-hydroxylase	Cancer	140-229	C00-C96
TTDI02424	Aspartate beta-hydroxylase	Cholangiocarcinoma	.	C22.1
TTDI02424	Aspartate beta-hydroxylase	Hepatocellular carcinoma	155	C22.0
TTDI02425	Interleukin-17 receptor	Autoimmune diseases	279	D84.9, M35.9
TTDI02425	Interleukin-17 receptor	Rheumatold arthritis	714	M05-M06
TTDI02426	ADAM 30	Cancer	140-229	C00-C96
TTDI02428	Mucin 5A	Xerophthalmia	.	E50.6-E50.7
TTDI02429	Follistatin	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI02430	Peroxiredoxin 4	Cancer	140-229	C00-C96
TTDI02431	Protein arginine N-methyltransferase 4	Cancer	140-229	C00-C96
TTDI02433	HIF prolyl hydroxylase-2	Cancer	140-229	C00-C96
TTDI02437	Cyclophilin D	Ischemia	459.89	I99.8
TTDI02438	B-type natriuretic peptide (BNP)	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI02439	Adiponectin receptor	Atherosclerosis	414.0, 440	I70
TTDI02441	CD97	Rheumatold arthritis	714	M05-M06
TTDI02442	Proteoglycan 4	Osteoarthritis	715	M15-M19, M47
TTDI02445	Activin type-IIB receptor	Muscle wasting disease	.	M62.50?
TTDI02446	Ribonuclease L	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
TTDI02447	MST-1 protein kinase	Ischemic heart diseases	410-414	I20-I25
TTDI02449	IGF binding protein-2	Cancer	140-229	C00-C96
TTDI02449	IGF binding protein-2	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI02450	Integrin alpha-E	Immune disorder	.	D80-D89
TTDI02451	Protein kinase C binding protein NELL1	Heart injury	.	S26
TTDI02454	Phosphodiesterase (PDE) 1B	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDI02456	Ubiquitin thioesterase-7	Cancer	140-229	C00-C96
TTDI02457	Ubiquitin thioesterase-8	Cancer	140-229	C00-C96
TTDI02460	Potassium channel KCNA1 Kv1.1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI02461	SCN8A sodium channel subunit	Multiple sclerosis	340	G35
TTDI02462	Serine protease HTRA1	Age related macular degeneration	.	H35.30
TTDI02466	Potassium channel KCNJ18 Kir2.6	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI02467	DNA mismatch repair protein PMS1	Cancer	140-229	C00-C96
TTDI02470	Butyrophilin like protein 3	Cancer	140-229	C00-C96
TTDI02471	Activated CDC42 kinase 1	Cancer	140-229	C00-C96
TTDI02472	Focal adhesion kinase-2	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI02473	Retinol dehydrogenase	Cancer	140-229	C00-C96
TTDI02476	GTPase activating protein	Pulmonary disease	460-519	J00-J99
TTDI02477	Bone morphogenetic protein-4 ligand	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDI02478	Nodal homolog ligand	Cancer	140-229	C00-C96
TTDI02479	Collagen VII	Epidermolysis bullosa	.	Q81
TTDI02480	Roundabout homolog 4	Acute lung injury	518	J80
TTDI02482	Polo-like kinase 2	Cancer	140-229	C00-C96
TTDI02483	Hepatocyte growth factor activator	Cancer	140-229	C00-C96
TTDI02484	Mannan-binding lectin serine protease-2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02485	Neurotrypsin	Sarcopenia	.	M62.9
TTDI02487	Cyclin A2	Myocardial infarction	410, 434.91	I21, I22, I61-I63
TTDI02488	Stabilin 1	Cancer	140-229	C00-C96
TTDI02488	Stabilin 1	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02489	Histone acetyltransferase p300	Cancer	140-229	C00-C96
TTDI02490	TRP cation channel C5	Anxiety disorder	300, 311	F32, F40-F42
TTDI02492	Caspase-2	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
TTDI02494	Neuropilin 2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02498	Integrin alpha-11	Rheumatold arthritis	714	M05-M06
TTDI02499	HLA class I antigen A-33 alpha	Colon cancer	153, 154	C18-C21
TTDI02500	Activated leukocyte cell adhesion molecule	Autoimmune diseases	279	D84.9, M35.9
TTDI02502	TIE 1 tyrosine kinase receptor	Cancer	140-229	C00-C96
TTDI02503	CD132	Immune disorder	.	D80-D89
TTDI02504	Biglycan	Duchenne dystrophy	.	G71.0
TTDI02505	Decorin	Ulcer	531-534	K25-K27
TTDI02509	G-protein coupled receptor 120	Metabolic disorders	270-279	E70-E89
TTDI02509	G-protein coupled receptor 120	Non-insulin dependent diabetes	.	E11.9
TTDI02511	G protein coupled receptor 101	Obesity	278	E66
TTDI02512	G protein coupled receptor 182	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDI02513	G-protein coupled receptor-39	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI02514	G-protein coupled receptor 85	Obesity	278	E66
TTDI02515	G protein coupled receptor 87	Cancer	140-229	C00-C96
TTDI02516	G protein coupled receptor 81	Coronary artery disease	410-414, 429.2	I20-I25
TTDI02517	Neuropeptide S receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDI02519	P2Y8 purinoceptor	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
TTDI02521	Prokineticin receptor-1	Premature labour	644, 765	O60.1, P07.3
TTDI02522	Sphingosine-1-phosphate receptor-2	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDI02523	Sphingosine-1-phosphate receptor-3	Breast cancer	174, 175, 217	C50, D24
TTDI02525	Heat shock protein beta 8	Ischemic heart diseases	410-414	I20-I25
TTDI02527	Glial cell neurotrophic factor ligand	Central nervous system disease	.	G00-G99
TTDI02527	Glial cell neurotrophic factor ligand	Huntington's disease	294.1, 333.4	F02.2, G10
TTDI02527	Glial cell neurotrophic factor ligand	Parkinson's disease	332	F02.3, G20
TTDI02528	ODF receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDI02529	CD59	Age related macular degeneration	.	H35.30
TTDI02529	CD59	Blood forming organ disorders	.	D75.9
TTDI02530	Cyclic nucleotide-gated channel beta-3 (CNGB3)	Achromatopsia	.	H53.51
TTDI02532	Nestin	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
TTDI02533	Homeobox protein Nkx 3.1	Cancer	140-229	C00-C96
TTDI02534	CD320 antigen	Cancer	140-229	C00-C96
TTDI02537	C-type lectin domain family 9 member A	Cancer	140-229	C00-C96
TTDI02538	Cellular retinol binding protein III	Cancer	140-229	C00-C96
TTDI02539	Prostacyclin synthase	Atherosclerosis	414.0, 440	I70
TTDI02540	Cell division cycle 2-like protein kinase 1	Skin infections	680-709	L00-L99
TTDI02541	I-kappa B kinase epsilon	Breast cancer	174, 175, 217	C50, D24
TTDI02545	Mycobacterium tuberculosis serine/threonine-protein kinase PknB	Mycobacterium tuberculosis infection	.	A15-A19
TTDI02547	GTPase HRas	Cancer	140-229	C00-C96
TTDI02548	TAR DNA binding protein 43	Motor neurone disease	335.2	G12.2
TTDI02549	Serpin I2	Cancer	140-229	C00-C96
TTDI02550	Granzyme B	Aneurysm	.	I72
TTDI02550	Granzyme B	Aortic aneurysm	.	I71
TTDI02552	Kallikrein 1	Respiratory disorder	518.81	J96
TTDI02554	Placenta specific protein 1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02556	Protein Wnt-5a ligand	Breast cancer	174, 175, 217	C50, D24
TTDI02556	Protein Wnt-5a ligand	Melanoma	172.9	C43
TTDI02557	Protein Wnt-7a ligand	Muscle wasting disease	.	M62.50?
TTDI02558	Vasoactive intestinal polypeptide	Cancer	140-229	C00-C96
TTDI02559	Kynurenine oxoglutarate transaminase II	Schizophrenia	295, 710.0	F20, M32
TTDI02560	Peptide YY ligand	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI02561	Ubiquitin-protein ligase E2	Cancer	140-229	C00-C96
TTDI02563	Histidine ammonia lyase	Cancer	140-229	C00-C96
TTDI02564	Tumor necrosis factor 14 ligand	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02565	Vascular endothelial cell growth inhibitor	Under research	.	.
TTDI02566	14-3-3 protein eta	Rheumatold arthritis	714	M05-M06
TTDI02570	Ketohexokinase	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDI02571	Solute carrier family 12A5	Epilepsy	290-319, 345	F01-F99, G40
TTDI02573	Galectin-1	Cancer	140-229	C00-C96
TTDI02574	Galectin-2	Inflammatory bowel disease	555, 556	K50, K51
TTDI02575	Geranyltranstransferase	Bone disease	.	M00-M99
TTDI02575	Geranyltranstransferase	Cancer	140-229	C00-C96
TTDI02576	Microtubule associated protein 4	Cancer	140-229	C00-C96
TTDI02581	Hemoglobin scavenger receptor	Anemia	280-285	D50-D64
TTDI02581	Hemoglobin scavenger receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02582	T-cell surface glycoprotein CD5	Autoimmune diseases	279	D84.9, M35.9
TTDI02582	T-cell surface glycoprotein CD5	Cancer	140-229	C00-C96
TTDI02584	Muscleblind like protein 1	Myotonic dystrophy type 1	.	G71.1
TTDI02587	dUTP pyrophosphatase	Plasmodium falciparum infection	.	B54
TTDI02588	Retinoschisin	Retinoschisis	.	H33.1
TTDI02590	Histone deacetylase-8	Cancer	140-229	C00-C96
TTDI02590	Histone deacetylase-8	Neurodegenerative diseases	330-337	G30-G32
TTDI02591	Amiloride sensitive cation channel 1	Neuropathic pain	356.0, 356.8	G64, G90.0
TTDI02593	Potassium channel KCNJ3 Kir3.1	Atrial fibrillation	272, 427.31	E78, I48
TTDI02597	Lipophilin B	Cancer	140-229	C00-C96
TTDI02598	DNA mismatch repair protein Mlh1	Cancer	140-229	C00-C96
TTDI02601	Prohibitin	Obesity	278	E66
TTDI02601	Prohibitin	Prostate tumor	185	C61
TTDI02604	CD107	Allergy	995.3	T78.4
TTDI02604	CD107	HIV infections	001-139, 042	A00-B99, B20
TTDI02605	Kynurenine 3-hydroxylase	Huntington's disease	294.1, 333.4	F02.2, G10
TTDI02606	Zinc transporter 8	Non-insulin dependent diabetes	.	E11.9
TTDI02607	Divalent metal transporter 1	Iron overload	.	R79.0
TTDI02608	Sphingosine-1-phosphate phosphatase 1	Autoimmune diseases	279	D84.9, M35.9
TTDI02608	Sphingosine-1-phosphate phosphatase 1	Multiple sclerosis	340	G35
TTDI02608	Sphingosine-1-phosphate phosphatase 1	Psoriasis	696	L40
TTDI02609	Interleukin-1 receptor accessory protein	Leukemia	208.9	C91-C95
TTDI02610	Interleukin-18 receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDI02611	Polyamine oxidase	Prostate tumor	185	C61
TTDI02612	Legumain	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02613	Von Hippel-Lindau disease tumor suppressor (VHL)	Renal cell carcinoma	189	C64
TTDI02614	Galactocerebrosidase	Leukodystrophy	.	E75.25
TTDI02616	Cyclin-dependent kinase inhibitor 1B	Deafness	.	H90-H91
TTDI02619	Sentrin specific protease-1	Non-insulin dependent diabetes	.	E11.9
TTDI02622	Cyclin dependent kinase 5 activator 1	Neurodegenerative diseases	330-337	G30-G32
TTDI02623	mRNA cap guanine N7 methyltransferase	Dengue virus infection	001-139, 042-075, 061	A00-B99, A80-A99, A90, B00-B34
TTDI02625	IKK complex associated protein	Graft-versus host disease	.	T86.0
TTDI02627	N-acetylgalactosaminyltransferase 2	Multiple sclerosis	340	G35
TTDI02628	Interleukin-27 ligand	Inflammatory bowel disease	555, 556	K50, K51
TTDI02629	Tyrosyl DNA phosphodiesterase 1	Cancer	140-229	C00-C96
TTDI02631	Torsin 1A	Central nervous system disease	.	G00-G99
TTDI02632	Cardiotrophin-like cytokine factor 1	Immune disorder	.	D80-D89
TTDI02633	Protein O-GlcNAcase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDI02634	CD83	Autoimmune diseases	279	D84.9, M35.9
TTDI02637	SLAM family member 6	Cancer	140-229	C00-C96
TTDI02638	Immune costimulatory protein B7H4	Cancer	140-229	C00-C96
TTDI02641	Protein BTG1	Interstitial cystitis	.	N30.1
TTDI02642	B melanoma antigen 1	Cancer	140-229	C00-C96
TTDI02643	Protein ARMET	Brain injury	.	S09.90
TTDI02643	Protein ARMET	Parkinson's disease	332	F02.3, G20
TTDI02644	Angiomotin	Cancer	140-229	C00-C96
TTDI02645	Huntingtin	Huntington's disease	294.1, 333.4	F02.2, G10
TTDI02646	Monoglyceride lipase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
TTDI02648	Signal transducer CD24	Cancer	140-229	C00-C96
TTDI02649	Interleukin-28B ligand	Under research	.	.
TTDI02650	Kidney associated antigen 1	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDI02652	mRNA of GLI2	Cancer	140-229	C00-C96
TTDI02653	mRNA of HNRNPA2B1	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDI02654	mRNA of ID1	Cancer	140-229	C00-C96
TTDI02655	mRNA of ISG15	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDI02656	mRNA of COPS5	Cancer	140-229	C00-C96
TTDI02657	mRNA of HD	Huntington's disease	294.1, 333.4	F02.2, G10
TTDI02658	mRNA of CD74	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02659	mRNA of MMP2	Ocular disease	.	H00-H59
TTDI02660	mRNA of MMP9	Ocular disease	.	H00-H59
TTDI02661	mRNA of COP1	Hepatocellular carcinoma	155	C22.0
TTDI02663	mRNA of SNCA	Parkinson's disease	332	F02.3, G20
TTDI02664	mRNA of TRPV1	Ocular inflammation	.	H00-H59
TTDI02665	mRNA of VEGF receptor	Ocular disease	.	H00-H59
TTDI02666	mRNA of WEE1	Hepatocellular carcinoma	155	C22.0
TTDI02667	mRNA of Hepcidin	Anemia	280-285	D50-D64
TTDI02668	miR-10b	Metastasis	.	C00-C97
TTDI02669	miR-122	Fatty liver disease	.	K70,K76.0
TTDI02670	miR-146a	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02671	miR-182	Metastasis	.	C00-C97
TTDI02672	miR-21	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI02673	miR-296	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDI02674	miR-33	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDI02675	mRNA of IGFBP2	Prostate tumor	185	C61
TTDI02676	mRNA of IGFBP5	Prostate tumor	185	C61
TTDI02677	mRNA of Coagulation factor XII	Blood clotting disorder	286	D65-D69
TTDI02678	mRNA of TGF beta-1 ligand	Cancer	140-229	C00-C96
TTDI02679	miR-191	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
TTDI02681	mRNA of CD40LG	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDI02682	mRNA of SCN1A	Seizures	345.9, 780.3	G40, P90, R56
TTDI02683	mRNA of NPR1	Cancer	140-229	C00-C96
TTDI02684	mRNA of KRAS	Cancer	140-229	C00-C96
TTDI02685	mRNA of ERBB3	Cancer	140-229	C00-C96
TTDI02686	mRNA of IL4R	Lung inflammation	.	D86
TTDNC00348	MEKK-1 kinase	Breast cancer	174, 175, 217	C50, D24
TTDNC00348	MEKK-1 kinase	Psoriasis	696	L40
TTDNC00350	endosialin	Colorectal cancer	153, 154	C18-C21
TTDNC00350	endosialin	Malignant melanoma	172, 208.9	C43, C91-C95
TTDNC00350	endosialin	Melanoma	172.9	C43
TTDNC00350	endosialin	Sarcoma	203	C81-C96
TTDNC00352	PK	HIV infections	001-139, 042	A00-B99, B20
TTDNC00356	Inhaled steroid	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
TTDNC00356	Inhaled steroid	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDNC00356	Inhaled steroid	SMART syndrome	.	J40-J44, J47
TTDNC00358	Afferent nerve	Bladder pain syndrome; Interstitial cystitis	595.1,338,780	N30.1, G89, R52
TTDNC00358	Afferent nerve	Chronic prostatitis; Chronic pelvic pain syndrome	601.1,338,780	N41.1, G89, R52
TTDNC00361	Hedgehog Signaling Pathway	Advanced basal cell carcinoma	173	C44
TTDNC00361	Hedgehog Signaling Pathway	Basal cell cancer	140-229, 173	C00-C96, C44
TTDNC00361	Hedgehog Signaling Pathway	Basal cell carcinoma	140-199, 173, 210-229	C00-C75, C44, C7A, C7B, D10-D36, D3A
TTDNC00361	Hedgehog Signaling Pathway	Cancer	140-229	C00-C96
TTDNC00361	Hedgehog Signaling Pathway	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDNC00361	Hedgehog Signaling Pathway	Neoadjuvant pancreatic cancer	140-199, 140-229, 157, 208.9, 210-229	C00-C75, C00-C96, C25, C7A, C7B, C91-C95, D10-D36, D3A
TTDNC00361	Hedgehog Signaling Pathway	Operable basal cell carcinoma	173	C44
TTDNC00361	Hedgehog Signaling Pathway	Skin cancers	172, 173	C43, C44
TTDNC00361	Hedgehog Signaling Pathway	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00362	Synthetic, peptide-based erythropoiesis	Anaemia	280-285, 585.9585.1-585.5403	D50-D64, N18
TTDNC00362	Synthetic, peptide-based erythropoiesis	Anemia	280-285	D50-D64
TTDNC00364	Influenza vaccine	Prophylaxis of H5N1 influenza	487	J09
TTDNC00366	JAK	Myelofibrosis	208.9, 289.83, 709.2	C91-C95, C94.4, D47.1, L90.5
TTDNC00366	JAK	Psoriasis	696	L40
TTDNC00366	JAK	Rheumatold arthritis	714	M05-M06
TTDNC00370	DKK1 protein	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00370	DKK1 protein	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDNC00371	IL-21	Autoimmune diseases	279	D84.9, M35.9
TTDNC00371	IL-21	Crohn's disease	555	K50
TTDNC00371	IL-21	Rheumatoid arthritis	710-719, 714	M05-M06
TTDNC00371	IL-21	Rheumatold arthritis	714	M05-M06
TTDNC00371	IL-21	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDNC00372	VLA-1	Rheumatold arthritis	714	M05-M06
TTDNC00373	IFN-alphaR	Hepatitis B virus infection	070.2-070.3	B16, B18.0, B18.1
TTDNC00373	IFN-alphaR	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDNC00373	IFN-alphaR	Multiple sclerosis	340	G35
TTDNC00373	IFN-alphaR	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00373	IFN-alphaR	Scleroderma	701.0710.1	L94.0-L94.1, M34
TTDNC00373	IFN-alphaR	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDNC00375	OxLDL	Arteriosclerosis	440	I70
TTDNC00375	OxLDL	Atherosclerosis	414.0, 440	I70
TTDNC00375	OxLDL	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDNC00377	secretase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00378	Amyloid precursor protein secretase	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00378	Amyloid precursor protein secretase	Mild cognitive impairment	331.83	F06.7
TTDNC00380	BET protein	Acutecoronary syndrome	411.1	I20.0
TTDNC00380	BET protein	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00380	BET protein	Atherosclerosis	414.0, 440	I70
TTDNC00385	VEGF-C	Lymphatic disease	.	I89.8
TTDNC00385	VEGF-C	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00386	catenin	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1, 238.7	C92.0, C92.1, D46
TTDNC00386	catenin	Cancer	140-229	C00-C96
TTDNC00386	catenin	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00387	CBP	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1, 238.7	C92.0, C92.1, D46
TTDNC00387	CBP	Cancer	140-229	C00-C96
TTDNC00387	CBP	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00388	PI3K alpha	Breast cancer	174, 175, 217	C50, D24
TTDNC00388	PI3K alpha	Cancer	140-229	C00-C96
TTDNC00388	PI3K alpha	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00388	PI3K alpha	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00390	HER	Breast cancer	174, 175, 217	C50, D24
TTDNC00390	HER	Glioma	140-199, 183, 191, 210-229	C00-C75, C56, C71, C7A, C7B, D10-D36, D3A
TTDNC00390	HER	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNC00391	Pim kinase	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00391	Pim kinase	Haematological malignancies	200-209	C81-C96
TTDNC00391	Pim kinase	Hematological malignancies	200-209	C81-C96
TTDNC00391	Pim kinase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00392	TORC1	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00392	TORC1	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNC00392	TORC1	Hematological malignancies	200-209	C81-C96
TTDNC00392	TORC1	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00392	TORC1	Multiple myeloma; Waldenstrom's macroglobulinemia	203.0, 273.3	C88.0, C90.0
TTDNC00392	TORC1	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00392	TORC1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00393	TORC2	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00393	TORC2	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNC00393	TORC2	Hematological malignancies	200-209	C81-C96
TTDNC00393	TORC2	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00393	TORC2	Multiple myeloma; Waldenstrom's macroglobulinemia	203.0, 273.3	C88.0, C90.0
TTDNC00393	TORC2	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00393	TORC2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00395	NADH oxidase	Fibrosis	709.2	L90.5
TTDNC00395	NADH oxidase	Refractory solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00397	Delta-like 4	Cancer	140-229	C00-C96
TTDNC00397	Delta-like 4	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00398	B7-H3	Glioblastoma multiforme	191	C71
TTDNC00398	B7-H3	Refractory metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00398	B7-H3	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00400	PIK-1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00405	Sonic hedgehog pathway	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00405	Sonic hedgehog pathway	Cancer	140-229	C00-C96
TTDNC00406	CD137 antigen	Autoimmune diseases	279	D84.9, M35.9
TTDNC00406	CD137 antigen	Cancer	140-229	C00-C96
TTDNC00406	CD137 antigen	Immune disorder	.	D80-D89
TTDNC00406	CD137 antigen	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00407	Stathim	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00408	MTF-1	Cancer	140-229	C00-C96
TTDNC00408	MTF-1	Metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00409	Stemness	Cholangiocarcinoma; Hepatocellular carcinoma; Ovarian cancer	.	C22.1,C22.0,C56
TTDNC00409	Stemness	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00409	Stemness	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00411	E2F1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00412	TYK2	Cancer	140-229	C00-C96
TTDNC00412	TYK2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00413	KIR	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00413	KIR	Cancer	140-229	C00-C96
TTDNC00414	LAG3	Allergy	995.3	T78.4
TTDNC00414	LAG3	Autoimmune diseases	279	D84.9, M35.9
TTDNC00414	LAG3	Cancer	140-229	C00-C96
TTDNC00414	LAG3	Hematological malignancies	200-209	C81-C96
TTDNC00414	LAG3	Under research	.	.
TTDNC00415	Notch	Cancer	140-229	C00-C96
TTDNC00415	Notch	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDNC00415	Notch	T-cell acute lymphocytic leukemia	204.0-208.9	C83-C88
TTDNC00415	Notch	T-cell lymphoblastic lymphoma	204.0-208.9	C84
TTDNC00418	RON	Cancer	140-229	C00-C96
TTDNC00418	RON	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00420	HB-EGF	Cancer	140-229	C00-C96
TTDNC00420	HB-EGF	Interstitial cystitis	.	N30.1
TTDNC00420	HB-EGF	Solid cancer	140-199	C00-C75, C7A, C7B
TTDNC00420	HB-EGF	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00422	Toposisomerase-1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00423	DS6	DS6-positive solid tumors	140-199	C00-C75, C7A, C7B
TTDNC00424	CD38	Cancer	140-229	C00-C96
TTDNC00424	CD38	Hematological malignancies	200-209	C81-C96
TTDNC00424	CD38	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00425	CK2	Cancer	140-229	C00-C96
TTDNC00425	CK2	Cervical cancer	140-229, 180	C00-C96, C53
TTDNC00425	CK2	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00425	CK2	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00425	CK2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00429	WNT signaling pathway	Breast cancer	174, 175, 217	C50, D24
TTDNC00429	WNT signaling pathway	Cancer	140-229	C00-C96
TTDNC00429	WNT signaling pathway	Malignant melanoma	172, 208.9	C43, C91-C95
TTDNC00433	PI3K beta	PTEN-deficient tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00433	PI3K beta	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00434	CDK	Cancer	140-229	C00-C96
TTDNC00434	CDK	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00435	HIF-1 pathway	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00437	CIF	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00438	MAP	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00439	DR5	Breast cancer	174, 175, 217	C50, D24
TTDNC00439	DR5	Colorectal cancer	153, 154	C18-C21
TTDNC00439	DR5	Hepatocellular carcinoma	155	C22.0
TTDNC00439	DR5	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
TTDNC00439	DR5	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDNC00439	DR5	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00439	DR5	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDNC00442	Ileal bile acid transfer	Hyperlipidemia	272.0-272.4	E78
TTDNC00442	Ileal bile acid transfer	Lipid metabolism disorder	.	E75-E78
TTDNC00442	Ileal bile acid transfer	Primary biliary cirrhosis	571.6	K74.3
TTDNC00442	Ileal bile acid transfer	Type 2 diabetes	250.00, 250.02	E11
TTDNC00443	Human pro-islet peptide	Diabetes mellitus type 2	250	E11
TTDNC00443	Human pro-islet peptide	Insulin dependent diabetes	.	E10
TTDNC00443	Human pro-islet peptide	Liver failure	.	K72.9
TTDNC00443	Human pro-islet peptide	Type 1/2 diabetes	250, 278	E08-E13, E66
TTDNC00444	Lysophosphatidic acid transferase	Type 1 diabetes	250, 250.01	E08-E13, E10
TTDNC00446	HPTP	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
TTDNC00446	HPTP	Peripheral arterial disease	443.9	I73.9
TTDNC00448	Cathepsin A	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDNC00448	Cathepsin A	Cardiovascular disease 	250	E08-E13
TTDNC00448	Cathepsin A	Diabetic complication	.	E08-E13
TTDNC00449	protease	Alpha-1 antitrypsin deficiency	273.4	E88.0
TTDNC00449	protease	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00449	protease	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDNC00449	protease	Bone disease	.	M00-M99
TTDNC00449	protease	Cancer	140-229	C00-C96
TTDNC00449	protease	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDNC00449	protease	Coagulation	.	I80-I82
TTDNC00449	protease	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDNC00449	protease	Genetic disorder	.	Q00-Q99
TTDNC00449	protease	Gram-negative bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00449	protease	HIV infections	001-139, 042	A00-B99, B20
TTDNC00449	protease	Heart disease	390-429	I00-I52
TTDNC00449	protease	Insulin dependent diabetes	.	E10
TTDNC00449	protease	Mycobacterium tuberculosis infection	.	A15-A19
TTDNC00449	protease	Plasmodium infection	.	B54
TTDNC00449	protease	Prostate tumor	185	C61
TTDNC00449	protease	Rheumatold arthritis	714	M05-M06
TTDNC00449	protease	Under research	.	.
TTDNC00451	MAG pDNA	HIV infection	001-139, 042	A00-B99, B20
TTDNC00451	MAG pDNA	HIV infections	001-139, 042	A00-B99, B20
TTDNC00451	MAG pDNA	HIV-1 infections	001-139, 042	A00-B99, B20
TTDNC00451	MAG pDNA	HIV-2 infections	79.53	B97.35
TTDNC00453	Triple reuptake	Attention deficit hyperactivity disorder	314.00, 314.01	F90
TTDNC00453	Triple reuptake	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
TTDNC00455	Vasopressin-1 receptor	Autism	299	F84.0
TTDNC00456	Phosphodiesterase 10A (PDE10A)	Central nervous system disease	.	G00-G99
TTDNC00456	Phosphodiesterase 10A (PDE10A)	Huntington's disease	294.1, 333.4	F02.2, G10
TTDNC00456	Phosphodiesterase 10A (PDE10A)	Schizoaffective disorder; Schizophrenia	295, 295.70	F20, F25
TTDNC00456	Phosphodiesterase 10A (PDE10A)	Schizophrenia	295, 710.0	F20, M32
TTDNC00457	Recombinant fusion protein	HIV infections	001-139, 042	A00-B99, B20
TTDNC00457	Recombinant fusion protein	Influenza A virus H1N1 infections	487, 488	J10, J11
TTDNC00457	Recombinant fusion protein	Influenza A virus infections	487, 488	J10, J11
TTDNC00457	Recombinant fusion protein	Influenza virus infections	487, 488	J10, J11
TTDNC00457	Recombinant fusion protein	Multiple sclerosis	340	G35
TTDNC00457	Recombinant fusion protein	Tuberculosis	010-018	A15-A19
TTDNC00460	Thymic stromal lymphopoietin	Asthma	493	J45
TTDNC00461	Sclerostin	Bone disease	.	M00-M99
TTDNC00461	Sclerostin	Bone-related conditions	710-739	M00-M99
TTDNC00461	Sclerostin	Fracture healing	.	S00-T88
TTDNC00461	Sclerostin	Metabolic bone disease	.	E50-E64,E70-E90
TTDNC00461	Sclerostin	Osteopenia	733.9	M85.8
TTDNC00461	Sclerostin	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDNC00461	Sclerostin	Postmenopausal osteoporosis	627.2, 733.0	M80-M81, N95.0
TTDNC00461	Sclerostin	Under research	.	.
TTDNC00463	B7RP1	Lupus	710	M32
TTDNC00463	B7RP1	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDNC00464	CD32b	Autoimmune diseases	279	D84.9, M35.9
TTDNC00466	BL	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00466	BL	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00468	Programmed cell death? ligand 1 (PD-L1)	Cancer	140-229	C00-C96
TTDNC00468	Programmed cell death? ligand 1 (PD-L1)	Metastatic melanoma	172	C43
TTDNC00468	Programmed cell death? ligand 1 (PD-L1)	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00470	Murine anti-OX40 Mab	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00471	Inhaled TLR7	Asthma	493	J45
TTDNC00472	Inhaled SGRM	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J45, J47
TTDNC00472	Inhaled SGRM	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDNC00473	C5	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDNC00477	Mesothelin-ADC	Cancer	140-229	C00-C96
TTDNC00477	Mesothelin-ADC	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00477	Mesothelin-ADC	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00479	S-PRAnt	Symptomatic uterine fibroids	219	D25
TTDNC00479	S-PRAnt	Uterine leiomyoma	218.9	D25
TTDNC00481	DNAPKi	Cancer	140-229	C00-C96
TTDNC00481	DNAPKi	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00481	DNAPKi	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00481	DNAPKi	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00483	NY-ESO-1	Cancer	140-229	C00-C96
TTDNC00483	NY-ESO-1	Melanoma	172.9	C43
TTDNC00483	NY-ESO-1	Multiple solid tumors	140-199	C00-C75, C7A, C7B
TTDNC00483	NY-ESO-1	Non-small-cell lung cancer	162, 183	C33, C34, C56
TTDNC00483	NY-ESO-1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00484	CD27	Cancer	140-229	C00-C96
TTDNC00484	CD27	Hematological malignancies	200-209	C81-C96
TTDNC00484	CD27	Lymphoma; Leukemia; Solid tumors	140-199, 202, 204-208	C00-C75, C7A, C7B, C81-C96
TTDNC00484	CD27	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00488	Second-generation proteasome	Cancer	140-229	C00-C96
TTDNC00488	Second-generation proteasome	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNC00488	Second-generation proteasome	Hematological malignancies	200-209	C81-C96
TTDNC00488	Second-generation proteasome	Lymphoma; Waldenstrm's macroglobulinemia	140-199, 202.8, 203.0, 210-229	C00-C75, C7A, C7B, C81-C96, C90.0, D10-D36, D3A
TTDNC00488	Second-generation proteasome	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00488	Second-generation proteasome	Relapsed/refractory myeloma	203.0, 277.3	C90.0, E85
TTDNC00488	Second-generation proteasome	Relapsed/refractory primary amyloidosis	277.3	E85
TTDNC00488	Second-generation proteasome	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00489	PD-1	Hematological malignancies	200-209	C81-C96
TTDNC00489	PD-1	Lung cancer	162	C33-C34
TTDNC00489	PD-1	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDNC00489	PD-1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00491	Multi-IAP	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00492	DOT1L	Leukaemia	204	C91.0
TTDNC00492	DOT1L	Leukemia	208.9	C91-C95
TTDNC00493	Cell-cycle	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
TTDNC00493	Cell-cycle	Acute lymphoblastic leukemia; Acute myeloid leukemia	204.0, 205.0, 238.7	C91.0, C92.0, D46
TTDNC00493	Cell-cycle	Leukemia	208.9	C91-C95
TTDNC00494	PKC	Diffuse large b-cell lymphoma	200.0, 202.8, 203.0	C81-C96, C83.3, C85.1, C90.0
TTDNC00494	PKC	Psoriasis	696	L40
TTDNC00497	DKK2 protein	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00497	DKK2 protein	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00498	Proto-oncogene pim-1	Cancer	140-229	C00-C96
TTDNC00498	Proto-oncogene pim-1	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00498	Proto-oncogene pim-1	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00499	STEAP1	Metastatic hormone-refractory prostate cancer	140-229, 185	C00-C96, C61
TTDNC00499	STEAP1	Prostate cancer	140-229, 185	C00-C96, C61
TTDNC00500	Nucleotide reverse transcriptase	Chronic HBV infection	070.2-070.3	B16, B18.0, B18.1
TTDNC00501	Tarmogen T cell immunity	Chronic HBV infection	070.2-070.3	B16, B18.0, B18.1
TTDNC00501	Tarmogen T cell immunity	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Acute liver failure	.	K72
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Acute lung injury	518	J80
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Adult respiratory distress syndrome	518.5, 518.82	J80
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Alopecia	704.09	L65.9
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Arthritis	710-719	M00-M25
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Asthma	493	J45
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Autoimmune diseases	279	D84.9, M35.9
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Endotoxic shock	.	R57.8
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Human immunodeficiency virus infection	279.3	D84.9
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Inflammatory bowel disease	555, 556	K50, K51
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Inflammatory disorders	.	.
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Ischemia-reperfusion injury	.	I00-I99
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Multiple sclerosis	340	G35
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Oral mucositis	528	K12.3
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Osteoarthritis	715	M15-M19, M47
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Psoriasis	696	L40
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Rheumatold arthritis	714	M05-M06
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Sciatica	.	M54.3-M54.4
TTDNC00502	Tumour necrosis factor receptor-1 (TNFR1)	Under research	.	.
TTDNC00504	CD3	Acne vulgaris	706.1	L70.0
TTDNC00504	CD3	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
TTDNC00504	CD3	Breast cancer	174, 175, 217	C50, D24
TTDNC00504	CD3	Melanoma	172.9	C43
TTDNC00504	CD3	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00504	CD3	Prostate tumor	185	C61
TTDNC00504	CD3	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00508	Endogenous gut peptide	Obesity	278	E66
TTDNC00510	cephalosporin	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00510	cephalosporin	Infections disease	.	A00-B99
TTDNC00510	cephalosporin	MRSA infection	41.12	A49.02
TTDNC00510	cephalosporin	Methicillin-resistant staphylococcus aureus	.	B95.62
TTDNC00510	cephalosporin	Serious infections	001-139	A00-B99
TTDNC00513	Bromodomain	Cancer	140-229	C00-C96
TTDNC00513	Bromodomain	NUT gene midline carcinoma	.	C00-D48
TTDNC00518	C5aR	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDNC00518	C5aR	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDNC00518	C5aR	Rheumatoid arthritis	710-719, 714	M05-M06
TTDNC00518	C5aR	Rheumatold arthritis	714	M05-M06
TTDNC00518	C5aR	Vasculitis	.	I77.6,I80
TTDNC00520	NKG2A	Autoimmune diseases	279	D84.9, M35.9
TTDNC00520	NKG2A	Rheumatoid arthritis	710-719, 714	M05-M06
TTDNC00521	Colony stimulating factor-1 receptor (CSF-1R)	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00522	TWEAK	Cancer	140-229	C00-C96
TTDNC00522	TWEAK	Lupus nephritis	583.81	M32.1, N08.5
TTDNC00522	TWEAK	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00524	Coagulation factor VIII	Atopic dermatitis	691.8, 692.9	L20, L20-L30
TTDNC00524	Coagulation factor VIII	Cancers	140-239	C00-C96
TTDNC00524	Coagulation factor VIII	Enthesopathy	726	M76-M77.9
TTDNC00524	Coagulation factor VIII	Hemophilia A	286	D66
TTDNC00524	Coagulation factor VIII	Rheumatold arthritis	714	M05-M06
TTDNC00524	Coagulation factor VIII	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00524	Coagulation factor VIII	Type 2 diabetes	250.00, 250.02	E11
TTDNC00526	P75 receptor	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
TTDNC00528	MTORC1	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNC00528	MTORC1	Hematological malignancies	200-209	C81-C96
TTDNC00528	MTORC1	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00528	MTORC1	Multiple myeloma; Waldenstrom's macroglobulinemia	203.0, 273.3	C88.0, C90.0
TTDNC00528	MTORC1	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00528	MTORC1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00529	MTORC2	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNC00529	MTORC2	Hematological malignancies	200-209	C81-C96
TTDNC00529	MTORC2	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00529	MTORC2	Multiple myeloma; Waldenstrom's macroglobulinemia	203.0, 273.3	C88.0, C90.0
TTDNC00529	MTORC2	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00529	MTORC2	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00531	PDE1	Cognitive impairment	331.83	G31.84
TTDNC00531	PDE1	Schizophrenia	295, 710.0	F20, M32
TTDNC00532	Ferroportin	Anemia	280-285	D50-D64
TTDNC00533	 p70 S6 Kinase	Cancer	140-229	C00-C96
TTDNC00536	IgG1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00537	Ultra-rapid-acting recombinant human insulin	Diabetes mellitus type 1	250	E10
TTDNC00537	Ultra-rapid-acting recombinant human insulin	Type 1 diabetes	250, 250.01	E08-E13, E10
TTDNC00540	CD37	Autoimmune diseases	279	D84.9, M35.9
TTDNC00540	CD37	Cancer	140-229	C00-C96
TTDNC00540	CD37	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDNC00540	CD37	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00541	Angiogenesis	Obesity	278	E66
TTDNC00541	Angiogenesis	Ocular disease	.	H00-H59
TTDNC00541	Angiogenesis	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00542	HDAC6	Autoimmune diseases	279	D84.9, M35.9
TTDNC00542	HDAC6	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00542	HDAC6	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00543	ENG protein	Breast cancer	174, 175, 217	C50, D24
TTDNC00543	ENG protein	Fallopian tube cancer; Peritoneal cancer	140-229, 183.2, 221.0	C00-C96, C57, D28
TTDNC00543	ENG protein	Macular degeneration	362.5	H35.3
TTDNC00543	ENG protein	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00543	ENG protein	Prostate cancer	140-229, 185	C00-C96, C61
TTDNC00544	DNMT	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00544	DNMT	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDNC00546	Folate-binding protein E39	Breast cancer	174, 175, 217	C50, D24
TTDNC00546	Folate-binding protein E39	Endometrial cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
TTDNC00546	Folate-binding protein E39	Endometrial cancer; Ovarian cancer	140-229, 182.0, 183	C00-C96, C54.1, C56
TTDNC00547	Pan-DAC	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDNC00547	Pan-DAC	Hematological malignancies	200-209	C81-C96
TTDNC00547	Pan-DAC	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDNC00547	Pan-DAC	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00549	Ras	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNC00549	Ras	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDNC00550	HepB	Hepatocellular carcinoma	155	C22.0
TTDNC00550	HepB	Inoperable/unresectable liver cancer	140-229, 155	C00-C96, C22.0
TTDNC00553	PKC-Delta	Reperfusion injury following acute myocardial infarction	410	I21, I21-I22, I22
TTDNC00554	Cholesterol absorption	Hypercholesterolemia	272	E78.0
TTDNC00554	Cholesterol absorption	Hyperlipidemia	272.0-272.4	E78
TTDNC00560	Neurotransmitter receptor	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00560	Neurotransmitter receptor	Schizophrenia	295, 710.0	F20, M32
TTDNC00561	M1 prime	Allergic asthma	493, 995.3	J45, T78.4
TTDNC00561	M1 prime	Asthma	493	J45
TTDNC00572	Aldosterone synthase	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDNC00572	Aldosterone synthase	Cushing's disease	255	E24.0
TTDNC00572	Aldosterone synthase	Heart failure	410, 428	I21, I22, I50
TTDNC00572	Aldosterone synthase	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDNC00572	Aldosterone synthase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00576	insulin	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDNC00576	insulin	Diabetes mellitus type 1	250	E10
TTDNC00576	insulin	Diabetes mellitus type 2	250	E11
TTDNC00576	insulin	Diabetic complication	.	E08-E13
TTDNC00576	insulin	Type 2 diabetes	250.00, 250.02	E11
TTDNC00579	SLGT2	Diabetes mellitus type 2	250	E11
TTDNC00579	SLGT2	Type 2 diabetes	250.00, 250.02	E11
TTDNC00582	Intranasal dopamine-receptor	Diabetic gastroparesis	250, 536.3	E08-E13, K31.8
TTDNC00584	Recombinant human interleukin-7	Diabetes mellitus type 1	250	E10
TTDNC00584	Recombinant human interleukin-7	HIV infections	001-139, 042	A00-B99, B20
TTDNC00584	Recombinant human interleukin-7	Human immunodeficiency virus infection	279.3	D84.9
TTDNC00584	Recombinant human interleukin-7	Malignant melanoma	172, 208.9	C43, C91-C95
TTDNC00584	Recombinant human interleukin-7	Multiple sclerosis	340	G35
TTDNC00584	Recombinant human interleukin-7	Renal cancer	140-229, 189	C00-C96, C64
TTDNC00585	IL-17 receptor	Asthma	493	J45
TTDNC00585	IL-17 receptor	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDNC00585	IL-17 receptor	Psoriasis	696	L40
TTDNC00586	Cardiac myosin	Heart failure	410, 428	I21, I22, I50
TTDNC00586	Cardiac myosin	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDNC00587	Oxazolidinone anti-bacterial	Tuberculosis	010-018	A15-A19
TTDNC00588	MABA	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
TTDNC00591	TOPKi	Cancer	140-229	C00-C96
TTDNC00591	TOPKi	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00591	TOPKi	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00591	TOPKi	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNC00591	TOPKi	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00593	GPNMB	Breast cancer	174, 175, 217	C50, D24
TTDNC00593	GPNMB	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDNC00593	GPNMB	Malignant melanoma	172, 208.9	C43, C91-C95
TTDNC00595	a2d ligand	Chronic pain	338.2,780	R52.1-R52.2, G89
TTDNC00596	BFGF signaling system	Spinal cord injuries	952	S14, S24, S34
TTDNC00597	DNMT1	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00597	DNMT1	Cancer	140-229	C00-C96
TTDNC00597	DNMT1	Glioblastoma	140-199, 191, 208.9, 210-229	C00-C75, C71, C7A, C7B, C91-C95, D10-D36, D3A
TTDNC00597	DNMT1	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00597	DNMT1	Myelodysplastic syndromes	208.9, 238.7	C91-C95, D46
TTDNC00597	DNMT1	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNC00600	Non-nucleoside NS5B	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDNC00600	Non-nucleoside NS5B	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDNC00602	Recombinant human angiotensin converting enzyme 2	Acute lung injury	518	J80
TTDNC00602	Recombinant human angiotensin converting enzyme 2	Asthma	493	J45
TTDNC00602	Recombinant human angiotensin converting enzyme 2	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDNC00602	Recombinant human angiotensin converting enzyme 2	Diabetes mellitus type 2	250	E11
TTDNC00605	Neurite outgrowth inhibitor (NOGO-A)	Amyotrophic lateral sclerosis	335.20, 434.91	G12.2, I61-I63
TTDNC00605	Neurite outgrowth inhibitor (NOGO-A)	Lateral sclerosis	.	G12.2
TTDNC00606	Oxytocin	Threatened pre-term labour	.	O60.1,P07.3
TTDNC00609	Hepatitis C virus	Hepatitis C virus infection	070.4, 070.5, 070.70, 573.3	B17.1, B18.2, K75.9
TTDNC00610	8-aminoquinoline	Malaria	84	B50-B54
TTDNC00610	8-aminoquinoline	Plasmodium vivax malaria	84	B50-B54
TTDNC00613	MEK2	Cancer	140-229	C00-C96
TTDNC00613	MEK2	Colorectal cancer	153, 154	C18-C21
TTDNC00613	MEK2	KRAS mutant non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33, C33-C34, C34, C91.0
TTDNC00613	MEK2	Lymphoma	202.8, 208.9	C81-C96, C91-C95
TTDNC00613	MEK2	Malignant melanoma	172, 208.9	C43, C91-C95
TTDNC00613	MEK2	Melanoma	172.9	C43
TTDNC00613	MEK2	Metastatic melanoma	172	C43
TTDNC00613	MEK2	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00613	MEK2	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNC00613	MEK2	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDNC00613	MEK2	Relapsed/refractory leukemia	208.9	C91-C95
TTDNC00616	ApoCIII	Coronary artery disease	410-414, 429.2	I20-I25
TTDNC00616	ApoCIII	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
TTDNC00616	ApoCIII	Severe hypertriglyceridemia	.	I20-I25
TTDNC00617	Factor XI	Clotting disorders	286	D65-D69
TTDNC00618	SMN2	Spinal muscular atrophy	335.0-335.1	G12.0-G12.1
TTDNC00621	FGFR4	Obesity	278	E66
TTDNC00623	Aminoglycoside	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDNC00623	Aminoglycoside	Severe bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00625	Activin receptor type II	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNC00625	Activin receptor type II	Sporadic inclusion body myositis	729.1	M60
TTDNC00628	Bacterial elongation factor Tu (EFTu)	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00628	Bacterial elongation factor Tu (EFTu)	Clostridium difficile infection	001-139, 008.45	A00-B99, A04.7
TTDNC00629	Integrin	Colorectal cancer	153, 154	C18-C21
TTDNC00629	Integrin	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
TTDNC00629	Integrin	Psoriasis	696	L40
TTDNC00631	Immune suppressant	Acne vulgaris	706.1	L70.0
TTDNC00631	Immune suppressant	Psoriasis	696	L40
TTDNC00632	Proprietary	Psoriasis	696	L40
TTDNC00633	Sirtuin	Psoriasis	696	L40
TTDNC00633	Sirtuin	Type 2 diabetes	250.00, 250.02	E11
TTDNC00634	CD79b	Diffuse large b-cell lymphoma	200.0, 202.8, 203.0	C81-C96, C83.3, C85.1, C90.0
TTDNC00634	CD79b	Hematological malignancies	200-209	C81-C96
TTDNC00634	CD79b	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00636	Factor D Fab	Geographic atrophy associated with AMD	362.5	H35.3
TTDNC00636	Factor D Fab	Macular degeneration	362.5	H35.3
TTDNC00645	Neurotrophic factor production	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDNC00645	Neurotrophic factor production	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, G64, G90.0
TTDNC00645	Neurotrophic factor production	Motor neurone disease	335.2	G12.2
TTDNC00645	Neurotrophic factor production	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDNC00645	Neurotrophic factor production	Spinal cord injuries	952	S14, S24, S34
TTDNC00646	Proteasome	Autoimmune diseases	279	D84.9, M35.9
TTDNC00646	Proteasome	Cachexia	799.4	R64
TTDNC00646	Proteasome	Cancer	140-229	C00-C96
TTDNC00646	Proteasome	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNC00646	Proteasome	Hematological malignancies	200-209	C81-C96
TTDNC00646	Proteasome	Huntington's disease	294.1, 333.4	F02.2, G10
TTDNC00646	Proteasome	Lymphoma; Waldenstrm's macroglobulinemia	140-199, 202.8, 203.0, 210-229	C00-C75, C7A, C7B, C81-C96, C90.0, D10-D36, D3A
TTDNC00646	Proteasome	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNC00646	Proteasome	Neurodegenerative diseases	330-337	G30-G32
TTDNC00646	Proteasome	Relapsed/refractory myeloma	203.0, 277.3	C90.0, E85
TTDNC00646	Proteasome	Relapsed/refractory primary amyloidosis	277.3	E85
TTDNC00646	Proteasome	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNC00647	Transforming growth factor	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDNC00650	APRIL	Lupus nephritis	583.81	M32.1, N08.5
TTDNC00652	SSKI	Late-stage non-small cell lung cancer	162, 203.0, 208.9	C33, C34, C90.0, C91-C95
TTDNC00653	GPR40	Diabetes mellitus	253.5, 588.1	E23.2, N25.1
TTDNC00653	GPR40	Diabetes mellitus type 2	250	E11
TTDNC00653	GPR40	Non-insulin dependent diabetes	.	E11.9
TTDNC00653	GPR40	Type 2 diabetes	250.00, 250.02	E11
TTDNC00655	Proprotein Convertase Subtilisin	Hypercholesterolaemia	.	E78.0
TTDNC00655	Proprotein Convertase Subtilisin	Hyperlipidemia	272.0-272.4	E78
TTDNC00657	Extended spectrum cephalosporin with affinity to penicillin-binding proteins	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNC00657	Extended spectrum cephalosporin with affinity to penicillin-binding proteins	Pneumonia/skin infections	001-139, 480-486, 770.0	A00-B99, J12, J13, J14, J15, J16, J17, J18, P23
TTDNC00659	LCS 16	Alzheimer's disease	331.0, 331.83	G30, G31.84
TTDNC00659	LCS 16	Contraception	.	Z30
TTDNC00662	Triple angiokinase	Idiopathic pulmonary fibrosis	516.3	J84.1
TTDNC00662	Triple angiokinase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDNC00662	Triple angiokinase	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00663	Anti-fibrotic kinase	Idiopathic pulmonary fibrosis	516.3	J84.1
TTDNC00663	Anti-fibrotic kinase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDNC00663	Anti-fibrotic kinase	Ovarian cancer	140-229, 183, 185	C00-C96, C56, C61
TTDNC00667	CCR9 chemokine receptor	Crohn's disease	555	K50
TTDNC00667	CCR9 chemokine receptor	Sjogren's syndrome	710.2	M35.0
TTDNC00668	Dopamine precursor	Parkinson's disease	332	F02.3, G20
TTDNC00670	TTR	Amyloidosis	277.3	E85
TTDNC00670	TTR	Cardiomyopathy	.	I42.0
TTDNC00670	TTR	TTR amyloidosis	277.3	E85
TTDNC00671	Clusterin	Cancer	140-229	C00-C96
TTDNC00671	Clusterin	Non-small-cell lung cancer	162, 183	C33, C34, C56
TTDNC00671	Clusterin	Prostate cancer	140-229, 185	C00-C96, C61
TTDNC00676	CD21	Autoimmune diseases	279	D84.9, M35.9
TTDNC00676	CD21	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDNC00676	CD21	Diffuse large b-cell lymphoma	200.0, 202.8, 203.0	C81-C96, C83.3, C85.1, C90.0
TTDNC00676	CD21	Non-hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNC00676	CD21	Refractory indolent non-Hodgkin's lymphoma	200, 202	C82-C85
TTDNC00678	Non-steroidal androgen synthesis	Metastatic castration-resistant prostate cancer	140-229, 185	C00-C96, C61
TTDNC00678	Non-steroidal androgen synthesis	Non-metastatic castration-resistant prostate cancer	185	C61
TTDNC00678	Non-steroidal androgen synthesis	Prostate cancer	140-229, 185	C00-C96, C61
TTDNC00679	Potassium-competitive acid	Acid-related diseases	531-534	K25-K27
TTDNC00679	Potassium-competitive acid	Gastroesophageal reflux disease	140-229, 530	C00-C96, K21
TTDNC00687	H5N1 inactivated split monovalent (Quebec)	Pre-pandemic and pandemic influenza prophylaxis	487, 488	J10, J11
TTDNC00691	Azole antifungal	Candidemia; Invasive candidiasis	112	B37
TTDNC00691	Azole antifungal	Fungal infection	110-118	B35-B49
TTDNC00691	Azole antifungal	Invasive aspergillosis	117.3	B44
TTDNR00643	Angiotensinogen	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDNR00648	Basigin	Graft-versus host disease	.	T86.0
TTDNR00648	Basigin	Liver cancer	140-229, 155, 203.0	C00-C96, C22.0, C90.0
TTDNR00649	BDNF/NT-3 growth factors receptor	Neurodegenerative diseases	330-337	G30-G32
TTDNR00649	BDNF/NT-3 growth factors receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
TTDNR00649	BDNF/NT-3 growth factors receptor	Obesity	278	E66
TTDNR00649	BDNF/NT-3 growth factors receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNR00652	Cardiotrophin-1	Acute liver failure	.	K72
TTDNR00652	Cardiotrophin-1	Heart disease	390-429	I00-I52
TTDNR00652	Cardiotrophin-1	Liver disease	570-574	K70-K77
TTDNR00671	Exportin-1	Cancer	140-229	C00-C96
TTDNR00671	Exportin-1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNR00685	Heat shock protein 27 	Atrial fibrillation	272, 427.31	E78, I48
TTDNR00685	Heat shock protein 27 	Cancer	140-229	C00-C96
TTDNR00702	Low-density lipoprotein receptor-related protein 6	Cancer	140-229	C00-C96
TTDNR00702	Low-density lipoprotein receptor-related protein 6	Gastrointestinal disease	.	K00-K93
TTDNR00709	Netrin-1	Parkinson's disease	332	F02.3, G20
TTDNR00714	Nuclear factor erythroid 2-related factor 2	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDNR00714	Nuclear factor erythroid 2-related factor 2	Ocular inflammation	.	H00-H59
TTDNR00726	Platelet glycoprotein 4	Lipid metabolism disorder	.	E75-E78
TTDNR00726	Platelet glycoprotein 4	Squamous cell carcinoma	199	C44
TTDNR00746	Serine/threonine-protein kinase pim-2	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDNR00746	Serine/threonine-protein kinase pim-2	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNR00764	Tyrosine-protein kinase receptor UFO	Cancer	140-229	C00-C96
TTDNR00764	Tyrosine-protein kinase receptor UFO	Metastasis	.	C00-C97
TTDNS00535	Nucleotide NS5B	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
TTDNS00536	smoothened receptor	Basal cell cancer	140-229, 173	C00-C96, C44
TTDNS00536	smoothened receptor	Basal cell carcinoma	140-199, 173, 210-229	C00-C75, C44, C7A, C7B, D10-D36, D3A
TTDNS00536	smoothened receptor	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDNS00536	smoothened receptor	Metastatic or locally advanced basal cell carcinoma	173	C44
TTDNS00536	smoothened receptor	Neoadjuvant pancreatic cancer	140-199, 140-229, 157, 208.9, 210-229	C00-C75, C00-C96, C25, C7A, C7B, C91-C95, D10-D36, D3A
TTDNS00536	smoothened receptor	Operable basal cell carcinoma	173	C44
TTDNS00536	smoothened receptor	Skin cancers	172, 173	C43, C44
TTDNS00536	smoothened receptor	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00538	ostatin receptor 5 	Cushing's disease	255	E24.0
TTDNS00539	ribosome A site	Bacterial infection	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-A09, A00-B99, A15-A19, A20-A28, A30-A49, A65-A69, A70-A74, A75-A79
TTDNS00539	ribosome A site	Chronic or accelerated-phase chronic myeloid leukaemia	208.9	C91-C95
TTDNS00541	PIGF	Metastatic colorectal cancer	153, 154	C18-C21
TTDNS00542	VEGFA	Angiogenesis disorder	.	I00-I99
TTDNS00542	VEGFA	Cancer	140-229	C00-C96
TTDNS00542	VEGFA	Cancers	140-239	C00-C96
TTDNS00542	VEGFA	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDNS00542	VEGFA	Colorectal cancer	153, 154	C18-C21
TTDNS00542	VEGFA	Coronary artery disease	410-414, 429.2	I20-I25
TTDNS00542	VEGFA	Diabetic angiopathy	250.7	E10.5, E11.5, E13.5
TTDNS00542	VEGFA	Glaucoma	365	H40-H42
TTDNS00542	VEGFA	Lateral sclerosis	.	G12.2
TTDNS00542	VEGFA	Macular degeneration	362.5	H35.3
TTDNS00542	VEGFA	Metastatic colorectal cancer	153, 154	C18-C21
TTDNS00542	VEGFA	Motor neurone disease	335.2	G12.2
TTDNS00542	VEGFA	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00542	VEGFA	Under research	.	.
TTDNS00544	Glucagon-like peptide 2 receptor	Diarrhea	787.91	A09, K59.1
TTDNS00544	Glucagon-like peptide 2 receptor	Gastrointestinal disease	.	K00-K93
TTDNS00544	Glucagon-like peptide 2 receptor	Inflammatory bowel disease	555, 556	K50, K51
TTDNS00544	Glucagon-like peptide 2 receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
TTDNS00544	Glucagon-like peptide 2 receptor	Short bowel syndrome	579.3	K91.8
TTDNS00545	anthrax protective antigen 	Anthrax	22	A22
TTDNS00545	anthrax protective antigen 	Inhalation anthrax	22	A22.minor
TTDNS00552	Kinase	Atherosclerosis	414.0, 440	I70
TTDNS00552	Kinase	Cancer	140-229	C00-C96
TTDNS00552	Kinase	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNS00552	Kinase	Non-Hodgkin's lymphoma	200, 202, 202.8	C81-C96, C82-C85
TTDNS00552	Kinase	Psoriasis	696	L40
TTDNS00552	Kinase	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00559	Glutamine receptor	Mucositis	.	K92.81
TTDNS00563	GABA	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
TTDNS00563	GABA	Cognitive impairment	331.83	G31.84
TTDNS00564	upregulating cAMP	Asthma	493	J45
TTDNS00564	upregulating cAMP	Cardiovascular; Metabolic disease	270-279	E70-E89
TTDNS00566	adrenergic receptor	Allergic reaction	995.3	T78.4
TTDNS00566	adrenergic receptor	Angina	413	I20
TTDNS00566	adrenergic receptor	Attention deficit hyperactivity disorder	314.00, 314.01	F90
TTDNS00566	adrenergic receptor	Brain injury	.	S09.90
TTDNS00566	adrenergic receptor	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDNS00566	adrenergic receptor	Cognition disorders	295	F20
TTDNS00566	adrenergic receptor	Cushing's disease	255	E24.0
TTDNS00566	adrenergic receptor	Glaucoma	365	H40-H42
TTDNS00566	adrenergic receptor	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDNS00566	adrenergic receptor	Orthostatic hypotension	458	I95.1
TTDNS00570	sodium pump	Cardiovascular disease	325, 390-459, 401, 428, 430-459	G45-G46, I00-I99, I10, I11, I12, I13, I15, I50, I60-I95
TTDNS00575	Na+-K+-ATPase transmembrane protein	Dental plaque inhibitor	.	.
TTDNS00579	taste receptor	Choleretic	1	A00
TTDNS00584	RNA synthesis	Hypercalcemia	275.42	E83.5
TTDNS00584	RNA synthesis	Testicular cancer	140-229	C00-C96
TTDNS00588	DNA intercalative bis-alkylating agents	Cancers	140-239	C00-C96
TTDNS00592	Abl	Acute lymphoblastic leukemia	189, 204.0	C64, C91.0
TTDNS00592	Abl	Acute myeloid leukemia	205.0, 238.7	C92.0, D46
TTDNS00592	Abl	Cancer	140-229	C00-C96
TTDNS00592	Abl	Chronic myelogenous leukemia	205.1, 208.9	C91-C95, C92.1
TTDNS00592	Abl	Chronic myeloid leukaemia	208.9	C91-C95
TTDNS00592	Abl	Leukemia	208.9	C91-C95
TTDNS00592	Abl	Philadelphia-positive ALL and CML	204.0, 205.1	C91.0, C92.1
TTDNS00596	ALK	ALK-positive NSCLC	140-199, 162, 210-229	C00-C75, C33, C34, C7A, C7B, D10-D36, D3A
TTDNS00596	ALK	ALK-positive advanced or metastatic NSCLC	162	C33, C34
TTDNS00596	ALK	Cancer	140-229	C00-C96
TTDNS00596	ALK	Late-stage B-cell lymphoma	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C96, C85.1, D10-D36, D3A
TTDNS00596	ALK	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00596	ALK	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDNS00596	ALK	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNS00596	ALK	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00597	ROS1	ALK-positive NSCLC	140-199, 162, 210-229	C00-C75, C33, C34, C7A, C7B, D10-D36, D3A
TTDNS00597	ROS1	ALK-positive advanced or metastatic NSCLC	162	C33, C34
TTDNS00597	ROS1	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNS00597	ROS1	Solid cancer	140-199	C00-C75, C7A, C7B
TTDNS00597	ROS1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00605	cystic fibrosis transmembrane conductance regulator	Cystic fibrosis	277.0, 709.2	E84, L90.5
TTDNS00605	cystic fibrosis transmembrane conductance regulator	Diarrhea	787.91	A09, K59.1
TTDNS00605	cystic fibrosis transmembrane conductance regulator	HIV-associated diarrhoea	.	A09
TTDNS00606	 calcium activated channel anoctamin 1	HIV-associated diarrhoea	.	A09
TTDNS00610	endothelium of blood vessels	Uncomplicated spider veins; Uncomplicated reticular veins	.	I80-I89
TTDNS00611	JAK1	Diabetic nephropathy	250, 250.4, 580-599	E08-E13, E10.2, E11.2, E13.2, N00-N29
TTDNS00611	JAK1	Essential thrombocythemia	238.71, 289.9	D47.3, D75.2, D75.8
TTDNS00611	JAK1	Hematologic malignancies; Solid tumors	140-199, 140-239, 200-209, 210-229	C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A
TTDNS00611	JAK1	Inflammatory diseases	140-229, 147, 173, 573.3, 710-719	C00-C96, C11, C44, K75.9, M00-M25
TTDNS00611	JAK1	Lupus	710	M32
TTDNS00611	JAK1	Myelofibrosis	208.9, 289.83, 709.2	C91-C95, C94.4, D47.1, L90.5
TTDNS00611	JAK1	Myeloproliferative disorder	.	D47.1
TTDNS00611	JAK1	Pancreatic cancer	140-229, 157, 202.8, 203.0, 208.9	C00-C96, C25, C81-C96, C90.0, C91-C95
TTDNS00611	JAK1	Polycythemia vera	238.4	D45
TTDNS00611	JAK1	Psoriasis	696	L40
TTDNS00611	JAK1	Pulmonary hypertension	416	I27.0, I27.2
TTDNS00611	JAK1	Rheumatold arthritis	714	M05-M06
TTDNS00611	JAK1	Rheumatold arthritis; Psoriasis; Diabetic nephropathy	250, 250.4, 580-599, 696, 710-719, 714	E08-E13, E10.2, E11.2, E13.2, L40, M00-M25, M05-M06, N00-N29
TTDNS00611	JAK1	Solid tumours	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
TTDNS00611	JAK1	Systemic lupus erythematosus	695, 710.0	L51-L54, M32
TTDNS00612	L-type  calcium channel 	Hypertension	401, 428	I10, I11, I12, I13, I15, I50
TTDNS00612	L-type  calcium channel 	Peri-operative hypertension	401	I10, I11, I12, I13, I15
TTDNS00614	mycobacteria proton pump	Multi-drug resistant tuberculosis	010-018	A15-A19
TTDNS00614	mycobacteria proton pump	Pulmonary multidrug-resistant tuberculosis	010-018	A15-A19
TTDNS00628	Multi-kinase	Cancer	140-229	C00-C96
TTDNS00628	Multi-kinase	Chronic lymphocytic leukemia	204.1, 238.7	C91.1, D46
TTDNS00628	Multi-kinase	Hematological malignancies	200-209	C81-C96
TTDNS00628	Multi-kinase	Lupus; Multiple myeloma	203.0, 710.0	C90.0, M32
TTDNS00628	Multi-kinase	Multiple myeloma	203.0, 208.9	C90.0, C91-C95
TTDNS00628	Multi-kinase	Myeloma	203.0, 208.9	C90.0, C91-C95
TTDNS00628	Multi-kinase	Non-small cell lung cancer	140-229, 162, 204.0	C00-C96, C33-C34, C91.0
TTDNS00628	Multi-kinase	Non-small-cell lung carcinoma	162, 208.9	C33, C34, C91-C95
TTDNS00629	Inactivated split ?quadrivalent	Seasonal influenza prophylaxis	487, 488	J10, J11
TTDNS00630	IV iron	Iron deficiency anaemia in chronic kidney disease	280	D50, N00-N29
TTDR00001	Alpha-amylase	Pancreatic disease	.	K85-K86
